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Abstract 
Sarain A is a marine alkaloid that was isolated from the Mediterranean sponge Reniera 
sarai; the alkaloid possesses antibacterial, insecticidal and antitumour properties.  As a 
result of the intriguing structure of this alkaloid, it has quickly become a popular target 
for organic chemists.  Arguably the most challenging part of its synthesis is the tricyclic 
core, which is surrounded by two macrocyclic rings.  This thesis describes two separate 
approaches towards the core, both utilising a thia-Claisen rearrangement as a key step. 
The first approach involved the ring expansion of a 5,5-bicyclic aminal to form an 
iminium ion intermediate which could be transformed into the core.  However, the 
inherent lack of nucleophilicity of an N-tosyl sulfonamide nitrogen atom in the bicyclic 
aminal made it difficult to perform the ring expansion.  The second method involved a 
modification of an acid catalysed rearrangement previously attempted within the Porter 
group; in the previous approach, a differentially protected bicyclic aminal opened with 
cleavage of a C-NTs rather than a C-NBn bond, leading to an undesired tricyclic 
product.  In the newly devised route, the protecting groups on the two nitrogen atoms of 
the bicycle were reversed in order to encourage ring opening in the desired fashion; 
however, the only attempt at this step did not result in the formation of the sarain core. 
In a different project that is related to the aforementioned research, a diastereoselective 
thia-Claisen rearrangement was developed which allows the formation of a key 
intermediate en route to the sarain core, in enantiomerically pure form.  To achieve this, 
thia-Claisen rearrangements were carried out on several S-allyl N,S-ketene acetals 
bearing a stereogenic centre on the allyl portion of the molecule to give diastereomeric 
ratios of 2:1 to 30:1.  Interestingly, introduction of a bromine atom onto the double bond 
of the allylic portion of the precursor increased and reversed the diastereoselectivity. 
Finally, following a discovery that was made whilst working towards the sarain core, a 
novel reaction for the high-yielding conversion of a wide range of alcohols into iodides 
using a thioiminium salt has been investigated and optimised.  The reaction conditions 
are essentially neutral, no aqueous workup is required, many functional groups can be 
tolerated and reaction times are generally short.  Furthermore, the thioiminium
 
salt can 
be stored for long periods without degradation.  This type of chemistry has since been 
further examined, and it can now be used to allow the conversion of alcohols directly 
into sulfide products that are precursors in Julia-Kocienski reactions.  
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1  Introduction 
1.1  The structure of the sarain alkaloids 
The marine environment contains a variety of organisms with secondary metabolites 
that are noticeably different to those found in land-based life.  Not only are a large 
number of these molecules structurally intriguing, but many possess potent biological 
activity, and therefore are of great interest to the pharmaceutical industry. 
Over the last few decades, many alkaloids have been isolated from marine species.  One 
fascinating group of such alkaloids, known as the sarains, was extracted from a Bay of 
Naples sponge, Reniera sarai, by Cimino and co-workers in the mid 1980s.
1
  The main 
metabolites are divided into two groups, each containing alkaloids with a distinct 
polycyclic skeleton.  The first group consists of sarains 1-3 (1-3, Figure 1) and 
isosarains 1-3 (4-6, Figure 1); the latter differ only from sarains 1-3 in their stereogenic 
centres at C1, C2 and C9, all of which are inverted.
1,2,3,4
  The common feature of these 
alkaloids is a trans-fused quinolizidone system, bound to an unsaturated piperidine ring, 
both directly and via two hydrocarbon chains.   
 
Figure 1  Sarains 1-3 (1-3) and isosarains 1-3 (4-6) 
The second group of metabolites comprises sarains A-C (7-9, Figure 2).
5,6
  The 
intriguing and unusual structure of these alkaloids consists of a fused central core 
containing a diazatricycloundecane cage, attached to a 14-membered ring.  This ring 
contains two cis- and one trans-double bond, as well as a vicinal diol.  Sarains A-C 
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differ in the size of the second macrocycle, with sarains A (7), B (8) and C (9) bearing a 
13-, 14-, and 15-membered ring respectively; sarains B (8) and C (9) also contain a (Z)-
olefin moiety in the second macrocycle.
6
 
 
 
Figure 2  Sarains A-C (7-9) 
Sarains A-C also exhibit an interesting zwitterionic property; that is, within the tricyclic 
core there is a strong ‘proximity effect’ between the tertiary amine (N1) and the 
carbonyl (C
2
=O, Figure 3). 
 
Figure 3  Proximity effect exhibited by sarains A-C 
This proximity interaction has been shown to be both acid and solvent sensitive.  
Treatment with acid causes a disappearance of the distinctive aldehyde proton and 
carbon signals in the NMR spectra, and the C=O peak in its IR spectrum.  Additionally, 
in 
1
H and 
13
C NMR spectra taken in CD3COOD, the aldehyde peaks moved to 5.25 and 
97.1 respectively, owing to the C-H shown in bold in tricyclic core 11 (Figure 3).
5,6,7
   
1.2  Properties of the sarain alkaloids 
Preliminary screenings of the biological activity of the sarains have indicated that they 
possess moderate antibacterial, antitumour and insecticidal properties.
8
  Sarains 1-3 (1-
3, Figure 1) demonstrated stronger biological activity than sarains A-C (7-9, Figure 2) 
when studied individually; however, both were less active than the crude extract from 
the Reniera sarai sponge itself.  This increased activity could either be a consequence of 
a synergistic effect of the group of sarains, or there may be a minor metabolite that has 
not been isolated to date which possesses high biological activity.  It should be noted 
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however that the activities of sarains A-C (7-9, Figure 2) may be influenced by pH, due 
to the proximity effect that was discussed in section 1.1.   
1.3  Biosynthesis 
Two different proposals for the biosynthetic origin of sarain A (7) have been published.  
The first of these was made by Marazano et al. in 1995; the proposed biosyntheses of 
manzamine A and keramaphidin B (natural products that have related biosynthetic 
origins to sarain A (7)) that were previously put forward by Baldwin et al. were 
important in helping Marazano and co-workers devise their biosynthetic proposal for 
sarain A (7, Figure 4).
 9,10
 
 
Figure 4  Structure of related marine alkaloids 
The proposed biosynthetic pathway begins with macrocycle 12, which upon protonation 
gives iminium species 13 (Scheme 1 – the linking chains have been omitted for 
clarity).
11
  An intramolecular cyclisation then occurs to afford 14, which is reduced to 
give enamine 15; reaction with an electrophile such as Br
+
 would then result in 
formation of iminium ion 16, which can undergo intramolecular cyclisation once more 
to yield tricycle 17.  Final hydrolysis of the iminium in product 17, followed by 
intramolecular attack of the tertiary amine onto the bromide gives the core skeleton 
found in sarains A-C. 
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Scheme 1  First possible biosynthetic pathway towards sarain A 
It is also worth noting that the aforementioned biosynthetic proposal can be used to 
explain the biosynthesis of sarain 2 (2), as upon cleavage of C-C linkages in the two 
molecules, it is clear that its skeleton shows similarities with that of sarain A - notably a 
10-membered alkyl chain (Figure 5, red).
7
 
 
Figure 5  Biogenetic hypothesis correlating the alkaloid skeleton of sarain A to sarain 2 
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The second biosynthetic explanation for sarain A was also proposed by Marazano et al. 
a decade later in 2005, after model experiments that were carried out in their laboratory 
(Scheme 2).
12
   
 
Scheme 2  Second possible biosynthetic pathway towards sarain A 
The first step in this retrobiosynthetic analysis is a retro-Mannich process which leads 
back to iminium ion 18 from sarain A (7); hydrolysis then gives secondary amine 19.  
Secondary amine 19 can be accessed from primary amine 20, whereby the forward 
reaction involves condensation of the primary amine and aldehyde, and reduction of an 
imine, enone and a carboxylic acid.  Finally, primary amine 20 can be formed by 
condensation of macrocycle 23 and aldehyde 21 with two malondialdehyde (22) units. 
1.4  Synthetic background 
Due to the unique complex structure of sarain A, many groups have embarked upon its 
challenging synthesis since its isolation.  The most challenging domain of sarain A to 
synthesise is arguably its tricyclic core; to date, 6 groups have accomplished its 
synthesis, with the first being by Weinreb et al. in 1991.
13
  Out of this collection of 
syntheses, two have been asymmetric approaches (Overman
14
 and Huang
15
) and the 
only total synthesis of sarain A was accomplished by Overman et al. in 2006.
16
  This 
section will give a brief overview of all the successful approaches made towards both 
the core and the complete structure of sarain A.  To begin with, Overman’s asymmetric 
total synthesis will be reviewed. 
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1.4.1  Overman’s asymmetric total synthesis  
In 1998, Overman and co-workers became the first group to complete an asymmetric 
synthesis of the sarain A core (Scheme 3).
14
  The synthesis began with conversion of 
azide 24 into oxazoline 25 in 4 steps.  Following this, a key intermolecular Michael 
addition reaction between oxazoline 25 and (Z)-enoate 26 under optimised conditions 
(78 ºC in DME:THF 2:1) gave Michael adduct 27 as a single stereoisomer; conversion 
into the lactam and subsequent alkylation gave lactam 28, which upon treatment with 
acid underwent cleavage of the oxazoline ring and translactamisation to provide lactam 
29.  Elaboration of 29 to give tetracycle 30 was achieved in 10 further steps.  To 
generate the core, tetracycle 30 was treated with 3.5 equivalents of BBr3 in 
dichloromethane, which promoted an N-tosyliminium ion-enoxysilane cyclisation to 
give core 31 as two diastereoisomers in a 3:1 ratio of 31a:31b (31b is the desired 
diastereoisomer). 
 
Scheme 3  Overman’s first asymmetric synthesis of the sarain core  
Overman has since improved on the diastereomeric ratio for the final cyclisation step; to 
achieve this, the methyl group of the side chain was replaced with a pent-4-enyl group 
(32, Scheme 4).
16
  This side chain served two functions: firstly, its increased bulk 
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sterically promotes cyclisation to the desired diastereoisomer (the dr increases from 
3:1(desired) to >1:20(desired)) and secondly it enables rapid and simple synthesis of the 
western macrocycle of sarain A in subsequent steps.  
 
Scheme 4  Latter steps towards ()-sarain A 
It was believed that the cyclisation proceded via the (E)-OTIPS enol ether as opposed to 
a boron enol or enolate; this is why a pyridine buffer was added in this step – to prevent 
the OSi bond from breaking before cyclisation and to promote double bond 
isomerisation to the (E)-isomer at higher temperatures.
 16,17,18
 
Following cyclisation to core 33, the western saturated macrocycle was made using ring 
closing metathesis as the key step and the eastern macrocycle was formed using Stille 
chemistry; completion of these two rings, along with functional and protecting group 
manipulation, led to completion of the first total synthesis of ()-sarain A (7) in 2006.  
1.4.2  Weinreb’s synthesis of the core 
The Weinreb group first synthesised the sarain core in 1991;
13
 since that date, many 
improvements to the route towards the core were made so that the eastern and western 
macrocycles of sarain A could be attached onto the core after its synthesis.
19,20,21
  In 
Weinreb’s most recently published route (Scheme 5), aziridine 35 (which was formed 
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from amine 34 in 82% yield) underwent a stereospecific [3+2] cycloaddition via 
azomethine ylide 36 to form bicycle 37 in good yield. 
 
Scheme 5  Weinreb’s synthesis of the core 
A series of relatively straightforward steps that achieve the introduction of a protected 
diol onto the ring junction and protecting group manipulation were next implemented 
on bicycle 37 to give bicycle 38; this was converted into allylsilane 39 in 6 steps.  
DIBAL reduction of the amide moiety in 39 and subsequent treatment with FeCl3 
promoted the crucial allylsilane/N-sulfonyliminium ion cyclisation to give rise to sarain 
core 40 as a mixture of epimers.   
Weinreb’s latest progress towards the complete structure of sarain A includes 
conversion of core 40 into nitrile 41 in five steps; these steps include a protecting group 
exchange and functionalisation at C
α
 (Scheme 6).
21
  The final step in this sequence 
involved deprotonation at C
α
, followed by a stereoselective alkylation (attack from the 
alkylating agent is from the least hindered equatorial position) and hence the mixture of 
epimers of 41 obtained is not detrimental to the synthesis. A further 8 steps result in the 
completion of the western macrocycle to give rise to 43. 
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Scheme 6  Weinreb’s latter steps towards the complete synthesis of sarain A 
The final few steps that have been published involve a Swern oxidation of the alcohol in 
43 and subsequent attack from ethynylmagnesium bromide to give alcohol 44; upon 
treatment of 44 with K2CO3 in MeOH, carbonate 45 is formed.  This compound 
contains the final two stereocentres of the eastern macrocycle and also a secondary 
amine that may help to complete the synthesis of the final part of the remaining ring. 
1.4.3  Heathcock’s synthesis of the core  
Heathcock’s approach to the sarain core (Scheme 7) employs an azomethine ylide 
cyclisation similar to that used in Weinreb’s synthesis of the core (Scheme 5);22 the 
intermediate azomethine ylide was formed using a procedure described by Grigg and 
co-workers whereby α-amino acid derivative 46 is condensed with paraformaldehyde.23  
Following cyclisation, bicycle 47 was obtained in 78% yield; after some lengthy 
protecting group manipulation, bicycle 48 was obtained and then treated with LiHMDS 
to promote clean isomerisation to β-ketoester 49.   
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Scheme 7  Heathcock’s synthesis of the sarain core 
Reduction of ketone 49 to alcohol 50, followed by dehydration and treatment with a 
base, resulted in a mixture of desired tricycle 52 and α,β-unsaturated ester 51.  
Treatment of the mixture of 51 and 52 with thiophenol and potassium carbonate in 
dimethylformamide successfully removed the nosyl group from tricycle 52 to give 
sarain core 53. 
Heathcock was the first to devise a synthetic route towards the eastern macrocycle of 
sarain A (Scheme 8).
24
  The synthesis started with conversion of ester 54 into acid 
chloride 55, which was then coupled with amine 56 to give amide 57 containing the two 
stereocentres of the eastern macrocycle.  Following this, a Sonogashira coupling closed 
the ring and hydrozirconation followed by exposure to wet silica gel afforded desired 
macrocycle 58. 
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Scheme 8  Heathcock’s synthesis of the eastern macrocycle of sarain A 
1.4.4  Marazano’s synthesis of the core 
Marazano’s approach towards the core mimics his biosynthetic proposal (see Scheme 
2); in this proposal (Scheme 9), 4 molecules (59, 60 and two malonaldehyde units - red) 
are condensed to form bicycle 61.
25
  The following steps include reduction of the side 
chain aldehyde, elongation and a ring closure of 62 to make core 63. 
 
Scheme 9  General biosynthetic strategy towards core 
Hence, the route taken by Marazano began with deprotonation of alanine derivative 64 
and treatment with bromoacrylamide 65, followed by acidic imine hydrolysis to give 
salt 66.  Salt 66 was then mixed with the sodium salt of malonaldehyde to form 
intermediate 67, which, when treated directly with sodium hydride and iodomethane 
gave bicycle 68 in 63% yield.  
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Scheme 10  Marazano’s synthesis of the core 
The enal moiety of bicycle 68 was reduced using hydrogenation in the presence of 
platinum oxide and tin dichloride to give alcohol 69 with mediocre diastereoselectivity.  
However, reduction of the crude mixture of 69 with DIBAL gave two products 70 and 
71, with the major product 71 containing the correct stereochemistry at the newly 
formed chiral centre.  This sequence was followed by treatment of 71 with BF3.Et2O to 
give cyclic enamine 72, which was converted into target precursor 73 in 7 steps.  
Finally, in a similar fashion to that employed by Weinreb (Scheme 5), reaction of 
precursor 73 with ferric chloride promoted the key cyclisation to give sarain core 74 in a 
reasonable yield. 
1.4.5  Cha’s synthesis of the core 
The Cha synthesis of the sarain core is the shortest reported to date (Scheme 11).  The 
synthesis began with a [4+3] cycloaddition between pyridinium salt 75 and 
cyclopentadiene to give cyclisation product 76 in 60% yield.
26,27
  The following 3 steps 
served to exchange the protecting group, giving N-Boc-compound 77.  A series of 
simple steps then converted 77 into diol 78, which upon treatment with TPAP and NMO 
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underwent oxidation to form lactone 79, along with a small amount of lactone 80.  The 
good selectivity achieved is thought to be a consequence of the two diol units in 78 
experiencing different steric interactions with the (Z)-α,β-unsaturated ester.   
 
Scheme 11  Cha’s synthesis of the sarain core 
Lactone 79 was subsequently opened to give 81 and the resulting alcohol protected; 
deprotonation using sodium hydride promoted an intramolecular Michael addition to 
give sarain core 82.   
 
Cha has also formed the western macrocycle of sarain A (Scheme 12); to achieve this, 
core 82 was initially converted into diol 83 in 4 steps.  The following five steps, one of 
which was an intramolecular Horner-Wadsworth-Emmons reaction, provided lactone 
84.   
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Scheme 12  Cha’s assembly of the western macrocycle of sarain A 
Incorporation of the two side chain olefins onto the core framework, followed by ring 
closing metathesis, dehydration and a final reduction, provided desired compound 86.  
Cha has also synthesised a compound analogous to 86, only instead of a PMB 
protecting group on the nitrogen atom, it contains a (CH2)4OPMB group; this increase 
in chain length should make formation of the eastern macrocycle achievable.
26
 
1.4.6  Huang’s asymmetric synthesis of the core 
In Huang’s recent asymmetric synthesis of the core (Scheme 13), lactam 87 undergoes a 
tandem Horner-Wadsworth-Emmons-aza-Michael reaction to give rise to lactam 88 in 
83% yield as a 3.1:1 mixture of trans- to cis-isomers.
15
  Lactam 88 is then converted 
into enone 89 in 4 steps, which, upon treatment with sodium hydride, undergoes a 
Michael addition to yield bicycle 90/91 as a 1:3 mixture of diastereoisomers 
respectively.   
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Scheme 13  Huang’s asymmetric synthesis of the sarain core 
Fortunately, Huang and co-workers were able to convert both diastereoisomers 90/91 
into core 94 via precursors 92 and 93.  This was achieved by removal of the O-benzyl 
protecting group to give 92/93, Swern oxidation, removal of the Boc-protecting group 
and workup of the product with KOH (to promote the final cyclisation and cause 
epimerisation of 93). 
1.4.7  Porter’s approaches towards the core  
1.4.7.1  Retrosynthesis - synthesis of key aldehyde intermediate 
A number of different strategies towards the sarain core have been adopted by the Porter 
group; all of these go via key aldehyde 96 (Scheme 14).  At this stage there are many 
pathways that have been taken in order to convert this molecule into sarain core 95, and 
the results from these will be discussed later in this section.
28
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* The methyl group at Cα is not part of the sarain core; however, it had to be added into Porter’s synthesis at an early 
stage to prevent isomerisation of bicycle 97 (and subsequent structures) during purification.  Without the methyl 
group in this position, it was difficult to maintain stereochemical purity.   
 
Scheme 14  Porter’s retrosynthesis of the sarain core* 
The bicyclic part of aldehyde 96 is initially formed by the reductive cyclisation of 
azide/lactam 98 into bicycle 97; this reaction is achieved by treatment of azide/lactam 
98 with tri-n-butylphosphine to give the corresponding iminophosphorane, followed by 
treatment with lithium aluminium hydride to effect cyclisation.
28
 
Another vital step is the thia-Claisen rearrangement that sets the correct relative 
stereochemistry of two stereogenic centres in thiolactam 99.  The precursor to this 
rearrangement is formed upon alkylation of thiolactam 101 with bromide 100, followed 
by heating to 40 ºC; deprotonation using triethylamine then promotes the [3,3]-
sigmatropic rearrangement.
28
 
1.4.7.2  Attempted transformations of key aldehyde into the sarain core 
Members of the Porter group had initially aimed to access the sarain core from aldehyde 
96 using a novel metal-catalysed ammonium ylide rearrangement (path a, Scheme 15).  
The required diazoester 103 was made in 3 steps from aldehyde 96, but unfortunately, 
the desired rearrangement did not occur despite attempts with a range of catalysts in 
different solvents; a complex mixture of products was obtained in all cases, with no 
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indication for the formation of sarain core 107.
29
  
 
Scheme 15  Rearrangement attempts towards the sarain core 
Attention was next turned to a similar rearrangement that could enable the formation of 
sarain core 95.  In this case, intramolecular N-alkylation by reaction with the nearby 
bromide in 104 would occur first, and, following deprotonation, bicycle 105 would ring 
open and then close to form target tricycle 95 via 106.
29
  However, the synthesis of 
bromide 104 was not possible and hence the proposed rearrangement could not be 
investigated. 
The final major attempt made within the group was an acid initiated rearrangement of 
aldehyde 109, which itself was synthesised in two steps from key aldehyde 96 (Scheme 
16).
28
  Upon protonation of the more basic nitrogen atom in aldehyde 109 to give 110, 
spontaneous ring opening of the bicyclic aminal was expected to give rise to amine 111, 
which, after condensation with the aldehyde, would form silyl enol ether 112; this 
would then attack the iminium ion and form sarain core 95. 
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Scheme 16  Acid-catalysed route towards the sarain core 
When aldehyde 109 was treated with a range of acids, the desired product was not 
observed; instead, decomposition of the starting material or recovery of starting material 
resulted in most cases.  However, when aldehyde 109 was subjected to acetic acid and 
methanol at 60 ºC, tricycle 118 was isolated as the main product (Scheme 17). 
 
Scheme 17  Acid catalysed rearrangement to form 5,7-tricycle 118 
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It is believed that tricycle 118 resulted from initial ring opening of the bicyclic aminal in 
aldehyde 109 in the undesired direction; the reaction could then take one of two 
pathways to give the product.  Firstly, condensation of the sulfonamide with the 
aldehyde, followed by subsequent attack from the enamine generated and trapping of 
the iminium ion with water would generate tricycle 118 via iminium ion 116 (path a, 
Scheme 17).  Alternatively, enolisation of aldehyde 113 followed by attack onto the 
iminium ion from the enol in 115 and subsequent reaction between the amine and the 
aldehyde in 117 would yield the same product, 118 (path b, Scheme 17). 
The mode of aminal opening can be explained by the fact that the more nucleophilic 
nitrogen atom supplies the electron push to encourage ring opening.  However, under 
acidic conditions, one would expect the same nitrogen (i.e. the more nucleophilic one) 
to become protonated, and hence ring opening to occur in the opposite direction to that 
observed.  The observation of 118 as the major product suggests that, under these 
conditions, aminal opening occurs without initial protonation of a nitrogen atom. 
1.5  [3,3]-Sigmatropic rearrangements 
As explained in section 1.4.7, a thia-Claisen rearrangement had been used to establish 
the correct relative stereochemistry in precursors to the sarain core.  The products 
obtained from these rearrangements are racemic, and, as a result, it would be desirable 
to replace this with an asymmetric variant.  The following section will discuss the 
Claisen and thia-Claisen rearrangements, followed by a discussion of asymmetric 
versions that can be found in the literature.    
1.5.1  Claisen rearrangement 
The Claisen rearrangement is a [3,3]-sigmatropic rearrangement of allyl vinyl ethers 
119 that provides a method for the generation of γ,δ-unsaturated carbonyl compounds 
(120, Scheme 18); this rearrangement provides a mild and effective way to form C-C 
bonds and is also a reliable way to generate tertiary and quaternary carbon centres.
30
  
The first example of this reaction was published by Ludwig Claisen in 1912; his 
original work focused on the reorganisation of allyl phenyl ether (121, Scheme 18) into 
rearranged product 122.
31
  Although this rearrangement involves an aromatic 
compound, the Claisen rearrangement has since been extended to and applied to 
aliphatic variants.   
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Scheme 18  The Claisen rearrangement (left) and [3,3] rearrangement of allyl phenyl ether 121 (right) 
1.5.1.1  Mechanistic features 
There are two feasible geometries that the transition states generated in Claisen 
rearrangements can adopt: (i) chair-like (123, Figure 6) and (ii) boat-like (124, Figure 
6).
30
  Both of these transition states are fully suprafacial [π2s + σ2s + π2s] processes and 
hence, according to the Woodward-Hoffman rules,
32
 are thermally allowed.  
 
Figure 6  Chair- (123) and boat-like (124) transition state conformations in Claisen rearrangements 
It has become generally accepted that the chair-like conformation is lower in energy and 
therefore most likely.  Despite this, work is still going on today in many research groups 
to find the precise nature and geometry of the transition state involved in this 
process.
33,34,35,36,37,38 
 
The chair-like transition states are typically highly ordered and repulsive interactions 
are minimised by placing bulky groups in pseudo-equatorial positions; when this is 
combined with well defined olefin geometries, the stereochemistry of the product can be 
easily predicted. 
Since its discovery in 1912, many variations of the Claisen rearrangement have been 
developed, these include: (i) the Ireland-Claisen rearrangement of silyl ketene acetals 
derived from allyl esters, (ii) the Johnson-Claisen rearrangement of ketene acetals 
generated from allylic alcohols and orthoesters, (iii) the aza-Claisen rearrangement of 
ketene O,N-acetals, (iv) the Belluš-Claisen rearrangement of γ,δ-unsaturated esters, 
amides and thioesters generated from reaction of allylic ethers, amines and thioethers 
with ketenes and (v) the thia-Claisen rearrangement, which is the sulfur analogue of the 
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Claisen rearrangement (Scheme 19). This thesis will focus on the thia-Claisen 
rearrangement.  
 
Scheme 19 – Simplified view of the Claisen-type rearrangement family 
1.5.2  Thia-Claisen rearrangement 
The thia-Claisen rearrangement is the sulfur analogue of the Claisen rearrangement 
(Scheme 20).  It was first reported in 1962 when Hackett et al. carried out work on allyl 
aryl sulfides;
39
 it has been used on a number of occasions in the total synthesis of 
natural products.
40,41,42,43,44 
 
 
Scheme 20  The thia-Claisen rearrangement 
In contrast to its oxygen analogue, the thia-Claisen rearrangement of S-allyl thiophenols 
generally requires higher temperatures and products can be unstable, making them 
difficult to isolate.  On the other hand, the aliphatic version proceeds under milder 
conditions, making it more easily applicable in synthesis. 
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Analogous to the Claisen rearrangement, the thia-Claisen rearrangement is believed to 
go through a chair-like transition state.  The mechanistic details of thia-Claisen 
rearrangements are the subject of current research.
45
  
1.5.3  Stereoselective [3,3]-rearrangements 
A consequence of the highly ordered transition state of Claisen-type rearrangements, in 
combination with well-defined olefin geometries in the starting material, is that chirality 
transfer from a stereogenic centre is generally excellent.  Two approaches have been 
developed to induce chiral information transfer in such rearrangements: (i) intra-
annularly; (ii) extra-annularly (Figure 7).  The intra-annular approach involves the 
stereogenic part being incorporated into the cyclic framework of the transition state.  
Thus, in this process, the chiral information in the six centres that are reorganised 
during the [3,3]-sigmatropic rearrangement is transferred in a concise and predictable 
fashion to give the product with good selectivity.  There are four main factors that 
influence intra-annular diastereoselectivity: (i) transition-state geometry, (ii) vinyl 
double bond geometry, (iii) allyl double bond geometry and (iv) the substituent at C
4
.  
This type of stereocontrolled Claisen rearrangement has been extensively reviewed.
30
 
 
Figure 7  Types of diastereoselective control methods in [3,3]-rearrangements 
The extra-annular process is one in which the inducing chiral centre is incorporated 
outside the transition state framework and is generally more difficult to achieve than 
intra-annular induction.  Four types of extra-annular stereocontrol methods can be 
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# This explanation does not rely on the reaction being nucleophilic, i.e. a system could adopt a conformation 
that has minimal allylic strain, even if it is not undergoing attack by a nucleophile. 
 
envisaged; the external stereogenic centre can be attached either to the allyl fragment (at 
C
5
 or C
6
) or the vinyl fragment (at C
1
 or C
2
). 
For the purpose of this work, only extra-annular control by incorporation of the chiral 
centre adjacent to C
6
 will be considered; this type of stereocontrol has been scarcely 
reported in the literature.  
1.5.3.1  [3,3]-Sigmatropic rearrangements directed by a stereocentre at C
6 
Asymmetric thia-Claisen rearrangements normally proceed through a low energy chair 
conformation containing minimal 1,3-diaxial interactions.  There are two important 
factors that affect the diastereoselectivity (see below).  Although some authors tend to 
rationalise their results using only one of these factors as an explanation, both are very 
similar (they differ only by a 30º rotation about a single bond) and so it is likely that 
both play some part.  
Factor 1: Minimise Allylic strain 
#
 
One factor that is important is minimising allylic strain; this is a type of strain energy 
resulting from the interaction between a substituent on one end of an olefin with an 
allylic substituent on the other.  Shown in Figure 8 (top) is an (E)-allylic system drawn 
in three different orientations; each are of different energies due to the differing 
amounts of allylic strain present.  The eclipsed conformations (125 and 126) are lowest 
in energy, with conformation 125 being lower in energy than 126 as the hydrogen atom 
(H*) is eclipsed with another hydrogen atom across the olefin, rather than the larger 
methyl group.  Conformation 127 is highest in energy as the two methyl groups are 
staggered with the hydrogen atom (H*). 
 
Figure 8  Allylic systems
46
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Figure 10 
The situation changes slightly for a (Z)-olefin; the highest energy orientation 130 has 
the methyl group eclipsed with the R-group.  However conformation 128, which has the 
small hydrogen atom eclipsed with the R-group, is still lowest in energy and therefore 
most frequently adopted. 
Attack onto a double bond of an allylic system (i.e. as in a Claisen-type rearrangement) 
that possesses minimal allylic strain would then be expected to occur from the less 
hindered side (131 and 132, Figure 9); hence, attack from a nucleophile is from the side 
that is opposite to the largest group.  This type of nucleophilic attack is outlined in 
Figure 9 along with the associated Newman projection 133. 
 
Figure 9  Nucleophilic attack on an allylic system possessing minimum allylic-strain 
Factor 2: Transition state stabilisation (Houk’s model)47,48,49,50 
Houk’s model (which was originally applied to nitrile oxide cycloadditions) states that 
when a nucleophile attacks a double bond in a cyclic transition state, the most 
electronegative substituent is placed perpendicular to the double bond, in the anti 
position, in order to maximise stabilisation in the transition state.  The smallest group 
must occupy the inside position, which is staggered with the double bond, and the 
remaining group occupies the outside position (136, Figure 11).  When this rule is 
applied to Claisen-type rearrangements, conformation 137 would result.  
Placement of the most electronegative group in the 
anti position results in the newly forming -bond 
being in the correct orientation to enable stabilisation 
by overlap with the low-lying * orbital of the C–X 
bond (134 and 135, Figure 10).  Such an effect, in 
related Ireland-Claisen rearrangements, has been characterised computationally by 
Kahn and Hehre as involving the more electron-poor face of the electrophilic 
component.
51 
 This explanation contrasts with the Felkin-Anh model for nucleophilic 
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attack onto a carbonyl group (138) , which places the medium group, rather than the 
small group, in the inside position (Figure 11).
52,53,54
 
 
Figure 11 Houk’s model for nucleophilic attack on an alkene (left) and the Felkin-Anh model (right) 
1.5.3.1.1  Belluš Claisen rearrangements of allyl sulfides  
Belluš et al. were the first to report a highly diastereoselective [3,3]-sigmatropic 
rearrangement directed by a stereogenic centre at C
6
.
55
  In their studies, allyl sulfide 139 
and an electron-deficient ketene derived from acid chloride 140 reacted to form 
zwitterionic intermediate 141, which, following a ketene-Claisen rearrangement, gave 
thioester 142 (Scheme 21). 
 
Scheme 21  Diastereoselective ketene-Claisen rearrangement 
The reaction could be conducted at low temperature due to charge neutralisation 
providing a sufficient driving force - this is thought to have helped towards the high 
level of diastereoselectivity obtained (Scheme 22).  The reaction could take one of two 
pathways; namely pathway a or pathway b (Scheme 22).  Pathway a is the lower energy 
pathway due mainly to the lack of 1,3-diaxial repulsive interactions present in 144.  
Conversely, pathway b goes via boat 145, which is of higher energy as it possesses 
stronger 1,3-diaxial repulsive interactions.  
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Belluš explained the diastereoselectivity obtained using transition states 144 and 145.  
Thus, with the two hydrogen atoms in 144 eclipsed across the allylic system, attack is 
from the less sterically encumbered face to give product 146 as the main 
diastereoisomer.   
 
Scheme 22  Diastereoselective ketene-Claisen rearrangement 
Interestingly, when XR
2
=NBn, lower diastereoselectivities were obtained in the [3,3]-
sigmatropic rearrangement; after performing modelling experiments on this system, the 
author explained the difference in diastereoselectivity as a consequence of boat 
conformation 145 simply being of significantly lower energy when XR
2
=NBn,  
resulting in a reduced energy difference between the two transition states.   
1.5.3.1.2  Aza-Claisen rearrangements  
Nubbemeyer et al. have focused on the development of diastereoselective zwitterionic 
aza-Claisen rearrangements.
56,57
  Unlike in the work described above on ketene-Claisen 
rearrangements, formation of zwitterionic intermediate 150 (Scheme 23) was not 
straightforward; mixing N-allylpyrrolidine 148 with a range of α,α-disubstituted 
carboxylic acid chlorides commonly resulted in a von Braun degradation, giving rise to 
allyl chloride 151 and the corresponding amide 152.  To make this unwanted process 
less likely, N-allylpyrrolidine 148 was treated with α-monosubstituted acid halides 149 
in the presence of trimethylaluminium at low temperatures (0 ºC).  These conditions 
enabled successful aza-Claisen rearrangements of 150 to occur to generate 154-157 as 
main products (Scheme 23).  These products (154-157) are useful intermediates in total 
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synthesis, for example in the syntheses of (+)-dihydrocanadensolide and ()-
petasinecin.
56,57
 
 
Scheme 23  Asymmetric aza-Claisen rearrangement and von Braun dealkylation pathway 
The levels of diastereoselectivity obtained from the rearrangements were generally 
excellent.  The stereochemical course of the reaction has been described using the chair- 
and boat-like intermediates given in Scheme 24.  Similarly to Belluš (see previous 
section), Nubbemeyer et al. explained their results by assuming that chair transition 
states are adopted and that allylic strain is minimised, hence giving four reactive chair 
conformations that the reaction could go through (158, 160, 161 and 162).  Of these 
conformations, 158 and 160 are expected to be most favourable since attack from the 
vinyl double bond onto the allylic double bond would take place from the less hindered 
side; conformation 160 is lower in energy than 158 as it lacks steric clashes between the 
hydrogen atom or R-group and 5-membered ring.   
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Scheme 24  Hypothetical transition states 
When R=H (hence 158=160 and 161=162), a low ratio of 3:2 155:156 was obtained.  
As expected, increasing the bulkiness of the R-group from a hydrogen atom to a larger 
group (e.g. 
i
Pr or CH2=CH2) raised the ratio of the expected major conformations 
154:155 to 1:97, along with trace amounts of 156 and 157.  Interestingly, when the R-
group had an extended π-system (e.g. Ph or CH=CHCH=CH), product 154 was 
predominant.  This is presumably because either the reaction proceeds via boat-like 
conformation 159 (although there is no obvious reason why this would happen for these 
substrates), or that some electronic aspect of the extended conjugation into the phenyl 
and butadiene systems results in conformation 158 being adopted. 
1.5.3.1.3  Thia-Claisen rearrangements 
Metzner and co-workers have performed some moderately diastereoselective thia-
Claisen rearrangements.
58
  The precursors to these [3,3]-rearrangements were 
synthesised in 3 steps from allyl dithioester 163; thia-Claisen rearrangements were then 
carried out in methylcyclohexane at room temperature or reflux (Scheme 25).  Initially, 
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[3,3]-rearrangements with a substrate that had the substituents R
1
 and R
3
 fixed as 
methyl and H respectively while R
2
 was varied, were attempted.  The levels of 
diastereoselectivity obtained were generally quite low, however, with R
2
=
t
Bu, a 1:3 
ratio of 164:165 was achieved.       
 
Scheme 25  Thia-Claisen rearrangements 
Metzner believes that conformation 166 is the most likely, since it has the smallest 
group (the hydrogen atom) in the inside position, the medium sized group (Me) in the 
outside position and the alkoxy group (R
2
) perpendicular to C=C so that attack from the 
vinyl double bond takes place antiperiplanar to it (Scheme 26). 
 
Scheme 26  Reactive pathway for thia-Claisen rearrangements 
1.5.3.1.4  Johnson-Claisen rearrangements  
Ogawa et al. have investigated the effect that substituted dioxane units have on 
Johnson-Claisen rearrangements (Scheme 27).
59
  Upon [3,3]-sigmatropic rearrangement 
of compound 168, diastereomers 172 and 173 were obtained in a 1:1.3 172:173 ratio; 
however, (Z)-analogue 169 gave a 5.2:1 ratio of 172:173.  Replacement of the hydroxyl 
group in 168 and 169 with the bulky TBS group to give 170 and 171 respectively was 
effective in increasing the diastereoselectivity from 1:1.3 to 1.5:1 for 170 and 5:1 to 
11.5:1 for 171. 
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Scheme 27  Asymmetric Johnson-Claisen rearrangements 
Ogawa has accounted for the preferential formation of product 172 over 173 in the 
reactions involving (Z)-alcohols 169 and 171 using reactive conformations 174 and 175, 
which both possess minimal allylic strain (Scheme 28).  Conformation 175 suffers from 
a steric clash between the C
5 
substituent
 
and the OR substituent of the dioxane ring and 
hence attack onto the allylic portion would be from the more hindered face.  However, 
conformation 174 has no such problem and is therefore more favourable, since attack 
onto the allyl group is from the least hinderd side.  Unsurprisingly, increasing the bulk 
of the R-group increases this effect and hence results in a larger ratio. 
 
Scheme 28  Reactive conformation for ortho Johnson-Claisen rearrangement 
For (E)-alcohols 168 and 170, there is no such clash in either conformation and hence 
the difference in energy between the two possible conformations is small, leading to a 
low diastereomeric ratio. 
More recently, Craig et al. studied the Johnson-Claisen rearrangements of of (E)- and 
(Z)-allylic alcohols bearing a sulfur substituent and have also shown that variation of the 
allylic substitution pattern can lead to changes in the diastereoselectivity.
60
  It was found 
that (E)-alkene 179 (where R=Me) underwent a completely unselective rearrangement.  
However, (Z)-alkene 176 gave a 3:1 mixture of products in good yield; other R-groups 
resulted in similar trends (Scheme 29) 
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Scheme 29  Johnson-Claisen rearrangement reactions 
Craig et al. explained these findings by assuming that with the (Z)-double bond 
geometry, the major product arises from conformation 184, whereby the C
7
-H bond, 
rather than the C
7
-R bond, eclipses the allylic C
4
-C
5
 bond to mimise allylic strain; attack 
from the vinyl moiety onto the allylic portion is then from the opposite face to the C-S 
bond.  However, for the (E)-double bond geometry, the lesser steric bulk associated 
with the C
5
-H bond compared to the C
4
-C
5
 bond (as in conformation 185) leads to lower 
selectivity (Scheme 30).   
 
Scheme 30  Rationale for stereochemical outcome of Johnson-Claisen rearrangement 
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Figure 12 
In other work on Johnson-Claisen rearrangements, Suzuki et al. 
have shown substrates such as 187 to undergo [3,3]-sigmatropic 
rearrangement with selectivity of around 3:1 for both the (E)- and 
(Z)- alkene precursor (Figure 12).
61
 Similarly, Takano et al. found 
that precursor 186, which is analogous to 187 except for the 
additional methyl group on the double bond, gave no preference for 
either diastereoisomer of product (Figure 12).
62
 
1.5.3.1.5  Ireland-Claisen rearrangements  
Mulzer et al. employed a highly diastereoselective Ireland-Claisen rearrangement whilst 
working towards the synthesis of ()-petasinecine (Scheme 31).63  The precursor 189 
for the key rearrangement was formed by reaction of allyl alcohol 188 with an acid 
chloride in the presence of pyridine; treatment of this ester with LiHMDS and 
trimethylsilyl chloride at low temperature promoted the [3,3]-sigmatropic 
rearrangement to form product 191 via 190.  Rearranged product 191 was not isolated 
but converted in situ into bicycle 192, which itself was isolated as a single 
diastereoisomer.  A four step linear sequence then converted 192 into desired alkaloid 
193. 
 
Scheme 31  Mulzer’s diastereoselective Ireland-Claisen rearrangement en route towards ()-petasinecine 
Mulzer and co-workers attributed this faultless diastereoselective reaction to the 
following two points: (i) deprotonation using LiHMDS occurs to give stereospecifically 
the (Z)-enolate due to chelation; (ii) a chair conformation is adopted.  With these two 
conditions in place, Mulzer chose to explain the diastereoselectivity using reactive 
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194, Figure 13 
conformation 190, in which attack from the vinyl moiety occurs anti to the C-N bond, 
giving diastereoisomer 191 as the sole product. 
Another factor contributing to the high level of diastereoselectivity 
obtained is the low temperature at which the rearrangement step is 
performed.  It is believed that the strong electron withdrawing nature of 
the Boc group helps to lower the energy of the 1,2-π* orbital via a σ*-π* 
interaction (194, 194, Figure 13).  In addition, the electron donating 
ability of the OBn and OTMS group on the vinyl fragment increases the energy of the 
5,6-π-orbital; a combination of these two effects leads to a strong HOMO-LUMO 
interaction and hence the reaction can be conducted at low temperatures.   
Cha et al. have also performed diastereoselective chelation-controlled Ireland-Claisen 
rearrangements; however their approach employs the acetonide unit to provide the 
extra-annular stereogenic centre (Scheme 32).
64
  This strategy provided moderate to 
good diastereomeric ratios upon [3,3]-sigmatropic rearrangement.  This work should be 
compared to that described by Mulzer et al. in the previous section; the noticeable 
differences between the two studies are that Cha’s work incorporates the stereogenic 
centre into an acetonide unit instead of a pyrrolidine, and that the rearrangement is 
carried out at room temperature, not 0 ºC.  
 
Scheme 32  Cha’s diastereoselective Ireland-Claisen rearrangements 
Cha’s results indicate that when R=H, low diastereomeric ratios are obtained from the 
rearrangements; however, increasing the size of the R-group provides much improved 
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diastereomeric ratios.  When R=Bn, the level of diastereoselectivity achieved is still not 
as high as that obtained by Mulzer on a similar substrate (Scheme 31); one reason for 
the difference in diastereoselectivity obtained could be that Mulzer’s rearrangement was 
carried out at a lower temperature (this was made possible due to the electron 
withdrawing nature of the NBoc group).  
 
Scheme 33  Reactive conformation for Ireland-Claisen rearrangement with (E)-double bond 
The major products 202 from these rearrangements are believed to arise from reactive 
conformation 201 (Scheme 33 – shown is reactive conformation for the (E)-alkene 
precursor).  This conformation is chair-like, contains a (Z)-silyl enol ether and is 
positioned so that an attack from the vinyl double bond onto the allylic portion is anti 
with respect to the alkoxy group. 
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2  Asymmetric thia-Claisen rearrangements65,66,67 
In the Porter group’s current synthetic approach towards the sarain core (Scheme 34), a 
thia-Claisen rearrangement is employed as one of the key steps.
28
  However, although 
this rearrangement is efficient in providing the correct relative stereochemistry of 
thiolactam 99, the product is racemic.  As a result, we sought an asymmetric variant of 
this rearrangement.   
 
Scheme 34  Thia-Claisen rearrangement as a key step towards sarain core 95 
2.1  Strategy 
We envisaged that use of a chiral bromide with general structure 203 may result in 
preferential formation of one diastereomeric product.  In accord with the literature 
shown in section 1.5.3, the reaction would proceed via chair conformation 204, in which 
attack onto the double bond would take place from the opposite side to the allylic 
oxygen and minimal A
1,3
-strain would be present (Scheme 35).  
 
Scheme 35  Proposed asymmetric thia-Claisen rearrangement  
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In addition, the effect of placing a removable bulky group onto the double bond of the 
bromide was to be tested.  We expected this to increase A
1,3
-strain, thus making 
conformation 204 even more favourable.  If this rearrangement was successful, the 
protecting groups could be removed, the diol cleaved and resultant aldehyde reduced to 
give target molecule 206 as a single enantiomer. 
Initially bromides 207 and 208 were targeted (Figure 14); it was anticipated that these 
could both be prepared from D-mannitol 209 (Scheme 36).
68,69
  The following two 
sections will describe our syntheses of these compounds. 
 
 
Figure 14  Bromide targets 207 and 208 
2.2  Formation of acetonide protected precursor 
D-Mannitol 209 was selectively protected at its 1,2- and 5,6-diol units to afford diol 210 
in 43% yield.  The method employed was an acid catalysed transacetalisation; the 
relatively low yield obtained is thought to be a consequence of the protection not being 
totally selective (Scheme 36). 
 
Scheme 36  Syntheic route towards bromide precursor 
Conversion of diol 210 to ,-unsaturated ester 213 was achieved by an oxidative 
cleavage and olefination; the aldehyde resulting from oxidative cleavage of 210 is 
known to be sensitive to racemisation and hence preferentially should not be isolated in 
order to preserve the stereochemistry at the chiral centre.  A number of protocols have 
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Figure 15 
been developed to avoid isolation of this compound and in this case, the procedure of 
Marshall et al. was chosen and implemented.
68,69
  
Thus, treatment of 210 with sodium periodate in aqueous sodium bicarbonate, followed 
by addition of triethyl phosphonoacetate 212 and K2CO3 afforded ,-unsaturated ester 
213 in 96% yield, with a selectivity of ca. 25:1 E:Z.
68
  DIBAL reduction of ester 213 
proceeded smoothly to afford (E)-allylic alcohol 214 in 77% yield; alcohol 214 was 
then converted to bromide 207 using N-bromosuccinimide and triphenylphosphine in 
93% yield.
70
 
2.3  Formation of bis-silyl ether protected precursor 
Formation of bis-silyl ether 208 was achieved in four steps from ester 213 (Scheme 37).  
The synthesis involved treatment of 213 with 60% aqueous acetic acid at room 
temperature to form diol 215, followed by TBS protection using a standard procedure to 
give ester 216.  
 
Scheme 37  Four step conversion of ester 213 into bromide 208 
As with the synthesis of bromide 207 (section 2.2), DIBAL reduction of ester 216, 
followed by bromination using N-bromosuccinimide and triphenylphosphine, gave bis-
silyl ether 208 in good yield. 
2.4  Thia-Claisen rearrangement  
N-Benzylpyrrolidine-2-thione (218) was prepared from lactam 102 
(Figure 15) using Lawesson’s reagent in THF, in 72% yield.71  S-
alkylation of thioamide 218 with bromides 207 and 208 in acetonitrile 
in the presence of 4 Å molecular sieves was followed by deprotonation 
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of the salts with triethylamine at 35 C.28  Gratifyingly, the thia-Claisen rearrangement 
occurred to afford a mixture of thiolactam products (Scheme 38); the results are 
summarised in Table 1. 
 
Scheme 38  Thia-Claisen rearrangements 
Entry Bromide Ratio
a
 
Yield of 
220 / %
b
 
Yield of 
221 / %
b
 
Yield of 
222 / %
b
 
1 207 
2.5:1:0.1 
220a:221a:222a 
38 10 1 
2 208 
30:1 
220b:221b 
41 1 Not isolated 
a 
Ratios measured from the 1H NMR spectrum of the crude reaction mixture. 
b Isolated yields of individual 
stereoisomers 
Table 1 Product ratios from thia-Claisen rearrangements 
As expected, the major products were diastereoisomers 220a/b and 221a/b, arising from 
a chair transition state, with only a trace amount of a third diastereoisomer 222a isolated 
from the acetonide-protected substrate 207 (entry 1).  Although the stereochemical 
assignments of lactams 220-222 were not known at this stage, we were later able to 
confirm their structures through a combination of X-ray crystallography and chemical 
correlations (section 2.7). 
The thia-Claisen rearrangements occurred successfully; however, the level of 
diastereoselectivity obtained was disappointingly low for the rearrangement involving 
acetonide 207 (ca. 2.5:1), reflecting a low level of facial selectivity imparted upon the 
exocyclic double bond by the adjacent stereocentre in intermediate 219.  However, an 
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excellent diastereomeric ratio was obtained for the [3,3]-sigmatropic rearrangement 
involving TBS protected bromide 208 (ca. 30:1), albeit in relatively low yield.   
2.5  Modification of precursors: bromination  
To overcome the issue of low diastereoselectivity that was obtained for the acetonide 
series (bromide 207), and bias the conformation of intermediate 219 towards a single 
rotamer, a vinylic substituent was introduced into the bromide precursor; it was believed 
that this could improve the diastereoselectivity because of increased allylic strain in the 
transition state.  Therefore, we decided to introduce a bromine substituent (which could 
be removed at a later stage) onto the double bond of the rearrangement substrate.  We 
also decided to do the same thing on TBS protected bromide 208, to see if any 
improvement on the excellent chiral induction already obtained could be achieved, and 
overcome the poor yield.  Our synthesis was thus modified to produce bromides 223 
and 224 (Figure 16), which contain a bromine substituent on the double bond.   
 
Figure 16  Dibromide targets 
Brominated phosphonate reagent 227 was prepared from phosphonate 225 in two 
steps.
72
  Firstly, treatment with aqueous sodium hydroxide and bromine solution formed 
dibromide 226 in 97% yield (Scheme 39).  This reaction was capricious, and it was 
found that a reproducible yield could only be obtained if the internal reaction 
temperature was kept below 10 C at all times throughout the addition of phosphonate 
225 and the product was extracted into chloroform immediately after the reaction.  
Subsequently, monodehalogenation of 226 using tin(II) chloride afforded 227 in 92% 
yield.  Care had to be taken during this reaction to avoid removal of the second bromine 
atom from 226.  Hence, cautious addition of the tin(II) chloride solution and regular 
analysis of the reaction mixture by TLC was essential. 
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Scheme 39  Formation of brominated phosphonate 227, and synthetic route toward bromide 223 
Diol 210 was treated with sodium periodate, and the resulting aldehyde reacted with 
brominated phosphonate 227 under analogous conditions to those used previously 
(section 2.2) giving an inseparable mixture of esters 228 in a 1.6:1 Z:E ratio.  Following 
this olefination, the mixture of esters was reduced using DIBAL to give allylic alcohols 
229 and 230, which were separable by column chromatography and were obtained in 
41% and 25% yield respectively from 210.  The major (Z)-alcohol 229 was treated with 
N-bromosuccinimide and triphenylphosphine to give the desired bromide 223 in 67% 
yield (Scheme 39). 
To synthesise bromide 224, ester mixture 228 was deprotected using 60% aqueous 
acetic acid to afford the expected (Z)- diol 232.  The (E)- diol reacted further and 5-
membered lactone 231 was obtained (Scheme 40). 
 
Scheme 40  Deprotection of ester 228 and subsequent TBS protection of (Z)-diol 232 
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TBS protection of (Z)-diol 232 was next accomplished using TBS chloride and 
imidazole in 87% yield to give ester 233 (Scheme 40).  Reduction of ester 233 was first 
attempted using DIBAL as before; however the major product was not the expected bis-
silyl ether (which was isolated in 17% yield), but mono-silyl ether 235 (Scheme 41).  
Although we cannot be certain as to which TBS group had been removed during the 
reduction, it is more likely that the primary one had been excised, as primary silyl ethers 
are typically more labile than secondary ones. 
 
Scheme 41  DIBAL and LiAlH4 reductions of ester 233 
Changing the reducing agent to LiAlH4 gave clean conversion of 233 to alcohol 234 in 
91% yield, with no purification step required (Scheme 41).  Initial attempts to convert 
alcohol 234 into bromide 224 using N-bromosuccinimide and triphenylphosphine were 
unsuccessful.  The reaction gave a mixture of products, which not only made isolation 
of the desired bromide difficult, but also reduced the yield dramatically.  Hence, as an 
alternative protocol, tosylation of alcohol 234 using tosyl chloride, triethylamine and 
DMAP gave tosylate 236 in 60% yield, followed by reaction with LiBr, which gave the 
desired bromide (224, Scheme 42) in 60% yield.
73
 
 
Scheme 42  Two step conversion of alcohol 234 into bromide 224 
2.6  Thia-Claisen rearrangement of bromo-alkene substrates 
Bromide 223 was next employed in the thia-Claisen rearrangement.  When subjected to 
the same conditions as used previously, thiolactams 238, 239 and 240 were obtained in 
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2%, 52% and 2% yields respectively, with excellent diastereoselectivity (Scheme 43); 
the results are summarised in Table 2.   
 
Scheme 43  Thia-Claisen Rearrangements 
Bromide 
Ratio
a
 
238:239:240:241 
Yield of 
238 / % 
Yield of 
239 / % 
Yield of 
240 / % 
Yield of 
241 / % 
223 1:12.2:0.6:ca. 0.1 2 52 2 
Not 
isolated 
          a 
Ratios measured from the 1H NMR spectrum of the crude reaction mixture 
Table 2  Product ratios from thia-Claisen rearrangement 
Although the fourth isomer 241 was not isolated from this reaction, it was isolated when 
the rearrangement was carried out using the (E)-analogue of bromide 223 (section 2.5).  
As a result, the characteristic signals of lactam 241 were known and therefore it could 
be identified in the crude 
1
H NMR spectrum, enabling a diastereomeric ratio for the 
product to be deduced for this rearrangement. 
Interestingly, the major product from this rearrangement was the (2R, 3'S, 4'S)-isomer 
239, in contrast to the non-brominated substrate which gave primarily the (2S, 3'R, 4'S)-
isomer 220 (which has the same stereochemistry as 238).  Similarly to the non-
brominated lactams 220-222, assignment of products 238-241 was not possible at this 
stage; however, these were determined after further studies (section 2.7). 
We next attempted the rearrangement with bromide 224; disappointingly, for reasons 
unknown, the desired thia-Claisen rearrangement did not occur on any occasion despite 
several attempts. 
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* When the thia-Claisen rearragements were carried out, the stereochemistries of the products were not known; 
however, for clarity, all of the structures are depicted with the stereochemistry that was deduced from these studies. 
 
2.7  Assignment of the configuration of thia-Claisen products
*
 
2.7.1  Non-brominated series 
It was hoped that the stereochemistry of thiolactams 220-221 could be deduced in the 
most direct manner, i.e. using X-ray crystallography.  Unfortunately this was not 
possible as the rearrangement products were not crystalline.  However, after 
deprotecting thiolactams 220a and 221a using 60% aqueous acetic acid at room 
temperature, two diastereomeric diols were generated (242 and 243 respectively) in 
excellent yield, with 243 being sufficiently crystalline to obtain a high-quality single 
crystal (Scheme 44). Its structure was unambiguously assigned by X-ray 
crystallography and thus, this revealed the stereochemistry of 221a (Figure 17). 
 
Scheme 44  Deprotection of lactams 220a and 221a 
 
Figure 17  X-ray crystal structure of diol 243 
Assignment of the stereochemistry of 220a was achieved indirectly by cleavage of each 
of diols 242 and 243 using silica gel-supported sodium periodate (Scheme 45), and 
reduction of the intermediate aldehydes (which were not isolated) using sodium 
borohydride to give alcohols 244 and 245, which was achieved in moderate yield.
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These products had identical 
1
H NMR data, but opposite specific rotations ( 20D][  = 
73.2 and 20D][  = +71.4 respectively), and hence these alcohols 244 and 245 could be 
identified as enantiomeric.  Therefore, the stereochemistry of 220a could be assigned, as 
having the opposite configuration at the 2 and 3' stereogenic centres to 221a. 
 
Scheme 45  Cleavage of diols 242 and 243, followed by NaBH4 reduction 
The stereochemical assignment of thiolactam 222 was not possible at this point, 
however, this assignment was successfully made later (section 2.7). 
Previous attempts within the Porter group to undertake silyl deprotection of thiolactams 
similar to 220b and 221b using TBAF resulted in epimerisation at the position α- to the 
thiocarbonyl.
28
  With this in mind, we sought a different method for the deprotection.  
Gratifyingly, deprotection of 220b and 221b using 60% aqueous acetic acid at 55 C 
overnight afforded two diols, which were identified as thiolactams 242 and 243 in 95% 
and 67% yield respectively (Scheme 46).  Hence, this revealed the stereochemistry of 
rearrangement products 220b and 221b. 
 
Scheme 46  Deprotection of thiolactams 220b and 221b 
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2.7.2  Brominated series 
In order to correlate the brominated series to the non-brominated series, the bromine 
substituent on the double bond of thiolactams 238-241 had to be removed.  Initial 
attempts at removal of the bromine substituent involved treatment of thiolactam 239 
with palladium acetate, formic acid, triphenylphosphine and triethylamine.
75
  The 
optimised conditions were found to require 30 equivalents of triethylamine and 20 
equivalents of formic acid for complete conversion of starting material.  Debromination 
gave a mixture of two products 221a and 222a (Scheme 47), whose structures were 
confirmed by 
1
H NMR comparison with the rearrangement products from the non-
brominated series. 
 
Scheme 47  Palladium catalysed debromination of 239 using HCOOH 
The presence of two stereoisomers suggested that epimerisation -to the thiocarbonyl 
group had taken place. Hence, whilst this result did not allow definite assignment of the 
stereochemistry of brominated thiolactam 239, it did indicate that the previously 
assigned diastereoisomer 221a was epimeric with 222a at the position - to the 
thicarbonyl group (vide supra).  As the stereochemistry of diastereomer 221a had 
already been unambiguously assigned, the configuration of 222a could be ascertained as 
that depicted. 
We next carried out the palladium-catalysed debromination using tributyltin hydride as 
the reducing agent.
76
  These conditions were chosen as they are neutral, which seemed 
appropriate as a base was thought to be the most likely cause of the epimerisation 
observed during the reaction involving triethylammonium formate.   
Treatment of lactam 239 with Pd(PPh3)4 and tributyltin hydride afforded debrominated 
isomer 221a in 50% yield, along with a small amount of lactam 244 (Scheme 48).  As 
the stereochemistry of 221a had previously been assigned, this result confirmed the 
stereochemistry of 239. 
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Scheme 48  Palladium catalysed debromination of lactams 238-240 using Bu3SnH 
Debromination using tributyltin hydride was also carried out for thiolactam 238, giving 
thiolactam 220a as the sole product in 60% yield, thus confirming the stereochemistry 
of thiolactam 238 (Scheme 48).  For completeness, thiolactam 240 was debrominated 
under the same conditions to give, as expected, debrominated product 222a in 49% 
yield.   
2.8  Methylated bromide – effect on the thia-Claisen rearrangement  
To help improve our understanding of the reactive conformations involved in the thia-
Claisen rearrangements previously described, bromide 146 (which bears a methyl group 
on the double bond instead of a bromine or hydrogen atom) was to be tested in the thia-
Claisen rearrangement (Scheme 49).  It was thought that this could indicate the effect 
that steric and electronic effects have on the diastereoselectivity in the thia-Claisen 
rearrangement.  
Bromide 248 was made in 3 steps from diol 210; the synthesis started with cleavage of 
diol 210 using sodium periodate, followed by Wadsworth-Emmons olefination of the 
resulting aldehyde to give ester 245 (and ester 246) that bears a methyl group on the 
double bond.  DIBAL reduction of ester 245 gave alcohol 247; this was followed by 
conversion into the corresponding bromide 248 (Scheme 49).  
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Scheme 49  Formation of methylated bromide precursor 248 
Bromide 248 was then subjected to the conditions previously described for thia-Claisen 
rearrangements; thiolactams 249 and 250 were isolated from the reaction in a ratio of 
2.5:1 (Scheme 50).  The minor diastereoisomer could only be obtained contaminated 
with a small amount of the major diastereoisomer.  As a result, we tried to grow X-ray 
quality crystals of the major diastereoisomer only, in an attempt to reveal its absolute 
stereochemistry; however, this was not possible despite many attempts.  
 
Scheme 50  Thia-Claisen rearrangement involving methylated bromide 248 
In order to determine the stereochemistry of the two newly formed centres in both 249 
and 250 (and therefore reveal whether thiolactam 249 or 250 was the major product 
from the reaction), thiolactams 249 and 250 were converted to their corresponding diols 
by treatment with 60% aqueous acetic acid (251 and 253 respectively, Scheme 51).  
However, although both diastereoisomers were obtained cleanly as determined by 
1
H 
NMR analysis, we were again unable to grow X-ray crystals. 
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Scheme 51  Deprotection of thiolactam products 
In a final attempt, diol 251 (which was derived from the major diasteroisomer) was 
converted into its di-para-nitrobenzoate 252, with the hope that it would be more 
crystalline.
77
  Disappointingly, once again we were again unable to grow X-ray quality 
crystals.  
Having not been able to identify the stereochemistry at the two key stereocentres in 
thiolactams 249 and 250, we cannot tell whether the added methyl group switches the 
diastereoselectivity from 2.5:1 220a:221a (Scheme 38, Table 1) to 1:2.5 249:250 or 
whether it results in almost identical diastereoselectivity to the disubstituted alkene (i.e. 
2.5:1 249:250).   
2.9  Model for the stereoselectivity in thia-Claisen rearrangements  
To rationalise the stereochemical course of these thia-Claisen rearrangements, the 
reactive conformations of intermediates 97 (Scheme 38, page 38) and 131 (Scheme 43, 
page 42) must be considered.  To deduce such conformations, we must use consider the 
two explanations described in section 1.5.3.1 and assume that the thia-Claisen 
rearrangement takes place through a chair-like transition state.   
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Figure 18 
Figure 20 
2.9.1  Brominated vs non-brominated series 
Three chair conformations can be used to explain the outcome of 
the rearrangements (254, 255 and 256, Figure 19).  Conformations 
255 and 256 have the hydrogen atom eclipsed with the R-group to 
minimise allylic strain and hence, would be lowest in energy.  
However, conformation 256 would also have attack onto the allylic 
system from the double bond from the opposite side to the allylic 
oxygen.  This, according to Houk’s Rule, gives 256 some 
additional stabilisation over conformation 255.  The final conformation, 254, leads to 
product 239; this suffers from additional allylic strain (254). 
 
Figure 19  Possible reactive conformations for thia-Claisen rearrangements 
This argument successfully predicts the reactions of 207 and 208, 
but not 223.  In order to help explain the reversal of 
diastereoselectivity in going from bromides 207 to 223, methylated 
bromide 248 (Figure 20) was made.  We believed that the major 
product obtained from the thia-Claisen rearrangement involving this bromide would 
provide an indication on whether the steric or electronic effect of the additional bromine 
atom in bromide 223 was causing the reversal of diastereoselectivity.  Unfortunately, 
the identity of the major diastereoisomer from the rearrangement involving methylated 
bromide 248 was not determined.  
The reasons why dibromide 223 leads to 239 – presumably through conformation 255 – 
remain unclear.  Hence, all that can be deduced is that electronic factors must be playing 
some role in increasing and inverting the sense of the diastereoselectivity between 
bromide 207 and dibromide 223, as the highest level of diastereoselectivity obtained 
with either non-substituted 207 or methyl-substituted bromide 248 was only 2.5:1.   
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† 
There is a nomenclature switch between bromides 259 and 260.  Conventionally, these would be denoted (Z)-
bromide and (E)-bromide respectively, since a bromine atom is of higher priority than a carbon atom.   However, for 
simplicity, cis and trans have been used in this case to follow the carbon chain, not the priority atoms. 
2.9.2  Acetonide vs TBS protecting group 
The increased diastereoselectivity obtained in reactions with TBS protected bromide 
208 (Figure 18) over its acetonide analogue 207 is most likely a consequence of the 
greater bulk of the TBS group, which increases the energy difference between 
conformation 256 and the alternative reactive conformations. 
2.10  Thia-Claisen studies using cis-analogues 
After the success achieved in the thia-Claisen rearrangements studied, we became 
interested in investigating the same [3,3]-sigmatropic rearrangements with the cis-
analogues of 207 and 223 (259 and 260 respectively), to see what level of asymmetric 
induction was achievable.
†
  It was thought that these analogues could give better 
diastereoselectivity, as this has been the case for some rearrangements presented in the 
literature (section 1.5.3.1).  Thus, bromide 259 was prepared in 3 steps from diacetonide 
210.  The cis-olefin in ester 257 was formed via a low salt and low temperature Wittig 
reaction carried out under protic solvent conditions.
78,79
  Alcohol 230, synthesised 
previously, was converted to bromide 260 directly in 54% yield (Scheme 18). 
 
Scheme 52  Synthesis of cis-bromide analogues 
The thia-Claisen rearrangement involving bromide 259 (Scheme 53) gave little 
asymmetric induction (ca. 2:0:1:1).  Brominated substrate 260 on the other hand gave 
moderate diastereoselectivity (ca. 4:1:0:1); however, this was less than that achieved 
when using trans-bromide 223.  Interestingly, for the thia-Claisen rearrangement 
involving cis-bromide 259, the fourth diastereomer 261 could not be identified in the 
1
H 
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NMR spectrum of the crude material (it could not be isolated from the rearrangement 
involving trans-bromide 207 either), even though it was expected to be one of the two 
major products from this reaction.  One possible explanation for this is that product 261 
decomposes once formed; Table 3 summarises the results obtained.  
 
Scheme 53  Thia-Claisen rearrangement 
Entry Bromide Ratio
a
 
Yield of 
222 / % 
Yield of 
261 / % 
Yield of 
220 / % 
Yield of 
221 / % 
1 259 
2:1:1  
222a:220a:221a 
18 
Not 
isolated 
10 11 
2 260 
3.7:1:0.3:1 
222b:261b:220b:221b 
39 ca. 9 ca. 1 6 
 a 
Ratios measured from the 1H NMR spectrum of the crude reaction mixture 
Table 3  Product ratios from thia-Claisen rearrangement 
2.10.1  Model for the stereoselectivity  
According to the literature, the two most likely reactive conformations for these 
rearrangements should be those shown in Figure 21; allylic strain across the conjugated 
system is not affected by the nature of the R-group in these conformations.  Both 
conformations have the same amount of allylic strain, however, since conformation 262 
would involve attack from the double bond onto the opposite face of the allylic system 
to the C-O bond, we would expect this to be lower in energy than 263 due to the 
stabilisation discussed in section 1.5.3.1.  However, this was not the case; in fact, 222a 
and 222b were the major products from the thia-Claisen rearrangement.  
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Figure 21 Expected, but not observed, reactive conformations for thia-Claisen rearrangements 
This model is clearly not correct, and hence there must be an alternative explanation.  
However, there is no obvious reason why the above conformations would not be 
adopted, and why 262 would not be of lower energy than 263.  As a result, we are keen 
to perform computational work in the near future to help identify the reactive 
conformations adopted during this reaction. 
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3  Approaches towards the sarain core 
Two new approaches towards the sarain core have been investigated and these will be 
discussed in the following section.  The first approach investigates the use of 
halocarbenes to form ammonium ylids, while the second method is an altered version of 
the route described in section 1.4.7. 
3.1  Ring expansion approach to the core 
Although previous strategies adopted by the Porter group towards the core of sarain A 
involved the extension of the aldehyde side-chain of 96 prior to insertion into a C-N 
bond (Figure 22, top),
28
 an alternative strategy would be to perform the C-N insertion 
prior to C-C bond formation (Figure 22, bottom). 
 
Figure 22  Two strategies towards the sarain core 
Detailed below is our proposed synthesis of sarain core 95 via this ring expansion 
approach.  All synthetic steps up to aldehyde 96 are identical to those previously 
developed within our group (section 1.4.7); however, key aldehyde 96 would then 
undergo a Wittig olefination reaction to form silyl enol ether 264, which, following the 
ring expansion, would cyclise onto the iminium ion in 265 to form sarain core 266 
(Scheme 54). 
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Scheme 54  Ring expansion approach towards the sarain core 
The ring expansion step that forms the iminium ion could be achieved in one of two 
ways.  In the first approach, reaction of bicycle 264 with a monohalocarbene would 
result in alkylation on the more nucleophilic nitrogen (NBn) to form ylide 268, which 
could ring open to give iminium ion 269 and subsequently ring close to give 5,6-bicycle 
270; expulsion of the halogen would then form iminium ion 265 (Scheme 55). 
Dihalocarbenes may also be effective in this chemistry, with the extra halogen being 
removed subsequently. 
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Scheme 55  Ring expansion via two different methods 
In the second approach, alkylation of 264 using an alkyl halide on the more nucleophilic 
nitrogen would lead to alkylated product 267a which is in equilibrium with amine 267b; 
deprotonation of either 267a or 267b would lead to 268 or 269 respectively.  The same 
sequence of steps from either of these precursors could then lead to ring expanded 
product 265 (Scheme 55).   This strategy requires the alkyl halide to bear a good leaving 
group that is also anion-stabilising (e.g.  R = sulfonate). 
3.1.1  Model substrate formation 
We decided to test the proposed ring expansion step on bicycle 276 (which lacks the 
side chain of 264).  Bicycle 276 was made in 9 steps from lactam 102, using a 
procedure previously developed within the group;
80
 the synthesis started with allylation 
of lactam 102 followed by ozonolysis of the double bond and reduction of the resultant 
intermediate in situ to give alcohol 272.  Alcohol 272 was mesylated and then converted 
into the corresponding azide 274 using sodium azide.  Reductive cyclisation of azide 
274 afforded secondary amine 275, which, upon tosylation gave the required bicycle 
276 in 36% overall yield from lactam 102 (Scheme 56).  
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Scheme 56  Formation of model precursor 276 
3.1.2  Ring expansion step - attempts 
We began our ring expansion attempts by treating model substrate bicycle 276 with two 
different carbenes: (i) dichlorocarbene (by reaction of chloroform with KO
t
Bu);
81
 (ii) 
monochlorocarbene (by reaction of dichloromethane with MeLi).  However, despite 
several attempts to perform the alkylation/ring expansion in different solvents and at 
various temperatures, we were unable to isolate anything other than starting material 
from all reactions (Scheme 57). 
 
 
 
 
Scheme 57 Attempted ring expansions using carbenes 
The ring expansion was next attempted with bromide 277 (Scheme 58).  However, once 
again, the desired alkylation did not occur on any occasion. 
 
Halogen Base Solvent Temp/ºC 
CHCl3 KO
t
Bu 
THF 
Et2O 
CHCl3 
30 to 25 
25 
25 
CH2Cl2 MeLi 
CH2Cl2 
THF 
35 to 25 
35 to 25 
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Scheme 58  Attempted ring expansions using an alkyl halide 
Interestingly, when the above reaction was repeated with nitromethane as the solvent, 
product 279 was observed.  Furthermore, when bicycle 276 was simply stirred in 
nitromethane alone, the same product was formed.  We believe that this product arises 
due to bicycle 276 fluctuating between its ring-opened and ring-closed state; as a result, 
when the reaction is performed in nitromethane, a nitro-Mannich reaction can occur to 
trap iminium ion 278 and give rise to product 279 (Scheme 59, right). 
 
Scheme 59  Nitro-Mannich reaction and hydrogenation of iminium ion 
In order to improve the chance of alkylation occurring on the desired nitrogen in bicycle 
276, a debenzylation was attempted to produce an unprotected secondary amine.
82
 
However, when bicycle 276 was treated with standard hydrogenation conditions, amine 
280 was isolated.  This result can be explained as being a result of hydrogenation of 
intermediate iminium ion 278 that is formed when the ring opens (Scheme 59).  
Debenzylation was also attempted using CAN in an acetonitrile and water mixture; 
however, only starting material was obtained from this reaction.
83
 
Although it was clear that the ring expansion strategy was not a viable way in which we 
could form the sarain core due to the non-nucleophilicity of the benzylated nitrogen 
atom, we were interested to see whether the nitrogen atom could be alkylated using 
alternative halides, even if they would not generate a product that could be transformed 
into the sarain core in subsequent steps.  To this end, bicycle 276 was treated with neat 
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iodomethane at room temperature, and alkylated product 281 was indeed isolated in 
81% yield (Scheme 60).   
 
Scheme 60  Methylation of sarain intermediate 
This step indicated that the desired nitrogen could be alkylated, however, only with 
exceptionally good electrophiles such as iodomethane.   
3.2  Protecting group reversal strategy towards the sarain core 
3.2.1  Strategy 
As described in section 1.4.7, previous members of the Porter group have attempted to 
form sarain core 95 via an acid catalysed ring opening/cyclisation.
28
  However, this 
route failed as in the key final step bicycle 109 opened in the undesired direction and led 
to the formation of tricycle 118 (Scheme 61). 
 
Scheme 61  Previous attempted acid catalysed ring opening/cyclisation to form the sarain core 
In light of this result, we speculated that by switching the protecting groups around on 
the bicycle (i.e. to give bicycle 282), the ring opening step may occur in the desired 
direction, hence enabling the formation of the sarain core (Scheme 62). 
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Scheme 62  Proposed acid catalysed route towards the sarain core 
Upon ring opening, secondary sulfonamide 283 would result; this would then attack the 
protonated aldehyde group to form 8-membered ring 284 which, following 
intramolecular attack of the silyl enol ether onto the iminium ion, would form sarain 
core 285. 
3.2.2  Proposed synthetic route 
A detailed synthetic strategy of our revised route towards the core is shown below 
(Scheme 63).  We planned to use the chemistry previously developed by the group to 
synthesise lactam 286 and thus, the thia-Claisen rearrangement would still be the key 
step that provides the correct relative stereochemistry that is present in lactam 286; at 
this stage, we planned not to use the asymmetric thia-Claisen rearrangement discussed 
in the previous chapter until a full route towards the sarain core had been developed.  
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Scheme 63  Proposed approach towards the sarain core 
The first step that differs from our previous method is a debenzylation of lactam 286 to 
afford lactam 287.  Following this, both the OH and NH groups of 287 would be 
converted to their p-toluenesulfonyl derivatives, and the tosylate displaced to form azide 
288.  The reductive cyclisation step to form the bicyclic system could then be 
performed, according to the precedent from earlier work; the resulting secondary amine 
would be protected with a benzyl group to give alkene 289.  At this stage we would 
have successfully interchanged the protecting groups on the nitrogen atoms compared 
with previous routes. 
All that would remain would be to convert alkene 289 into aldehyde 290 via the 
corresponding alcohol, and reaction of this aldehyde with TBSCN, followed by 
reduction of the nitrile would give rise to aldehyde 282.  This key precursor would be 
treated with acid in an attempt to convert it into sarain core 285 in the fashion described 
in Scheme 62. 
3.2.3  Early steps  
The synthesis started with methylation of lactam 102, followed by thionation using 
Lawesson’s reagent to give thiolactam 101 in 87% over the two steps.  Following this, 
the thia-Claisen rearrangement was performed; alkylation of thiolactam 101 with allylic 
bromide 100 (made from reduction of ethyl-4-bromocrotonate using DIBAL, in 77% 
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yield) followed by treatment with triethylamine gave alcohol 99 in 80% yield.  
Thiolactam 99 was then hydrolysed using mCPBA to give lactam 286 in 88% yield 
(Scheme 64). 
 
Scheme 64  Early steps towards the sarain core
28
 
3.2.4 Debenzylation of N-benzyl lactam  
Debenzylation of the nitrogen atom in lactam 286 was required so that a tosyl protecting 
group could be introduced at a later stage.  To this end, N-benzyl lactam 286 was 
subjected to dissolving metal reduction using 5 equivalents of sodium in liquid 
ammonia.
84
  Although these conditions were effective in removing the benzyl group 
from the nitrogen atom to form amide 287, a considerable amount of alkene reduction 
was also observed, giving alcohol 292 as a by-product (Scheme 65). 
 
Scheme 65  Debenzylation of lactam 286 
However, after reaction optimisation, it was found that by reducing the amount of 
sodium metal to 2 equivalents and stirring the mixture for only 5-15 minutes, 
unprotected lactam 287 could be routinely isolated as the sole product in good yields. 
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3.2.5  Formation of N-tosyl bicycle 
The next hurdle that had to be overcome was the conversion of lactam 287 into N-tosyl 
bicycle 293 (Scheme 66).  This conversion could conceivably be achieved in one of two 
ways: (i) via tosyl protection of the OH and NH moieties in the molecule and 
displacement of the tosylate to give azide 288 – path a; (ii) via conversion of the alcohol 
into the corresponding azide, via the mesylate, followed by tosylation of the remaining 
nitrogen atom – path b. 
 
Scheme 66  Possible pathways towards bicycle 292 
It was important that the nitrogen atom in lactam 288 was protected prior to the 
cyclisation (i.e. the sequence of steps towards bicycle 293 had to go via azide 288), 
otherwise a bicycle with two unprotected nitrogen atoms would be formed, each 
requiring different protecting groups. 
3.2.5.1  N-Tosyl protection before azide formation 
We first attempted tosylation of both the lactam nitrogen and the alcohol of 287 in one 
step; the alcohol group was to be converted into the corresponding azide in the 
following step and so a good leaving group on the oxygen was required.  Thus, lactam 
287 was treated with 2.2 equivalents of sodium hydride in THF, followed by the 
addition of excess tosyl chloride.  The desired bis-protected product 295 was isolated, 
but was accompanied by undesired lactone 294 (Scheme 67).  Lactone 294 was thought 
to have arisen due to protection on nitrogen happening first and then cyclisation of the 
alcohol onto an N-protected lactam.  This cyclisation occurs readily because the 
sulfonamide protecting group is electron withdrawing and hence renders the carbon 
centre of the lactam very electrophilic and susceptible to attack from the nearby alcohol 
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(cf. previous routes where the lactam nitrogen bears a benzyl group –Scheme 16, section 
1.4.7). 
 
Scheme 67  Attempted formation of di-tosylated product 295 
3.2.5.2  Azide formation before N-tosylation 
We next decided to use a mild mesylation procedure to convert alcohol 287 into the 
corresponding mesylate, and then following conversion to the azide, the nitrogen atom 
would be protected.  Hence, alcohol 287 was treated with methanesulfonyl chloride and 
triethylamine in dichloromethane at room temperature; pleasingly, mesylate 296 was 
isolated in very good yield with no trace of the equivalent lactone by-product that is 
shown in Scheme 67.  
 
Scheme 68  Mesylation of alcohol 
The next step in our synthesis involved conversion of mesylate 296 into azide 300.  
Thus, mesylate 296 and sodium azide were dissolved in DMF and the solution stirred at 
60 ºC.  Despite the usual reliability of this reaction when used on other substrates,
28,29
 in 
this case we obtained a 1:1 mixture of azide 300 and tetrazole 299 (Scheme 69 and 
Table 4, entry 1). 
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Scheme 69  Attempted azide formation; formation of tetrazole 299 
Tetrazole 299 was believed to have formed in this case as the unprotected lactam (which 
is more nucleophilic than its N-benzylated equivalent – see Scheme 16, section 1.4.7) is 
able to attack the nearby carbon centre in an intramolecular fashion to form intermediate 
297, which then undergoes a [3+2] cycloaddition with the azide anion to form tricycle 
298; this then ring opens to form tetrazole 299.
85
  To thwart this process, we first 
increased the NaN3 loading from 3 equivalents up to 5; it was believed that excess azide 
may force the desired reaction to happen faster than the undesired intramolecular 
cyclisation.  Indeed, this increased the azide 300:tetrazole 299 ratio to 5:1 (entry 2, 
Table 4). 
After studying the effect of concentration on the ratio of azide 300 to tetrazole 299 
(entry 3), we then tried altering the reaction temperature and the order that the reagents 
were added (entries 4-7, Table 4).   
Entry
a
 Temp / ºC Equiv. NaN3 Ratio 300:299
e
 
1 60 3 1:1 
2 60 5 5.0:1 
3
b
 60 5 2.4:1 
4 40 5 3.5:1 
5 80 5 6.4:1 
6
c
 80 5 3.1:1 
7
d
 80 5 7.3:1 
               
Table A Optimisation of azide forming step 
 
 
Table 4  Optimisation of azide formation step 
a
 Reactions conducted at 0.1 M concentration of 296; the solution was at rt until all reagents 
were added, followed by heating to the specified temperature. 
b
 0.2 M concentration of 296. 
c
 Solution of mesylate in DMF was preheated prior to addition of NaN3. 
d Solution of 
sodium azide in DMF was preheated prior to addition of mesylate 296. 
e
 Ratio determined 
by 1H NMR analysis. 
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It was found that decreasing the temperature promoted tetrazole formation (entry 4) and 
conversely, increasing the temperature to 80 ºC encouraged azide formation (entry 5).  
In light of this result, we attempted the reaction at 80 ºC with: (i) a preheated solution of 
mesylate in DMF (entry 6) and (ii) a preheated solution of sodium azide in DMF (entry 
7).  As expected, the reaction which involved preheating a solution of mesylate 296 in 
DMF gave more tetrazole product (as intermediate 297 would begin forming before 
NaN3 is added) and the preheated solution of sodium azide in DMF gave an increased 
ratio of azide to tetrazole (i.e. there is no occasion where intermediate 297 can form 
without competition from the azide forming step). 
After the optimisation described above, the conditions that we employed for the azide 
formation step were those of entry 7; azide 300 was obtained in 73% yield along with 
12% of tetrazole 299.  The unprotected lactam moiety in azide 300 was subsequently 
sulfonylated with ease using sodium hydride as a base to give N-tosyl lactam 288 in 
excellent yield (Scheme 70). 
 
Scheme 70  Two step conversion of lactam 296 into azide 288 
3.2.6  Reductive cyclisation and benzyl protection  
The group’s previous methods towards the core (Scheme 14, section 1.4.7) involved a 
reductive cyclisation step that uses tri-n-butylphosphine followed by lithium aluminium 
hydride.  When these conditions were used on azide 288, lactam 302 formed very 
quickly after the addition of tri-n-butylphosphine (by TLC analysis) and did not 
disappear after the addition of lithium aluminium hydride.  Unsurprisingly, simple 
addition of tri-n-butylphosphine to a mixture of azide 288 and THF gave the same result 
(Scheme 71).   
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Scheme 71  Attempted reductive cyclisation; formation of lactam 302 
It was believed that intermediate 301 formed upon addition of tri-n-butylphosphine as 
desired.  However, due to the high electronegativity of the tosyl-lactam carbon in 301, 
intramolecular attack from the iminophosphorane moiety occurs to generate lactam 302 
before lithium aluminium hydride is added to the reaction (Scheme 71). 
In an attempt to circumvent this problem, we targeted the formation of an intermediate 
such as aminal 304 before reduction of the azide.  With intermediate 304 synthesised, 
subsequent reduction of the azide would provide the desired bicycle.  Thus, reduction of 
the lactam moiety in 288 to hemiaminal 304 was attempted using sodium borohydride; 
(Scheme 72).  However, formation of hemiaminal 304 was followed by spontaneous 
ring opening to give aldehyde 305, which was further reduced to alcohol 306.  In 
addition, lactam 302 was isolated; this presumably arises through reduction of the azide 
to the amine followed by cyclisation to form the lactam ring (Scheme 72).   
 
Scheme 72  Attempted reduction of lactam to N,O-acetal using NaBH4  
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We next attempted the reduction using DIBAL.
86
  Gratifyingly, upon treatment of azide 
288 with 1.2 equivalents of DIBAL in dichloromethane, hemiaminal 304 was isolated in 
very good yield as a mixture of diastereoisomers (Scheme 73).  Ring cyclisation was 
then performed by reaction of hemiaminal 304 with tri-n-butylphosphine to give bicycle 
303 in 90% yield. 
 
Scheme 73  Formation of bicycle 289 via hemiaminal 304 
Finally, bicycle 303 was N-protected with a benzyl group to give di-protected bicycle 
289 with the correct arrangement of the two protecting groups (i.e. opposite to that used 
in previous route). 
3.2.7  Hydroboration/oxidation of alkene 
3.2.7.1  Previous strategy employed by the Porter group 
The previous strategy adopted by our group on an analogous transformation (Scheme 
74) involved reaction of alkene 97 with Wilkinson’s catalyst and pinacolborane in THF; 
attempts that used BH3.THF and 9-BBN were unsuccessful.
28,87
 A one-pot procedure 
whereby the intermediate boronate was not isolated, but instead converted directly into 
alcohol 307 using sodium perborate was found to be highest yielding.  However, in all 
cases, product 307 was accompanied by an appreciable amount of over-reduced product 
308 (up to 27%).   
 
Scheme 74  Previous strategy adopted by the group for hydroboration/oxidation reaction 
A proposed mechanism for the hydroboration of an alkene with the related 
catecholborane and Wilkinson’s catalyst shows the reaction to involve oxidative 
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addition of the B-H bond to Rh(I), alkene insertion into the Rh-H bond and finally, 
reductive elimination of the B-C bond to give the boronate product (Scheme 75).
88
  
 
Scheme 75  A possible mechanism for alkene hydroborations mediated by Wilkinson’s catalyst 
In this detailed study, Burgess also states that mixing of Wilkinson’s catalyst 309 and 
catecholborane alone (i.e. in the absence of an alkene) results in significant degradation 
of catecholborane, giving rise to a number of products (Scheme 76).  The most 
significant of these are thought to be dihydride complex 310, a known catalyst for 
hydrogenation reactions, and H2 itself (the source of 308); we assume that something 
similar might happen with pinacolborane, although to our knowledge this study has 
never been carried out.  In addition, Wilkinson’s catalyst is known to undergo 
oxidation, especially when in solution, and the resulting oxidised catalyst is thought to 
be a more potent hydrogenation catalyst.
89
 
 
Scheme 76  Reaction of Wilkinson’s catalyst with catecholborane 
With this information in hand, the Porter group decided to repeat the reaction shown in 
Scheme 74 with thorough degassing of the solution to reduce this oxidation effect.  
Pleasingly, an increased ratio of 307:308 and yield of alcohol 307 was obtained (86%). 
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3.2.7.2  Work on current alkene 
When these reaction conditions were used on bicycle 289, alcohol 312 was obtained in 
up to 82% yield (via boronate 311), with a small amount of reduced product 313 
obtained (Scheme 77).  However, on repetition, the reaction was found to be capricious; 
a low ratio of alcohol 312 to reduced product 313 (up to 1:2 312:313) was commonly 
obtained and hence an alternative, more reliable procedure for this transformation was 
sought. 
 
Scheme 77  Hydroboration/oxidation of alkene using Wilkinson’s catalyst 
We next attempted the reaction using a procedure described by Crudden et al. whereby 
a stream of air was passed through the reaction mixture (Scheme 78);
90
 although this 
contradicts with the procedure previously used (Scheme 77), the authors claim that a 
much improved alcohol to reduced product ratio can be obtained using this method.  
However, when this protocol was implemented on alkene 289, no improvement on the 
ratio was observed.   
 
Scheme 78  Alternative attempts at hydroboration/oxidation step 
In the same paper, Crudden and co-workers also use an alternative catalyst, [Rh(µ-
Cl)(C2H4)2]2, in the presence of triphenylphosphine, to perform their hydroboration 
step; use of this catalyst was found to give more consistent results.  However, in our 
case, this procedure only converted 30% of the starting material to product after 4 days 
of stirring and did not increase the ratio of 312:313. 
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At this stage, we decided to continue with our route towards the core using the original 
method for hydroboration/oxidation shown in Scheme 77, even though the yields 
obtained were variable; several grams of alcohol 312 was obtained. 
3.2.8  Final stages towards the sarain core 
The final stages towards the sarain core began with  oxidation of alcohol 312 to give 
aldehyde 290 using Dess-Martin periodinane and pyridine in 59% yield (Scheme 79); 
following this, addition of TBSCN gave desired nitrile 314 in 70% yield.  Finally, 
DIBAL reduction of nitrile 314 gave the required rearrangement precursor 282 in a 
disappointingly low yield (up to 30%). 
 
Scheme 79  Final steps towards rearrangement precursor 
27 
Although this sequence of steps was capable of providing a small quantity of aldehyde 
282, the low yields obtained (in addition to the troublesome step depicted in Scheme 77) 
prevented any significant quantity of aldehyde 282 from being synthesised. 
3.2.9  Attempted rearrangement to give the sarain core 
The key rearrangement step was attempted only once on a 7 milligram scale, due to lack 
of material and time constraints.  The conditions used were the same as those that were 
previously employed by the Porter group,
28
 which had given some success on a similar 
substrate.  Unfortunately, there was no indication that sarain core 285 had formed from 
analysis of the crude 
1
H NMR spectrum. The 
1
H NMR spectrum of the crude reaction 
mixture indicated that several products were formed, and there was no evidence for the 
formation of 285. 
 
Scheme 80  Attempted rearrangement to give sarain core 285 
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It must be noted that although this reaction did not proceed as we desired, more success 
may have been obtained if the reaction was done on a larger scale with a more 
manageable amount of starting material and solvent (the small amount of AcOH/MeOH 
used in the reaction evaporated after a few hours at 60 ºC). 
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4  A new method for alcohol activation 
4.1  Alcohol iodination91 
4.1.1  Iodination studies on an intermediate en route to sarain A  
Previous work in the Porter group has revealed that hydrolysis of thiolactam 99 using 
methyl iodide in mild aqueous base generates the expected alcohol 286, as well as a 
small amount of iodide 317 (Scheme 81).
28
  This undesired side-reaction prompted the 
group to adopt a different strategy in order to hydrolyse thiolactam 99; namely, using 
mCPBA (Scheme 64).  Despite this result being undesired, the nature in which iodide 
317 had formed from 99 warranted further investigation. 
 
Scheme 81  Attempted hydrolysis of thiolactam 99; the formation of iodide 317 
The products from this reaction were thought to arise through initial methylation of the 
sulfur atom, cyclisation of the alcohol to form intermediate 315, and following 
expulsion of methanethiol (or, following a second methylation, dimethyl sulfide), 
iminium ion 316 could undergo either hydrolysis to form alcohol 286, or nucleophilic 
attack by an iodide ion to generate iodide 317. 
We anticipated that exclusion of water from the reaction mixture would enhance 
formation of iodide 317.  Hence, alcohol 99 was treated with two equivalents of methyl 
iodide in THF at reflux for two days (Scheme 82).  Pleasingly, iodide 317 was 
generated in 82% yield, with no trace of alcohol 286 being formed.   
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Scheme 82  Iodination of sarain A intermediate 99 using MeI 
With this intramolecular one-step conversion of alcohol/thioamide 99 into iodide/amide 
317 a success, it seemed plausible that if an alcohol was treated with a methylated 
thioamide intermolecularly in the absence of water, it may be possible to convert a 
range of alcohols into iodides in a similar fashion.  Moreover, if the thioamide chosen 
was N,N-dimethylthioformamide (318), the by-products expelled from the reaction 
would be the readily removable DMF and methanethiol (Scheme 83).     
 
Scheme 83  Proposed transformation of alcohol to iodide using a thioamide derived salt 
4.1.2  Iodination of alcohols: related literature 
A wide range of procedures are known for the direct conversion of alcohols into 
iodides; however, most of these procedures are based on phosphorus chemistry,
92
 for 
example PPh3/I2/imidazole,
93
 PPh3/NIS,
94
 PPh3/DEAD/MeI
95
 and P(OPh)3/MeI.
96,97
  All 
of the aforementioned procedures produce phosphine oxides or phosphonates as by-
products, often resulting in difficult workup procedures and product isolation.  In 
addition, separation of polar iodides from the phosphine oxide by-products can be 
difficult even after column chromatography. 
Other reagents that have been used for this transformation include BF3-Et2O/KI,
98
 
P4/I2,
99
 Cl2SO–DMF/KI,
100
 MgI2,
101
 ClSiMe3/NaI,
102
 PBu3I2/C6H6/HMPA
103
 and 
CeCl3.7H2O/KI.
104
  However, such procedures commonly suffer from one or more of 
the following problems: low yields, long reaction times, harsh reaction conditions, 
tedious workup procedures, low functional group compatibility and non-commercially 
available reagents. 
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There is some precedent for our proposed iodination method.  The use of S-alkylated 
thioureas for the activation of alcohols has been studied by Kajigaeshi et al., where 
N,N,N',N'-tetramethylthiourea (319) was reacted with the alkyl bromide and 
subsequently a sodium alkoxide was added to generate an unsymmetrical sufide 320 
(Scheme 84).
105
  
 
Scheme 84  Preparation of unsymmetrical sulfides 
Further related precedent comes from the reaction of alcohols with haloiminium halide 
322, to give an alkyl halide (Scheme 85).
106,107,108
  The haloimium salts required for 
these transformations are formed from reaction of DMF and oxalyl halide (321).  
However, this reaction is not amenable to the synthesis of iodoalkanes.  
 
Scheme 85  Formation of haloalkanes with haloiminium salts 322 
4.1.3  Results: Intermolecular iodination of alcohols 
4.1.3.1  Solvent Screening 
Initial iodination studies employed para-methylphenethyl alcohol (323) as a test 
substrate.  Upon treatment of alcohol 323 with two equivalents of thioamide 318 and 
four equivalents of MeI in various solvents at elevated temperatures, all reactions 
produced some iodide 324 but failed to go to completion within 24 hours.  However, 
addition of 2 equivalents of imidazole significantly increased the rate, enabling the 
iodination to be screened in a selection of common solvents (Scheme 86; Table 5).  The 
role of the imidazole is not entirely clear, as it could act as a base or as a nucleophilic 
catalyst. 
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Scheme 86  Solvent screening for iodination of a primary alcohol 
Entry
a
 Solvent 
Conversion to 
products / % 
Ratio of products
b
  
Iodide 324:formate 325 
1 THF 100 11.0:1 
2 CH2Cl2 100 5.9:1 
3 Et2O 39 1:3.6 
4 toluene 92 11.0:1 
5 MeCN 96 10.5:1 
6 DMF
c
 5 0:1 
a
 Conditions: 2 equiv. thioamide 318, 4 equiv. MeI, 2 equiv. imidazole,  reflux, 4 h.  
b
 Conversion  and  ratio 
determined  from  integration  of  crude 1H NMR spectra.  
c
 Reaction conducted at 120 C. 
 
Table 5
 
 Screening of solvents for iodination reaction 
In addition to the desired iodide 324, formate 325 was generated as a by-product in all 
cases (entries 1-6, Table 5).  The most selective reactions affording iodide 324 relative 
to formate 325 were observed with THF, toluene or MeCN as the solvent, giving ratios 
of approximately 11:1 iodide 324:formate 325 (entries 1, 4 and 5 respectively).  
Interestingly, with DMF as the solvent, the reaction was extremely slow and formate 
325 was the only product observed. 
Formate 325 was thought to arise through hydrolysis of alkoxyiminium ion 328 by 
adventitious water (Scheme 87).
106,109,110
  In an attempt to suppress formation of formate 
325, various drying agents (molecular sieves, magnesium sulfate, magnesium oxide) 
were added to the reaction.  However, none were successful in preventing formation of 
formate 325. 
 
Scheme 87  Proposed mechanism for conversion of alcohol 326 into iodide 330 and formate 329 
   
   
76 
 
At this stage we decided to continue with optimisation of the reaction as we did not 
believe that the small amount of formate by-product formed would have any detrimental 
effect on the yield; further insight into the source of the formate by-product was gained 
subsequently (see section 4.1.3.4). 
4.1.3.2  Optimisation 
Next, the possibility of pre-forming salt 327, rather than forming it in situ was 
considered.  It was believed a cleaner reaction should result, and undesired side-
reactions should decrease due to the reduced number of excess electrophilic and 
nucleophilic reagents present in the reaction mixture.  Furthermore, a pre-formed salt 
would simplify the procedure significantly.  Salt 327 was formed by stirring a mixture 
of N,N-dimethylthioformamide (318) and methyl iodide in anhydrous ether overnight 
(Scheme 88).  Upon completion, the solid (which precipitates from the reaction 
mixture) was filtered, washed and dried thoroughly, giving a white crystalline salt 327 
in excellent yield, which was then stored at 25 C. 
 
Scheme 88  Formation of salt 327 
Gratifyingly, when salt 327 was employed in the reaction shown in Scheme 86 instead 
of thioamide 318 and iodomethane, the reaction was still effective  
(Table 6, entry 1).  As a result, it was decided to optimise the iodination using pre-
formed salt 327, toluene as the solvent and alcohol 323 as the test starting material.  
Table 6 summarises the optimisation studies.  Initially, 1.5 equivalents of salt 327 and 1 
equivalent of imidazole were used.  The reaction was complete in 90 minutes at 85 C, 
with a good ratio of iodide 324:formate 325 being achieved (Scheme 89; Table 6, entry 
1).  Reducing the amount of imidazole present was not detrimental to the conversion of 
the reaction; however with 0.25 equivalents of imidazole the reaction was slightly 
slower (entries 2 and 3).   
 
Scheme 89  Optimisation of iodination conditions 
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Entry 
Equiv.  
salt 327 
Equiv. 
imidazole 
Temp/C Time/h 
Conversion to 
products/% 
Ratio of Products
a
  
324: 325 
1 1.5 1 85 1.5 100 12:1 
2 1.5 0.5 85 1.5 100 13:1 
3 1.5 0.25 85 3 100 16:1 
4 1.1 0.5 85 4 90 8:1
 
5 2 0.5 85 1.25 100 13:1 
6 3 0 85 3.5 24 50:1 
7 1.5 1 20 18 44 1:1 
8 1.5 0.5 20 18 25 0:1 
9 1.5 0.5 85
b
 1.5 100 24:1 
a
Ratio determined from integration of crude 1H NMR spectra.  
b
The solution of alcohol was heated to 85 ºC prior to 
addition of salt 19 and imidazole. 
Table 6  Optimisation of iodination reaction 
When less than 1.5 equivalents of salt 327 was used the product ratio 324:325 was 
reduced and longer reaction times resulted (entry 4), whilst an increase in amount of salt 
327 had no significant effect on either the ratio or reaction time (entry 5).  Exclusion of 
imidazole, even with 3 equivalents of salt 327, led to a high ratio of iodide 324:formate 
325, but very slow reaction rate (entry 6).  When the reaction was attempted at room 
temperature, the conversion was not only poor, but a significant increase in formate 325 
formation was observed.  In fact, when just 0.5 equivalents of imidazole was added, 
formate 325 was the sole product (entries 7 and 8). 
For entries 1-6 (Table 6) the reagents were mixed together at room temperature and 
subsequently heated to 85 C.  In light of the observed formate formation at room 
temperature (entries 7 and 8), the reaction conditions of entry 2 was repeated but with 
alcohol 323 being heated to 85 C in toluene prior to addition of salt 327 and imidazole 
(entry 9).  Pleasingly, this almost doubled the ratio of iodide 324:formate 325 to 24:1 
and gave an isolated yield of 92% of iodide 324.  As a result of this optimisation study, 
it was decided that the conditions of entry 9 were the most effective and desirable for 
the iodination reaction in terms of reaction time, quantity of reagents needed and ratio 
of iodide 324:formate 325 achieved. 
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Figure 23  
1
H NMR spectra of crude (left) and purified (right) reaction products 
A sample of salt 327 which had been stored at 25 C for 18 weeks was used in the 
iodination reaction of alcohol 323 under the optimised conditions and gave iodide 324 
in 90% yield.  This small reduction in yield of only 2% meant that the salt could also be 
pre-formed and stored without any significant degradation well in advance of its use.  
It is also noteworthy that the reaction requires no aqueous work-up; the reaction mixture 
is simply concentrated in vacuo to remove the solvent, methanethiol and most of the 
DMF to give the crude material with very few impurities present.  Figure 23 shows the 
1
H NMR spectra of crude and purified reaction products. 
4.1.3.3  Scope 
The scope and functional group compatibility of the iodination was next examined by 
treatment of various alcohols under the optimised conditions, in THF, toluene and 
acetonitrile.  Despite early indications that acetonitrile was a suitable solvent (Table 5), 
it became evident at an early stage that this was not the case for all alcohol substrates; 
for example, the reaction in entry 3 (Scheme 90) did not work in acetonitrile, despite 
working well in THF and toluene.  As a result, the scope of the iodination was 
investigated in THF and toluene only.  Pleasingly, the iodination was found to be highly 
tolerant of a range of functional groups, including nitro, tert-butyl carbamate, tertiary 
amine, nitrile, silyl ether, alkene, ester and acetal moieties (entries 2-8).  The yields 
obtained were generally excellent (82-93%) and reaction times were short.  
Additionally, a moderately hindered D-galactose derived primary alcohol (entry 9) was 
iodinated, albeit in slightly lower yield and longer reaction time.  
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Scheme 90  Scope of iodination reaction 
  Toluene THF 
 
Entry 
 
Alcohol Time/h 
Yield of 
iodide/% 
Yield of 
formate/% 
Time/h  
Yield of 
iodide/% 
Yield of 
formate/% 
1 
OH
 
1.25 92 2 1 90
a,b
 4 
2 
O2N
OH
 
1.5 84 3 1.5 85 4
c
 
3 
N
H
O
O OH
 
2 82 6 2 87
d
 4 
4 N
CN
OH
 
1.33 91 3 1.5 87
e
 4 
5 OHTBSO  3.5 90 2 2.5 84 3 
6 OH 1.33 81 4 1 83 2 
7 
O
O
OH 
1.5 93 1 1.5 91 4 
8 
O O
OH
 
0.83 88 7 0.83 82 9 
9 
O
OH
O
O
O
O
 
18 70 13 18 63 29 
10 
N
H
OH
 
1.5   1.5   
11
f
 
HO
 
2.5 0 27 2 0 24 
12 
OH
 
3.5 86 3 2.5 87 3 
13 OBn
OH
TBSO  
48 75 6 48 70 8 
14 OTBS
OH
TBSO  
72 60 0 48 76 0 
15 
O
O
O
O
O
HO  
6 0 10 7 0 16 
16 
O OH
OH
 
3 62 2 2 59
g
 3
h
 
17 BnO
OH
OH 
1 82 8 1 83
g
 5
i
 
18 
OH
 
6   6   
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  Toluene THF 
 
Entry 
 
Alcohol Time/h 
Yield of 
iodide/% 
Yield of 
formate/% 
Time/h  
Yield of 
iodide/% 
Yield of 
formate/% 
19 
OH
 
5   5
j
   
20 TBSO
OTBS
OH 
48 64 0 48
k
 61 0 
21 
OH
O
O
 
2.5 71 0 4
k
 41 0 
22 
OH
 
1   1
j
   
a 90% yield obtained when reaction carried out using 18 week old salt 327 in toluene, taking 1.5 h.  
b
 In MeCN, 83%  
isolated yield .   
c
 Eliminated   product   also  isolated   in  7%/6% yield.  
d
Reaction  failed  in MeCN.  
e
 In   MeCN,  
84%   isolated   yield.   
f
 Prepared  directly  from  corresponding  acid  using  LiAlH4  in THF at  room  temperature  
for 1 h, in 79%  yield. 
g Yield  is of  1°-iodo-2°-alcohol  compound. 
h 
Eliminated  product  337 also isolated  in 21% 
(Tol), 25% (THF).  
i Diiodide product also isolated in 3% (Tol), 3% (THF).
 j
 Reaction   done   at   room   
temperature.
 k
 Reaction done at 55 ºC with a substrate concentration of 0.14 M. 
Table 7 Iodination of a range of alcohols 
Secondary alcohols can also
 
be converted to iodides; in a slight modification to the 
general procedure, 1 equivalent of imidazole was required to accelerate the reaction and 
reaction times were extended in some cases (entries 12-14).  The alcohols in entries 13, 
14 and 17 (334, 332 and 333 respectively) were formed using standard procedures from 
triol 331 (Scheme 91).
111
  
 
Scheme 91  Formation of alcohol precursors  
Attempted iodination of allylic and benzylic alcohols proved troublesome due to their 
increased reactivity.  For the reaction involving cinnamyl alcohol (entry 19), the starting 
material was consumed at room temperature; however no iodide was isolated.  
Similarly, no iodide product was seen for the reaction involving benzyl alcohol (entry 
22).  However, iodination of two allylic alcohols that are not additionally conjugated to 
   
   
81 
 
 
* Details regarding the formation of these alcohols can be found in section 2. 
an aromatic ring (entries 20 and 21) was possible when the reaction was carried out 
under dilute conditions and at a reduced temperature.*     
It was not possible to iodinate highly hindered alcohols such as the primary, secondary 
and tertiary alcohols of entries 11, 15 and 18.  The increased steric encumbrance 
presumably prevents the iodide ion from being able to access the electrophilic carbon 
atom; for entries 11 and 15, a small amount of the corresponding formate was the only 
product isolated.   In addition, secondary amine (entry 10) could not be iodinated and 
instead a complex mixture of products was isolated.  Following this result, we believe 
that unprotected amines are incompatible functional groups to our reaction conditions as 
they are a competing nucleophile.   
Given the observed difference in reaction rate between primary and secondary alcohols 
(entries 1-9 vs entries 12-14), we decided to a subject a primary-secondary diol to the 
iodination conditions to find out whether a selective reaction was possible.  When 1,2-
diol 335 was used (entry 16 and Scheme 92), the reaction gave rise to desired iodide 
336 in mediocre yield; this is a consequence of the additional formation of 
dideoxygenated alkene side-product 337.  In addition, a small amount of formate 338 
was isolated.   In an attempt to thwart formation of alkene 337, 1,3-diol 333 (entry 17) 
was tested.  Diol 333 was prepared directly from 1,2,4-butanetriol (331, Scheme 91).  
 
Scheme 92  Attempted iodination of a 1,2-diol 
As expected, alcohol 333 was converted cleanly to primary iodide 339 
in very good yield in both THF and toluene (entry 17 and Figure 24).  
This pleasing result indicates that selective iodination of primary 
alcohols in the presence of secondary alcohols is possible in good 
yield.  In addition, benzyl ethers are yet another functional group compatible with the 
reaction conditions. 
Figure 24 
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4.1.3.4  Origin of the formate by-product 
Although in the early stages of this work it was unclear how the formate by-product was 
arising, the most likely reason for its formation was discovered whilst testing the scope 
of the reaction.  It is now believed that formate by-product 329 is a consequence of 
hydrolysis of intermediate alkoxyiminium ion 328 upon isolation, rather than in the 
reaction mixture itself (Scheme 93).  Hence, substrates that do not react further than the 
stable alkoxyiminium ion intermediate 328 would appear by TLC to have been 
converted into formate by-product 329 in situ, but in fact, this by-product was only a 
result of hydrolysis of alkoxyiminium ion 328 upon TLC. 
 
Scheme 93  Formation of formate by-product 
This theory was reinforced on many occasions for a variety of alcohols, as the formation 
of the formate by-product was seen to decrease (when the reaction was monitored by 
1
H 
NMR) as the reaction proceeded.  We now believe that the second part of the reaction 
shown in Scheme 93 (i.e. the displacement of DMF by an iodide ion) proceeds fastest in 
toluene and THF, and hence during a set time period this results in a better conversion 
of the alkoxyiminium ion intermediate into the iodide product, giving less formate by-
product. 
4.1.3.5 Stereochemical course of the reaction 
In order to determinine whether the iodination reaction proceeds via an SN1 or SN2 
mechanism, the stereochemical course of the reaction was studied using (R)-octan-2-ol 
(340) as a substrate (Scheme 94).  Samples were removed during the course of reactions 
and analysed by 
1
H NMR and chiral GC (Figure 25). 
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Scheme 94  Conversion of (R)-octan-2-ol (340) to (S)-2-iodooctane (341) 
 
 
Figure 25  Percentage conversion to 341 (left) and enantiomeric excess of 341 in the reaction of alcohol 
340 with salt 327 (right). 
After 1 hour in toluene at 85 ºC, alcohol 340 had undergone 61% conversion to iodide 
341; the enantiomeric excess of this iodide was found to be 68%. As the reaction 
proceeded, the enantiomeric purity of the product dropped, and after 8 hours, the iodide 
could be isolated in 73% yield, but with only 11% ee.  Similar results were obtained in 
THF at reflux, but with a more rapid formation of 341 and a more rapid deterioration of 
ee.  After 8 hours, racemic 341 was obtained in 78% yield.  Conversely, carrying out the 
reaction in toluene at 55 ºC led to slower conversion, but also to a slower degradation of 
the enantiomeric purity. In this case, the enantiomeric excess of iodide 341 after 8 hours 
was 81%. 
These results suggest that the initial conversion of 340 to 341 occurs, as expected, with 
inversion of configuration; in the presence of excess iodide, however, further SN2 
reactions interconvert 341 and its enantiomer, racemising the product.
112
 
4.2  C-X bond formation 
We believed that it could be possible to use similar chemistry to that in the iodination 
procedure in order to form other types of bonds such as C-C, C-S and C-O.  This could 
be achieved by performing the reaction using a thioiminium salt which has a non-
e
e
 (
%
) 
e
e
 (
%
) 
Time (h) Time (h) 
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nucleophilic counterion (i.e. not an iodide ion) and then a nucleophile (Nu) of choice 
could be added (Scheme 95). 
 
Scheme 95  Thioiminium salt with a non-nucleophilic counterion and its use to for other types of bonds 
This type of reaction is appealing for a number of reasons: (i) the by-products are 
readily removable (as in the iodination procedure); (ii) the thioiminium salt should be 
easy to make; (iii) a COH bond would be converted into CS, CC or COR bond in a 
single step.   
The two most common alternative ways to perform such a transformation are the 
Mitsunobu reaction or through the intermediacy of an activated substrate such as a 
halide or a sulfonate (Scheme 96).
113,114
  The Mitsunobu reaction has the disadvantage 
of producing triphenylphosphine oxide as a by-product and the latter method is a two-
step process.   
R
OH
R
OLG
R
NuNu
LG = Leaving group
Nu = Nucleophile
R
Nu PPh3,
DEAD
NuH
 
Scheme 96  Mitsunobu reaction (left) and two-step process (right) 
4.2.1  Conversion of alcohols to 1-phenyltetrazol-5-yl sulfides
115
 
4.2.1.1  Formation of thioiminium salts 
Initial studies in this area were carried out by an undergraduate student, Mark Frain.  He 
initially targeted two thioiminium salts (342 and 343, Scheme 97), each of which was 
accessible from thioamide 318; however, salt 343 was found to be a better choice as it 
was crystalline unlike salt 342, and therefore easier to isolate and handle. 
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Scheme 97  Thioiminium salts with non-nucleophilic counterions 
4.2.1.2  Formation of C-S bonds 
Frain carried out initial studies with a range of nucleophiles, and 1-phenyl-(1H)-
tetrazole-5-thiol (345) showed the most promise; this was appealing since use of a thiol 
nucleophile enables the formation of C-S bonds.  In addition, we were aware that the 
products obtained from these transformations were desirable as they can be directly 
converted into Julia-Kocienski olefination precursors.
113,114
 
 
Scheme 98  Attempted C-S bond formation using a thiol nucleophile 
Following Frain’s initial work, we set out optimise the reaction.  Firstly, a solvent 
screen was implemented with various medium to high boiling point solvents; alcohol 
344 was reacted with salt 343 (1.5 equivalents), imidazole (0.5 equivalents) and thiol 
345 (1.2 equivalents).  It was found that the reaction was slow in both THF and DMF 
(entries 2 and 4); however, the reaction was faster in MeCN (entry 3) and even more so 
in toluene (entry 1).  As a result, toluene was the solvent of choice for this reaction 
(Table 8). 
Entry
#
 Solvent Temperature 
Conversion to 
product / % 
1 Toluene 90 ºC 91 
2 THF Reflux 52 
3 MeCN Reflux 83 
4 DMF 90 ºC 57 
     #
Conditions: 1.5 equiv. salt 343, 0.5 equiv. imidazole, 1.2 equiv. thiol 345, 18 h, 0.2M substrate conc. 
Table 8  Solvent screen 
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Figure 26 
Secondly, as the reaction took 18 hours for a 90% reaction conversion 
when salt 343 was used in toluene, salt 347 (made in 93% yield from 
thioamide 318 - Figure 26) was used in the reaction instead, with the 
hope that a faster rate would be observed.  We considered that the rate might increase as 
methanethiol, as opposed to the less volatile ethanethiol, would be the by-product and 
hence any equilibrium between ROCH(SR’)NMe2 and ROCH=N
+
Me2 would be 
displaced to the right.  However, this was not the case and the reaction rate did not 
increase.  We therefore continued our studies with salt 343 as it is derived from cheaper 
starting materials.  
In an alternative attempt to increase the rate of reaction, we increased the concentration 
of the solution and the imidazole and thiol loading from 0.5 and 1.2 equivalents to 1 and 
2 equivalents respectively; gratifyingly, the reaction went to completion in 18 h and the 
1
H NMR spectrum of the crude reaction mixture showed fewer impurities in the crude 
material.  Using these new conditions, the yield of the sulfide product obtained with 
alcohol 344 as the starting material was 76% (entry 1, Table 9). 
 
 
Entry
a
 
 
Alcohol Time / h 
Isolated yield of 
sulfide / % 
1 
O
O
OH
 
18 76 
2
b
 
O O
OH
 
18 80 
3 OH 18 70 
4
b
 
N
H
O
O OH
 
24 76 
5 
OH
 
18 83 
6 
OH 
18 67 
7
c
 
N
Ph
NC OH
 
18 88 
8
b
 TBSO OH 18 62
d 
9 OH 
6 75 
10
e
 
OH
 
1 91 
11
e
 
OH
 
1 90 
                
 
 
 
 
 
Table 9  Scope of sulfide formation reaction 
a 
General reaction conditions: 1.5 equiv. salt 343, 1 equiv. imidazole, 2 equiv. thiol  345, 
toluene (substrate conc. 0.4-0.5 M),  90 ºC.  
b 
Acid sensitive: 5 equiv.  Imidazole required.  
c
 2 
equiv. imidazole added. 
d
 Yield is of  deprotected product, i.e. -hydroxy sulfide. 
e
 Allylic  or 
benzylic: 1.2  equiv. thiol. 
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The scope of the optimised procedure was then examined and the results can be seen in 
Table 9.  For substrates that do not possess acid sensitive functional and/or protective 
groups (entries 1, 3, 5, 6, 7, 9, 10 and 11), the corresponding sulfide products could be 
obtained in good yield; the reaction works with primary (linear and branched), 
secondary, allylic and benzylic alcohols, requires no aqueous work-up and functional 
groups such as esters, nitriles, alkenes and tertiary amines are compatible.  For benzylic 
and allylic alcohols, the thiol loading was reduced to 1.2 equivalents and the reaction 
time was significantly less due to the increased rate of reaction.   
However, for acid sensitive substrate 348 (a THP ether), under the same conditions, the 
desired product was only isolated in 31% yield as it was accompanied by a significant 
amount of by-product 350 in 32% yield; we believe that this product is formed after 
initial deprotection of the alcohol by an acid source, followed by attack onto the 
oxonium ion by thiol 345 (Scheme 99, top).   
The lack of stability of this acid sensitive group to our reaction conditions was thought 
to be a consequence of the formation of HBF4 (Scheme 99, bottom).   
 
Scheme 99  Formation of by-product 350 (top) and generation of HBF4 during the reaction (bottom) 
To overcome this problem, we first tried the reaction involving alcohol 348 using the 
sodium salt of thiol 345 instead of thiol 345 itself (so that NaBF4 rather than HBF4 
would be the by-product).  However, the lack of solubility of the thiolate anion in the 
solvent resulted in a very slow reaction and 100% conversion to the product was not 
possible.  We next reverted to thiol 345 as the nucleophile and varied the amount of 
imidazole added; it was believed that extra imidazole would buffer the acid formed and 
therefore make the conditions more suitable for acid sensitive substrates (Table 10). 
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Entry 
Equivalents of 
imidazole 
Ratio of products 
349:350 
Yield 349 / % Yield 350 / % 
1 0.5 1:5.4   
2 1 1:1.4  31 32 
3 2 1:0.4   
4 5 1:0  80 0 
*Conditions: 1.5 equiv. salt 343, imidazole (above), 2 equiv. thiol 345, toluene, 90 ºC, 18 h, 0.4-0.5 M substrate    
concentration  
Table 10  Optimisation of imidazole loading for acid sensitive substrates 
It was found that on increasing the imidazole loading to 2 equivalents, the amount of 
by-product 350 obtained decreased; with 5 equivalents of imidazole used (entry 4), no 
by-product 350 was present and sulfide 349 was isolated in 80% yield.   
We next tested the newly optimised conditions (i.e. 5 equivalents of imidazole for acid 
sensitive substrates) on two other acid sensitive alcohols - a Boc-protected amine (entry 
4, Table 9) and silyl ether respectively (entry 8, Table 9).  For the reaction involving the 
Boc-protected amine a 76% yield was obtained and no by-products were evident in the 
1
H NMR spectrum of the crude reaction mixture.  However, when silyl-protected 
alcohol 351 (entry 8) was used in the reaction, alcohol 353 was isolated as the sole 
product in 62% yield (Scheme 100).  We believe that the BF4

 counterion may supply 
the fluoride ion that attacks the silicon atom and leads to deprotection.   
 
Scheme 100  Deprotection of silyl ether in C-S bond forming step 
4.2.1.3  Attempted conversion of alcohols to phenyl sulfides 
Thiophenol was briefly examined examined in place of thiol 345 in the reaction with 
alcohol 351. Interestingly, when thiophenol (355) was used, no sulfide product was 
obtained; instead, the corresponding formate (which is formed upon hydrolysis of 
alkoxyiminium ion intermediate 328, Scheme 95) was isolated as the sole product. 
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The lack of reactivity of thiophenol suggests that the high acidity of thiol 345 (pKa = 
2.9
116
 vs. 6.5 for thiophenol 
116
) may be an important factor in the observed success of 
this reaction.  The low pKa of thiol 345 means that it will be largely deprotonated by the 
imidazole present in solution (pKBH+ = 7.0); as a result, it may be thiol anion 354 that is 
reacting.  Conversely, thiophenol cannot be deprotonated to anion 356 as easily and 
therefore reacts slowly due to its lower nucleophilicity (Figure 27). 
 
Figure 27  Thiol nucleophiles and their corresponding anions 
4.2.1.4  Attempted conversion of alcohols to fluorides, azides and nitriles 
The results obtained from our attempts to form other types of bonds can be seen in 
Scheme 101.  
 
Scheme 101  Attempted formation of nitriles, azides and fluorides 
We were unable to synthesise nitrile 357 using TMSCN as the nucleophile or azide 358 
using TMSN3 as the nucleophile; all that could be isolated from these reactions was the 
corresponding formate and silylated alcohol products. In order to produce more active 
nucleophiles, methanol (1 equivalent) was also added to both reactions (it was hoped 
that MeOTMS would form and therefore release the more nucleophilic anions CN

 or 
N3

); however this did not result in an improved reaction.   
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Formation of C-F bonds was also attempted and we were encouraged when a small 
amount of fluoride 359 was seen in the crude 
1
H NMR spectrum from the reaction 
involving CsF as a nucleophile (Scheme 101);* however, despite several alterations to 
the conditions so that the nucleophilicity of the fluoride source would increased (Table 
11), we were unable to improve this result and were not able to isolate fluoride 359.   
Nucleophile conditions Result 
CsF <1% in crude 
KF or NaF No product 
KF/18-crown-6 No product 
(
t
BuOH)4TBAF
117
 No product 
 
Table 11  Fluoride formation conditions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* The fluoride was identified by observation of a CH2F group (
2JHF = 47.3 Hz) at 4.4 ppm, and by comparison with 
literature data for this compound.
118
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5  Conclusions and future perspectives 
This thesis has described two distinct approaches that have been taken in order to 
synthesise the sarain core.  The first strategy towards the sarain core involved a ring 
expansion of bicycle 264 to give iminium ion 265, which would subsequently cyclise to 
give tricyclic core 95 (Scheme 102).  However, due to the inherent lack of 
nucleophilicity of the benzyl protected nitrogen atom in a model system, the initial 
alkylation step could not be achieved despite many attempts.   
 
Scheme 102  Attempted ring expansion approach towards the core of sarains A-C 
The second approach towards the sarain core involved the modification of an acid 
catalysed ring opening strategy that had previously been developed within the group 
(Scheme 103).  In this approach, to prevent the bicycle from opening in the undesired 
direction during the key ring opening step (as had occurred previously within the 
group’s studies), the protecting groups on the two nitrogen atoms were exchanged.   The 
precursor for this rearrangement was therefore made in 13 steps from thiolactam 101; 
synthesis of bicycle 282 was not as straightforward as first envisaged due to the 
increased electron withdrawing nature of the sulfonamide motif compared to the benzyl 
protecting group.  The key rearrangement step was attempted only once, on a small 
scale, due to time constraints; unfortunately, examination of the crude 
1
H NMR 
spectrum from this reaction showed no signs of the formation of core structure 285.  
Future work with regards to this strategy would involve re-attempting the key 
cyclisation step under different acidic conditions.  
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Scheme 103  Previous and revised approach towards the core  
A vital step in all of our current and previous attempted syntheses of the sarain core is a 
thia-Claisen rearrangement that provides key intermediate 99 (Scheme 103) as a 
racemic product with the correct relative stereochemistry; this thesis also provides 
information on an asymmetric variant of this rearrangement that has been developed 
(Scheme 104). 
 
Scheme 104  Past and present thia-Claisen rearrangements: racemic and asymmetric 
It was found that introduction of a fixed chiral centre into the bromide precursor for this 
rearrangement (in the form of an acetonide motif or a di-silyl ether) was effective in 
providing moderate to excellent diastereoselectivity in the thia-Claisen rearrangements 
(2.5:1 to 30:1).  Additionally, in an attempt to increase allylic strain and therefore 
enhance the level of diastereoselectivity achieved, a bulky removable group (a bromine 
atom) was placed onto the double bond of bromide precursor 203; surprisingly, upon 
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thia-Claisen rearrangement, the diastereomeric ratio increased and reversed from 2.5:1 
to 1:12.  All of the bromides used in the [3,3]-sigmatropic rearrangements were made 
from commercial D-mannitol.  Future work in this area may involve investigating a 
series of Claisen-like rearrangements of precursors that contain a bromine atom on the 
double bond, to see whether the increase and reversal in diastereoselectivity that was 
seen in our thia-Claisen rearrangement occurs for the [3,3]-sigmatropic rearrangements 
of other substrates.  
Whilst working towards the core of sarain A, previous members of the group had 
discovered that a small amount of iodide 317 is generated upon reaction of thiolactam 
99 with methyl iodide and mild aqueous base; after removal of all water from this 
reaction, we have since found that iodide 317 can be isolated as the sole product 
(Scheme 81 and Scheme 82).  The chemistry discovered in this unexpected 
intramolecular alcohol iodination was then used to enable the development of a new 
intermolecular alcohol iodination reaction (Scheme 105) 
 
Scheme 105  Novel alcohol iodination method using a thioiminium salt 
In this novel iodination reaction, a primary, secondary or allylic alcohol is reacted with 
thioiminium salt 327 and imidazole to form alkoxyiminium ion 328; subsequent attack 
from the iodide nucleophile gives rise to the corresponding iodide.  The reaction is high 
yielding, tolerant of a wide variety of functional and protecting groups and the 
thioiminium salt is stable for several months.  In addition, purification is very 
straightforward; the crude material is simply concentrated in vacuo to remove the 
volatile DMF and methanethiol by-products.  The major advantage of this procedure 
over existing phosphorus based methods is that no triphenylphosphine oxide is 
produced as a by-product, which can cause problems during product purification. 
The aforementioned methodology was then extended to allow the formation of other 
types of bonds, namely sulfides.  In this approach (Scheme 106), the alcohol is mixed 
with salt 343, (which has a non-nucleophilic counterion) along with imidazole to form 
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alkoxyiminium ion intermediate 328 in a similar fashion to that shown in Scheme 105; 
the thiol nucleophile then attacks this intermediate to give rise to the corresponding 
sulfide.   
 
Scheme 106  Novel alcohol to sulfide reaction 
As is the case for the iodination procedure (Scheme 105), products can be purified using 
this method very easily in good yields.  The thioiminium salt is also stable and many of 
the common functional and protecting groups are tolerated.  In comparison to the 
iodination procedure, reaction times are generally longer, however, formation of allylic 
and benzylic sulfides could be achieved in higher yields in shorter reaction times.   
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6  Experimental 
General  
All reactions that that were performed in non-aqueous conditions were carried out under 
an argon atmosphere in a flame dried flask.  
Chemicals 
Chemicals were purchased from Alfa Aesar, Acros, Avocado, Fisher, Fluka, Lancaster 
and Sigma-Aldrich Co. Ltd and were used without any further purification, unless stated 
otherwise.   
 NEt3 was distilled from CaH2 and stored over KOH.   
 Pyridine was distilled from CaH2 and stored over 4 Å molecular sieves.   
 NBS and TsCl were recrystallised according to the procedure  given in  Purification  
 of Laboratory Materials.
119
 
 Lawesson’s Reagent was prepared using the procedure by Clausen et al.120 
 DMP was prepared using the procedure by Boeckman et al.121 
Solvents 
Anhydrous DCM, THF, toluene, hexane, MeCN and ether were obtained after passing 
through alumina drying columns (UCL Anhydrous Solvent System) and were stored 
under argon over anhydrous molecular sieves. 
 DMF was distilled from, and stored over 4 Å molecular sieves 
 DMSO was distilled from CaH2 and stored over 4 Å molecular sieves 
Petrol refers to petroleum ether, boiling point = 40-60 ºC. 
Chromatography 
Flash chromatography was carried out on Merck silica gel 60 (40-60 μm) or either 
neutral or slightly acidic aluminium oxide (deactivated to grade III with 6% w/v water, 
50-200 µm).   
Preparative TLC was performed on a glass plate pre-coated with normal phase Merck 
silica gel 60 F254, 0.25 mm thickness.  
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TLC was performed on Merck Kieselgel 60 F254 aluminium sheets, visualised at short 
wavelength ultraviolet light (254 nm) and was stained with either potassium 
permanganate, iodine, CAM, 2,4-dinitrophenylhydrazine or vanillin. 
Spectroscopy 
1
H and 
13
C NMR spectra were recorded on Bruker AMX-300, Bruker AVANCE-400, 
Bruker AVANCE-500 and Bruker AVANCE-600 spectrometers.  
1
H and 
13
C NMR 
shifts are given in parts per million (ppm), and are quoted with reference to the solvent 
peak (CHCl3 in CDCl3 at 7.26 ppm, C6HD5 in C6D6 at 7.16 ppm, CHD2OD in CD3OD 
at 3.31 ppm for 
1
H NMR and 77.0 ppm, 128.1 ppm, 49.0 ppm for 
13
C NMR 
respectively).  The signals are denoted as s = singlet, d = doublet, t = triplet, q = quartet 
(and combinations thereof), quin = quintet, non = nonet, m = multiplet, br = broad.  
Coupling constants, J, are given in hertz.  COSY, HSQC, HMBC and DEPT were used 
to aid all assignments of spectra.   
IR were recorded on a PerkinElmer Spectrum 100 FTIR (ATR mode).  Signals are 
denoted as br  broad.  Mass spectra were recorded using a VG ZAB-SE or ZAB-SE4F 
instrument by Dr Lisa Harris (UCL).   
 
Miscellaneous 
Melting points were determined with an Electrothermal 9100 instrument.   
Optical rotations ([α]D) were recorded with a Perkin Elmer 343 polarimeter.   
Chiral GC analysis was carried out using a Supelco Beta-Dex™ 120 column (30 m × 
0.25 mm i.d.); carrier gas He, flow rate 100 mL min
–1
, oven temperature 80 ºC (20 min) 
then increasing at 2 ºC per min. 
Crystallographic data for the structural analysis has been deposited with the Cambridge 
Crystallographic Data Centre, CCDC No. 681439. Copies of this information may be 
obtained free of charge from the Director, CCDC, 12 Union Road, Cambridge, CB2 1 
EZ, UK (fax: +44-1223-336033; e-mail: deposit@ccdc.cam.ac.uk or http:// 
www.ccdc.ac.uk. 
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ASYMMETRIC THIA-CLAISEN REARRANGEMENT 
1,2:5,6-Di-O-isopropylidene-D-mannitol (210)
68,69
 
 
A solution of D-mannitol (209, 10.0 g, 54.9 mmol), para-
toluenesulfonic acid (52.0 mg, 0.30 mmol) and 2,2-
dimethoxypropane (14.3 g, 137 mmol) in DMSO (20 mL) was 
stirred at rt for 24 h.  To this solution was added 3% aq. NaHCO3 (100 mL) and the 
organic material extracted with EtOAc (3  100 mL), washed with H2O (3  50 mL), 
dried (MgSO4) and concentrated in vacuo.  The solid was recrystallised from 
hexane/EtOAc, washed with cold Et2O/hexane (1:3) and dried to give diol 210 (6.19 g, 
43%) as a white solid: mpt. 122-123 C [lit.122 = 118-120 C]; 17][
D
 +2.1 (c 0.80 in 
CHCl3) [lit.
123
 +6.0 (c 0.60 in CHCl3)]; υmax/cm
1
 (KBr disc) 3315br, 2982, 1068; 
1
H 
NMR (CDCl3, 300 MHz) δ 1.35 (6H, s) and 1.42 (6H, s, 2  C(CH3)2), 2.56 (2H, br s, 
OH), 3.74 (2H, d, J 6.3 Hz, CHOH), 3.98 (2H, dd, J 8.4, 5.4 Hz, OCHH), 4.03-4.22 
(4H, m, OCHH and CH2CH); 
13
C NMR (CDCl3, 75 MHz) δ 25.2 and 26.7 (2  
C(CH3)2), 66.7 (CH2), 71.2 (CHOH). 76.2 (CH2CH), 109.4 (CMe2); m/z (ESI) 285 
(MNa
+
, 100%), 263 (9). HRMS found 285.1321, C12H22O6Na (MNa
+
) requires 
285.1309. 
 
(S,E)-Ethyl 3-(2,2-dimethyl-1,3-dioxolan-4-yl)acrylate (213)
68
  
 
To a solution of diol 210 (5.99 g, 22.8 mmol) in aq. NaHCO3 
(5% w/v, 50 mL) at 0 C was added a solution of NaIO4 (6.00 g, 
27.6 mmol) in H2O (50 mL) and the resulting solution stirred 
for 1 h.  After cooling the mixture to 0 C, triethyl phosphonoacetate (19.0 mL, 95.1 
mmol) and K2CO3 (6 M, 150 mL) were added successively, whilst the temperature was 
maintained at 0 C.  After stirring the solution at rt for 24 h, H2O was added to dissolve 
the solid present, and the organic material was extracted with DCM (4  120 mL), dried 
(MgSO4) and concentrated in vacuo.  Purification by flash chromatography (SiO2, 
petrol/EtOAc 9:1) afforded ester 213 (7.84 g, 86%) as a colourless oil: 19][
D
  +32.8 (c 
0.74 in CHCl3) [lit.
124
 +38.0 (c 1.00, CHCl3)]; υmax/cm
1
 (thin film) 2986, 1720, 1651; 
1
H NMR (CDCl3, 300 MHz) δ 1.29 (3H, t, J 7.2 Hz, CH3CH2), 1.40 (3H, s) and 1.45 
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(3H, s, C(CH3)2), 3.67 (1H, dd, J 8.2, 7.1 Hz, CHHCH), 4.08-4.24 (3H, m, CHHCH 
and CH2CH3), 4.66 (1H, td, J 7.1, 5.6 Hz, OCH), 6.09 (1H, dd, J 15.6, 1.4 Hz, 
O=CCH), 6.87 (1H, dd, J 15.6, 5.6 Hz, O=CCH=CH); 
13
C NMR (CDCl3, 75 MHz) δ 
14.2 (CH3CH2), 25.7 and 26.4 (C(CH3)2), 60.6 (CH3CH2), 68.8 (CH2CH), 74.9 
(CH2CH), 110.2 (CMe2), 122.4 (O=CCH=CH), 144.6 (O=CCH), 166.0 (O=C) ; m/z 
(FAB
+
) 201 (MH
+
, 76%), 185 (29), 154 (100); HRMS found 201.1120, C10H17O4 (MH
+
) 
requires 201.1127. 
 
(S,E)-3-(2,2-Dimethyl-1,3-dioxolan-4-yl)prop-2-en-1-ol (214)
70
 
 
To a solution of ester 213 (6.05 g, 30.2 mmol) in DCM (90 mL) at 
–78 C was added DIBAL (1.2 M in toluene, 62.9 mL, 75.5 mmol) 
dropwise, and the resulting mixture stirred for 3 h at –78 C.  After warming to rt, 
MeOH (150 mL), Et2O (200 mL) and aq. sat. Rochelle’s salt (200 mL) were added 
successively, and the solution stirred for 1 h.  The aqueous phase was diluted with H2O 
(120 mL) and the organic material was extracted with EtOAc (4  150 mL), washed 
with brine (150 mL), dried (MgSO4) and concentrated in vacuo.  Purification by flash 
chromatography (SiO2, petrol/EtOAc 7:3) provided alcohol 214 (4.14 g, 87%) as a pale 
yellow oil: 19][
D
 +33.3 (c 1.00 in CHCl3) [lit.
125
 +33.9 (c 3.60 in CHCl3)]; υmax/cm
1
 
(thin film) 3395br (OH), 2986 (CH), 1680 (C=C); 
1
H NMR (CDCl3, 300 MHz) δ 1.39 
(3H, s) and 1.43 (3H, s, C(CH3)2), 3.60 (1H, t, J 7.9 Hz, CH=CHCHCHH), 4.11 (1H, 
dd, J 8.2, 6.2 Hz, CH=CHCHCHH), 4.18 (2H, dd, J 5.1, 1.4 Hz, CH2OH), 4.53 (1H, m, 
CH=CHCH), 5.72 (1H, dd, J 15.5, 7.5 Hz, HOCH2CH=CH), 5.96 (1H, dt, J 15.5, 5.1 
Hz, HOCH2CH=CH); 
13
C NMR (CDCl3, 75 MHz) δ 25.9 and 26.7 (C(CH3)2), 62.5 
(CH2OH), 69.3 (CH=CHCHCH2), 76.5 (CH=CHCHCH2), 109.4 (CMe2), 128.3 
(HOCH2CH=CH), 133.6 (HOCH2CH=CH).  
 
(S,E)-4-(3-Bromoprop-1-enyl)-2,2-dimethyl-1,3-dioxolane (207)
70
 
 
To a stirred solution of alcohol 214 (0.75 g, 4.74 mmol) in DCM 
(50 mL) at 0 C was added triphenylphosphine (1.37 g, 5.22 
mmol), followed by NBS (0.89 g, 5.00 mmol) portionwise over a few minutes.  The 
solution was stirred at rt for 2 h and then the reaction was quenched with H2O (30 mL).  
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The organic material was then extracted with DCM (3  90 mL), washed with brine (20 
mL), dried (MgSO4) and concentrated in vacuo.  Purification by flash chromatography 
(SiO2, petrol/Et2O 4:1) afforded bromide 207 (0.96 g, 93%) as a colourless oil: 
19][
D
 +50.0 (c 1.02 in CHCl3); υmax/cm
1
 (thin film) 2986; 
1
H NMR (CDCl3, 300 MHz) δ 
1.39 (3H, s) and 1.42 (3H, s, C(CH3)2), 3.61 (1H, t, J  7.6 Hz, OCHH), 3.92 (2H, d, J 
7.4 Hz, CH2Br), 4.10 (1H, dd, J 8.2, 6.3 Hz, OCHH), 4.52 (1H, m, OCH), 5.75 (1H, dd, 
J 15.2, 7.1 Hz, BrCH2CH=CH), 6.00 (1H, dt, J 15.2, 7.6 Hz, BrCH2CH=CH); 
13
C NMR 
(CDCl3, 75 MHz) δ 25.8 and 26.6 (C(CH3)2), 31.3 (CH2Br), 69.2 (OCH2), 75.8 (OCH), 
109.6 (CMe2), 129.7 (BrCH2CH=CH), 132.5 (BrCH2CH=CH). 
 
(S,E)-Ethyl 4,5-dihydroxypent-2-enoate (215) 
 
A solution of ester 213 (1.00 g, 5.00 mmol) in aq. AcOH (60% 
v/v, 50 mL) was stirred at rt for 24 h.  Petrol (50 mL) was added 
and the aq. layer separated and concentrated in vacuo.  The residue was dried by 
azeotroping successively with EtOH (3  50 mL) and toluene (3  50 mL) to give diol 
215 (0.78 g, 98%) as a cloudy oil:  20][
D
 –8.0 (c 1.03 in CHCl3)  [lit.
64
 –5.5 (c 1.57 in 
CHCl3)]; υmax/cm
1
 (thin film) 3398br, 2937, 1715, 1659; 
1
H NMR (CDCl3, 300 MHz) δ 
1.29 (3H, t, J 7.2 Hz, CH3), 2.34-2.89 (2H, br s, OH), 3.55 (1H, dd, J 11.2, 6.9 Hz, 
CHHOH), 3.77 (1H, dd, J 11.2, 3.2 Hz, CHHOH), 4.22 (2H, q, J 7.2 Hz, CH3CH2), 
4.43 (1H, br s, CHOH), 6.14 (1H, dd, J 15.7, 1.7 Hz, O=CCH=CH), 6.90 (1H, dd, J 
15.7, 4.4 Hz, O=CCH=CH); 
13
C NMR (CDCl3, 75 MHz) δ 14.2 (CH3), 60.7 (CH3CH2), 
65.5 (CH2OH), 71.7 (CHOH), 122.0 (O=CCH=CH), 146.2 (O=CCH=CH), 166.6 
(C=O); m/z (CI) 161 (MH
+
, 51%), 143 (55), 115 (52) 97 (100); HRMS found 161.0803, 
C7H13O4 (MH
+
) requires 161.0808. 
 
(S,E)-Ethyl 4,5-bis(tert-butyldimethylsilyloxy)pent-2-enoate (216) 
 
To a solution of diol 215 (5.00 g, 31.2 mmol) and imidazole 
(8.50 g, 125 mmol) in DCM (80 mL) at 0 C was added 
TBSCl (10.4 g, 68.7 mmol) and the mixture stirred at rt for 4 h.  The solution was 
diluted with H2O (250 mL), the organic material extracted with DCM (3  150 mL), 
washed with brine (200 mL), dried (MgSO4) and concentrated in vacuo.  Purification by 
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flash chromatography (SiO2, petrol/EtOAc 49:1) afforded ester 216 (9.35 g, 77%) as a 
colourless oil:  19][
D
 25.2 (c 0.68 in CHCl3); υmax/cm
1
 (thin film) 2930, 1725, 1661; 
1
H 
NMR (CDCl3, 300 MHz) δ 0.01-0.07 (12H, m, 2  Si(CH3)2), 0.87 (9H, s) and 0.89 
(9H, s, 2  C(CH3)3), 1.27 (3H, t, J 7.1 Hz, CH3CH2), 3.48 (1H, dd, J 9.9, 6.5 Hz, 
TBSOCHH), 3.58 (1H, dd, J 9.9, 6.3 Hz, TBSOCHH), 4.19 (2H, q, J 7.1 Hz, CH3CH2), 
4.30-4.35 (1H, m, TBSOCH), 6.04 (1H, dd, J 15.6, 1.8 Hz, O=CCH=CH), 7.01 (1H, dd, 
J 15.6, 4.2 Hz, O=CCH=CH);
 13
C NMR (CDCl3, 75 MHz) δ 4.8 and –4.8 (2  SiCH3), 
14.3 (CH3CH2), 18.3 and 18.4 (2  CMe3), 25.8 and 25.9 (2  C(CH3)3), 60.3 
(CH3CH2), 67.2 (TBSOCH2), 72.7 (TBSOCH), 120.8 (C=OCH=CH), 148.6 
(C=OCH=CH), 166.8 (O=C); m/z (ES
+
) 411 (100), 389 (MH
+
, 50%), 257 (64); HRMS 
found 389.2556, C19H41O4Si2 (MH
+
) requires 389.2538. 
 
(S,E)-4,5-Bis(tert-butyldimethylsilyloxy)pent-2-en-1-ol (217)  
 
To a solution of ester  216 (4.00 g, 10.3 mmol) in DCM (35 mL) 
at –78 C was added DIBAL (1.2 M in toluene, 20.7 mL, 24.7 
mmol) dropwise, and the resulting mixture stirred for 4 h at –78 C.  After warming the 
reaction mixture to rt, MeOH (50 mL), Et2O (60 mL) and aq. sat. Rochelle’s salt (50 
mL) were added successively, and the mixture stirred for 1 h.  The solution was diluted 
with H2O (50 mL), organic material extracted with EtOAc (3  50 mL), washed with 
brine (30 mL), dried (MgSO4) and the solvent removed in vacuo.  Purification by flash 
chromatography (SiO2, petrol/EtOAc 9:1) provided alcohol 217 (3.05 g, 85%) as a 
colourless oil: 19][
D
 16.8 (c 0.63 in CHCl3); υmax/cm
1
 (thin film) 3332br, 2929; 
1
H 
NMR (CDCl3, 300 MHz) δ 0.03-0.07 (12H, m, 2  Si(CH3)2), 0.88 (9H, s) and 0.89 
(9H, s, 2  C(CH3)3), 1.41 (1H, br s, OH), 3.44 (1H, dd, J 10.0, 5.9 Hz, TBSOCHH), 
3.53 (1H, dd, J 10.0, 6.5 Hz, TBSOCHH), 4.14-4.21 (3H, m, TBSOCH and CH2OH), 
5.72 (1H, dd, J 15.5, 3.8 Hz, HOCH2CH=CH) 5.87 (1H, dt, J 15.5, 5.2 Hz, 
HOCH2CH=CH);
 13
C NMR (CDCl3, 75 MHz) δ 4.6 (Si(CH3)2), 18.3 and 18.4 (2  
CMe3), 25.9 and 26.0 (2  C(CH3)3), 63.3 (CH2OH), 68.0 (TBSOCH2), 73.5 
(TBSOCH), 129.6 (HOCH2CH=CH), 132.3 (HOCH2CH=CH); m/z (ES
+
) 369 (MNa
+
, 
100%), 215 (17); HRMS found 369.2268, C17H38O3Si2Na (MNa
+
) requires 369.2252. 
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(S,E)-1-Bromo-4,5-bis(tert-butyldimethylsilyloxy)pent-2-ene (218)  
 
To a stirred solution of alcohol 217 (2.85 g, 8.23 mmol) in DCM 
(80 mL) at 0 C was added triphenylphosphine (2.37 g, 9.04 mmol), followed by N-
bromsuccinimide (1.54 g, 8.65 mmol) portionwise over a few minutes and the solution 
stirred at rt for 3 h.  The reaction was quenched with H2O (100 mL) and the organic 
material extracted with DCM (3  100 mL), washed with brine (170 mL), dried 
(MgSO4) and concentrated in vacuo.  Purification by flash chromatography (SiO2, 
petrol/Et2O 24:1) afforded bromide 218 (2.37 g, 71%) as a colourless oil: 
19][
D
 18.7 (c 
0.73 in CHCl3); υmax/cm
1
 (thin film) 2929; 
1
H NMR (CDCl3, 300 MHz) δ 0.60 (12H, 
m, 2  Si(CH3)2), 0.89 (9H, s) and 0.90 (9H, s, 2  C(CH3)3), 3.42 (1H, dd, J 9.9, 6.2 
Hz, TBSOCHH), 3.54 (1H, dd, J 9.9, 6.2 Hz, TBSOCHH), 3.96 (2H, d, J 7.2 Hz, 
BrCH2), 4.19 (1H, m, TBSOCH), 5.75 (1H, dd, J 15.3, 5.0 Hz, BrCH2CH=CH),  5.91 
(1H, m, BrCH2CH=CH);
 13
C NMR (CDCl3, 75 MHz) δ 4.7 and –4.6 (2  Si(CH3)2), 
18.3 and 18.4 (2  CMe3), 25.9 and 26.0 (2  C(CH3)3), 32.5 (BrCH2), 67.7 
(TBSOCH2), 73.0 (TBSOCH), 126.7 (BrCH2CH=CH), 136.0 (BrCH2CH=CH); m/z 
(EI
+
) 431/433 (MNa
+
, 12/13%), 351/353 (40/40), 330 (38), 329 (84), 307 (45), 197 (56), 
189 (61), 177 (81), 176 (100). HRMS found 431.1418, C17H37
79
BrO2Si2Na (MNa
+
) 
requires 431.1413. 
 
1-Benzylpyrrolidine-2-thione (219)
71
 
 
To a solution of lactam 102 (4.57 mL, 28.5 mmol) in THF (90 mL) was 
added Lawesson’s reagent (6.35 g, 15.7 mmol) and the solution heated to 40 
C with stirring for 2 h.  After allowing the mixture to reach rt, the reaction was 
quenched with H2O (60 mL) and the organic material extracted with EtOAc (3  100 
mL), washed with brine (3  60 mL), dried (MgSO4) and concentrated in vacuo.  
Purification by flash chromatography (SiO2, petrol/EtOAc 2:1) afforded thiolactam 219 
(3.90 g, 72%) as a pale yellow solid:  mpt. 72-73 C [lit.126 70-72 C]; υmax/cm
1
 (solid) 
2945, 1636, 1504; 
1
H NMR (CDCl3, 300 MHz) δ 2.02 (4H, quin, J 7.8 Hz, NCH2CH2), 
3.07 (2H, t, J 7.8 Hz, CH2C=S), 3.56 (2H, t, J 7.8 Hz, NCH2), 4.96 (2H, s, NCH2Ph), 
7.24-7.34 (5H, m, Aromatic CH); 
13
C NMR (CDCl3, 75 MHz) δ 19.4 (NCH2CH2), 44.9 
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(CH2C=S), 51.6 (NCH2Ph), 54.0 (NCH2), 128.0, 128.3 and 128.8 (Aromatic CH), 
135.1 (NCH2C), 201.7 (C=S). 
 
(S)-1-Benzyl-3-((R)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)allyl)pyrrolidine-2-thione 
(220a), (R)-1-benzyl-3-((S)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl) allyl)pyrrolidine-
2-thione (221a) and (S)-1-benzyl-3-((S)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-
yl)allyl)pyrrolidine-2-thione (222a)  
 
A mixture of thioamide 219 (0.59 g, 
3.08 mmol), E-bromide 207 (0.75 g, 
3.41 mmol) and 4Å molecular sieves 
(0.75 g) in MeCN (5 mL) was stirred under an argon atmosphere for 3 d.  Further 
MeCN (10 mL) was added and the mixture warmed to 35 C.  Triethylamine (0.48 mL, 
3.44 mmol) was added and the resulting solution stirred at 35 C for 5 h.  The mixture 
was cooled to rt, diluted with DCM (150 mL), washed with 2% citric acid (2  200 mL), 
dried (MgSO4) and concentrated in vacuo.  Purification by flash chromatography (SiO2, 
petrol:EtOAc 19:1) afforded rearrangement products 220a (390 mg, 38%), 221a (107 
mg,  10%) and 222a (10 mg, 1%), all as a pale yellow oils: 
  
For 220a:  17][
D
 5.6 (c 0.68 in CHCl3); υmax/cm
1
 (thin film) 3067, 2931, 1638, 1505, 
1585;
 1
H NMR (CDCl3, 500 MHz)
 δ 1.18 (3H, s) and 1.31 (3H, s, C(CH3)2), 2.10 (1H, 
m) and 2.26 (1H, m, NCH2CH2), 3.02 (1H, m, CH2=CHCH), 3.11 (1H, m, NC=SCH), 
3.44 (1H, m) and 3.59 (1H, m, NCH2CH2), 3.61 (1H, t, J 7.9 Hz) and 4.02 (1H, dd, J 
8.0, 6.4 Hz, OCH2), 4.26 (1H, m, OCH), 4.80 (1H, d, J 14.3 Hz, NCHHPh), 5.19 (1H, 
dd, J 10.2, 1.8 Hz, CHH=CH), 5.22 (1H, dd, J 17.4, 1.8 Hz, CHH=CH), 5.25 (1H, d, J 
14.3 Hz, NCHHPh), 5.93 (1H, ddd, J 17.4, 10.2, 9.1 Hz, CH2=CH), 7.30 (5H, m, 
Aromatic CH);
 13
C NMR (CDCl3, 125 MHz) δ 22.4 (NCH2CH2), 25.4 and 26.3 
(C(CH3)2), 47.7 (CH2=CHCH), 51.8 (NCH2Ph), 52.9 (NCH2), 58.0 (NC=SCH), 68.0 
(OCH2), 74.5 (OCH), 109.1 (CMe2), 118.7 (CH2=CH), 128.0, 128.3 and 128.8 
(Aromatic CH), 135.0 (Aromatic C), 135.1 (CH2=CH), 205.4 (C=S); m/z (CI) 332 
(MH
+
, 31%), 316 (24), 275 (37), 230 (80), 191 (100), 91 (40); HRMS found 332.1677, 
C19H26NO2S (MH
+
) requires 332.1684. 
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For 221a:  22][
D
 +82.2 (c 0.60 in CHCl3); υmax/cm
1
 (CDCl3 cast) 2983, 2931, 2873, 
1637, 1503, 1452;
 1
H NMR (CDCl3, 500 MHz)
 δ 1.35 (3H, s) and 1.39 (3H, s, 
C(CH3)2), 1.85 (1H, m) and 2.17 (1H, m, NCH2CH2), 2.60 (1H, m, CH2=CHCH), 3.41 
(1H, m, NC=SCH), 3.48-3.52 (2H, m, NCH2CH2), 3.57 (1H, dd, J 8.2, 6.7 Hz) and 3.94 
(1H, dd, J 8.2, 6.1 Hz, OCH2), 4.91 (1H, d, J  14.4 Hz, NCHHPh), 4.99 (1H, m, OCH), 
5.02 (1H, d, J 14.4 Hz, NCHHPh), 5.06 (1H, dd, J 10.3, 1.6 Hz, CHH=CH), 5.16 (1H, 
dd, J 17.2, 1.0 Hz, CHH=CH), 5.76 (1H, ddd, J 17.2, 10.3, 9.5 Hz, CH2=CH), 7.26-7.32 
(5H, m, Aromatic CH);
 13
C NMR (CDCl3, 125 MHz) δ 24.5 (NCH2CH2), 25.8 and 27.1 
(C(CH3)2), 51.5 (NCH2Ph), 52.6 (NC=SCH), 53.1 (CH2=CHCH), 54.2 (NCH2), 68.7 
(OCH2), 75.1 (OCH), 109.3 (CMe2), 119.2 (CH2=CH), 128.0, 128.4 and 128.8 
(Aromatic CH), 135.0 (CH2=CH), 135.3 (Aromatic C), 202.7 (C=S); m/z (CI) 332 
(MH
+
, 22%), 274 (100). HRMS found 332.1676, C19H26NO2S (MH
+
) requires 
332.1684. 
 
For 222a:  22][
D
 27.7 (c 1.35, CHCl3); υmax/cm
1
 (CDCl3 cast) 2981, 2920, 1644;
 1
H 
NMR (CDCl3, 500 MHz)
 δ 1.35 (3H, s) and 1.46 (3H, s, C(CH3)2), 1.97 (1H, m) and 
2.15 (1H, m, NCH2CH2), 3.34 (1H, dt, J 8.4, 3.0 Hz, CH2=CHCH), 3.42-3.53 (3H, m, 
NC=SCH and NCH2CH2), 3.74 (1H, dd, J 8.0, 5.8 Hz) and 4.05 (1H, m, OCH2), 4.07 
(1H, m, OCH), 4.89 (1H, d, J 14.3 Hz) and 5.09 (1H, d, J 14.3 Hz, NCH2Ph), 5.12 (1H, 
dd, J 10.6, 1.2 Hz) and 5.23 (1H, dd, J 17.3, 1.2 Hz, CH2=CH), 5.54 (1H, ddd, J 17.3, 
10.6, 8.4 Hz,  CH2=CH), 7.27-7.32 (5H, m, Aromatic CH);
 13
C NMR (CDCl3, 125 
MHz) δ 20.5 (NCH2CH2), 25.8 and  27.1 (C(CH3)2), 49.6 (CH2=CHCH), 51.8 
(NCH2Ph), 52.8 (NCH2), 54.7 (NC=SCH), 68.7 (OCH2), 74.8 (OCH), 109.5 (CMe2), 
120.2 (CH2=CH), 128.0, 128.4 and 128.8 (Aromatic CH), 133.0 (CH2=CH), 135.2 
(Aromatic C), 204.0 (C=S); m/z (EI) 331 (M
+
, 16%), 316 (14), 91 (12), 65 (19), 55 (21), 
51 (100); HRMS found 331.1605, C19H25NO2S (M
+
) requires 331.1601. 
 
 
 
 
 
 
   
   
104 
 
(S)-3-((3R,4S)-4,5-Bis(tert-butyldimethylsilyloxy)pent-1-en-3-yl)-1-
benzylpyrrolidine-2-thione (220b) and (R)-3-((3S,4S)-4,5-bis (tert-
butyldimethylsilyloxy)pent-1-en-3-yl)-1-benzylpyrrolidine-2-thione (221b) 
 
A mixture of thioamide 219 (0.21 g, 1.10 mmol), 
bromide 218 (0.50 g, 1.22 mmol) and 4Å molecular 
sieves (0.50 g) in MeCN (3 mL) was stirred under an 
argon atmosphere for 5 d; further MeCN was added (6 mL) and the mixture warmed to 
35 C.  Triethylamine (123 mg, 0.17 mL, 1.22 mmol) was added and the resulting 
solution stirred at 35 C for 7 h.  The mixture was cooled to rt, diluted with DCM (100 
mL), washed with 2% citric acid (2  150 mL), dried (MgSO4) and concentrated in 
vacuo.  Purification by flash chromatography (SiO2, petrol/EtOAc 199:1 to 9:1) 
afforded 220b (220 mg, 38%) as a white solid and 221b (7.00 mg, 1%) as a yellow oil:  
 
For 220b: mpt. 51-52 C; 17][
D
 14.0 (c 0.88 in CHCl3); υmax/cm
1
 (solid) 2932, 1630;
 
1
H NMR (CDCl3, 500 MHz)
 δ 0.05 (3H, s) and 0.03 (9H, m, 2  Si(CH3)2), 0.83 (9H, 
s) and 0.86 (9H, s, 2  C(CH3)3), 2.02-2.11 (2H, m, NCH2CH2), 2.76 (1H, m, 
CH2=CHCH), 3.26 (1H, m, NC=SCH),
 
3.37 (1H, m, NCHHCH2), 3.47 (1H, m, 
NCHHCH2),
 
3.59 (1H, dd, J 10.5, 4.8 Hz, OCHH),
 
3.78 (1H, dd, J 10.5, 4.4 Hz,
 
OCHH), 4.27 (1H, m, OCH), 4.83 (1H, d, J 14.3 Hz, NCHHPh), 5.05 (1H, dd, J 9.7, 
1.7 Hz, CHH=CH), 5.06 (1H, d, J 16.3 Hz, CHH=CH), 5.11 (1H, J 14.3 Hz, NCHHPh), 
5.92 (1H, td, J 16.3, 9.7 Hz, CH2=CH), 7.29 (5H, m, Aromatic CH); 
13
C NMR (CDCl3, 
125 MHz) δ –5.3, 5.2, 4.6 and 3.7 (2  Si(CH3)2), 18.2 and 18.3 (2  CMe3), 24.5 
(NCH2CH2), 26.0 (2  C(CH3)3), 49.7 (CH2=CHCH), 51.5 (NCH2Ph), 52.2 (NCH2), 
56.0 (C=SCH), 66.0 (OCH2), 72.8 (OCH), 117.8 (CH2=CH), 127.9, 128.3 and 128.8 
(Aromatic CH), 135.3 (Aromatic C), 136.9 (CH2=CH), 203.3 (C=S); m/z (CI) 520 
(MH
+
, 18%), 504 (25), 462 (44), 388 (100), 330 (11), 230 (54), 191 (33), 91 (34); 
HRMS found 520.3115, C28H50NO2SSi2 (MH
+
) requires 520.3101. 
 
For 221b:  20][
D
 +14.0 (c 0.30 in CHCl3); υmax/cm
1
 (CDCl3 cast) 2928, 1624;
 1
H NMR 
(CDCl3, 500 MHz)
 δ 0.02 (3H, s), 0.01 (3H, s), 0.17 (3H, s) and 0.22 (3H, s, 2  
Si(CH3)2), 0.89 (9H, s) and 0.91 (9H, s, C(CH3)3),  1.84 (1H, m) and 2.17 (1H, m, 
NCH2CH2), 2.42 (1H, td, J  9.9, 2.1 Hz, CH2=CHCH), 3.36 (1H, m, NC=SCH),
 
3.45 
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(1H, m, NCHHCH2), 3.47 (1H, dd, J 10.7, 4.1 Hz, OCHH),
 
3.63 (1H, m, NCHHCH2),
 
3.67 (1H, dd, J 10.7, 2.5 Hz, OCHH),  4.85 (1H, d, J 14.7 Hz,
 
NCHHPh), 4.87 (1H, m, 
OCH), 5.02 (1H, dd, J 10.2, 2.2 Hz, CHH=CH), 5.06 (1H, d, J 14.7 Hz, NCHHPh), 
5.07 (1H, dd, J 17.3, 2.2 Hz, CHH=CH), 5.90 (1H, ddd, J 17.3, 10.2, 7.3 Hz, CH2=CH), 
7.30 (5H, m, Aromatic CH); 
13
C NMR (CDCl3, 125 MHz) δ –4.0 and 3.9 (2  
Si(CH3)2), 18.4 and 18.5 (2  CMe3), 26.0 and 26.1 (2  C(CH3)3), 26.3 (NCH2CH2), 
51.3 (NCH2Ph), 52.2 (NCH2), 52.4 (C=SCH), 53.2 (CH2=CHCH), 66.3 (OCH2), 72.9 
(OCH), 118.5 (CH2=CH), 127.9, 128.3 and 128.7 (Aromatic CH), 135.5 (Aromatic C), 
136.0 (CH2=CH), 202.9 (C=S); m/z (CI) 520 (MH
+
, 100%), 504 (44), 388 (42). HRMS 
found 520.3110, C28H50NO2SSi2 (MH
+
) requires 520.3101. 
 
Triethyl dibromophosphonoacetate (226)
72
 
 
To a solution of NaOH (20.0 g, 500 mmol) in H2O (60 mL) at 10 
C was added Br2 (12.8 mL, 250 mmol) dropwise over ca. 30 min.  
To this, phosphonate 225 (10.6 mL, 53.5 mmol) was added dropwise with the internal 
temperature being maintained below 10 C.  The product was extracted immediately 
with CHCl3 (4  100 mL), washed with H2O (2  20 mL), dried (MgSO4) and the 
solvent removed in vacuo to give dibromide 226 (19.8 g, 97%) as a cloudy oil: 
υmax/cm
1
 (CDCl3 cast) 2984, 2936, 1733; 
1
H NMR (CDCl3, 300 MHz) δ 1.36 (3H, t, J  
7.1 Hz, CO2CH2CH3), 1.40 (6H, m, P=O(OCH2CH3)2),  4.31-4.47 (6H, m, 3  CH2);  
13
C NMR (CDCl3, 125 MHz) 13.8 (C=OCH2CH3), 16.4 and 16.5 (P=O(OCH2CH3)2), 
46.4 (CBr2), 64.7 (C=OCH2CH3), 66.4 and 66.5 (P=O(OCH2CH3)2), 163.8 (C=O);  m/z 
(CI) 381/383/385 (MH
+
, 47/100/46%), 353/355/357 (16/32/16). HRMS found 
380.9094, C8H16
79
Br2O5P (MH
+
) requires 380.9102. 
 
Triethyl bromophosphonoacetate (227)
72
 
 
To a solution of dibromide 226 (18.6 g, 48.5 mmol) in EtOH (45 
mL) at 10 C was added a solution of SnCl2 (7.80 g, 41.1 mmol) in 
H2O (95 mL) was added over ca. 20 min with the internal temperature being maintained 
at 10 C.  The product was extracted immediately with CHCl3 (4  100 mL), dried 
(MgSO4) and the solvent removed in vacuo to give phosphonate 227 (13.5 g, 92%) as a 
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colourless oil: υmax/cm
1
 (CDCl3 cast) 2982, 1741; 
1
H NMR (CDCl3, 500 MHz) δ 1.29 
(3H, t, J 7.2 Hz, C=OCH2CH3),  1.35 (6H, t, J 7.1 Hz, P=O(OCH2CH3)2), 4.20-4.28 
(6H, m, 3  CH2), 4.34 (1H, d, J 14.0 Hz, CHBr);  
13
C NMR (CDCl3, 125 MHz) 14.0 
(C=OCH2CH3), 16.4 (P=OCH2CH3), 36.5 (CBr), 63.2 and 64.7 (C=OCH2CH3 and 
P=O(OCH2CH3)2), 165.1 (C=O); m/z (FAB
+
) 325/327 (MNa
+
, 98/100%), 303 (31), 247 
(30).  HRMS found 324.9810, C8H16
79
BrO5PNa (MNa
+
) requires 324.9816. 
 
(S,Z)-Ethyl 2-bromo-3-(2,2-dimethyl-1,3-dioxolan-4-yl)acrylate and  
(S,E)-ethyl 2-bromo-3-(2,2-dimethyl-1,3-dioxolan-4-yl)acrylate (228) - inseparable 
mixture  
 
To a solution of diacetonide 210 (2.49 g, 9.50 
mmol) in aq. NaHCO3 (5% w/v, 25 mL) at 0 
C was added a solution of NaIO4 (2.48 g, 
11.4 mmol) in H2O (25 mL).  After stirring for 1 h, the solution was cooled to 0 C and 
then phosphonate 227 (12.0 g, 39.4 mmol) and K2CO3 (6 M, 70 mL) were added 
successively and the reaction stirred overnight at rt.  After dissolving any remaining 
solid in H2O (ca. 50 mL), the organic material was extracted with DCM (3  150 mL), 
dried (MgSO4) and the solvent removed in vacuo.  Purification by flash chromatography 
(SiO2, petrol/EtOAc 98:2) afforded an inseparable 1.6:1 mixture of Z:E ester 228 (4.57 
g, 86%) as a colourless oil: max/cm
–1
 (CDCl3 cast) 2985, 2935, 1783, 1729, 1631; 
1
H 
NMR (CDCl3, 300 MHz) δ 1.30-1.40 (6H, m, CH3CH2 of MAJ and CH3CH2 of MIN), 
1.33 (3H, s) and 1.37 (3H, s, C(CH3)2 of MIN), 1.41 (3H, s) and 1.46 (3H, s, C(CH3)2 of 
MAJ) 3.71 and 4.20-4.35 (8H, m, OCH2CH of MAJ, OCH2CH of MIN, OCH2CH3 of 
MAJ and OCH2CH3 of MIN), 4.95 (1H, q, J  6.7 Hz, OCH of MAJ), 5.22 (1H, q, J  7.3 
Hz, OCH of MIN), 6.80 (1H, d, J  6.9 Hz, BrC=CH of MIN), 7.36 (1H, d,  J  6.7 Hz, 
BrC=CH of MAJ); m/z (CI) 279/281 (MH
+
, 8/5%),  263/265 (100/100).  HRMS found 
279.0229, C10H16
79
BrO4 (MH
+
) requires 279.0226. 
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(S,Z)-2-Bromo-3-(2,2-dimethyl-1,3-dioxolan-4-yl)prop-2-en-1-ol (229) and  
(S,E)-2-Bromo-3-(2,2-dimethyl-1,3-dioxolan-4-yl)prop-2-en-1-ol (230)  
 
To a solution of E- and Z-esters 228 (3.15 g, 
11.3 mmol) in DCM (30 mL) at 78 C was 
added DIBAL (1.2 M in toluene, 22.7 mL, 27.2 mmol) dropwise and the solution stirred 
for 6 h at 78 C.  After allowing the reaction mixture to warm to rt, MeOH (50 mL), 
Et2O (60 mL) and aq. sat. Rochelle’s salt (60 mL) were added successively, and the 
mixture stirred for 1 h. The solution was diluted with H2O (50 mL), organic material 
extracted with EtOAc (3  50 mL), washed with brine (100 mL), dried (MgSO4) and the 
solvent removed in vacuo.  Purification by flash chromatography (SiO2, petrol/EtOAc 
19:19:1) afforded E-alcohol 229 (1.35 g, 41% from 210) and Z-alcohol 230 (0.81 g, 
25% from 210) as colourless oils: 
 
For 229:  22][
D
 = +12.1 (c 1.34 in CHCl3); max/cm
–1
 (DCM cast) 3439 br, 2987, 2929, 
2869, 1667; 
1
H NMR (CDCl3, 300 MHz) δ 1.40 (3H, s) and 1.44 (3H, s, C(CH3)2), 3.65 
(1H, dd, J 8.3, 7.1 Hz) and  4.22 (1H, dd, J 8.3, 6.3 Hz, OCH2), 4.25 (2H, s, CH2OH), 
4.92 (1H, td, J 7.1, 6.3 Hz, OCH), 6.20 (1H, d, J 7.3 Hz, BrC=CH); 
13
C NMR (CDCl3, 
125 MHz) 25.7 and 26.6 (C(CH3)2), 67.8 (OCH2), 68.6 (CH2OH), 75.2 (OCH), 109.7 
(CMe2), 128.0 (BrC=CH), 129.0 (BrC=CH); m/z (CI)  237/239 (MH
+
, 56/52%) 221/223 
(30/23), 196/198 (98/100); HRMS found 237.0119, C8H14
79
BrO3 (MH
+
) requires 
237.0121. 
 
For 230:  max/cm
–1
 (DCM cast) 3421 br, 2976, 2903, 1665; 
1
H NMR (CDCl3, 500 
MHz) δ 1.36 (3H, s) and 1.40 (3H, s, C(CH3)2), 3.62 (1H, dd, J 8.4, 7.1 Hz) and  4.10 
(1H, dd, J 8.4, 6.3 Hz, OCH2), 4.40 (2H, s, CH2OH), 4.83 (1H, ddd, J 8.2, 7.1, 6.3 Hz, 
OCH), 6.05 (1H, d, J 8.2 Hz, BrC=CH);  
13
C NMR (CDCl3, 125 MHz) 25.8 and 26.7 
(C(CH3)2), 63.8 (CH2OH), 69.2 (OCH2), 72.6 (OCH), 110.0 (CMe2), 129.6 (CBr) 
132.3 (BrC=CH). 
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(S,Z)-4-(2,3-Dibromoprop-1-enyl)-2,2-dimethyl-1,3-dioxolane (223)  
 
To a solution of alcohol 229 (0.95 g, 4.03 mmol) in DCM (35 mL) 
at 0 C was added triphenylphosphine (1.16 g, 4.42 mmol), 
followed by N-bromosuccinimide (0.75 g, 4.21 mmol) portionwise over a few minutes 
and the solution was stirred at rt for 3 h.  The reaction was quenched with H2O (50 mL), 
organic material extracted with DCM (3  50 mL), washed with brine (100 mL), dried 
(MgSO4) and the solvent removed in vacuo.  Purification by flash chromatography 
(SiO2, petrol/EtOAc 23:2) afforded bromide 223 (0.80 g, 67%) as a yellow oil: 
υmax/cm
1
 (CDCl3 cast) 2986, 2932, 1647; 
1
H NMR (CDCl3, 500 MHz) δ 1.39 (3H, s) 
and 1.42 (3H, s, C(CH3)2), 3.65 (1H, dd, J 8.4, 6.8 Hz, OCHH),  4.20 (1H, d, J 11.7 Hz, 
CHHBr), 4.23 (1H, d, J 11.7 Hz, CHHBr), 4.24 (1H, dd, J 8.4, 6.4 Hz, OCHH), 4.85 
(1H, app. q, J 6.9 Hz, OCH), 6.27 (1H, d, J 7.1 Hz, BrC=CH);  
13
C NMR (CDCl3, 125 
MHz) 25.6 and 26.6 (C(CH3)2), 37.4 (CH2Br), 68.4 (OCH2), 75.7 (OCH), 110.0 
(CMe2), 124.2 (CBr), 132.7 (BrC=CH);  m/z (CI) 299/301/303 (MH
+
, 28/52/22%), 
241/243/245 (27/53/23) 219/221 (27/27), 189/191 (50/50), 161/163 (100/99). HRMS 
found 298.9289, C8H13
79
Br2O2 (MH
+
) requires 298.9282. 
 
3-Bromo-5-(hydroxymethyl)furan-2(5H)-one (231) and (S,Z)-ethyl 2-bromo-4,5-
dihydroxypent-2-enoate (232)   
 
Ester mixture 228 (3.20 g, 11.5 mmol) and 60% aq. AcOH (60 mL) were 
stirred at rt for 2 d.  Petrol (60 mL) was added, the aq. layer separated and 
concentrated in vacuo.  The residue was dried by azeotroping successively 
with EtOH (3  60 mL) and toluene (3  60 mL) to give lactone 231 (0.76 g, 35% from 
210) as a yellow oil:  20][
D
 +27.0 (c 0.91 in CHCl3); υmax/cm
1
 (CDCl3 cast) 3397br, 
2984, 1713, 1627;  
1
H NMR (CDCl3, 500 MHz) δ 1.35 (3H, t, J  7.2 Hz, CH3), 3.65 
(1H, dd, J 11.2, 7.2 Hz, CHHOH), 3.83 (1H, dd, J 11.2, 3.2 Hz, CHHOH),  4.30 (2H, q, 
J 7.2 Hz, CH3CH2),  4.71 (1H, td, J 7.2, 3.2 Hz, CHOH), 7.30 (1H, d, J 7.6 Hz, 
CBr=CH); 
13
C NMR (CDCl3, 125 MHz) δ 14.1 (CH3), 63.0 (CH3CH2), 64.1 (CH2OH), 
72.6 (CHOH), 117.4 (CBr), 143.2 (CBr=CH), 161.9 (C=O);  m/z (CI) 239/241 (MH
+
, 
8/7%), 223 (97), 221 (100), 195 (45), 193 (48), 177 (93), 175 (94). HRMS found 
238.9915, C7H12
79
BrO4 (MH
+
) requires 238.9919. 
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Further elution gave diol 232 (1.49 g, 6.26 mmol, 54% from 
210) as a colourless oil: 20][
D
 51.5 (c 0.20 in CHCl3); υmax/cm
1
 
(CDCl3 cast) 3400br, 2930, 1756, 1607; 
1
H NMR (CDCl3, 500 
MHz) δ 3.83 (1H, dd, J 12.3, 4.8 Hz, CHH), 3.99 (1H, dd, J  12.3, 3.9 Hz, CHH),  5.08 
(1H, ddd, J 4.8, 3.9, 1.8 Hz, CH2CH),  7.54 (1H, d, J 1.8 Hz, CBr=CH); 
13
C NMR 
(CDCl3, 125MHz) δ 62.2 (CH2), 83.2 (CH2CH), 114.5 (CBr), 150.0 (CBr=CH) 168.3 
(C=O); m/z (CI) 193/195 (MH
+
, 46/46%), 177 (99), 175 (100). HRMS found 192.9495, 
C5H6
79
BrO3 (MH
+
) requires 192.9500.  
 
(S,Z)-Ethyl 2-bromo-4,5-bis(tert-butyldimethylsilyloxy)pent-2-enoate (233) 
 
To a solution of diol 232 (1.23 g, 5.17 mmol) and imidazole 
(1.75 g, 25.7 mmol) in DCM (30 mL) at 0 C was added 
TBSCl (2.33 g, 15.4 mmol) and the solution stirred for 3 h at rt.  The reaction was 
quenched with H2O (50 mL), the organic material extracted with DCM (3  50 mL), 
washed with brine (50 mL), dried (MgSO4) and concentrated in vacuo.  Purification by 
flash chromatography (SiO2, petrol/EtOAc 19:1) afforded ester 233 (2.09 g, 87%) as a 
colourless oil: 20][
D
 +1.9 (c 0.57 in CHCl3); υmax/cm
1
 (CDCl3 cast) 2955, 2929, 2886, 
2858, 1723, 1630; 
1
H NMR (CDCl3, 500 MHz) δ 0.04 (9H, m) and 0.07 (3H, s, 2  
Si(CH3)2), 0.86 (18H, s, 2  C(CH3)3), 1.31 (3H, t, J 7.1 Hz, CH3CH2), 3.56 (1H, dd, J 
10.3, 4.9 Hz, TBSOCHH), 3.63 (1H, dd, J 10.3, 6.3 Hz, TBSOCHH), 4.30 (2H, q, J 7.1 
Hz, CH3CH2), 4.62 (1H, ddd, J 8.0, 6.3, 4.9 Hz, TBSOCH), 7.12 (1H, d, J 8.0 Hz, 
CBr=CH);
 13
C NMR (CDCl3, 125 MHz) δ 5.5 and 4.6 (2 x Si(CH3)2)), 14.2 
(CH3CH2), 25.8, 25.9, 26.0 (2 x C(CH3)3), 62.7 (CH3CH2), 66.2 (TBSOCH2), 74.1 
(TBSOCH), 115.8 (CBr) 145.9 (CBr=CH), 162.2 (C=O); m/z (CI) 467/469 (MH
+
, 
2/3%), 335/337 (100/99). HRMS found 467.1637, C19H40
79
BrO4Si2 (MH
+
) requires 
467.1648. 
 
(S,Z)-2-Bromo-4,5-bis(tert-butyldimethylsilyloxy)pent-2-en-1-ol (234) 
 
To a solution of LiAlH4 (1 M solution in THF, 1.18 mL, 1.18 
mmol) in Et2O (15 mL) at 0 C was added a solution of ester 233 
(500 mg, 1.07 mmol) in Et2O (15 mL) over a few minutes; the solution was stirred at 0 
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C for 15 minutes.  The reaction was quenched with H2O (20 mL) and stirred for a 
further 30 minutes.  The organic material was extracted with Et2O (3  200 mL), 
washed with H2O (100 mL), dried (MgSO4) and solvent removed in vacuo to afford 
alcohol 234 (403 mg, 91%) as a pale yellow oil: 20][
D
 +0.5 (c  0.78 in CHCl3); υmax/cm
1
 
(CDCl3 cast) 3369br, 2954, 2929, 2886, 2857, 1664; 
1
H NMR (CDCl3, 500 MHz) δ 
0.07-0.11 (12H, m, 2  Si(CH3)2), 0.90 and 0.91 (18H, 2  C(CH3)3), 1.40 (1H, br s, 
OH), 3.55 (1H, dd, J 10.4, 5.1 Hz) and 3.60 (1H, dd, J 10.4, 6.4 Hz, TBSOCH2), 4.23-
4.28 (2H, m, CH2OH), 4.56 (1H, m, TBSOCH), 5.99 (1H, d, J 7.6 Hz, CBr=CH);  
13
C 
NMR (CDCl3, 125 MHz) δ 4.5 and 4.5 (2  Si(CH3)2), 18.2 and 18.5 (2  CMe3), 
25.9 and 26.0 (2  C(CH3)3), 66.8 (TBSOCH2), 68.2 (CH2OH), 73.6 (TBSOCH), 126.7 
(CBr), 130.9 (CBr=CH); m/z (FAB
+
) 447/449 (MNa
+
, 41/40%), 369 (72), 367 (70), 295 
(65), 293 (69), 189 (100). HRMS found 447.1370, C17H37
79
BrO3Si2Na (MNa
+
) requires 
447.1362. 
 
Toluene-4-sulfonic acid 2-bromo-4,5-bis-(tert-butyl-dimethyl-silanyloxy)-pent-2-
enyl ester (236) 
 
To a solution of alcohol 234 (120 mg, 0.28 mmol), triethylamine 
(120 μL, 0.86 mmol) and DMAP (5.20 mg, 42.6 μmol) in DCM 
(3 mL) at 0 C was added TsCl (64.0 mg, 0.34 mmol), and the solution stirred for 5 h at 
rt.  The solution was diluted with DCM (10 mL), washed successively with HCl (1 M, 5 
mL), aq. sat. NaHCO3 (5 mL) and brine (2  5 mL), dried (MgSO4) and solvent 
removed in vacuo.  Purification by flash chromatography (SiO2, petrol/EtOAc 99:1) 
afforded tosylate 236 (82.0 mg, 60%) as a colourless oil: 20][
D
 12.5 (c 0.42 in CHCl3); 
υmax/cm
1
 (CDCl3 cast) 2954, 2929, 2857, 1599;  
1
H NMR (CDCl3, 500 MHz) δ 0.02 
(3H, s), 0.03 (6H, s) and 0.05 (3H, s, 4  Si(CH3)2), 0.85 (9H, s) and 0.86 (9H, s, 2  
C(CH3)3), 2.46 (3H, s, PhCH3), 3.46 (1H, dd, J 10.3, 4.9 Hz, TBSOCHH), 3.53 (1H, dd, 
J 10.3, 6.4 Hz, TBSOCHH), 4.47 (1H, ddd,  J 7.7, 6.4, 4.9 Hz, OCH), 4.62 (1H, d, J 
12.4 Hz ) and 4.66 (1H, d, J, 12.4 Hz, CH2OTs),  6.02 (1H, d, J 7.7 Hz, CBr=CH), 7.35 
(2H, d, J 8.3 Hz) and 7.81 (2H, d, J 8.3 Hz, Aromatic CH);  
13
C NMR (CDCl3, 125 
MHz) δ 4.6 (2 x Si(CH3)2), 18.2 and 18.4 (2 x CMe3), 21.8 (PhCH3), 25.9 and 26.0 (2 
 C(CH3)3), 60.5 (TBSOCH2), 73.3 (CH2OPh) 73.5 (TBSOCH), 117.9 (Aromatic C or 
CBr=CH), 128.1 and 130.0 (Aromatic CH), 132.9 (Aromatic C or CBr=CH), 136.0 
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(CBr=CH), 145.2 (Aromatic C or CBr=CH); m/z (CI) 579/581 (MH
+
, 8/8%), 449 (100), 
447 (66), 409 (76), 407 (58), 345 (45), 277 (75). HRMS found 579.1647, 
C24H44
79
BrO5SSi2 (MH
+
) requires 579.1631. 
 
(S,Z)-1,2-Dibromo-4,5-bis(tert-butyldimethylsilyloxy)pent-2-ene (224)  
 
To a solution of tosylate 236 (0.51 g, 0.88 mmol) in MeCN (30 
mL) at 0 C was added LiBr (0.38 g, 4.42 mmol) and the solution 
stirred at rt for 24 h.  After removal of the MeCN in vacuo, brine was added (30 mL) 
and the organic material extracted with EtOAc (2  50 mL), dried (MgSO4) and the 
solvent removed in vacuo to yield dibromide 224 (250 mg, 60%) as a colourless oil:  
20][
D
 +38.4 (c  0.85 in CHCl3); υmax/cm
1 
(CDCl3 cast) 2954, 2929, 2857; 
1
H NMR 
(CDCl3, 500 MHz) δ 0.04-0.10 (12H, m, 2  Si(CH3)2), 0.88 (9H, s) and 0.89 (9H, s, 2 
 C(CH3)3), 3.53 (1H, dd, J 10.3, 5.2 Hz, OCHH), 3.59 (1H, dd, J 10.3, 6.2 Hz, 
OCHH), 4.18 (1H, dd, J 11.3, 0.6 Hz, CHHBr), 4.23 (1H, dd, J 11.3, 0.5, Hz, CHHBr), 
4.49 (1H, m, OCH), 6.05 (1H, d, J 7.9 Hz, CBr=CH); 
13
C NMR (CDCl3, 125 MHz) δ 
4.6 and 4.4 (2  Si(CH3)2), 18.2 and 18.5 (2  CMe3), 25.9 and 26.0 (2  C(CH3)3), 
38.1 (CH2Br), 66.5 (OCH2), 74.0 (OCH), 122.3 (CBr), 135.4 (C(Br)=CH);  m/z (EI) 
429/431/433 ([MtBu]+, 6/11/6%), 207 (22), 205 (17), 189 (30), 148 (15), 147 (100). 
HRMS found 428.9903, C17H27
79
Br2O2Si2 ([M
t
Bu]
+
) requires 428.9916. 
 
(S)-1-Benzyl-3-((R)-2-bromo-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)allyl)pyrrolidine 
-2-thione (238) (R)-1-benzyl-3-((S)-2-bromo-1-((S)-2,2-dimethyl-1,3-dioxolan-4-
yl)allyl)pyrrolidine-2-thione (239) and (S)-1-benzyl-3-((S)-2-bromo-1-((S)-2,2-
dimethyl-1,3-dioxolan-4-yl)allyl)pyrrolidine-2-thione (240)  
 
A mixture of thioamide 219 (116 mg, 0.61 mmol), 
Z-bromide 223 (200 mg, 0.67 mmol) and 4Å 
molecular sieves (250 mg) in MeCN (1 mL) was 
stirred under an argon atmosphere for 4 d.  Further 
MeCN (2 mL) was added and the mixture warmed 
to 35 C.  Triethylamine (94.0 μL, 0.67 mmol) was 
added and the resulting solution stirred at 35 C for 7 h.  The mixture was cooled to rt, 
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diluted with DCM (30 mL), washed with 2% citric acid (2  50 mL), dried (MgSO4) 
and concentrated in vacuo.  Purification by flash chromatography (SiO2, petrol/EtOAc 
19:1) afforded successive products 238 (130 mg, 52%) as a pale yellow oil, 239 (6.0 
mg, 2%) as a colourless oil and 240 (5.0 mg, 2%) as a colourless oil: 
 
For 238: 20][
D
 33.5 (c 0.65 in CHCl3); υmax/cm
1
 (CDCl3 cast) 2985, 2883, 1625, 1507, 
1452, 1311; 
1
H NMR (CDCl3, 500 MHz) δ 1.24 (3H, s) and 1.40 (3H, s, C(CH3)2), 2.20 
(1H, m) and 2.30 (1H, m, NCH2CH2), 3.34 (1H, m, C=SCH), 3.48 (1H, m, NCHHCH2), 
3.58-3.62 (2H, m, CH2=CBrCH and NCHHCH2), 3.88 (1H, t, J 8.1 Hz) and 4.01 (1H, 
dd, J 8.1, 6.4 Hz, OCH2), 4.41 (1H, ddd, J 8.1, 6.4, 5.6 Hz, OCH), 4.87 (1H, d, J 14.3 
Hz) and 5.15 (1H, d, J 14.3 Hz, NCH2Ph), 5.66 (1H, d, J 1.8 Hz) and 6.07 (1H, dd, J 
1.8, 0.6 Hz, CH2=CBr), 7.30-7.35 (5H, m, Aromatic CH);
 13
C NMR (CDCl3, 125 MHz) 
δ 22.8 (NCH2CH2), 25.2 and 26.6 (C(CH3)2), 52.2 (NCH2Ph), 52.5 (NCH2CH2), 52.9 
(CH2=CBrCH), 56.3 (C=SCH), 67.2 (OCH2), 74.6 (OCH), 109.2 (CMe2), 121.0 
(CH2=CBr), 128.2, 128.5, 129.0 (Aromatic CH), 131.8 (CBr), 135.0 (Aromatic C), 
201.7 (C=S); m/z (CI) 410/412 (MH
+
, 24/26%), 338/340 (79/79), 141 (100). HRMS 
found 410.0774, C19H25
79
BrNO2S (MH
+
) requires 410.0789.  
 
For 239: 20][
D
 +31.5 (c 1.08 in CHCl3); υmax/cm
1
 (CDCl3 cast) 2983, 2934, 2874, 1625, 
1499, 1452, 1316; 
1
H NMR (CDCl3, 500 MHz) δ 1.28 (3H, s) and 1.34 (3H, s, 
C(CH3)2), 2.30-2.40 (2H, m, NCH2CH2), 3.21 (1H, t, J 8.5 Hz, C=SCH), 3.51 (1H, ddd, 
J 11.0, 8.5, 7.0 Hz) and 3.62 (1H, ddd, J 11.0, 8.8, 5.2 Hz, NCH2CH2), 3.76 (1H, dd, J 
8.5, 6.8 Hz, OCHH), 3.88 (1H, dd, J 10.1, 1.8 Hz, CH2=CBrCH), 4.10 (1H, dd, J 8.5, 
6.1 Hz, OCHH), 4.44 (1H, ddd, J 10.1, 6.8, 6.1 Hz, OCH), 4.79 (1H, d, J 14.6 Hz) and 
5.16 (1H, d, J 14.6 Hz, NCH2Ph), 5.51 (1H, dd, J 1.8, 0.5 Hz) and 5.90 (1H, dd, J 1.8, 
0.4 Hz, CH2=CBr), 7.26-7.32 (5H, m, Aromatic CH);
 13
C NMR (CDCl3, 125 MHz) δ 
22.2 (NCH2CH2), 26.0 and 26.5 (C(CH3)2), 51.9 (NCH2Ph), 52.8 (NCH2CH2), 55.2 
(CH2=CBrCH), 56.9 (C=SCH), 68.7 (OCH2), 74.7 (OCH), 110.1 (CMe2), 119.8 
(CH2=CBr), 127.9, 128.2, 128.7 (Aromatic CH), 133.5 (CBr), 135.3 (Aromatic C), 
203.7 (C=S); m/z (CI) 410/412 (MH
+
, 16/14%), 352/354 (46/50), 338/340 (63/63), 330 
([MHHBr]+, 100). HRMS found 410.0800, C19H25
79
BrNO2S (MH
+
) requires 410.0790. 
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For 240:  υmax/cm
1
 (CDCl3 cast) 2984, 2932, 2877, 1615, 1507, 1453; 
1
H NMR 
(CDCl3, 500 MHz) δ 1.37 (3H, s) and 1.49 (3H, s, C(CH3)2), 2.18 (1H, m) and 2.40 
(1H, m, NCH2CH2), 3.48-3.69 (4H, m, C=SCH, CH2=CBrCH and NCH2CH2), 3.82 
(1H, dd, J  8.6, 5.0 Hz) and 4.15 (1H, dd, J 8.6, 6.2 Hz, OCH2), 4.37 (1H, ddd, J 11.2, 
6.2, 5.0 Hz, OCH), 4.91 (1H, d, J 14.4 Hz) and 5.08 (1H, d, J 14.4 Hz, NCH2Ph), 5.55 
(1H, d, J 1.6 Hz) and 6.04 (1H, d, J 1.6 Hz, CH2=CBr), 7.29-7.34 (5H, m, Aromatic 
CH);
 13
C NMR (CDCl3, 125 MHz) δ 20.6 (NCH2CH2), 25.6 and 27.1 (C(CH3)2), 52.0 
(NCH2Ph), 52.7 (CH2=CBrCH), 53.1 (NCH2CH2), 55.0 (C=SCH), 68.1 (OCH2), 76.1 
(OCH), 110.0 (CMe2), 123.6 (CH2=CBr), 128.1, 128.4 (Aromatic CH), 128.6 (CBr),  
128.8 (Aromatic CH), 135.0 (Aromatic C), 202.9 (C=S); m/z (CI) 410/412 (MH
+
, 
2/2%),  183 (100) 141 (17), 119 (18). HRMS found 410.0786, C19H25
79
BrNO2S (MH
+
) 
requires 410.0789. 
 
(S)-1-Benzyl-3-((2S,3R)-1,2-dihydroxypent-4-en-3-yl)pyrrolidine-2-thione (242) 
 
Acetonide 220a (270 mg, 0.82 mmol) and aq. AcOH (60% v/v, 15 mL) 
were stirred at rt for 24 h.  Petrol (15 mL) was added and the aq. Layer 
was separated and concentrated in vacuo.  The residue was dried by 
azeotroping successively with EtOH (3  15 mL) and toluene (3  15 mL) to give diol 
242 (232 mg, 98%) as a pale yellow oil:  17][
D
 159.3 (c 1.00 in CHCl3); υmax/cm
1
 
(CDCl3 cast) 3362br, 3069, 3030, 2922, 2878, 1637, 1510, 1452, 1310; 
1
H NMR 
(CDCl3, 400 MHz) δ 2.03 (1H, m NCH2CHH), 2.15 (1H, br s, OH), 2.22 (1H, m, 
NCH2CHH), 2.58 (1H, m, CH2=CHCH), 3.30 (1H, br t, J 8.3 Hz, NC=SCH), 3.45 (1H, 
m) and 3.53 (1H, m, NCH2CH2), 3.58 (2H, d, J 5.8 Hz, CH2OH), 3.98 (1H, d, J 2.8 Hz, 
OH), 4.12 (1H, m, CHOH),  4.93 (1H, d, J 14.3 Hz) and 5.07 (1H, d, J 14.3 Hz, 
NCH2Ph), 5.15 (1H, d, J 10.6 Hz) and 5.16 (1H, d, J 16.7 Hz, CH2=CH), 5.96 (1H, ddd, 
J 16.7, 10.6, 9.7 Hz, CH2=CH), 7.29-7.35 (5H, m, Aromatic CH);
 13
C NMR (CDCl3, 
125 MHz) δ 24.9 (NCH2CH2), 50.2 (CH2=CHCH)), 52.2 (NCH2Ph), 52.8 (NCH2CH2), 
58.5 (C=SCH), 65.3 (CH2OH), 72.9 (CHOH),  119.8 (CH2=CH), 128.3, 128.4, 129.0 
(Aromatic CH), 134.4 (CH2=CH), 134.8 (Aromatic C), 202.3 (C=S); m/z (CI) 292 
(MH
+
, 25%), 274 (10), 230 (32), 191 (78), 91 (100). HRMS found 292.1364, 
C16H22NO2S (MH
+
) requires 292.1371. 
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(R)-1-Benzyl-3-((2S,3S)-1,2-dihydroxypent-4-en-3-yl)pyrrolidine-2-thione (243) 
 
Acetonide 221a (100 mg, 0.30 mmol) and aq. AcOH (60% v/v, 5 mL) 
were stirred at rt for 4 h.  Petrol (5 mL) was added and the aq. layer 
was separated and concentrated in vacuo.  The residue was dried by 
azeotroping successively with EtOH (3  5 mL) and toluene (3  5 mL).  Purification by 
flash chromatography (SiO2, petrol/EtOAc 7:3) afforded diol 243 (80.0 mg, 92%) as a 
white solid:  mpt 111-112 C; 17][
D
 +10.3 (c 0.51 in CHCl3); υmax/cm
1
 (solid) 3368br, 
2920, 2873, 1630, 1518; 
1
H NMR (CDCl3, 500 MHz) δ 1.85 (1H, m) and 2.22 (1H, m, 
NCH2CH2), 2.53 (1H, m, CH2=CHCH), 3.40-3.51 (2H, m, NCH2CH2), 3.48 (1H, ddd, J  
11.3, 6.8, 1.1 Hz, CHHOH), 3.59 (1H, m, NC=SCH), 3.68 (1H, ddd, J 11.3, 3.0, 1.0 Hz, 
CHHOH), 4.12 (1H, dddd, J 10.0, 6.8, 3.0, 1.0 Hz, CHOH), 4.88 (1H, d, J 14.3 Hz) and 
5.02 (1H, d, J 14.3 Hz, NCH2Ph), 5.06 (1H, dd, J  10.2, 0.7 Hz) and 5.20 (1H, dd, J 
17.1, 0.7 Hz, CH2=CH), 5.52 (1H, dtd, J 17.1, 10.2, 1.0 Hz, CH2=CH), 7.28-7.34 (5H, 
m, Aromatic CH);
 13
C NMR (CDCl3, 125 MHz) δ 24.2 (NCH2CH2), 51.5 
(CH2=CHCH), 52.0 (NCH2Ph), 53.3 (NCH2CH2), 54.2 (C=SCH), 64.8 (CH2OH), 71.4 
(CHOH),  120.0 (CH2=CH), 128.3, 128.5, 129.0 (Aromatic CH), 134.9 (Aromatic C), 
135.2 (CH2=CH), 202.1 (C=S); m/z (CI) 292 (MH
+
, 100%), 274 (31). HRMS found 
292.1367, C16H22NO2S (MH
+
) requires 292.1371. 
 
(S)-1-Benzyl-3-((R)-1-hydroxybut-3-en-2-yl)pyrrolidine-2-thione (244)  
 
Preparation of silica gel-supported NaIO4: 
To a solution of NaIO4 (2.57 g, 12.0 mmol) in hot H2O (ca. 70 C, 5 mL) was added 
SiO2 (10.0 g) and the contents shaken vigorously until a free flowing powder had 
formed.   
 
To a suspension of silica gel-supported NaIO4 powder (0.32 g) in DCM (2 
mL) was added a solution of diol 242 (102 mg, 0.35 mmol) in DCM (2 
mL) and the mixture stirred for 1 h at rt.  After removal of the solid by 
filtration, the DCM was removed by concentration in vacuo and the intermediate 
aldehyde was dissolved in an EtOH/THF mixture (2:1, 6 mL) and NaBH4 (130 mg, 3.44 
mmol) added.  The solution was stirred for 15 minutes at rt, then HCl (1 M) added until 
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the mixture was neutral.  The organic material was extracted with EtOAc (3  40 mL), 
dried (MgSO4) and concentrated in vacuo.  Purification by flash chromatography (SiO2, 
petrol/EtOAc 7:3) afforded alcohol 244 (46.1 mg, 51%) as a pale yellow oil: 20][
D
 73.2 
(c 0.40 in CHCl3); υmax/cm
1
 (CDCl3 cast) 3410br, 2923, 2875, 1639, 1508, 1452, 1309; 
1
H NMR (CDCl3, 500 MHz) δ 1.87 (1H, ddt, J 12.8, 8.8, 6.1 Hz) and 2.17 (1H, dtd, J 
12.8, 9.1, 5.9 Hz, NCH2CH2), 2.62 (1H, br s, OH), 3.02 (1H, m, CH2=CHCH), 3.33 
(1H, ddd, J 9.1, 6.3, 3.6 Hz, C=SCH), 3.44 (1H, ddd, J 11.2, 9.1, 6.1 Hz) and 3.49 (1H, 
ddd, J 11.2, 8.8, 5.9 Hz, NCH2CH2), 3.71 (1H, dd, J 11.5, 6.5 Hz) and 3.84 (1H, dd, J 
11.5, 9.1 Hz, CH2OH), 4.90 (1H, d, J 14.3 Hz) and 5.05 (1H, d, J 14.3 Hz, NCH2Ph), 
5.10 (1H, dd, J 10.5, 1.8 Hz) and 5.20 (1H, dd, J 17.3, 1.8 Hz, CH2=CH), 5.64 (1H, 
ddd, J 17.3, 10.5, 8.8 Hz, CH2=CH), 7.28-7.34 (5H, m, Aromatic CH);
 13
C NMR 
(CDCl3, 125 MHz) δ 23.1 (NCH2CH2), 49.3 (CH2=CHCH)), 51.8 (NCH2Ph), 52.8 
(NCH2CH2), 55.1 (C=SCH), 63.0 (CH2OH), 118.4 (CH2=CH), 128.1, 128.3, 128.8 
(Aromatic CH), 134.9 (Aromatic C), 135.6 (CH2=CH), 202.7 (C=S); m/z (CI) 262 
(MH
+
, 100%), 244 (27), 191 (40), 86 (57). HRMS found 262.1258, C15H20NOS (MH
+
) 
requires 262.1266. 
 
(R)-1-Benzyl-3-((S)-1-hydroxybut-3-en-2-yl)pyrrolidine-2-thione (245)  
 
To a suspension of silica gel-supported NaIO4 powder (0.32 g) in DCM 
(1 mL) was added a solution of diol 243 (47.0 mg, 0.16 mmol) in DCM 
(1 mL) and the mixture stirred for 1 h at rt.  After removal of the solid by 
filtration the DCM was removed by concentratinon in vacuo and the intermediate 
aldehyde was dissolved in an EtOH/THF mixture (2:1, 3 mL) and NaBH4 (60.0 mg, 
1.59 mmol) added.  The solution was stirred for 15 minutes at rt, then HCl (1 M) was 
added until neutral.  The resulting solution was diluted with H2O (5 mL), organic 
material extracted with EtOAc (3  20 mL), dried (MgSO4) and concentrated in vacuo.  
Purification by preparative TLC (SiO2, petrol/EtOAc 1:1) afforded alcohol 245 (13.0 
mg, 31%) as a pale yellow oil: 20][
D
 +71.4 (c 0.28 in CHCl3). 
Other spectroscopic data was identical to that for 244. 
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(S)-1-Benzyl-3-((2S,3R)-1,2-dihydroxypent-4-en-3-yl)pyrrolidine-2-thione (242) 
 
A solution of lactam 220b (100 mg, 0.19 mmol) in a 1:1 mixture of 
60% aq. AcOH (10 mL) and THF (10 mL) was stirred at 50 C for 24 
h.  Petrol (30 mL) was added, the aq. layer separated and concentrated 
in vacuo.  The residue was dried by azeotroping successively with EtOH (3  40 mL) 
and toluene (3  40 mL) to give diol 242 (52.2 mg, 93%) as a yellow oil, which gave 
spectroscopic data identical to that of previous samples. 
 
(R)-1-Benzyl-3-((2S,3S)-1,2-dihydroxypent-4-en-3-yl)pyrrolidine-2-thione (243) 
 
A solution of lactam 221b (6.0 mg, 11.6 μmol) in a 1:1 mixture of 
60% aq. AcOH (1 mL) and THF (1 mL) was stirred at 50 C for 24 h.  
Petrol (5 mL) was added, the aq. layer separated and concentrated in 
vacuo.  The residue was dried by azeotroping successively with EtOH (3  5 mL) and 
toluene (3  5 mL) to give diol 243 (2.30 mg, 67%) as a white solid, which gave 
spectroscopic data identical to that of previous samples. 
 
(R)-1-Benzyl-3-((S)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)allyl)pyrrolidine-2-thione 
(221a) and (S)-1-benzyl-3-((S)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)allyl) 
pyrrolidine-2-thione (222a)  
 
To a solution of bromide 239 (60.0 mg, 0.15 
mmol), PPh3 (3.10 mg, 0.01 mmol), NEt3 (0.44 g, 
0.60 mL, 4.30 mmol) and Pd(OAc)2  (1.3 mg, 4.0 
µmol) in DMF (1 mL) was added HCOOH (0.11 mL, 2.92 mmol) and the solution 
stirred at 65 C for 6 h.  After cooling to rt, the reaction mixture was diluted with brine 
(10 mL) and the organic material extracted with Et2O (2  10 mL), dried (MgSO4) and 
the solvent removed in vacuo.  Purification by flash chromatography (SiO2, 
petrol/EtOAc 19:1) afforded thiolactams 221a (17.0 mg, 35%) and 222a (10.0 mg, 
21%) as colourless oils: 
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Spectroscopic data for 221a and 222a was identical to those of samples prepared 
directly from thia-Claisen rearrangement. 
 
(R)-1-Benzyl-3-((S)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)allyl)pyrrolidine-2-thione 
(221a) and (R)-1-benzyl-3-((S)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-
yl)allyl)pyrrolidin-2-one (244)  
 
To a solution of Pd(PPh3)4 (2.80 mg, 2.00 µmol) in THF (0.5 mL) was 
added a solution of bromide 239 (50.0 mg, 0.12 mmol) and SnBu3H 
(50.0 µL, 0.19 mmol) in THF (0.5 mL) and the solution heated to 
reflux for 24 h.  The mixture was cooled to rt, diluted with brine (10 mL) and the 
organic material extracted with DCM (3  25 mL).  The extracts were washed with 
brine (20 mL), dried (MgSO4) and the solvent removed in vacuo.  Purification by flash 
chromatography (SiO2, petrol/EtOAc 19:1) afforded product 221a (20.0 mg, 50%) as a 
colourless oil:  
 
For 221a, spectroscopic data was identical to that of the sample prepared via thia-
Claisen rearrangement.  
 
Further elution gave lactam 244 (ca. 1.00 mg, ca. 3%) as a pale yellow 
oil: υmax/cm
1
 (CDCl3 cast) 2922, 2853, 1682; 
1
H NMR (CDCl3, 500 
MHz) δ 1.33 (3H, s) and 1.35 (3H, s, C(CH3)2), 1.82 (1H, m, 
NCH2CHH), 2.03 (1H, m, NCH2CHH), 2.32 (1H, dt, J 10.0, 2.5 Hz, 
CH2=CHCH), 3.04 (1H, m, C=OCH), 3.13 (2H, dd, J 8.3, 5.7 Hz, NCH2CH2), 3.58 
(1H, dd, J 8.3, 6.7 Hz, OCHH), 3.96 (1H, dd, J 8.3, 6.1 Hz, OCHH), 4.35 (1H, d, J 14.8 
Hz, NCHHPh), 4.45 (1H, d, J 14.8 Hz, NCHHPh), 4.74 (1H, dt, J 12.6, 6.1 Hz, OCH), 
5.13 (1H, dd, J 10.2, 1.8 Hz, CHH=CH), 5.51 (1H, dd, J 17.1, 1.8 Hz CHH=CH), 5.96 
(1H, dt, J 17.1, 10.2 Hz, CH2=CH), 7.19-7.31 (5H, m, Aromatic CH);
 13
C NMR 
(CDCl3, 150 MHz) δ 22.4 (NCH2CH2), 25.7 and 27.0 (C(CH3)2), 41.5 (C=OCH), 45.0 
(NCH2CH2), 46.5 (NCH2Ph), 51.3 (CH2=CHCH), 68.6 (OCH2), 75.2 (OCH), 109.2 
(CMe2), 119.8 (CH2=CH), 127.5, 128.1, 128.6 (Aromatic CH), 134.6 (CH2=CH), 136.7 
(Aromatic C), 174.8 (C=O); m/z (CI) 316 (MH
+
, 42%), 286 (30), 258 (100), 215 (30), 
175 (32), 111 (33), 91 (45), 74 (42). HRMS found 316.1916, C19H26NO3 (MH
+
) requires 
316.1913. 
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(S)-1-Benzyl-3-((R)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)allyl)pyrrolidine-2-thione 
(220a)  
 
To a solution of Pd(PPh3)4 (0.50 mg, 0.43 μmol) in THF (0.2 mL) 
was added a solution of bromide 238 (9.00 mg, 22.0 µmol), and 
SnBu3H (9.00 µL, 33.5 µmol) in THF (0.3 mL) and the solution 
heated to reflux overnight.  The mixture was cooled to rt, diluted with brine (5 mL) and 
organic material extracted with DCM (3  10 mL).  The extracts were washed with 
brine (10 mL), dried (MgSO4) and solvent removed in vacuo.  Purification by 
preparative TLC (SiO2, petrol/EtOAc 9:1 ( 3 runs)) afforded product 220a (4.00 mg, 
60%) as a pale yellow oil: 
 
Spectroscopic data of 220a is identical to that of the sample prepared via thia-Claisen 
rearrangement. 
 
(S)-1-Benzyl-3-((S)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)allyl)pyrrolidine-2-thione 
(222a)  
 
To a solution of Pd(PPh3)4 (700 µg, 48.0 µmol) in THF (0.15 mL) 
was added a solution of bromide 240 (10.0 mg, 24.0 μmol) and 
SnBu3H (12.0 µL, 0.05 mmol) in THF (0.15 mL) and the solution 
heated to reflux for 24 h.  The mixture was cooled to rt, diluted with 
brine (3 mL) and the organic material extracted with DCM (3  10 mL).  The extracts 
were washed with brine (5 mL), dried (MgSO4) and the solvent removed in vacuo.  
Purification by flash chromatography (SiO2, petrol/EtOAc 19:1) afforded product 222a 
(ca. 3.90 mg, 49%) as a colourless oil. 
 
Spectroscopic data for 222a is identical to that of the sample prepared via thia-Claisen 
rearrangement. 
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(S,Z)-Ethyl-3-(2,2-dimethyl-1,3-dioxolan-4-yl)-2-methylacrylate (246) and (S,E)-
ethyl 3-(2,2-dimethyl-1,3-dioxolan-4-yl)-2-methylacrylate (245) 
 
To a solution of diol 210 (2.00 g, 7.63 mmol) in 5% aq. NaHCO3 (10 
mL) was added a solution of NaIO4 (1.99 g, 9.30 mmol) in H2O (15 
mL) dropwise and the resulting solution stirred for 1 h.  Ethyl 2-
(diethoxyphosphoryl)propanoate (4.50 mL, 20.5 mmol) and K2CO3 (6 M, 35 mL) were 
added successively and the solution stirred at rt for 5 d.  H2O was added to dissolve the 
solid present and the organic material was extracted with DCM (3  40 mL), washed 
with brine (30 mL), dried (MgSO4) and concentrated in vacuo.  Purification by flash 
chromatography (SiO2, petrolpetrol/Et2O 19:1) afforded Z-ester 246 (695 mg, 21%) 
as a colourless oil: 20][
D
 = 45.9 (c 0.41 in CHCl3); υmax/cm
1
 (DCM cast) 2986, 1714, 
1652; 
1
H NMR (CDCl3, 600 MHz) δ 1.32 (3H, t, J 7.1 Hz, CH2CH3), 1.40 (3H, s) and 
1.47 (3H, s, C(CH3)2), 1.94 (3H, s, C(CH3)), 3.62 (1H, dd, J 8.0, 6.9 Hz, OCHHCH), 
4.21 (2H, q, J 7.1 Hz, CH2CH3), 4.32 (1H, dd, J 8.0, 6.7 Hz, OCHHCH), 5.28 (1H, app. 
q, J 6.9 Hz, OCH), 6.09 (1H, dd, J 6.8, 1.5 Hz, CMe=CH); 
13
C NMR (CDCl3, 150 
MHz) δ 14.3 (CH2CH3), 20.1 (C(CH3)), 25.5 and 26.7 (C(CH3)2), 60.7 (CH2CH3), 69.6 
(OCH2CH), 74.0 (OCH), 109.4 (CMe2), 129.4 (CMe=CH), 142.3 (CMe=CH), 167.0 
(C=O); m/z (CI) 215 (MH
+
, 9%), 199 (30), 181 (40), 169 (32), 157 (100); HRMS found 
215.1278, C11H19O4 (MH
+
) requires 215.1283. 
 
Further elution (SiO2, petrol/Et2O 19:185:15) afforded E-ester 
245 (1.09 g, 33%) as a colourless oil: 20][
D
 = +13.0 (c 0.49 in 
CHCl3); υmax/cm
1
 (DCM cast) 2986, 1714; 
1
H NMR (CDCl3, 
600 MHz) δ 1.31 (3H, t, J 7.2 Hz, CH2CH3), 1.43 (3H, s) and 1.47 (3H, s, C(CH3)2), 
1.91 (3H, d, J 1.3 Hz, C(CH3)), 3.65 (1H, t, J 7.9 Hz) and 4.18 (1H, dd, J 8.3, 6.2 Hz, 
OCH2CH), 4.19-4.26 (2H, m, OCH2CH3), 4.88 (1H, td, J 8.0, 6.2 Hz, OCH), 6.70 (1H, 
dq, J 8.3, 1.5 Hz, CMe=CH); 
13
C NMR (CDCl3, 150 MHz) δ 13.1 (C(CH3), 14.3 
(CH2CH3), 25.9 and 26.7 (C(CH3)2), 61.0 (CH2CH3), 68.7 (OCH2CH), 72.8 (OCH), 
109.8 (CMe2), 131.1 (CMe=CH), 138.0 (CMe=CH), 167.4 (C=O); m/z (CI) 215 (MH
+
, 
15%), 197 (20), 181 (23), 169 (26), 143 (34), 141 (100); HRMS found 215.1285, 
C11H19O4 (MH
+
) requires 215.1283. 
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(S,E)-3-(2,2-Dimethyl-1,3-dioxolan-4-yl)-2-methylprop-2-en-1-ol (247)  
 
To a solution of ester 245 (846 mg, 3.95 mmol) in DCM (20 mL) at 
–78 C was added DIBAL (1.0 M in hexane, 8.40 mL, 8.40 mmol) 
dropwise, and the resulting mixture stirred for 1 h at –78 C.  MeOH (40 mL) and Et2O 
(30 mL) were added and the solution stirred at –78 C for 30 mins.  After this time 
period, the solution was warmed to rt and aq. sat. Rochelle’s salt (40 mL) was added, 
and the solution stirred for 1 h.  The aqueous phase was diluted with H2O (50 mL), and 
the organic material was extracted with EtOAc (4  50 mL), washed with brine (50 mL) 
dried (MgSO4) and concentrated in vacuo.  Purification by flash chromatography (SiO2, 
petrol/EtOAc 7:3) afforded alcohol 247 (510 mg, 75%) as a colourless oil: 21][
D
 = +11.3 
(c 0.36 in CHCl3); υmax/cm
1
 (DCM cast) 3408 br, 2987, 2933, 2873, 1681; 
1
H NMR 
(CDCl3, 600 MHz) δ 1.42 (3H, s) and 1.45 (3H, s, C(CH3)2), 1.76 (3H, s, C(CH3)), 3.57 
(1H, t, J 8.0 Hz, OCHHCH), 4.06 (2H, s, CH2OH), 4.11 (1H, dd, J 8.0, 6.0 Hz, 
OCHHCH), 4.85 (1H, td, J 8.4, 6.0 Hz, OCH), 5.50 (1H, dq, J 8.6, 1.5 Hz, CMe=CH); 
13
C NMR (CDCl3, 150 MHz) δ 14.1 (CCH3), 26.0 and 26.8 (C(CH3)2), 67.7 (CH2OH), 
69.4 (OCH2CH), 72.4 (OCH), 109.1 (CMe2), 121.9 (CMe=CH), 141.1 (CMe=CH);  
 
(S,E)-4-(3-Bromo-2-methylprop-1-enyl)-2,2-dimethyl-1,3-dioxolane (248)  
 
To a stirred solution of alcohol 247 (408 mg, 2.37 mmol) in DCM 
(20 mL) at 0 C was added triphenylphosphine (684 mg, 2.61 
mmol), followed by N-bromsuccinimide (443 mg, 2.49 mmol) portionwise over a few 
minutes and the solution stirred at rt for 2 h 10 mins.  The reaction was quenched with 
H2O (15 mL) and the organic material extracted with DCM (3  30 mL), washed with 
brine (30 mL), dried (MgSO4) and concentrated in vacuo.  Purification by flash 
chromatography (SiO2, petrol/EtOAc 4:1) afforded bromide 248 (450 mg, 81%) as a 
pale yellow oil: 21][
D
 = +19.7 (c 0.59 in CHCl3); υmax/cm
1
 (DCM cast) 2986, 2937, 
2873; 
1
H NMR (CDCl3, 400 MHz) δ 1.41 (3H, s) and 1.44 (3H, s, C(CH3)2), 1.87 (3H, 
d, J 1.2 Hz, C(CH3)=CH), 3.57 (1H, t, J 8.0 Hz, OCHH), 3.94 (1H, d, J 9.8 Hz) and 
3.97 (1H, d, J 9.8 Hz, BrCH2), 4.11 (1H, dd, J 8.0, 6.1 Hz, OCHH), 4.77 (1H, dt, J 8.0, 
6.1 Hz, OCH), 5.63 (1H, d, J 8.4 Hz, CMe=CH); 
13
C NMR (CDCl3, 125 MHz) δ 15.3 
(C(CH3)=CH), 25.9 and 26.7 (C(CH3)2), 39.6 (BrCH2), 69.0 (OCH2), 72.7 (OCH), 
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109.3 (CMe2), 128.1 (CMe=CH), 137.1 (CMe=CH); m/z (CI) 235/237 (MH
+
, 19/19%), 
128 (100); HRMS found 235.0343, C9H16
79
BrO2 (MH
+
) requires 235.0334. 
 
1-Benzyl-3-(1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-2-methylallyl)pyrrolidine-2-
thione (249) 
 
A mixture of thioamide 219 (225 mg, 1.18 mmol), bromide 248 (305 
mg, 1.30 mmol) and 4Å molecular sieves (300 mg) in MeCN (3 mL) 
was stirred under an argon atmosphere for 5 d; further MeCN was 
added (6 mL) and the mixture warmed to 40 C.  Triethylamine (181 
µL, 1.29 mmol) was added and the resulting solution stirred at 40 C for 8 h.  The 
mixture was cooled to rt, diluted with DCM (100 mL), washed with 2% citric acid (2  
150 mL), dried (MgSO4) and concentrated in vacuo.  Purification by flash 
chromatography (SiO2, petrol/Et2O 19:147:3) afforded thiolactam 249 (167 mg, 41%) 
as a white solid; mpt. 53-54 C: 22][
D
 = +34.6 (c 0.34 in CHCl3); υmax/cm
1
 (solid) 2985, 
2932, 2877, 1643, 1508, 1453; 
1
H NMR (CDCl3, 600 MHz) δ 1.31 (3H, s) and 1.36 
(3H, s, C(CH3)2), 1.82 (3H, s, C(CH3)=CH2), 2.14-2.20 (2H, m, NBnCH2CH2), 3.19 
(1H, t, J 1.9 Hz, C=SCH), 3.28 (1H, dd, J 10.6, 1.9 Hz, OCHCH), 3.49 (1H, m, 
NBnCHH), 3.62 (1H, dd, J 8.3, 7.3 Hz, OCHH), 3.64 (1H, m, NBnCHH), 4.06 (1H, dd, 
J 8.3, 6.0 Hz, OCHH), 4.49 (1H, ddd, J 10.6, 7.3, 6.0 Hz, OCH), 4.82 (2H, m, 
C(CH3)=CH2), 4.91 (1H, d, J 14.6 Hz) and 5.07 (1H, d, J 14.6 Hz, NCH2Ph), 7.29-7.36 
(5H, m, Aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ 22.0 (NBnCH2CH2), 23.0 
(C(CH3)=CH2), 26.0 and 26.6 (C(CH3)2), 51.9 (NCH2Ph), 52.5 (OCHCH), 52.8 
(NBnCH2), 56.0 (C=SCH), 69.2 (OCH2), 75.0 (OCH), 109.5 (CMe2), 113.0 
(CMe=CH2), 127.8, 128.3 and 128.7 (Aromatic CH), 135.3 (Aromatic C), 144.9 
(CMe=CH2), 204.7 (C=S); m/z (EI) 345 (M
+
, 13%), 330 (14), 244 (76), 229 (35), 191 
(100); HRMS found 345.1763, C20H27O2NS (M
+
) requires 345.1757. 
 
1-Benzyl-3-((2S)-1,2-dihydroxy-4-methylpent-4-en-3-yl)pyrrolidine-2-thione (251) 
 
A solution of acetonide 249 (16.0 mg, 46.4 µmol) in 60% aq. 
AcOH/THF (2:1, 1.5 mL) was heated to 40 ºC and stirred for 18 h.  
Petrol (5 mL) was added, the aq. layer separated and concentrated in 
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vacuo.  The residue was dried by azeotroping successively with EtOH (3  5 mL) and 
toluene (3  5 mL).  Purification by preparative TLC (SiO2, petrol/EtOAc 1:1 (× 3 
runs)) afforded diol 251 (12.0 mg, 86%) as a cloudy oil: υmax/cm
1
 (DCM cast) 3396 br, 
2921, 2876, 1643, 1509, 1452; 
1
H NMR (CDCl3, 600 MHz) δ 1.71 (3H, s, CH3), 2.03, 
(1H, dtd, J 12.6, 8.8, 6.1 Hz, NCH2CHH), 2.18 (1H, ddt, J 12.6, 9.1, 6.0 Hz, 
NCH2CHH),  2.18-2.29 (1H, br s, one of OH), 2.92 (1H, dd, J 11.0, 3.9 Hz, OCHCH), 
3.40 (1H, ddd, J 9.1, 6.1, 3.9 Hz, CHC=S), 3.48 (1H, ddd, J 14.7, 8.8, 6.0 Hz, 
NCHHCH2), 3.49 (1H, dd, J 11.1, 3.0 Hz, OCHH), 3.57 (1H, ddd, J 14.7, 8.8, 6.0 Hz, 
NCHHCH2), 3.68-3.77 (2H, m, OCHH and one of OH), 4.23 (1H, ddd, J 11.0, 7.1, 3.0 
Hz, OCH), 4.87 (2H, m, CH2=CMe), 4.97 (1H, d, J 14.6 Hz) and 5.03 (1H, d, J 14.6 
Hz, NCH2Ph),  7.31-7.39 (5H, m, Aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ 22.7 
(CH3), 23.3 (NCH2CH2), 51.4 (OCHCH), 52.1 (NCH2Ph), 52.9 (NCH2CH2), 54.9 
(CHC=S), 65.4 (OCH2), 71.5 (OCH), 114.9 (CH2=CMe), 128.2, 128.5 and 128.9 
(Aromatic CH), 134.6 and 143.8 (Aromatic C and CH2=CMe), 203.4 (C=S); m/z (EI) 
305 (M
+
, 7%), 274 (11), 272 (19), 245 (16), 244 (100); HRMS found 305.1446, 
C17H23O2NS (M
+
) requires 305.1444. 
 
1-Benzyl-3-((2S)-1,2-dihydroxy-4-methylpent-4-en-3-yl)pyrrolidine-2-thione (253) 
 
A solution of impure acetonide 250 (6.00 mg, 17.4 µmol) in 60% aq. 
AcOH/THF (2:1, 1.5 mL) was heated to 40 ºC and stirred for 18 h.  
Petrol (5 mL) was added, the aq. layer separated and concentrated in 
vacuo.  The residue was dried by azeotroping successively with EtOH (3  5 mL) and 
toluene (3  5 mL).  Purification by preparative TLC (SiO2, petrol/EtOAc 1:1 (× 3 
runs)) afforded diol 253 (2.00 mg, 38%) as a white feathery solid: mpt. 42-45 C; 
υmax/cm
1
 (solid) 3398 br, 2924, 2879, 1642, 1506, 1452; 
1
H NMR (CDCl3, 600 MHz) δ 
1.87 (3H, s, CH3), 2.01 (1H, dddd, J 12.8, 9.3, 9.1, 8.3 Hz, NCH2CHH), 2.25 (1H, 
dddd, J 12.8, 9.0, 8.3, 3.8 Hz, NCH2CHH), 2.56-2.66 (2H, br m, 2  OH), 3.12 (1H, td, 
J 9.2, 3.0 Hz, C=SCH), 3.19 (1H, dd, J 7.9, 3.0 Hz, OCHCH), 3.47 (1H, dt, J 11.1, 8.3 
Hz, NCHHCH2), 3.57 (1H, J 11.1, 9.1, 3.8 Hz, NCHHCH2), 3.55 (1H, dd, J 12.2, 4.8 
Hz, OCHH), 3.64-3.71 (1H, br m, OCHH), 4.01 (1H, m, OCH), 4.97 (1H, d, J 14.2 Hz, 
NCHHPh), 5.01 (2H, m, CH2=CMe), 5.10 (1H, d, J 14.2 Hz, NCHHPh), 7.31-7.40 (5H, 
m, Aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ; 23.2 (NCH2CH2), 23.4 (CH3), 49.5 
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(OCHCH), 52.1 (NCH2CH2), 52.3 (NCH2Ph), 56.6 (C=SCH), 63.9 (OCH2), 70.6 
(OCH), 114.7 (CH2=CMe), 128.3, 128.5 and 129.0 (Aromatic CH), 134.7 and 145.1 
(Aromatic C and CH2=CMe), 203.6 (C=S); m/z (EI) 305 (M
+
, 4%), 274 (6), 272 (10), 
245 (19), 244 (100); HRMS found 305.1446, C17H23O2NS (M
+
) requires 305.1444. 
 
(2S)-3-(1-Benzyl-2-sulfanylidenepyrrolidin-3-yl)-4-methyl-2-[(4-nitrophenyl) 
carbonyloxy]pent-4-en-1-yl 4-nitrobenzoate (252) 
 
To a solution of diol 251 (22.0 mg, 0.07 mmol) in DCM (1 
mL) at 0 ºC was added para-nitrobenzoyl chloride (40.0 mg, 
0.22 mmol), NEt3 (50.0 µL, 0.36 mmol) and DMAP (5 mg, 
mmol) and the mixture stirred at rt for 18 h.  The reaction 
was quenched by the addition of H2O (1 mL) and the 
organic material extracted into DCM (3 × 3 mL), washed with brine (2 mL), dried 
(MgSO4) and solvent removed in vacuo.  Purification by preparative TLC (SiO2, 
petrol/EtOAc 3:2) gave thiolactam 252 (22.0 mg, 51%) as a white solid: mpt. 136-138 
ºC; 22][
D
 = +23.0 (c 0.1 in CHCl3); υmax/cm
1
 (solid) 2921, 2851, 1724, 1606, 1526, 
1453, 1347; 
1
H NMR (CDCl3, 600 MHz) δ 1.87-1.95 (1H, m, NBnCH2CHH), 1.92 (3H, 
s, CH3), 2.21 (1H, m, NBnCH2CHH), 3.03 (1H, td, J 9.7, 1.9 Hz, CHC=S), 3.24 (1H, t, 
J 11.1, 2.7 Hz) and 3.36 (1H, dt, J 11.1, 8.6 Hz, NBnCH2), 3.78 (1H, d, J 14.2 Hz, 
NCHHPh), 4.21 (1H, dd, J 11.7, 1.9 Hz, OCHCH), 4.41 (1H, dd, J 12.3, 5.7 Hz) and 
4.84 (1H, dd, J 12.3, 2.4 Hz, OCHH), 5.07 (1H, s) and 5.01 (1H, s, CH2=C), 5.27 (1H, 
d, J 14.2 Hz, NCHHPh), 5.86 (1H, ddd, J 11.7, 5.6, 2.2 Hz, OCH), 7.02 (2H, d, J 8.2 
Hz), 7.17-7.21 (3H, m) and 8.19-8.32 (8H, m, Aromatic CH); 
13
C NMR (CDCl3, 150 
MHz) δ 21.2 (NBnCH2CH2), 22.9 (CH3), 46.9 (OCHCH), 51.8 (NBnCH2), 52.0 
(NCH2Ph), 55.8 (CHC=S), 65.5 (OCH2), 72.0 (OCH), 114.9 (CH2=C), 123.8 and 123.8 
(Aromatic CH), 128.2 (Aromatic C), 128.4, 128.8, 131.0 and 131.4 (Aromatic CH), 
134.5 (NCH2C), 135.1 (Aromatic C), 143.6 (CH2=C), 150.8 and 151.1 (Aromatic C), 
164.3 (CHOC=O), 164.5 (CH2OC=O), 203.7 (C=S); m/z (CI) 604 (MH
+
, 100%), 437 
(53), 288 (100); HRMS found 604.1747, C31H30O8N3S (MH
+
) requires 604.1754 
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(S,Z)-Ethyl 3-(2,2-dimethyl-1,3-dioxolan-4-yl)acrylate (257)
78,79
 
 
To a solution of diacetonide 210 (4.70 g, 17.9 mmol) suspended in 
4:1 MeOH/H2O (90 mL) was added NaHCO3 (4.47 g, 53.2 mmol) 
and the solution cooled to 0 C.  To this, a solution of NaIO4 (5.43 g, 
25.0 mmol) in MeOH/H2O (1:1 v/v, 30 mL) was added dropwise and the reaction 
stirred for 2 h at rt.  After cooling to 60 C, PPh3CHCO2Et (15.0 g, 43.1 mmol) was 
added dropwise and the solution stirred for 2 h at 60 C, and then overnight at 0 C.  
To this solution, DCM (100 mL) was added and the Ph3PO precipitate removed by 
filtration.  The organic material was extracted with DCM (3  30 mL), dried (MgSO4) 
and concentrated in vacuo.  Purification by flash chromatography (SiO2, petrol/EtOAc 
97:3) gave ester 257 (2.92 g, 41%) as a colourless oil: υmax/cm
1
 (CDCl3 cast) 2986, 
2938, 1716, 1644; 
1
H NMR (CDCl3, 500 MHz) δ 1.28 (3H, t, J  7.1 Hz, CH3CH2),  1.39 
(3H, s) and 1.45 (3H, s, C(CH3)2), 3.61 (1H, dd, J 8.3, 6.8 Hz, OCHH), 4.15-4.17 (2H, 
m, CH3CH2), 4.38 (1H, dd, J 8.3, 7.0 Hz, OCHH), 5.49 (1H, m, OCH), 5.84 (1H, dd, J 
11.7, 1.7 Hz, C=OCH), 6.35 (1H, dd, J 11.7, 6.7 Hz, C=OCH=CH);  
13
C NMR (CDCl3, 
125 MHz) 14.3 (CH3CH2), 25.5 and 26.6 (C(CH3)2), 60.5 (CH3CH2), 69.5 (OCH2), 
73.6 (OCH), 109.8 (CMe2), 120.9 (C=OCH), 149.3 (C=OCH=CH), 165.7 (C=O);  m/z 
(CI) 201 (MH
+
, 7%), 183 (16), 156 (19), 145 (19), 144 (100). HRMS found 201.1128, 
C10H17O4 (MH
+
) requires 201.1127. 
 
(S,Z)-3-(2,2-Dimethyl-1,3-dioxolan-4-yl)prop-2-en-1-ol (258)
70
 
 
To a solution of ester 257 (2.46 g, 12.3 mmol) in DCM (40 mL) at 
78 C was added DIBAL (1.2 M in toluene, 25.5 mL, 30.7 mmol) 
dropwise, and the solution stirred for 2 h at 78 C.  After warming the reaction mixture 
to rt, MeOH (80 mL), Et2O (100 mL) and aq. sat. Rochelle’s salt (100 mL) were added 
successively, and the mixture stirred for 1 h. The solution was diluted with H2O (60 
mL), organic material extracted with EtOAc (3  80 mL).  The combined extracts were 
washed with brine (100 mL), dried (MgSO4) and the solvent removed in vacuo.  
Purification by flash chromatography (SiO2, petrol/EtOAc 4:17:3) afforded title 
alcohol 258 (1.73 g, 89%) as a colourless liquid: 20][
D
 +12.8 (c 1.08 in CHCl3); 
υmax/cm
1
 (CDCl3 cast) 3395, 2987, 2936, 2873, 1647; 
1
H NMR (CDCl3, 500 MHz) δ 
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1.39 (3H, s) and 1.42 (3H, s, C(CH3)2), 3.57 (1H, t, J 7.8 Hz) and 4.09 (1H, dd, J 8.2, 
6.2 Hz, OCH2), 4.21 (1H, ddd, J 13.1, 6.0, 1.1 Hz) and 4.30 (1H, ddd, J 13.1, 7.1, 1.3 
Hz, CH2OH), 4.85 (1H, m, OCH), 5.56 (1H, m, HOCH2CH=CH), 5.83 (1H, m, 
HOCH2CH=CH); 
13
C NMR (CDCl3, 125 MHz) 26.0 and 26.8 (C(CH3)2), 58.7 
(CH2OH), 69.6 (OCH2), 72.0 (OCH), 109.5 (CMe2), 129.7 (HOCH2CH=CH), 133.2 
(HOCH2CH=CH). 
 
(S,Z)-4-(3-Bromoprop-1-enyl)-2,2-dimethyl-1,3-dioxolane (259)
70
 
 
To a stirred solution of alcohol 258 (1.61 g, 10.2 mmol) in DCM (70 
mL) at 0 C was added triphenylphosphine (2.94 g, 11.2 mmol), 
followed by N-bromosuccinimide (1.90 g, 10.6 mmol) portionwise over a few minutes.  
After stirring the solution at rt for 3 h, H2O (80 mL) was added and the organic material 
extracted with DCM (3  80 mL).  The combined extracts were washed with brine (150 
mL), dried (MgSO4) and the solvent removed in vacuo.  Purification by flash 
chromatography (SiO2, petrol/Et2O 85:15) afforded bromide 259 (1.63 g, 72%) as a 
colourless oil:  20][
D
 146.9 (c 0.98 in CHCl3); υmax/cm
1
 (CDCl3 cast) 2986, 2936, 
2873, 1056; 
1
H NMR (CDCl3, 500 MHz) δ 1.40 (3H, s), 1.43 (3H, s, C(CH3)2), 3.59 
(1H, t, J 7.2 Hz, OCHH), 3.98 (1H, dd, J 10.4, 7.9 Hz,  CHHBr), 4.08 (1H, t, J 10.4 Hz, 
CHHBr), 4.16 (1H, dd, J 8.2, 6.2 Hz, OCHH), 4.89 (1H, m, OCH), 5.59 (1H, dd, J 
10.8, 8.3 Hz, BrCH2CH=CH), 5.92 (1H, m, BrCH2CH=CH); 
13
C NMR (CDCl3, 125 
MHz);  25.9 and 26.0 (CH3CCH3 and CH2Br), 26.7 (CH3CCH3), 69.2 (OCH2), 71.3 
(OCH), 109.8 (CMe2), 129.4 (BrCH2CH=CH), 132.3 (BrCH2CH=CH);  m/z (CI) 221 
(MH
+
, 6%), 142 (83), 112 (32), 84 (100). HRMS found 221.0181, C8H14
79
BrO2 (MH
+
) 
requires 221.0177. 
 
(S,E)-4-(2,3-Dibromoprop-1-enyl)-2,2-dimethyl-1,3-dioxolane (260)  
 
To a stirred solution of alcohol 230 (0.43 g, 1.82 mmol) in DCM (20 
mL) at 0 C was added triphenylphosphine (0.52 g, 1.98 mmol), 
followed by N-bromosuccinimide (0.34 g, 1.91 mmol) portionwise over a few minutes 
and the solution was stirred at rt for 24 h.  The reaction was quenched with H2O (30 
mL), organic material extracted with DCM (3  30 mL), washed with brine (50 mL), 
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dried (MgSO4) and the solvent removed in vacuo.  Purification by flash chromatography 
(SiO2, petrol/Et2O 97:3) afforded bromide 260 (0.29 g, 54%) as a colourless oil: 
20][
D
 4.0 (c 0.43 in CHCl3); υmax/cm
1
 (CDCl3 cast) 2986, 2933, 2873, 1638; 
1
H NMR 
(CDCl3, 500 MHz) δ 1.37 (3H, s) and 1.41 (3H, s, (CH3)2), 3.65 (1H, dd, J 8.5, 7.0 Hz) 
and 4.15 (1H, dd, J 8.5, 6.2 Hz, OCH2), 4.19 (1H, d, J 11.4 Hz) and 4.42 (1H, d, J 11.4 
Hz, CH2Br), 4.71 (1H, ddd, J 8.3, 7.0, 6.2 Hz, OCH) 6.04 (1H, d, J 8.3 Hz, C(Br)=CH);  
13
C NMR (CDCl3, 125 MHz) 25.7 and 26.6 (C(CH3)2), 32.2 (CH2Br), 68.5 (OCH2), 
72.7 (OCH), 110.1 (CMe2), 124.2 (BrC=CH) 134.8 (BrC=CH);  m/z (CI) 299/301/303 
(MH
+
, 17/27/15%), 283/285/287 (26/48/25), 241/243/245 (50/95/45), 227/229/231 
(63/100/47). HRMS found 298.9279, C8H13
79
Br2O2 (MH
+
) requires 298.9282. 
 
(S)-1-Benzyl-3-((R)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)allyl)pyrrolidine-2-thione 
(220a), (R)-1-benzyl-3-((S)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)allyl)pyrrolidine-
2-thione (221a) and (S)-1-benzyl-3-((S)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)allyl) 
pyrrolidine-2-thione (222a) 
 
A mixture of thioamide 219 (0.24 
g, 1.26 mmol), Z-bromide 259 
(0.30 g, 1.36 mmol) and 4Å 
molecular sieves (0.30 g) in MeCN (2 mL) was stirred under an argon atmosphere for 3 
d.  Further MeCN (6 mL) was added and the mixture warmed to 35 C.  Triethylamine 
(0.19 mL, 1.36 mmol) was added and the resulting solution stirred at 35 C for 7 h.  The 
mixture was cooled to rt, diluted with DCM (30 mL), washed with 2% citric acid (2  
70 mL), dried (MgSO4) and concentrated in vacuo.  Purification by flash 
chromatography (SiO2, petrol/EtOAc 24:14:1) afforded thiolactam products 220a 
(42.1 mg, 10%), 221a (46.1 mg, 11%) and 222a (75.0 mg, 18%), all as pale yellow oils: 
 
For 220a, 221a and 222a, the spectroscopic data was identical to that for material 
previously obtained. 
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(S)-1-Benzyl-3-((R)-2-bromo-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)allyl)pyrrolidine 
-2-thione (220b), (R)-1-benzyl-3-((S)-2-bromo-1-((S)-2,2-dimethyl-1,3-dioxolan-4-
yl)allyl)pyrrolidine-2-thione (221b), (S)-1-benzyl-3-((S)-2-bromo-1- ((S)-2,2-
dimethyl-1,3-dioxolan-4-yl)allyl)pyrrolidine-2-thione (222b) and (R)-1-benzyl-3-
((R)-2-bromo -1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)allyl)pyrrolidine-2-thione 
(261b) 
 
A mixture of thioamide 209 (73.0 mg, 0.38 mmol), 
E-bromide 260 (125 mg, 0.42 mmol) and 4Å 
molecular sieves (125 mg) in MeCN (1 mL) was 
stirred under an argon atmosphere for 4 d.  Further 
MeCN was added (2 mL) and the mixture warmed to 
35 C.  Triethylamine (59.0 μL, 0.42 mmol) was 
added and the resulting solution stirred at 35 C for 8 h.  The mixture was cooled to rt, 
diluted with DCM (20 mL), washed with 2% citric acid (2  50 mL), dried (MgSO4) 
and concentrated in vacuo.  Purification by flash chromatography (SiO2, petrol/EtOAc 
99:19:1) afforded thiolactams 220b (ca. 1.60 mg, ca. 1%) as a pale yellow oil, 221b 
(9.00 mg, 6%) as a colourless oil, 222b (56.1 mg, 39%) as a colourless oil and 261b 
(ca.14.0 mg, ca. 9%) as a yellow oil:  
 
For 220b, 221b and 222b:  Spectroscopic data was identical to that of previously 
prepared samples.   
 
For 261b:  
1
H NMR (CDCl3, 600 MHz) δ 1.41 (3H, s) and 1.47 (3H, s, C(CH3)2), 2.00-
2.48 (2H, m, NCH2CH2), 2.97 (1H, m), 3.52 (1H, m) and 3.65-3.71 (2H, m, C=SCH, 
CH2=CBrCH and NCH2CH2), 3.87 (1H, dd, J 8.0, 7.6 Hz) and 4.14 (1H, dd, J 8.0, 5.8 
Hz, OCH2), 4.49 (1H, m, OCH), 4.92 (1H, d, J 14.3 Hz) and 5.08 (1H, d, J 14.3 Hz, 
NCH2Ph), 5.61 (1H, d, J 1.4 Hz) and 5.98 (1H, d, J 1.4 Hz, CH2=CHBr), 7.30-7.36 
(5H, m, Aromatic CH). 
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APPROACHES TOWARDS THE SARAIN CORE 
Ring expansion method 
 
3-Allyl-1-benzylpyrrolidin-2-one (271)
80
 
 
To a solution of diisopropylamine (8.50 mL, 60.2 mmol) in THF (200 mL) at 
78 ºC was added nBuLi (2.5 M in hexanes, 25.6 mL, 64.0 mmol) and the 
solution stirred for 15 min.  To this was added a solution of lactam 102 (10.0 
g, 57.1 mmol) in THF (50 mL) dropwise and the solution stirred at 78 ºC for 30 min.  
Allyl bromide (5.00 mL, 57.8 mmol) was then added and the solution warmed to rt and 
stirred for 18 h.  H2O (75 mL) was added and the organic material extracted with EtOAc 
(3 × 100 mL), dried (MgSO4) and solvent removed in vacuo.  Purification by flash 
chromatography (SiO2, petrol/EtOAc 1:43:7) afforded alkene 271 (10.5 g, 86%) as a 
colourless oil: υmax/cm
1
 (neat) 3030, 2975, 2915, 1678; 
1
H NMR (CDCl3, 600 MHz) δ 
1.72 (1H, m) and 2.14 (1H, m, NBnCH2CH2), 2.22 (1H, m, CHHCH=CH2), 2.55-2.62 
(1H, dtd, J 12.3, 8.7, 4.1 Hz, CHC=O), 2.63-2.68 (1H, m, CHHCH=CH2), 3.19 (2H, dd, 
J 8.3, 5.7 Hz, NBnCH2), 4.44 (1H, d, J 14.6 Hz) and 4.50 (1H, d, J 14.6 Hz, NCH2Bn), 
5.07 (1H, app. d, J 10.1 Hz) and 5.11 (1H, app. d, J 17.1, Hz, CH=CH2), 5.80 (1H, ddt, 
J 17.1, 10.1, 6.9 Hz, CH=CH2), 7.22-7.25 (2H, m) , 7.30 (1H, m) and 7.32-7.36 (2H, m, 
Aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ 23.9 (NBnCH2CH2), 35.5 and 41.4 
(CH2CH=CH2 and CHC=O), 44.8 (NBnCH2), 46.7 (NCH2Ph), 116.9 (CH=CH2), 127.5, 
128.1 and 128.7 (Aromatic CH), 135.6 (CH=CH2), 136.6 (Aromatic C), 176.0 (C=O). 
 
1-Benzyl-3-(2-hydroxyethyl)pyrrolidin-2-one (272)
80
 
 
An ozone enriched stream of oxygen was bubbled through a solution of 
alkene 271 (9.80 g, 45.6 mmol) in MeOH (250 mL) until a blue colour 
persisted.    After this time, oxygen was bubbled through the solution until 
the blue colour dissipated.  NaBH4 (17.2 g, 455 mmol) was added in 10 portions over 1 
h and the solution stirred for a further 1 h.  The reaction was quenched with H2O (100 
mL) and 2 M HCl (50 mL) and the organic material extracted with EtOAc (3 × 200 
mL), dried (MgSO4) and solvent removed in vacuo.  Purification by flash 
chromatography (SiO2, petrol/EtOAc 1:1 EtOAc) afforded alcohol 272 (8.40, 79%) as a 
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colourless oil: υmax/cm
1
 (neat) 3398 br, 2938, 2870, 1658; 
1
H NMR (CDCl3, 400 MHz) 
δ 1.68-1.82 (2H, m, NBnCH2CHH and CHHCH2OH), 1.93 (1H, m, CHHCH2OH), 2.23 
(1H, m, NBnCH2CHH), 2.68 (1H, qd, J 9.3, 4.7 Hz, CHC=O), 3.26 (2H, dd, J 8.9, 5.0 
Hz, NBnCH2), 3.76-3.90 (2H, m, CH2OH), 4.45 (1H, d, J 14.8 Hz) and 4.49 (1H, d, J 
14.8 Hz, NCH2Ph), 7.21-7.40 (5H, m, Aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ 
25.9 (NBnCH2CH2), 34.7 (CH2CH2OH), 42.4 (CHC=O), 45.5 (NBnCH2), 47.0 
(NCH2Ph), 62.1 (CH2OH), 127.7, 128.1 and 128.8 (Aromatic CH), 136.1 (Aromatic C), 
177.5 (C=O). 
 
2-(1-Benzyl-2-oxopyrrolidin-3-yl)ethyl methanesulfonate (273)
80
 
 
To a solution of alcohol 272 (4.96 g, 21.3 mmol) in DCM (150 mL) at 0 ºC 
was added NEt3 (6.30 mL, 45.2 mmol), followed by MsCl (3.60 mL, 46.5 
mmol) and the mixture stirred at 0 ºC for 2.5 h.  H2O (50 mL) was added 
and the organic material extracted with DCM (3 × 100 mL), washed with 
brine (50 mL), dried (MgSO4) and solvent removed in vacuo to give crude mesylate 273 
(8.04 g, 121%) as a colourless oil, which was used without further purification: 
υmax/cm
1
 (neat) 3029, 2934, 1671; 
1
H NMR (CDCl3, 400 MHz) δ 1.65-1.75 (1H, m, 
NBnCH2CHH), 1.89 (1H, m, CHHCH2OMs), 2.25-2.36 (2H, m, NBnCH2CHH and 
CHHCH2OMs), 2.63 (1H, m, CHC=O), 3.05 (3H, s, CH3), 3.22 (2H, dd, J 8.8, 5.0 Hz, 
NBnCH2), 4.39-4.52 (4H, m, NBnCH2 and CH2OMs), 7.21-7.38 (5H, m, Aromatic 
CH); 
13
C NMR (CDCl3, 100 MHz) δ 25.3 (NBnCH2CH2), 31.2 (CH2CH2OMs), 37.3 
(SO2CH3), 38.5 (CHC=O), 44.8 (NBnCH2), 46.8 (NCH2Ph), 68.3 (CH2OMs), 127.7, 
128.1 and 128.8 (Aromatic CH), 136.3 (Aromatic C), 175.4 (C=O). 
 
3-(2-Azidoethyl)-1-benzylpyrrolidin-2-one (274)
80
 
 
To a solution of crude mesylate 273 (8.04 g, ca. 25.0 mmol) in DMSO (60 
mL) was added NaN3 (5.48 g, 84.3 mmol) and the solution stirred at 60 ºC 
for 2 h.  The reaction was quenched by the addition of H2O and the organic 
material was extracted into EtOAc (3 × 150 mL), washed with brine (100 mL), dried 
(MgSO4) and solvent removed in vacuo.  Purification by flash chromatography (SiO2, 
petrol/EtOAc 1:1) gave azide 274 (4.90 g, 89% from alcohol 272) as a colourless oil: 
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υmax/cm
1
 (neat) 2934, 2872, 2091, 1676; 
1
H NMR (CDCl3, 600 MHz) δ 1.65-1.72 (2H, 
m, CHHCH2N3 and NBnCH2CHH), 2.18-2.27 (2H, m, CHHCH2N3 and 
NBnCH2CHH), 2.58 (1H, dtd, J 9.2, 8.8, 5.5 Hz, CHC=O), 3.21 (2H, dd, J 8.7, 5.1 Hz, 
NBnCH2), 3.49 (2H, m, CH2N3), 4.46 (1H, d, J 14.7 Hz) and 4.48 (1H, J 14.7 Hz, 
NCH2Ph), 7.21-7.36 (5H, m, Aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ 25.2 
(NBnCH2CH2), 30.8 (CH2CH2N3), 39.5 (CHC=O), 44.8 (NBnCH2), 46.8 (NCH2Ph), 
49.6 (CH2N3), 127.6, 128.1 and 128.7 (Aromatic CH), 136.4 (Aromatic C), 175.7 
(C=O). 
 
1-Benzyl-octahydropyrrolo[2,3-b]pyrrole (275)
80
 
 
To a solution of azide 274 (396 mg, 1.53 mmol) in THF (25 mL) was added 
PBu3 (0.95 mL, 3.80 mmol) and the solution stirred at rt for 30 min.  After 
this time, LiAlH4 (1 M in THF, 0.95 mL, 0.95 mmol) was added dropwise and the 
solution stirred for 50 min.  Sat. aq. Rochelle’s salt (1 M, 16 mL) was added and the 
mixture stirred for 1 h.  The organic material was extracted into EtOAc (3 × 100 mL), 
washed with brine (100 mL), dried (MgSO4) and solvent removed in vacuo.  
Purification by flash chromatography (Al2O3, petrol/EtOAc 1:193:17) gave amine 
275 (233 mg, 71%) as a yellow oil: υmax/cm
1
 (neat) 3289 br, 2956, 2866, 2793, 1653, 
1603; 
1
H NMR (CDCl3, 600 MHz) δ 1.42 (1H, m, NHCH2CHH), 1.51 (1H, m) and 1.73 
(1H, m, NBnCH2CH2),  1.95 (1H, m, NHCH2CHH), 2.00-2.30 (1H, br s, NH), 2.34 
(1H, td, J 8.8, 6.3 Hz, NHCHH), 2.59-2.67 (1H, m, CHCHNBn), 2.80 (1H, ddd, J 8.8, 
6.7, 3.7 Hz, NHCHH), 2.82-3.00 (2H, m, NBnCH2), 3.65 (1H, d, J 13.1 Hz) and 3.83 
(1H, d, J 13.1 Hz, NCH2Ph), 4.12 (1H, app. d, J 7.7 Hz, NCHN), 7.20-7.37 (5H, m, 
Aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ 30.8 (NBnCH2CH2), 33.7 
(NHCH2CH2), 41.5 (CHCHNBn), 45.0, 52.0 and 57.3 (NBnCH2, NHCH2 and 
NCH2Ph), 83.2 (NCHN), 126.9, 128.3 and 129.0 (Aromatic CH), 139.4 (Aromatic C). 
 
1-Benzyl-6-tosyl-octahydropyrrolo[2,3-b]pyrrole (276)
80
 
 
To a solution of amine 275 (97.0 mg, 0.48 mmol) in DCM (4 mL) was 
added NEt3 (0.15 mL, 1.09 mmol) dropwise, followed by TsCl (0.20 g, 1.05 
mmol) and the solution stirred at rt for 2 h.  After the addition of H2O (5 mL), the 
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organic material was extracted into EtOAc (3 × 10 mL), washed with brine (10 mL), 
dried (MgSO4) and solvent removed in vacuo.  Purification by flash chromatography 
(SiO2, DCM/MeOH 1:991:49) gave bicycle 276 (144 mg, 85%) as a pale yellow 
solid: mpt. 84-86 C; υmax/cm
1
 (solid) 2968, 2868, 2781, 1598; 
1
H NMR (CDCl3, 400 
MHz) δ 1.20-1.31 (1H, m, NTsCH2CHH), 1.35-1.50 (2H, m, NTsCH2CHH and 
NBnCH2CHH), 1.85-2.00 (1H, m, NBnCH2CHH), 2.40-2.52 (1H, m, NBnCHH), 2.41 
(3H, s, CH3), 2.55-2.71 (2H, m, CHCHNBn and NBnCHH), 3.31 (1H, m) and 3.62 
(1H, dd, J 12.5, 7.8 Hz, NTsCH2), 4.00 (1H, d, J 13.6 Hz) and 4.06 (1H, d, J 13.6 Hz, 
NCH2Ph), 5.08 (1H, app. d, J 6.7 Hz, NCHN),  7.20-7.40 (7H, m, Aromatic CH), 7.77 
(2H, d, J 8.2 Hz, SO2CCH); 
13
C NMR (CDCl3, 150 MHz) δ 21.6 (CH3), 29.9 and 32.4 
(NBnCH2CH2 and CHCHNBn), 41.9 (CH2CH2NTs), 48.1 and 50.5 (NBnCH2 and 
NTsCH2), 55.4 (NCH2Ph), 84.8 (NCHCN), 126.7, 127.2, 128.1, 128.8 and 129.7 
(Aromatic CH), 137.3 (NCH2C), 139.3 (SO2CCHCHC), 143.2 (SO2C). 
 
N-(2-(1-Benzyl-2-(nitromethyl)pyrrolidin-3-yl)ethyl)-4-methylbenzenesulfonamide 
(279) 
 
Bicycle 276 (4.0 mg, 0.01 mmol) was stirred in MeNO2 at rt under argon 
for 18 h.  After this time the solvent was removed in vacuo to give amine 
279 (4.3 mg, 92%) as an orange solid: mpt. 50-54 C; υmax/cm
1
 (solid) 3287 br, 2929, 
2806, 1598, 1547; 
1
H NMR (CDCl3, 600 MHz) δ 1.42 (1H, m, NBnCH2CHH), 1.50 
(1H, m) and 1.60 (1H, m, NHTsCH2CH2), 1.90 (1H, m, NBnCH2CHH), 2.11 (1H, m, 
NBnCHCH), 2.38-2.46 (1H, m, NBnCHH), 2.45 (3H, s, PhCH3), 2.90 (1H, m, 
NBnCHH), 2.93-3.01 (3H, m, CH2NHTs and NBnCH), 3.50 (1H, d, J 12.9 Hz) and 
3.92 (1H, d, J 12.9 Hz, CH2Ph), 4.35 (2H, m, CH2NO2), 4.53 (1H, br s, NH), 7.24-7.40 
(5H, m, Aromatic CH), 7.34 (2H, d, J 8.4 Hz, SO2CCHCH), 7.74 (2H, app. d, J 8.4 Hz, 
SO2CCH); 
13
C NMR (CDCl3, 150 MHz) δ 21.6 (PhCH3), 28.8 (NBnCH2CH2), 34.4 
(CH2CH2NHTs), 39.5 (NCHCH), 41.4 (NHTsCH2), 52.0 (NBnCH2), 59.2 (NCH2Ph), 
67.3 (NBnCH), 78.2 (CH2NO2), 127.1, 127.4, 128.5, 128.8 and 129.8 (Aromatic CH), 
136.7 (SO2C), 138.4 (NCH2C), 143.6 (SO2CCHCHC); m/z (ES+) 416 ([MH]
+
, 100%); 
HRMS found 416.1631, C21H26N3O4S ([MH]
+
) requires 416.1644. 
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N-(2-(1-Benzylpyrrolidin-3-yl)ethyl)-4-methylbenzenesulfonamide (280)  
 
To a solution of bicycle 276 (10.0 mg, 28.1 µmol) in THF/EtOH (3:2, 7 
mL) was added Pd-C (1.5 mg) under an argon atmosphere.  The mixture 
was evacuated of air and then H2 was added; this was repeated another 2 
times and the solution stirred for at rt for 18 h.  After this time, the flask was flushed 
with argon, the product filtered through Celite® and solvent removed to give amine 280 
(9.9 mg, 98%) as a yellow oil: υmax/cm
1
 (neat) 3276 br, 2925, 2790, 1599; 
1
H NMR 
(CDCl3, 600 MHz) δ 1.40 (1H, m, NBnCH2CHH), 1.52-1.63 (2H, m, NHTsCH2CH2), 
1.96 (1H, m, NBnCH2CHH), 2.26 (1H, m, NBnCH2CH), 2.31 (1H, m, J 9.4, 5.9 Hz, 
NBnCHHCH), 2.42 (3H, s, PhCH3), 2.56 (1H, m) and 2.63 (1H, m, NBnCH2), 2.70 
(1H, dd, J 9.4, 7.6 Hz, NBnCHHCH), 2.88 (1H, dt, J 12.8, 7.1 Hz) and 2.94 (1H, ddd, J 
12.8, 7.1, 6.0 Hz, CH2NHTs), 3.61 (1H, d, J 12.7 Hz) and 3.70 (1H, d, J 12.7 Hz, 
NCH2Ph), 7.26-7.37 (7H, Aromatic CH and SO2CCHCH), 7.69 (2H, d, J 8.2 Hz, 
SO2CCH); 
13
C NMR (CDCl3, 150 MHz) δ 21.5 (PhCH3), 29.1 (NBnCH2CH2), 34.5 
(NHTsCH2CH2), 34.5 (NBnCH2CH), 41.3 (CH2NHTs), 53.4 (NBnCH2), 59.7 
(NBnCH2CH), 60.3 (NCH2Ph), 127.0, 127.4, 128.4, 129.3 and 129.7 (Aromatic CH), 
137.0 and 137.7 (SO2C and NCH2C), 143.2 (SO2CCHCHC); m/z (FAB) 359 (MH
+
, 
45%), 286 (39), 176 (100); HRMS found 359.1792, C20H27N2O2S (MH
+
) requires 
359.1793. 
 
1-Benzyl-6-methanesulfonyl-1-methyl-octahydropyrrolo[2,3-b]pyrrol-1-ium iodide 
(281) 
 
Bicycle 276 (37.0 mg, 0.10 mmol) was stirred with iodomethane (64.3 
µL, 1.03 mmol) at rt under argon.  After this time, the excess 
iodomethane was removed in vacuo.  Purification by flash 
chromatography (SiO2, DCM/MeOH 9:1) gave salt 281 (42.0 mg, 81%) as a yellow 
solid: mpt. 100-102 C; υmax/cm
1
 (solid) 2957, 1596; 
1
H NMR (CDCl3, 400 MHz) δ 
1.72 (2H, m, NTsCH2CH2), 1.80 (1H, m, NBnCH2CHH), 2.45 (3H, s, PhCH3), 2.62 
(1H, m, NBnCH2CHH), 2.91 (3H, s, NCH3), 3.08 (1H, ddd, J 11.5, 6.3, 3.7 Hz, 
NBnCHH), 3.55 (1H, ddd, J 11.8, 6.9, 5.5 Hz) and 3.69 (1H, dt, J 11.8, 7.5 Hz, 
NTsCH2), 3.88 (1H, m, NCHCH), 4.64 (1H, ddd, J 11.5, 6.9, 3.1 Hz, NBnCHH), 4.86 
(1H, d, J 13.0 Hz) and 5.71 (1H, d, J 13.0 Hz, NCH2Ph), 6.39 (1H, d, J 8.3 Hz, NCHN), 
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7.43-7.56 (5H, m, Aromatic CH), 7.64 (2H, m, SO2CCHCH), 7.92 (2H, d, J 8.4 Hz, 
SO2CCH); 
13
C NMR (CDCl3, 100 MHz) δ 21.7 (PhCH3), 27.4 (NBnCH2CH2), 30.1 
(NTsCH2CH2), 43.2 (NCHCH), 43.8 (NCH3), 51.0 (NTsCH2), 62.0 (NBnCH2), 66.5 
(NCH2Ph), 95.5 (NCHN), 128.0, 128.0, 129.4, 130.8, 132.7 and 132.8 (Aromatic CH 
and Aromatic C), 145.7 (SO2CCHCHC); m/z (ES+) 371 ([MI]
+
, 100%), 150 (28); 
HRMS found 371.1782, C21H27N2O2S ([MI]
+
) requires 371.1793. 
 
Acid catalysed rearrangement method 
 
1-Benzyl-3-methylpyrrolidin-2-one (291)
28
 
 
To a solution of 1-benzyl-2-pyrrolidinone (102, 16.5 mL, 86.4 mmol) in THF 
(250 mL) at 78 C was added nBuLi (2.5 M in hexanes, 41.0 mL, 104 
mmol) dropwise and the mixture stirred for 30 min.  MeI (10.8 mL, 173 mmol) was 
then added very slowly and the solution stirred for 30 min at 78 C, followed by a 
further 1 h at rt.  The reaction mixture was quenched by the addition of NH4
+
Cl

 (100 
mL) and the organic material extracted into EtOAc (3  250 mL), washed with brine 
(200 mL), dried (MgSO4) and solvent removed in vacuo.  Purification by flash 
chromatography (SiO2, petrol/EtOAc 7:32:3) gave lactam 291 (15.8 g, 95%) as a 
yellow oil: υmax/cm
1
 (neat) 2964, 2931, 2872, 1678; 
1
H NMR (CDCl3, 400 MHz) δ 
1.29 (3H, d, J 7.0 Hz, CH3), 1.55-1.65 (1H, m) and 2.22 (1H, m, NBnCH2CH2), 2.52 
(1H, m, CH), 3.13-3.22 (2H, m, NBnCH2), 4.44 (1H, d, J 14.7 Hz) and 4.49 (1H, d, J 
14.7 Hz, NCH2Ph), 7.20-7.37 (5H, m, Aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ 
16.6 (CH3), 27.2 (NBnCH2CH2), 36.9 (CH), 44.8 (NBnCH2), 46.9 (NCH2Ph), 127.6, 
128.2 and 128.8 (Aromatic CH), 136.8 (Aromatic C), 177.5 (C=O). 
 
1-Benzyl-3-methylpyrrolidine-2-thione (101)
28
 
 
To a solution of lactam 291 (17.0 g, 89.9 mmol) in THF (400 mL) was added 
Lawesson’s reagent (21.8 g, 49.4 mmol) and the resulting mixture stirred at 
40 C for 2 h.  After cooling to rt, H2O (100 mL) was added and the organic 
material extracted into EtOAc (3  150 mL), washed with brine (150 mL), dried 
(MgSO4) and concentrated in vacuo.  Purification by flash chromatography (SiO2, 1:19 
   
   
134 
 
1:9) gave thiolactam 101 (17.0 g, 92%) as a pale yellow oil: υmax/cm
1
 (neat) 2963, 
2927, 2870, 1498, 1448; 
1
H NMR (CDCl3, 600 MHz) δ 1.41 (3H, d, J 7.1 Hz, CH3), 
1.65 (1H, m) and 2.29 (1H, m, NBnCH2CH2), 2.98 (1H, app. sext, J 7.4 Hz, CHCH3), 
3.46-3.55 (2H, m, NBnCH2), 4.97 (1H, d, J 14.3 Hz) and 5.06 (1H, d, J 14.3 Hz, 
NCH2Ph), 7.30-7.38 (5H, m, Aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ 19.7 
(CH3), 28.4 (NBnCH2CH2), 49.0 (CHMe), 52.0 (NCH2Ph), 52.0 (NBnCH2), 128.1, 
128.3 and 128.9 (Aromatic CH), 135.3 (Aromatic C), 206.8 (C=S). 
 
(E)-4-Bromobut-2-en-1-ol (100)
28
 
 
To a solution of ethyl-4-bromocrotonate (20.6 g, 107 mmol) in 
toluene (70 mL) at 78 C was added DIBAL (1.2 M in toluene, 224 mL, 269 mmol) 
and the mixture stirred for 1 h.  To the reaction was added Et2O (30 mL), then MeOH 
(30 mL) and the solution stirred at 78 C for 1 h.  The solution was warmed to 0 C 
and aq. sat. Rochelle’s salt (50 mL) was added and the resulting solution stirred at rt for 
1 h.  The organic material was extracted into Et2O (3  150 mL), washed with H2O (100 
mL), brine (100 mL), dried (MgSO4) and concentrated in vacuo.  Purification by flash 
chromatography (SiO2, petrol/Et2O 4:11:1) gave volatile bromide 100 (11.2 g, 77%) 
as a orange oil: υmax/cm
1
 (neat) 3296 br, 2934, 2858, 1667; 
1
H NMR (CDCl3, 400 
MHz) δ 1.55 (1H, br s, OH), 3.98 (2H, app. d, J 6.3 Hz, CH2Br), 4.20 (2H, app. d, J 3.5 
Hz, CH2OH), 5.90-6.02 (2H, m, CHCH2OH and CHCH2Br); 
13
C NMR (CDCl3, 150 
MHz) δ 32.1 (CH2Br), 62.6 (CH2OH), 127.5 (CHCH2Br), 134.1 (CHCH2OH). 
 
(±)-(R)-1-Benzyl-3-((S)-1-hydroxybut-3-en-2-yl)-3-methylpyrrolidine-2-thione 
(99)
28
 
 
A solution of thiolactam 101 (6.30 g, 30.7 mmol) and bromide 100 (5.19 g, 
34.6 mmol) in MeCN (4.6 mL) was stirred at rt for 4 d.  The solution was 
diluted with MeCN (160 mL), heated to 40 C and NEt3 (4.70 mL, 33.7 
mmol) was added; the resulting mixture was stirred for 6.5 h.  The mixture 
was cooled to rt, diluted with DCM (200 mL), washed with 10% citric acid (100 mL) 
and organic layer collected.  Further organic material was extracted from the aqueous 
layer (2  200 mL) and these extracts washed with 10% citric acid (100 mL).  The 
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combined organic material was washed with brine (100 mL), dried (MgSO4) and 
concentrated in vacuo.  Purification by flash chromatography (SiO2, petrol/EtOAc 
9:17:3) gave thiolactam 99 (6.80 g, 80%) as a pale yellow solid: mpt. 59-51 C; 
υmax/cm
1
 (solid) 3330 br, 2971, 2956, 2876, 1668, 1503, 1450; 
1
H NMR (CDCl3, 400 
MHz) δ 1.25 (3H, s, CH3), 1.73 (1H, ddd, J 12.9, 7.9, 4.5 Hz) and 2.19 (1H, ddd, J 12.9, 
9.4, 7.8 Hz, NBnCH2CH2), 2.96 (1H, dt, J 9.9, 6.7 Hz, CHCH2OH), 3.40-3.53 (2H, m, 
NBnCH2), 3.58-3.68 (2H, m, CH2OH), 5.00 (1H, d, J 14.3 Hz) and 5.05 (1H, d, J 14.3 
Hz, NCH2Ph), 5.26-5.32 (2H, m, CH=CH2), 5.60-5.70 (1H, dt, J 17.0, 9.9 Hz, 
CH=CH2), 7.28-7.38 (5H, m, Aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ 27.2 
(CH3), 28.6 (NBnCH2CH2), 51.1 and 52.1 (NCH2Ph and NBnCH2), 54.6 (CHCH2OH), 
56.7 (CMe), 63.2 (CH2OH), 120.3 (CH=CH2), 128.3, 128.4 and 129.0 (Aromatic CH), 
135.1 (Aromatic C), 135.5 (CH=CH2), 208.7 (C=S). 
 
(±)-(R)-1-Benzyl-3-((S)-1-hydroxybut-3-en-2-yl)-3-methylpyrrolidin-2-one (286)
28
 
 
To a solution of thiolactam 99 (11.5g, 41.8 mmol) in DCM (500 mL) at 0 
C was added mCPBA (22.4 g, 135 mmol) in 0.25 equivalent portions every 
10 min.  After this addition, the mixture was stirred for a further 1 h at 0 C.  
The solution was warmed to rt, poured into sat. NaHCO3 (200 mL) and organic material 
collected.  Further extraction of the organic material with DCM (2  200 mL) followed 
by drying (MgSO4) and concentration in vacuo gave the crude material.  Purification by 
flash chromatography (SiO2, petrol/EtOAc 1:1  EtOAc) gave alcohol 286 (9.53 g, 
88%) as a yellow solid: mpt. 54-55 C; υmax/cm
1
 (solid) 3363 br, 2923, 2861, 1670; 
1
H 
NMR (CDCl3, 400 MHz) δ 1.26 (3H, s, CH3), 1.64 (1H, ddd, J 12.9, 7.9, 3.6 Hz) and 
2.16 (1H, ddd, J 12.9, 9.2, 8.0 Hz, NBnCH2CH2), 2.29 (1H, m, CHCH2OH), 3.14-3.25 
(2H, m, NBnCH2), 3.66 (1H, dd, J 11.3, 4.5 Hz) and 3.94 (1H, dd, J 11.3, 4.3 Hz, 
CH2OH), 4.42 (1H, d, J 14.7 Hz) and 4.48 (1H, d, J 14.7 Hz, NCH2Ph), 5.17-5.25 (2H, 
m, CH=CH2),  5.80 (1H, dt, J 16.9, 10.1 Hz, CH=CH2),  7.20-7.39 (5H, m, Aromatic 
CH); 
13
C NMR (CDCl3, 150 MHz) δ 22.9 (CH3), 29.9 (NBnCH2CH2), 44.2 (NBnCH2), 
47.0 (CMe), 47.1 (NCH2Ph), 53.2 (CHCH2OH), 63.1 (CH2OH), 119.4 (CH=CH2), 
127.8, 128.2 and 128.9 (Aromatic CH), 136.1 (Aromatic C), 136.2 (CH=CH2), 179.0 
(C=O). 
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(±)-(R)-3-((S)-1-Hydroxybut-3-en-2-yl)-3-methylpyrrolidin-2-one (287) and (±)-(R)-
3-((S)-1-hydroxybutan-2-yl)-3-methylpyrrolidin-2-one (292) 
 
To liquid ammonia at 78 C was added a solution of alcohol 286 (1.03 g, 
3.97 mmol) in THF (60 mL) and the mixture stirred for 15 min.  Na pieces 
were added (183 mg, 7.95 mmol) and the solution stirred for a further 10 
min.  The reaction was quenched by the addition of NH4
+
Cl

 (50 mL) and was left to 
stir at 20 C overnight.  The THF was removed in vacuo and the organic material 
extracted with EtOAc (5  70 mL), dried (MgSO4) and solvent removed in vacuo to 
afford alcohol 287 (545 mg, 81%) as a white solid: mpt. 74-77 C; υmax/cm
1
 (solid) 
3251 br, 2961, 2926, 2873, 1677; 
1
H NMR (CDCl3, 600 MHz) δ 1.27 (3H, s, CH3), 1.79 
(1H, dddd, J 12.9, 7.9, 3.3, 0.6 Hz, CHHCH2NH), 2.28 (1H, dt, J 10.1, 4.8 Hz, 
CHCH2OH), 2.32 (1H, ddd, J 12.9, 9.1, 7.9 Hz, CHHCH2NH), 3.31-3.42 (2H, m, 
CH2NH), 3.65 (1H, m, CHHOH), 3.78 (1H, br s, OH), 3.90 (1H, dd, J 11.2, 4.8 Hz, 
CHHOH), 5.22 (1H, dd, J 17.0, 1.9 Hz) and 5.27 (1H, dd, J 10.1, 1.9 Hz, CH=CH2), 
5.83 (1H, dt, J 17.0, 10.1 Hz, CH=CH2), 6.30 (1H, br s, NH); 
13
C NMR (CDCl3, 150 
MHz) δ 22.6 (CH3), 32.3 (CH2CH2NH), 39.7 (CH2NH), 45.6 (CCH3), 52.7 
(CHCH2OH), 63.0 (CH2OH), 119.4 (CH=CH2), 136.0 (CH=CH2), 182.6 (C=O); m/z 
(FAB) 192 (MNa
+
, 100%), 176 (23); HRMS found 192.0997, C9H15NO2Na (MNa
+
) 
requires 192.1000. 
 
When excess Na was used (5 equiv.) and the reaction stirred for longer 
than 10 mins, alcohol 287 was isolated as a white solid along with alcohol 
292: mpt. 69-70  C; υmax/cm
1
 (solid) 3252 br, 2960, 2933, 2877, 1675; 
1
H NMR (CDCl3, 400 MHz) δ 0.99 (3H, t, J 7.4 Hz, CH2CH3), 1.31 (3H, s, CCH3), 
1.32-1.36 (1H, m, CHCH2OH), 1.43 (1H, m) and 1.54 (1H, m, CH2CH3), 1.83 (1H, 
dddd, J 13.1, 7.8, 3.1, 0.6 Hz) and 2.26 (1H, dt, J 13.1, 8.8 Hz, CH2CH2NH), 3.30-3.46 
(2H, m, CH2NH), 3.68 (1H, m) and 3.86 (1H, d, J 11.9 Hz, CH2OH), 4.61 (1H, br s, 
OH), 6.52 (1H, br s, NH); 
13
C NMR (CDCl3, 100 MHz) δ 12.8 (CH2CH3), 18.5 
(CH2CH3), 22.9 (CCH3), 33.5 (CH2CH2NH), 40.0 (CH2NH), 47.5 (CCH3), 48.5 
(CHCH2OH), 59.5 (CH2OH), 183.5 (C=O); m/z (CI) 172 (MH
+
, 100%), 154 (25), 112 
(32), 99 (47); HRMS found 172.1334, C9H18O2N (MH
+
) requires 172.1338. 
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(±)-2-[(3R,4S)-4-Ethenyl-3-methyl-2-oxooxolan-3-yl]-N-[(4-methylbenzene) 
sulfonyl]-S-(4-methylphenyl)ethane-1-sulfonamido (294) and (±)-(S)-2-((R)-3-
methyl-2-oxo-1-tosylpyrrolidin-3-yl)but-3-enylmethylbenzenesulfonate (295)  
 
To a solution of NaH (60% dispersion in mineral oil-washed with 
hexane, 32.0 mg, ca. 0.80 mmol) in THF (3 mL) at 0 C was added 
alcohol 287 (50.0 mg, 0.30 mmol) and the solution stirred for 1 h 20 min.  TsCl (124 
mg, 0.65 mmol) was added and the mixture stirred at rt for 18 h.  H2O (3 mL) was then 
added slowly and the organic material extracted into DCM (3  10 mL), washed with 
brine (10 mL), dried (MgSO4) and solvent removed in vacuo.  Purification by flash 
chromatography (SiO2, petrol/EtOAc 9:1) gave lactone 294 (58.0 mg, 41%) as a white 
solid: mpt. 98-100 C; υmax/cm
1
 (solid) 2973, 2927, 1763, 1597; 
1
H NMR (CDCl3, 600 
MHz) δ 1.24 (3H, s, CH3CC=O), 1.74 (1H, ddd, J 13.2, 11.7, 5.4 Hz) and 1.87 (1H, 
ddd, J 13.2, 11.7, 4.9 Hz, CH2CH2NTs2), 2.45 (6H, s, 2  PhCH3), 2.85 (1H, br q, J 8.7 
Hz, CHCH2O), 3.73 (1H, m) and 3.80 (1H, m, CH2NTs2), 4.01 (1H, t, J 9.6 Hz) and 
4.32 (1H, dd, J 9.3, 7.7 Hz, CH2O), 5.19 (1H, dt, J 17.0, 1.3 Hz) and 5.26 (1H, ddd, J 
10.2, 1.3, 0.8 Hz, CH=CH2), 5.65 (1H, ddd, J 17.0, 10.2, 8.3 Hz, CH=CH2), 7.33 (4H, 
app. d, J 8.4 Hz, 2  SO2CCHCH), 7.81 (4H, app. d, J 8.4 Hz, 2  SO2CCH); 
13
C NMR 
(CDCl3, 150 MHz) δ 20.2 (CH3CC=O), 21.7 (2  PhCH3), 31.8 (CH2CH2NTs2), 44.0 
(CH3CC=O), 44.8 (CH2NTs2), 51.8 (CHCH2O), 68.4 (CH2O), 120.3 (CH=CH2), 128.4 
and 129.8 (Aromatic CH), 131.3 (CH=CH2), 135.1 (2  SO2C), 145.0 (2  
SO2CCHCHC), 179.5 (C=O); m/z (ES+) 500 (MNa
+
, 100%), 306 (27), 180 (27); 
HRMS found 500.1177, C23H27NO6NaS2 (MNa
+
) requires 500.1178. 
 
Further elution (SiO2, petrol/EtOAc 9:14:1) afforded tosylate 295 (45.0 
mg, 32%) as a pale yellow oil: υmax/cm
1
 (DCM cast) 2977, 2926, 1728, 
1597; 
1
H NMR (CDCl3, 400 MHz) δ 1.00 (3H, s, CH3CC=O), 1.70 (1H, 
ddd, J 13.2, 7.9, 3.9 Hz) and 2.18 (1H, ddd, J 13.2, 8.9, 7.9 Hz, NTsCH2CH2), 2.40-
2.50 (1H, m, CHC=O), 2.45 (3H, s) and 2.46 (3H, s, PhCH3), 3.68 (1H, dt, J 9.9, 7.9 
Hz) and 3.81 (1H, ddd, J 9.9, 8.9, 3.9 Hz, NTsCH2), 3.97 (1H, dd, J 10.2, 7.5 Hz) and 
4.08 (1H, dd, J 10.2, 4.7 Hz, CH2OTs), 5.08 (1H, dd, J 16.9, 1.5 Hz) and 5.13 (1H, dd, 
J 10.0, 1.5 Hz, CH=CH2), 5.32 (1H, dt, J 16.9, 10.0 Hz, CH=CH2), 7.31-7.36 (4H, m, 2 
 SO2CCHCH), 7.72 (2H, app. d, J 8.3 Hz) and 7.86 (2H, app. d, J 8.4 Hz, 2  
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SO2CCH),); 
13
C NMR (CDCl3, 150 MHz) δ 21.7 and 21.7 (2  PhCH3), 22.0 
(CH3CC=O), 28.7 (NTsCH2CH2), 44.0 (NTsCH2) 47.0 (CH3CC=O), 49.3 (CHC=O), 
69.5 (CH2OTs), 121.3 (CH=CH2), 127.8 and 127.9 (2  SO2CCH), 129.7 and 129.9 (2 
 SO2CCHCH), 132.6 (CH=CH2), 132.7 and 134.6 (2 × SO2C), 145.0 and 145.4 (2  
SO2CCHCHC), 176.1 (C=O); m/z (ES+) 500 (MNa
+
, 100%), 369 (32), 306 (50); 
HRMS found 500.1163, C23H27NO6NaS2 (MNa
+
) requires 500.1178. 
 
The same mixture of products was obtained when the reaction was attempted with NEt3 
(1.05 equiv.), TsCl (2.1 equiv.), THF at 0 C to reflux as the first step, followed by NaH 
(2.1 equiv.) at 0 C to rt. 
 
(±)-(S)-2-((R)-3-Methyl-2-oxopyrrolidin-3-yl)but-3-enyl methanesulfonate (296) 
 
To solution of alcohol 287 (25.0 mg, 0.15 mmol) in DCM (1.7 mL) at 0 
C was added NEt3 (43.0 µL, 0.31 mmol) followed by MsCl (24.0 µL, 
0.31 mmol) and the mixture stirred at rt for 24 h.  After adding H2O to the 
reaction mixture (1 mL), the organic material was extracted into EtOAc (3  5 mL), 
washed with brine (5 mL), dried (MgSO4) and solvent removed in vacuo.  Purification 
by flash chromatography (SiO2, petrol/EtOAc 3:7  EtOAc) gave mesylate 296 (37.1 
mg, 82%) as a white solid: mpt. 81-82 C υmax/cm
1
 (solid) 3385 br, 3244 br, 2969, 
2933, 1688; 
1
H NMR (CDCl3, 600 MHz) δ 1.22 (3H, s, CCH3), 1.80 (1H, ddd, J 13.0, 
7.8, 3.6 Hz) and 2.23 (1H, ddd, J 13.0, 8.9, 7.5 Hz, CH2CH2NH), 2.64 (1H, m, 
CHCH2OMs),  3.00 (3H, s, SO2CH3), 3.29-3.39 (2H, m, CH2NH), 4.31 (1H, dd, J 9.9, 
8.6 Hz) and 4.37 (1H, dd, J  9.9, 4.6 Hz, CH2OMs), 5.27 (1H, d, J 17.0 Hz) and 5.32 
(1H, app. d, J 10.0 Hz, CH=CH2), 5.63 (1H, dt, J 17.0, 10.0 Hz, CH=CH2), 6.64 (1H, br 
s, NH); 
13
C NMR (CDCl3, 150 MHz) δ 23.1 (CCH3), 30.8 (CH2CH2NH), 37.3 
(SO2CH3), 39.0 (CH2NH), 44.5 (CCH3), 53.5 (CHCH2OMs), 69.8 (CH2OMs), 121.1 
(CH=CH2), 133.7 (CH=CH2), 181.(C=O); m/z (CI) 248 (MH
+
, 55%), 152 (100); HRMS 
found 248.0957, C10H18O4NS (MH
+
) requires 248.0957. 
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(±)-(R)-3-((S)-1-Azidobut-3-en-2-yl)-3-methylpyrrolidin-2-one (300) and (±)-(S)-2-
((R)-7-methyl-6,7-dihydro-5H-pyrrolo[1,2-e]tetrazol-7-yl)but-3-en-1-ol (299) 
 
To a solution of NaN3 (3.00 g, 46.2 mmol) in DMSO (13.7 mL) at 80 C 
was added a solution of mesylate 296 (2.29 g, 9.27 mmol) in DMSO (6.4 
mL) dropwise.  After stirring for 4 h the mixture was cooled to rt and H2O 
(10 mL) was added.  The organic material was extracted into EtOAc (3  20 mL), 
washed with brine (15 mL), dried (MgSO4) and solvent removed in vacuo.  Purification 
by flash chromatography (SiO2, petrol/EtOAc 7:31:1) gave azide 300 (1.31 g, 73%) 
as a white solid: mpt. 40-41 C; υmax/cm
1
 (solid) 3178 br, 3084, 2966, 2924, 2101, 
1675; 
1
H NMR (CDCl3, 600 MHz) δ 1.19 (3H, s, CH3), 1.79 (1H, ddd, J 13.1, 8.0, 3.6 
Hz) and 2.22 (1H, ddd, J 13.1, 8.9, 7.4 Hz, CH2CH2NH), 2.53 (1H, td, J  9.9, 4.2 Hz, 
CHCH2N3), 3.27-3.37 (3H, m, CHHN3 and CH2NH), 3.49 (1H, dd, J 12.3, 4.3 Hz, 
CHHN3), 5.23-5.33 (2H, m, CH=CH2), 5.54 (1H, dt, J 16.7, 9.9 Hz, CH=CH2), 6.32 
(1H, br s, NH); 
13
C NMR (CDCl3, 150 MHz) δ 23.1 (CH3), 30.6 (CH2CH2NH), 38.9 
(CH2NH), 44.7 (CCH3), 50.0 (CHCH2N3), 51.7 (CH2N3), 120.5 (CH=CH2), 135.2 
(CH=CH2), 181.1(C=O); m/z (CI) 195 (MH
+
, 100%); HRMS found 195.1241, 
C9H15N4O (MH
+
) requires 195.1246. 
 
Further elution provided tetrazole 299 (144 mg, 8%) as a thick colourless 
oil: υmax/cm
1
 (DCM cast) 3390 br, 2979, 2932, 2886, 1679, 1640; 
1
H NMR 
(CDCl3, 600 MHz) δ 1.49 (3H, s, CH3), 2.10-2.16 (1H, br t, J 5.8 Hz, OH), 
2.55-2.65 (2H, m, NCH2CHH and CHCH=CH2), 3.13 (1H, dt, J 13.6, 7.3 
Hz, NCH2CHH), 3.80 (2H, br t, J 5.5 Hz, CH2OH), 4.32 (2H, t, J 7.3 Hz, NCH2), 5.30 
(2H, m, CH=CH2), 5.50 (1H, m, CH=CH2); 
13
C NMR (CDCl3, 150 MHz) δ 24.9 (CH3), 
39.1 (CCH3), 40.9 (NCH2CH2), 43.8 (NCH2), 54.0 (CHCH=CH2), 62.3 (CH2OH), 
121.3 (CH=CH2), 134.4 (CH=CH2), 166.4 (NCN); m/z (CI) 195 (MH
+
, 100%); HRMS 
found 195.1252, C9H15N4O (MH
+
) requires 195.1246. 
 
(±)-(R)-3-((S)-1-Azidobut-3-en-2-yl)-3-methyl-1-tosylpyrrolidin-2-one (288) 
 
A solution of azide 300 (52.0 mg, 0.27 mmol) in THF (2.5 mL) at 0 C was 
added to NaH (60% dispersion in mineral oil-washed with hexane, 13.0 
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mg, ca. 0.33 mmol) and the mixture stirred for 1 h.  TsCl (61.0 mg, 0.32 mmol) was 
then added and the resulting solution stirred for 18 h at rt.  H2O (5 mL) was added and 
the organic material extracted into DCM (3  5 mL), washed with brine (5 mL), dried 
(MgSO4) and solvent removed in vacuo.  Purification by flash chromatography (SiO2, 
petrol/EtOAc 9:17:3) gave azide 288 (87.0 mg, 94%) as a cream solid: mpt. 66-68 
C; υmax/cm
1
 (solid) 2920, 2852, 2097, 1727, 1596; 
1
H NMR (CDCl3, 600 MHz) δ 1.08 
(3H, s, CH3CC=O), 1.73 (1H, ddd, J 13.2, 8.2, 4.5 Hz) and 2.16 (1H, ddd, J 13.2, 9.0, 
7.1 Hz, NCH2CH2), 2.44-2.50 (1H, m, CHCH2N3), 2.46 (3H, s, PhCH3),  3.18 (2H, d, J 
7.0 Hz, CH2N3), 3.79 (1H, ddd, J 10.1, 8.2, 7.1 Hz) and 3.83 (1H, ddd, J 10.1, 9.0, 4.5 
Hz, CH2NTs), 5.20 (1H, dd, J 17.0, 1.5 Hz) and 5.23 (1H, dd, J 10.0, 1.5 Hz, CH=CH2), 
5.40 (dt, J 17.0, 10.0 Hz, CH=CH2), 7.36 (2H, d, J 8.3 Hz, SO2CCHCH), 7.94 (2H, app. 
d, J 8.3 Hz, SO2CCH); 
13
C NMR (CDCl3, 150 MHz) δ 21.7 (PhCH3), 23.0 
(CH3CC=O), 27.6 (NCH2CH2), 44.0 (CH2NTs), 47.0 (CH3CC=O), 49.8 (CHCH2N3), 
51.4 (CH2N3), 121.0 (CH=CH2), 128.1 (SO2CCH), 129.7 (SO2CCHCH), 133.9 
(CH=CH2), 134.6 (SO2C), 145.4 (SO2CCHCHC), 176.5 (C=O); m/z (FAB) 371 (MNa
+
, 
100%), 275 (19), 176 (61), 147 (60); HRMS found 371.1147, C16H20N4O3SNa (MNa
+
) 
requires 371.1154. 
 
(±)-4-Methyl-N-(2-((3R,4S)-3-methyl-2-oxo-4-vinylpyrrolidin-3-yl)ethyl) 
benzenesulfonamide (302) 
 
To a solution of azide 288 (15.0 mg, 43.1 µmol) in THF (0.4 mL) was 
added PBu3 (19.0 µL, 76.1 µmol) and the mixture stirred for 1 h.  To this 
was added benzaldehyde (10.0 µL, 98.1 µmol) and the solution stirred for 
a further 3 h.  The mixture then cooled to 0 C and a solution of NaBH4 (1.0 mg, 26 
µmol) in EtOH (0.5 mL) was added dropwise and the solution stirred for 1 h.  H2O (1 
mL) was added and the organic material extracted into DCM (3  5 mL), washed with 
brine (5 mL), dried (MgSO4) and solvent removed in vacuo.  Purification by preparative 
TLC (SiO2, EtOAc) gave lactam 302 (12.2 mg, 90%) as a white solid: mpt. 176-178 C; 
υmax/cm
1
 (solid) 3261 br, 2957, 2925, 2874, 1688, 1599; 
1
H NMR (CDCl3, 600 MHz) δ 
1.08 (3H, s, CH3CC=O), 1.39 (1H, m) and 1.63 (1H, m, CH2CH2NHTs), 2.39 (3H, s, 
PhCH3), 2.65 (1H, q, J 8.1 Hz, NHCH2CH), 2.96-3.08 (2H, dd, J 10.0, 8.7 Hz, 
CH2NHTs), 3.15 (1H, ddd, J 10.0, 7.7, 1.5 Hz) and 3.37 (1H, dd, J 10.0, 8.2 Hz, 
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NHCH2), 5.07 (1H, dt, J 17.1, 1.3 Hz) and 5.12 (1H, app. d, J 10.3 Hz, CH=CH2), 5.65 
(1H, m, NHTs), 5.67 (1H, ddd, J 17.1, 10.3, 8.3 Hz, CH=CH2), 6.03 (1H, br s, NH), 
7.29 (2H, d, J 8.2 Hz, SO2CCHCH), 7.72 (2H, d, J 8.2 Hz, SO2CCH); 
13
C NMR 
(CDCl3, 150 MHz) δ 20.5 (CH3CC=O), 21.6 (PhCH3), 32.5 (CH2CH2NHTs), 39.2 
(CH2NHTs), 43.8 (NHCH2), 45.0 (CC=O), 52.0 (NHCH2CH), 118.8 (CH=CH2), 127.2 
(SO2CCH), 129.8 (SO2CCHCH), 134.0 (CH=CH2), 137.4 (SO2C), 143.3 
(SO2CCHCHC), 182.0 (C=O); m/z (CI) 323 (MH
+
, 29%), 167 (100); HRMS found 
323.1424, C16H23N2O3S (MH
+
) requires 323.1429. 
 
(±)-N-((3R,4S)-4-(Azidomethyl)-3-(hydroxymethyl)-3-methylhex-5-enyl)-4-
methylbenzenesulfonamide (306) 
 
To a solution of amide 288 (10.0 mg, 31.0 µmol) in EtOH (0.7 mL) 
was added NaBH4 (11.0 mg, 290 µmol) and the solution stirred for 5 
h.  The reaction mixture was neutralised with 1 M HCl and the 
organic material extracted into EtOAc (3  2 mL), washed with brine (5 mL), dried 
(MgSO4) and solvent removed in vacuo.  Purification by preparative TLC (SiO2, 
EtOAc) gave alcohol 306 (2.00 mg, 20%) as a colourless oil: υmax/cm
1
 (DCM cast) 
3514 br, 3287 br, 2923, 2851, 2096, 1599; 
1
H NMR (CDCl3, 600 MHz) δ 0.75 (3H, s, 
HOCH2CCH3), 1.50 (1H, dt, J 14.4, 6.9 Hz) and 1.60 (1H, dt, J 14.4, 6.9 Hz, 
CH2CH2NHTs), 1.73 (1H, br s, OH), 2.26 (1H, td, J 9.5, 4.1 Hz, CHCH2N3), 2.43 (3H, 
s, PhCH3), 2.99 (2H, q, J 6.9 Hz, CH2NHTs), 3.15 (1H, dd, J 12.4, 9.5 Hz, CHHN3), 
3.30 (1H, br d, J 11.1 Hz, CHHOH), 3.37-3.42 (2H, m, CHHN3 and CHHOH), 4.98 
(1H, br t, J 6.0 Hz, NHTs), 5.16 (d, J 17.0, 1.7 Hz) and 5.22 (1H, dd, J 10.0, 1.7 Hz, 
CH=CH2), 5.70 (1H, dt, J 17.0, 10.0 Hz, CH=CH2), 7.31 (2H, d, J 8.3 Hz, 
SO2CCHCH), 7.75 (2H, d, J 8.3 Hz, SO2CCH); 
13
C NMR (CDCl3, 150 MHz) δ 19.0 
(HOCH2CCH3), 21.7 (PhCH3), 35.8 (CH2CH2NHTs), 38.8 (CH2NHTs), 39.2 
(HOCH2CCH3), 49.4 (CHCH2N3), 51.3 (CH2N3), 67.8 (CH2OH), 119.6 (CH=CH2), 
127.2 (SO2CCH), 129.9 (SO2CCHCH), 136.1 (SO2C), 137.0 (CH=CH2), 143.6 
(SO2CCHCHC); m/z (ES+) 275 (MNa
+
, 100%), 345 (12), 317 (15); HRMS found 
375.1472, C16H24N4O3NaS (MNa
+
) requires 375.1467. 
 
Amide 302 (5.00 mg, 50%) was also isolated as a white solid. 
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(±)-(R)-3-((S)-1-Azidobut-3-en-2-yl)-3-methyl-1-tosylpyrrolidin-2-ol (304) 
 
[Major diastereoisomer (MAJ): Minor diastereoisomer (MIN) = 2.9:1]  
To a solution of amide 288 (1.94 g, 5.57 mmol) in DCM (50 mL) at 78 
C was added DIBAL (1.2 M in toluene, 5.60 mL, 6.72 mmol) and the 
mixture stirred for 2.5 h.  The reaction was quenched by the addition of 
Et2O (20 mL), MeOH (20 mL) and sat. aq. Rochelle’s salt (20 mL) and the solution 
slowly warmed to rt and stirred for 1 h.  The organic material was extracted into EtOAc 
(3  100 mL), washed with brine (100 mL), dried (MgSO4) and solvent removed in 
vacuo to give the crude material.  Purification by flash chromatography (SiO2, 
petrol/Et2O 3:2) gave a mixture of diastereoisomers of alcohol 304 (1.85 g, 95%) as a 
thick pale yellow oil: υmax/cm
1
 (DCM cast) 3496 br, 2975, 2096, 1598; 
1
H NMR 
(CDCl3, 600 MHz) δ 0.52 (3H, s, NCHCCH3
MAJ
), 1.02 (3H, s, NCHCCH3
MIN
), 1.66 
(1H, dd, J 12.1, 7.1 Hz, NTsCH2CHH
MAJ
), 1.73-1.83 (2H, m, NTsCH2CHH
MIN
), 1.86 
(1H, td, J 9.5 4.4 Hz, CHCH2N3
MIN
), 2.06 (1H, m, app. q, J 11.4 Hz, NTsCH2CHH
MAJ
), 
2.42 (3H, s, PhCH3
MAJ
), 2.44 (3H, s, PhCH3
MIN
), 2.72 (1H, td, J 9.3, 4.7 Hz, 
CHCH2N3
MAJ
), 2.75 (1H, m, OH
MAJ
), 3.12-3.32 (3H, m, NTsCHH
MIN
 and CH2N3
MIN
), 
3.16 (1H, ddd, J 10.6, 9.4, 7.1 Hz, NTsCHH
MAJ
), 3.22 (1H, dd, J 12.4, 9.3 Hz) and 3.29 
(1H, dd, J 12.4, 4.7 Hz, CH2N3
MAJ
), 3.52-3.55 (1H, m, NTsCHH
MIN
), 3.57 (1H, td, J 
9.4, 0.9 Hz, NTsCHH
MAJ
), 4.78 (1H, ddd, J 17.0, 1.5, 0.7 Hz, CH=CHH
MIN
), 4.81 (1H, 
m, CHOH
MAJ
), 5.03 (1H, d, J 2.9 Hz, CHOH
MIN
), 5.12 (1H, dd, J 10.2, 1.7 Hz, 
CH=CHH
MIN
), 5.26 (2H, m, CH=CH2
MAJ
), 5.61 (1H, ddd, J 17.0, 10.2, 9.5 Hz 
CH=CH2
MIN
), 5.78 (1H, ddd, J 17.8, 10.0, 9.3 Hz, CH=CH2
MAJ
), 7.30 (2H, dd, J 8.6, 0.7 
Hz, SO2CCHCH
MAJ
), 7.32 (2H, d, J 8.2 Hz, SO2CCHCH
MIN
), 7.73 (2H, m, 
SO2CCH
MAJ
), 7.74 (2H, m, SO2CCH
MIN
); 
13
C NMR (CDCl3, 150 MHz) δ 15.7 
(NCHCCH3
MIN
), 16.4 (NCHCCH3
MAJ
), 21.7 (PhCH3
MAJ
 and PhCH3
MIN
), 33.9 
(NTsCH2CH2
MIN
), 33.9 (NTsCH2CH2
MAJ
), 44.9 (NTsCH2
MIN
), 45.2 (NTsCH2
MAJ
), 46.9 
(CHCH2N3
MAJ
), 48.0 (NCHCCH3
MIN
), 48.3 (NCHCCH3
MAJ
), 49.0 (CHCH2N3
MIN
), 51.7 
(CH2N3
MAJ
), 51.7 (CH2N3
MIN
), 87.3 (CHOH
MIN
), 89.1 (CHOH
MAJ
), 119.5 
(CH=CH2
MAJ
), 120.1 (CH=CH2
MIN
), 127.1 (SO2CCH
MAJ
), 127.2 (SO2CCH
MIN
), 129.9 
(SO2CCHCH
MAJ
), 130.0 (SO2CCHCH
MIN
), 135.4 (CH=CH2
MIN
), 135.9 (CH=CH2
MAJ
), 
135.9 (SO2C
MAJ
), 136 (SO2C
MIN
), 143.8 (SO2CCHCHC
MAJ
), 144.0 (SO2CCHCHC
MIN
); 
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m/z (FAB) 373 (MNa
+
, 10%), 329 (33), 307 (34), 289 (20), 176 (100); HRMS found 
373.1316, C16H22O3N4SNa (MNa
+
) requires 373.1310. 
 
(±)-(3aR,4S)-3a-Methyl-1-tosyl-4-vinyl-octahydropyrrolo[2,3-b]pyrrole (303) 
 
To a solution of azide 304 (3.50 g, 10.0 mmol) in THF (100 mL) was added 
PBu3 (3.96 mL, 15.0 mmol) and H2O (270 µL, 15.0 mmol) and the solution 
stirred for 1 h.  After this time, H2O (50 mL) was added and the THF was 
removed in vacuo.  The organic material was extracted into EtOAc (3  
100mL), dried (MgSO4) and solvent removed in vacuo.  Purification by flash 
chromatography (SiO2, petrol/EtOAc 1:11:4) gave amine 303 (2.75 g, 90%) as a pale 
yellow solid: mpt. 45-46 C; υmax/cm
1
 (solid) 2955, 2924, 2869, 1640, 1598; 
1
H NMR 
(CDCl3, 600 MHz) δ 0.88 (3H, s, NCHCCH3), 1.22 (1H, ddd, J 12.6, 6.1, 2.5 Hz) and 
1.95 (1H, ddd, J 12.6, 10.5, 7.6 Hz,. NTsCH2CH2), 2.38 (1H, m, NHCH2CH), 2.42 (3H, 
s, PhCH3), 2.88 (1H, ddd, J 10.5, 9.5, 6.1 Hz, NTsCHH), 3.04 (2H, m, NHCH2), 3.50 
(1H, ddd, J 9.5, 7.6, 2.5 Hz, NTsCHH), 4.31 (1H, s, NCHN), 5.08 (1H, m) and 5.10 
(1H, m, CH=CH2), 5.69 (1H, ddd, J 17.1, 10.6, 7.6 Hz, CH=CH2), 7.32 (2H, d, J 8.2 
Hz, SO2CCHCH), 7.73 (2H, d, J 8.2 Hz, SO2CCH); 
13
C NMR (CDCl3, 150 MHz) δ 
21.6 (PhCH3), 23.9 (NCHCCH3), 31.6 (NTsCH2CH2), 47.7 (NTsCH2), 48.9 (NHCH2), 
52.6 (NCHC), 53.3 (NHCH2CH), 85.3 (NCHN), 117.8 (CH=CH2), 127.8 (SO2CCH), 
129.6 (SO2CCHCH), 133.5 (SO2C), 134.4 (CH=CH2), 143.6 (SO2CCHCHC); m/z 
(ES+) 307 (MH
+
, 100%), HRMS found 307.1474, C16H23N2O2S (MH
+
) requires 
307.1480.      
 
(±)-(3S,3aR)-1-Benzyl-3a-methyl-6-tosyl-3-vinyl-octahydropyrrolo[2,3-b]pyrrole 
(289) 
 
To a solution  of amine 303 (93.0 mg, 0.30 mmol) in THF (4 mL) at 0 C 
was added BnBr (54.0 µL, 0.45 mmol), followed by NEt3 (47 µL, 0.34 
mmol) and the mixture stirred at rt for 18 h.  After this time, H2O was 
added (2 mL) and the organic material extracted into EtOAc (3  5 mL), 
dried (MgSO4) and solvent removed in vacuo.  Purification by flash chromatography 
(SiO2, petrol/EtOAc 9:14:1) afforded alkene 289 (108 mg, 90%) as a yellow solid: 
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mpt. 46-48 C; υmax/cm
1
 (solid) 2977, 2930, 2796, 1641, 1597; 
1
H NMR (CDCl3, 600 
MHz) δ 0.83 (3H, s, NCHCCH3), 1.00 (1H, dt, J 12.7, 7.8 Hz) and 1.92 (1H, ddd, J 
12.7, 6.9, 5.4 Hz, NTsCH2CH2), 2.43 (1H, m, CH2=CHCH), 2.45 (3H, s, PhCH3), 2.63 
(1H, t, J 9.6 Hz) and 2.80 (1H, dd, J 9.9, 7.4 Hz, NBnCH2), 3.34 (1H, ddd, 11.4, 7.9, 
6.9 Hz) and 3.48 (1H, ddd, J 11.4, 7.8, 5.4 Hz, NTsCH2), 3.95 (1H, d, J 14.1 Hz) and 
4.16 (1H, d, J 14.1 Hz, NCH2Ph), 4.77 (1H, s, NCHN), 4.97 (1H, ddd, J 17.1, 2.9, 1.8 
Hz) and 5.02 (1H, ddd, J 10.3, 1.8, 0.9 Hz, CH=CH2), 5.64 (1H, ddd, J 17.1, 10.3, 8.1 
Hz, CH=CH2), 7.23-7.26 (1H, m) and 7.27-7.36 (6H, m, Aromatic CH), 7.78 (2H, app. 
d, J 8.2 Hz, SO2CCH); 
13
C NMR (CDCl3, 150 MHz) δ 21.6 (PhCH3), 24.8 
(NCHCCH3), 33.6 (NTsCH2CH2), 49.3 (NTsCH2), 51.0 (CH2=CHCH), 53.4 
(NBnCH2), 54.7 (NCH2Ph), 54.8 (NCHC), 90.5 (NCHN), 117.1 (CH=CH2), 126.6, 
127.4, 128.1, 128.5 and 129.6 (Aromatic CH), 135.8 (CH=CH2), 136.4 (SO2C), 139.9 
(NCH2C), 143.3 (SO2CCHCHC); m/z (CI) 397 (MH
+
, 100%), 277 (39), 241 (69); 
HRMS found 397.1956, C23H29N2O2S (MH
+
) requires 397.1950. 
 
(±)-2-((3S,3aR)-1-Benzyl-3a-methyl-6-tosyl-octahydropyrrolo[2,3-b]pyrrol-3-yl) 
ethanol (313) and (±)-(3S,3aR)-1-benzyl-3-ethyl-3a-methyl-6-tosyl-octahydro 
pyrrolo[2,3-b]pyrrole (312) 
 
To a degassed ( 5) solution of alkene 289 (2.00 g, 5.05 mmol) in THF (46 
mL) was added Wilkinson’s catalyst (137 mg, 0.15 mmol) and the solution 
immediately degassed ( 5).  To this, pinacolborane was added (2.00 mL, 
13.8 mmol) and the solution was degassed once more ( 5) and the resulting mixture 
stirred at rt for 18 h.  The reaction mixture was cooled to 0 C and H2O (47 mL) and 
NaBO3.4H2O (2.75 g, 17.9 mmol) were added successively; the solution was stirred at 0 
C for 15 min and then at rt for 5 h.  H2O (50 mL) was added and the organic material 
was extracted into EtOAc (3  150 mL), washed with brine (100 mL), dried (MgSO4) 
and concentrated in vacuo to give the crude alcohol.  Purification by flash 
chromatography (SiO2, petrol/EtOAc 9:14:1) gave bicycle 313 (101 mg, 5%) as a 
thick yellow oil: υmax/cm
1
 (neat), 2960, 2928, 2874, 1598; 
1
H NMR (CDCl3, 600 MHz) 
δ 0.74-0.82 (6H, m, CH2CH3 and NCHCCH3), 1.01 (1H, dt, J 12.8, 7.2 Hz, 
NTsCH2CHH), 1.11 (1H, m) and 1.27-1.38 (1H, m, CH2CH3), 1.63-1.72 (1H, m, 
CHCH2CH3), 1.92 (1H, m, NTsCH2CHH), 2.38 (1H, t, J 9.8 Hz, NBnCHH), 2.42 (3H, 
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s, PhCH3), 2.82 (1H, dd, J 9.8, 7.9 Hz, NBnCHH), 3.34 (1H, dt, J 11.2, 7.0 Hz) and 
3.44 (1H, dt, J 11.2, 7.2 Hz, NTsCH2), 3.95 (1H, d, J 14.3 Hz) and 4.14 (1H, d, J 14.3 
Hz, NCH2Ph), 4.74 (1H, s, NCHN), 7.20-7.40 (7H, m, Aromatic CH), 7.76 (2H, d, J 
8.0 Hz, SO2CCH); 
13
C NMR (CDCl3, 150 MHz) δ 13.3 (CH2CH3), 21.7 (PhCH3), 21.9 
(CH2CH3), 24.9 (NCHCCH3), 32.8 (NTsCH2CH2), 48.1 (CHCH2CH3), 49.7 (NTsCH2), 
52.6 (NCHCCH3), 55.0 (NBnCH2), 56.0 (NBnCH2), 91.4 (NCHN), 126.7, 127.6, 
128.2, 128.5 and 129.7 (Aromatic CH), 136.4, 140.3 and 143.4 (Aromatic C); m/z (CI) 
399 (MH
+
, 100%), 243 (14); HRMS found 399.2106, C23H31N2O2S (MH
+
) requires 
399.2106. 
 
Further elution (SiO2, petrol/EtOAc 7:31:1) gave desired alcohol 312 
(1.71 g, 82%) as a yellow oil: υmax/cm
1
 (neat) 3500 br, 2953, 2930, 2873, 
1598; 
1
H NMR (CDCl3, 600 MHz) δ 0.78 (3H, s, NCHCCH3), 1.05 (1H, 
ddd, J 12.9, 7.6, 6.9 Hz, CHHCH2NTs), 1.36 (1H, dddd, J 13.3, 10.5, 7.0, 
5.6 Hz) and 1.57 (1H, dddd, J 13.3, 7.6, 7.0, 4.3 Hz, CH2CH2OH), 1.87 
(1H, dddd, J 10.5, 9.8, 7.8, 4.3 Hz, CHCH2NBn), 1.92 (1H, dt, J 12.9, 6.9 Hz, 
CHHCH2NTs), 2.42 (3H, s, PhCH3), 2.45 (1H, t, J 9.8 Hz) and 2.81 (1H, dd, J 9.8, 7.8 
Hz, CH2NBn), 3.35 (1H, dt, J 11.1, 6.9 Hz) and 3.43 (1H, ddd, J 11.1, 7.6, 6.4 Hz, 
CH2NTs),  3.46 (1H, dt, J 10.4, 7.0 Hz) and 3.52 (1H, ddd, J 10.4, 7.6, 5.6 Hz, 
CH2OH), 3.95 (1H, d, J 14.1 Hz) and 4.11 (1H, d, J 14.1 Hz, NCH2Ph), 4.72 (1H, s, 
NCHN), 7.22 (1H, m, Aromatic CH), 7.26-7.32 (6H, m, Aromatic CH), 7.56 (2H, d, J 
6.6 Hz, SO2CCH); 
13
C NMR (CDCl3, 150 MHz) δ 21.6 (PhCH3), 24.4 (NCHCCH3), 
31.9 (CH2CH2OH), 32.8 (CH2CH2NTs), 42.7 (CHCH2NBn), 49.5 (CH2NTs), 52.7 
(NCHC), 54.9 (NCH2Ph), 55.9 (CH2NBn), 61.9 (CH2OH), 90.9 (NCHN), 126.7 
(Aromatic CH), 127.6 (SO2CCH), 128.3, 128.5 and 129.8 (Aromatic CH), 136.2 
(Aromatic C), 140.1 (NCH2C), 143.5 (Aromatic C); m/z (CI) 415 (MH
+
, 55%), 120 
(100); HRMS found 415.2041, C23H31N2O3S (MH
+
) requires 415.2055. 
 
(±)-(R)-3-((S)-1-Hydroxybut-3-en-2-yl)-3-methylpyrrolidin-2-one (311) 
 
To a degassed ( 5) solution of alkene 289 (50.0 mg, 0.13 mmol) in THF (1.2 mL) was 
added Wilkinson’s catalyst (3.50 mg, 3.78 µmol) and the resulting mixture immediately 
degassed ( 5).  Pinacolborane (54.0 µL, 0.37 mmol) was then added and the solution 
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stirred for 18 h.  After this time, H2O (1 mL) was added and the 
organic material extracted into Et2O (3  5 mL), washed with brine (5 
mL), dried (MgSO4) and solvent removed in vacuo.  Purification by 
flash chromatography (SiO2, petrol/EtOAc 19:19:1) gave borane 
311 (43.0 mg, 65%) as a yellow oil: υmax/cm
1
 (CDCl3 cast) 2976, 2927, 1598; 
1
H NMR 
(CDCl3, 600 MHz) δ 0.56-0.68 (2H, m, CH2B), 0.76 (3H, s, NTsCHCCH3), 1.03 (1H, 
dt, J 12.8, 7.2 Hz, NTsCH2CHH), 1.15-1.18 (13H, m, 2  C(CH3)2 and CHHCH2B), 
1.40 (1H, m, CHHCH2B), 1.66-1.72 (1H, m, NBnCH2CH), 1.93 (1H, dt, J 12.8, 7.0 Hz, 
NTsCH2CHH), 2.40 (1H, t, J 9.8 Hz, NBnCHH), 2.42 (3H, s, PhCH3), 2.80 (1H, dd, J 
9.8, 7.7 Hz, NBnCHH), 3.35 (1H, dt, J 11.0, 6.7 Hz) and 3.40 (1H, dt, J 11.0, 7.2 Hz, 
NTsCH2), 3.95 (1H, d, J 14.1 Hz) and 4.10 (1H, d, J 14.1 Hz, NCH2Ph), 4.71 (1H, s, 
NCHN), 7.21 (1H, m, Aromatic CH), 7.26-7.33 (6H, m, Aromatic CH and 
SO2CCHCH), 7.73 (2H, d, J 8.3 Hz, SO2CCH); 
13
C NMR (CDCl3, 150 MHz) δ 22.1 
(PhCH3), 23.0 (CH2CH2B), 24.7 (NTsCHCCH3), 24.9 (2  C(CH3)2), 32.7 
(NTsCH2CH2), 47.4 (NBnCH2CH), 48.5 (NTsCH2), 52.7 (NTsCHCCH3), 55.0 
(NCH2Ph), 56.5 (NBnCH2), 83.2 (2  C(CH3)2), 91.4 (NCHN), 126.6, 127.3, 128.3, 
128.6 and 129.9 (Aromatic CH), 136.3 (SO2C), 140.2 (NCH2C), 143.4 (SO2CCHCHC); 
m/z (CI) 525 (100), 369 (8); HRMS found 525.2962, C29H42N2O4SB (MH
+
) requires 
525.2958. 
 
(±)-2-((3S,3aR)-1-Benzyl-3a-methyl-6-tosyl-octahydropyrrolo[2,3-b]pyrrol-3-
yl)acetaldehyde (290) 
 
To a solution of alcohol 312 (322 mg, 0.78 mmol) in DCM (10.5 mL) at 0 
C was added pyridine (0.54 mL, 6.70 mmol) followed by DMP (708 mg, 
1.67 mmol) and the solution stirred at rt for 18 h.  Sat. Na2S2O3 (10 mL) 
and sat. NaHCO3 (10 mL) were then added and the solution stirred 
vigorously for 1 h.  The organic material was extracted with DCM (3  30 mL), washed 
with sat. CuSO4 (20 mL), H2O (20 mL), dried (MgSO4) and concentrated in vacuo.  
Purification by flash chromatography (SiO2, petrol/EtOAc 7:33:2) afforded aldehyde 
290 (190 mg, 59%) as a thick yellow oil: υmax/cm
1
 (CDCl3 cast) 2956, 2922, 1723, 
1598; 
1
H NMR (CDCl3, 600 MHz) δ 0.78 (3H, s, NCHCCH3), 1.11 (1H, ddd, J 12.8, 
7.5, 6.4 Hz) and 1.88 (1H, dt, J 12.8, 7.0 Hz, CH2CH2NTs), 2.28-2.36 (2H, m, 
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CHHCHO and CHCH2NBn), 2.39-2.49 (2H, m, CHHCHO and CHHNBn), 2.43 (3H, s, 
PhCH3), 2.89 (1H, dd, J 10.2, 7.4 Hz, CHHNBn), 3.39 (1H, ddd, J 10.9, 7.2, 6.4 Hz) 
and 3.44 (1H, ddd, J 10.9, 7.5, 6.8 Hz, CH2NTs), 4.02 (2H, s, NCH2Ph), 4.68 (1H, s, 
NCHN), 7.20-7.25 (1H, m) and 7.27-7.33 (4H, m, Aromatic CH), 7.28 (2H, d, J 8.3 Hz, 
2  SO2CCHCH), 7.76 (2H, d, J 8.3 Hz, 2  SO2CCH), 9.66 (1H, m, CHO); 
13
C NMR 
(CDCl3, 150 MHz) δ 21.7 (PhCH3), 24.1 (NCHCCH3), 33.1 (CH2CH2NTs), 39.8 
(CHCH2NBn), 43.8 (CH2CHO), 49.2 (CH2NTs), 52.3 (NCHC), 55.0 (NCH2Ph), 55.7 
(CH2NBn), 90.4 (NCHN), 126.8 (Aromatic CH), 127.6 (SO2CCH), 128.3, 128.6 and 
129.8 (Aromatic CH), 136.1, 139.7 and 143.6 (Aromatic C), 200.9 (CHO); m/z (CI) 413 
(MH
+
, 100%); HRMS found 413.1902, C23H29N2O3S (MH
+
) requires 413.1899. 
 
(±)-3-((3S,3aR)-1-Benzyl-3a-methyl-6-tosyl-octahydropyrrolo[2,3-b]pyrrol-3-yl)-2-
(tert-butyldimethylsilyloxy)propanenitrile (314) 
 
[Diastereoisomer one (D-1) : Diastereoisomer two (D-2) = 1:1]  
To a solution of aldehyde 290 (75.0 mg, 0.18 mmol) in DCM (1.1 mL) was 
added TBSCN (52.0 mg, 0.37 mmol) followed by 0.3 M LiCl in DCM 
(sonicated for 30 min, 8.00 µL, 2.40 µmol) and the mixture stirred for 3 d.  
The reaction was quenched with H2O (1 mL) and organic material extracted 
into EtOAc (3  5 mL), washed with brine (5 mL), dried (MgSO4) and solvent removed 
in vacuo to give the crude material.  Purification by flash chromatography (SiO2, 
petrol/EtOAc 9:117:3) gave a mixture of diastereomeric nitriles 314 (70.0 mg, 70%) 
as a thick colourless oil: υmax/cm
1
 (DCM cast) 2956, 2930, 2860, 1599; 
1
H NMR 
(CDCl3, 400 MHz) δ 0.02 (3H, s), 0.03 (3H, s) 0.12 (3H, s) and 0.14 (3H, s, Si(CH3)2
D-1
 
and Si(CH3)2
D-2
), 0.78 (3H, s) and 0.80 (3H, s, C(CH3)3
D-1
 and C(CH3)3
D-2
), 0.83 (6H, s) 
and 0.83 (18H, s, C(CH3)3
D-1
, C(CH3)3
D-2
, NTsCHCCH3
D-1
 and NTsCHCCH3
D-2
), 1.09-
1.19 (2H, m, NTsCH2CHH
D-1
 and NTsCH2CHH
D-2
), 1.56-1.76 (2H, m) and 1.88-2.00 
(3H, m, CH2CHCN
D-1
, CH2CHCN
D-2
, NBnCH2CH
D-1
), 2.02-2.12 (1H, m, 
NBnCH2CH
D-2
), 2.46 (6H, s, PhCH3
D-1
 and PhCH3
D-2
), 2.50 (1H, t, J 9.8 Hz), 2.55 (1H, 
t, J 9.8 Hz) and 2.88 (2H, dt, J 9.8, 7.8 Hz, NBnCH2
D-1
 and NBnCH2
D-2
), 3.38-3.50 (4H, 
m, NTsCH2
D-1
and NTsCH2
D-2
), 4.03 (1H, d, J 14.0 Hz), 4.03 (1H, d, J 14.2 Hz), 4.08 
(1H, d, J 14.0 Hz) and 4.10 (1H, d, J 14.2 Hz, NCH2Ph
D-1
 and NCH2Ph
D-2
), 4.25 (1H, t, 
J 6.8 Hz) and 4.30 (1H, dd, J 7.6, 4.0 Hz, CHCN
D-1
 and CHCN
D-2
), 4.72 (1H, s) and 
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4.73 (1H, s, NCHN
D-1
 and NCHN
D-2
), 7.20-7.28 (2H, m) 7.26-7.40 (12H, m, 5  
Aromatic CH
D-1
, 5  Aromatic CHD-2, SO2CCHCH
D-1
 and SO2CCHCH
D-2
), 7.78 (2H, 
d, J 8.3 Hz) and 7.79 (2H, d, J 8.2 Hz, SO2CCH
D-1
 and SO2CCH
D-2
); 
13
C NMR (CDCl3, 
150 MHz) δ 5.5, 5.3, 5.2 and 5.1 (Si(CH3)2
D-1
 and Si(CH3)2
D-2
), 18.0 and 18.0 
(C(CH3)3
D-1
 and C(CH3)3
D-2
), 21.7 (PhCH3
D-1
 and PhCH3
D-2
), 23.6, 23.7, 25.5 and 25.6 
(C(CH3)3
D-1
, C(CH3)3, NTsCHCCH3
D-1
 and NTsCHCCH3
D-2
), 32.6 and 32.7 
(NTsCH2CH2
D-1
 and NTsCH2CH2
D-2
), 35.7 and 36.1 (CH2CHCN
D-1
 and CH2CHCN
D-2
), 
41.7 and 42.6 (NBnCH2CH
D-1
 and NBnCH2CH
D-2
), 49.1 and 49.2 (NTsCH2
D-1
 and 
NTsCH2
D-2
), 52.7 and 53.0 (NTsCHCCH3
D-1
 and NTsCHCCH3
D-2
), 54.9 and 54.9 
(NCH2Ph
D-1
 and NCH2Ph
D-2
), 55.4 and 55.7 (NBnCH2
D-1
 and NBnCH2
D-2
), 60.8 and 
61.8 (CHCN
D-1
 and CHCN
D-2
), 90.0 and 90.2 (NCHN
D-1
 and NCHN
D-2
), 119.7 and 
119.8 (CN
D-1
 and CN
D-2
), 126.8, 126.8, 127.6, 128.3, 128.4, 128.5, 128.5 and 129.8 
(Aromatic CH
D-1
 and Aromatic CH
D-2
), 136.0 and 136.1 (SO2C
D-1
 and SO2C
D-2
), 139.8 
and 139.8 (NCH2C
D-1
 and NCH2C
D-2
), 143.6 (SO2CCHCHC
D-1
 and SO2CCHCHC
D-2
); 
m/z (CI) 554 (MH
+
, 100%), 398 (12), 107 (37); HRMS found 554.2867, C30H44N3O3SSi 
(MH
+
) requires 554.2873. 
 
(±)-3-((3S,3aR)-1-Benzyl-3a-methyl-6-tosyl-octahydropyrrolo[2,3-b]pyrrol-3-yl)-2-
(tert-butyldimethylsilyloxy)propanal (282) 
 
[Major diastereoisomer (MAJ) : Minor diastereoisomer MIN = 1.6:1]  
To a solution of nitrile 314 (50.0 mg, 0.09 mmol) in toluene (176 µL) at 
78 ºC was added DIBAL (1 M in toluene, 177 µL, 0.18 mmol) dropwise 
and the solution stirred for 2 h.  After this time, MeOH (88 µL) was added 
and the solution was warmed to 0 ºC and stirred for 1.5 h.  H2SO4 (0.5 M, 
88 µL) was then added, the mixture stirred vigorously for 1 h and H2O (0.5 mL) added.  
The organic material was extracted into EtOAc (3 × 2mL), washed with brine (2 mL), 
dried (MgSO4) and solvent removed in vacuo.  Purification by flash chromatography 
(SiO2, petrol/EtOAc 1:93:17) gave aldehyde 282 (15.0 mg, 30%) as a pale yellow oil: 
υmax/cm
1
 (DCM cast) 2954, 2928, 2856, 1736, 1598; 
1
H NMR (CDCl3, 600 MHz) δ 
0.09 (3H, s, Si(CH3)2
MIN
), 0.08 (3H, s, Si(CH3)2
MAJ
), 0.02 (3H, s, Si(CH3)2
MIN
), 
0.02 (3H, s, Si(CH3)2
MAJ
), 0.74 (3H, s, NCHCCH3
MAJ
), 0.75 (3H, s, NCHCCH3
MIN
), 
0.80 (9H, s, C(CH3)3
MIN
), 0.84 (9H, s, C(CH3)3
MAJ
), 1.39-1.46 (2H, m) and 1.52-1.66 
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(2H, m, CH2CHOTBS
MAJ
 and CH2CHOTBS
MIN
), 1.84-1.97 (4H, m, NBnCH2CH
MAJ
, 
NBnCH2CH
MIN
, NTsCH2CH2
MAJ
 and NTsCH2CH2
MIN
), 2.43 (6H, s, PhCH3
MAJ
 and 
PhCH3
MIN
), 2.45 (1H, t, J 9.8 Hz, NBnCHH
MAJ
), 2.46 (1H, t, J 9.8 Hz, NBnCHH
MIN
), 
2.77-2.84 (2H, m, NBnCHH
MAJ
 and NBnCHH
MIN
), 3.33-3.44 (4H, m, NTsCH2
MAJ
 and 
NTsCH2
MIN
), 3.77 (1H, ddd, J 8.9, 3.2, 1.4 Hz, CHOTBS
MAJ
), 3.83 (1H, td, J 6.6, 1.9 
Hz, CHOTBS
MIN
), 3.97 (1H, d, J 14.1 Hz, NCHHPh
MIN
), 3.98 (1H, d, J 14.1 Hz, 
NCHHPh
MAJ
), 4.08 (2H, d, J 14.1 Hz, NCHHPh
MAJ
 and NCHHPh
MIN
), 4.69 (1H, s, 
NCHN
MIN
), 4.71 (1H, s, NCHN), 7.18-7.36 (Aromatic CH and Aromatic CH
MIN
), 7.72-
7.79 (4H, m, NCCHCHCMe
MAJ
 and NCCHCHCMe
MIN
), 9.47 (1H, d, J 1.9 Hz, 
CHO
MIN
), 9.52 (1H, d, J 1.4 Hz, CHO
MAJ
); 
13
C NMR (CDCl3, 150 MHz) δ; m/z (CI) 
557 (MH
+
, 100%), 401 (15); HRMS found 557.2854, C30H45N2O4SSi (MH
+
) requires 
557.2869. 
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A NEW METHOD FOR ALCOHOL ACTIVATION 
Alcohol Iodination 
(±)-N-Benzyl-3-(1-iodobut-3-en-2-yl)-3-methylpyrrolidin-2-one (317) 
To a solution of alcohol 99 (98.0 mg, 0.36 mmol) in THF (5 mL) was added 
MeI (62.3 L, 0.72 mmol) and the solution stirred at reflux for 2 days.  The 
organic material was extracted with DCM (3 × 5 mL), washed with brine 
(10 mL), dried (MgSO4) and concentrated in vacuo to give iodide 317 (133 mg, 82%) as 
a white solid: mpt. 108-111 C; υmax/cm
1
 (solid) 2885, 1681; 
1
H NMR (CDCl3, 600 
MHz) δ 1.21 (3H, s, CH3), 1.61 (1H, ddd, J 13.1, 8.0, 3.9 Hz) and 2.06 (1H, ddd, J 13.1, 
8.9, 7.4 Hz, NCH2CH2), 2.66 (1H, td, J 10.0, 2.9 Hz, CHCH2I), 3.08-3.20 (3H, m, 
CHHI and NCH2CH2), 3.43 (1H, dd, J 9.5, 2.9 Hz, CHHI), 4.44 (2H, s, NCH2Ph), 5.17 
(1H, dd, J 16.9, 1.6 Hz) and 5.28 (1H, dd, J 10.0, 1.6 Hz, CH=CH2), 5.42 (1H, dt, J 
16.9, 10.0 Hz, CH=CH2), 7.21-7.35 (5H, m, Aromatic CH); 
13
C NMR (CDCl3, 150 
MHz) δ 7.4 (CH2I), 23.7 (CH3), 27.9 (NCH2CH2), 43.4 (NCH2CH2), 46.8 (NCH2Ph), 
47.7 (CMe), 53.5 (CHCH2I), 120.4 (CHCH2), 127.7, 128.2 and 128.7 (Aromatic CH), 
136.0 (CHCH2), 136.3 (Aromatic C), 177.1 (C=O). 
 
N,N,N-Trimethylmethanethioamide iodide (327) 
 
To a solution of HCSNMe2 (318, 2.90 mL, 33.7 mmol) in dry ether (70 
mL) was added MeI (2.30 mL, 37.0 mmol) and the solution stirred at rt 
for 18 h.  The precipitate was collected by filtration under argon and was washed with 
cold dry ether (2 × 25 mL) and dried in vacuo for 10 min to give salt 327 (7.47 g, 96%) 
as a crystalline white solid which was stored in a freezer under argon: mpt. 131-132 C; 
υmax/cm
1
 (solid) 2983, 1639, 1619, 1442, 1408; 
1
H NMR (CDCl3, 600 MHz) δ 3.16 
(3H, s, SCH3), 3.40 (3H, s) and 3.90 (3H, s, N(CH3)2), 11.14 (1H, s, HC=SMe); 
13
C 
NMR (CDCl3, 150 MHz) δ 16.6 (SCH3), 42.7 and 48.9 (N(CH3)2), 183.5 (HC=SMe); 
m/z (CI) 104 ([MI]+, 5%), 92 (10), 91 (11), 90 (100); HRMS found 104.0537, 
C4H10NS ([MI]
+
) requires 104.0534. 
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General procedure for iodinations – Method A 
To a solution of alcohol (1.0 equiv.) in toluene/THF (0.20-0.25M substrate or 0.14 M 
substrate for allylic alcohols) at 85 °C (or 55 ºC for allylic alcohols) in toluene
 
or reflux 
in THF was added salt 327 (1.5 equiv.) and imidazole (0.5 equiv. or 1 equiv. for 
secondary alcohols) successively.  Upon completion (reaction monitored by TLC or 
1
H 
NMR), the solvent was removed in vacuo to give the crude product.  Purification by 
flash chromatography (as described) afforded pure iodides. 
For yields and reaction times, please refer to Table 7, section 4.1.3.3. 
 
1-(2-Iodoethyl)-4-methylbenzene (324) 
 
The crude material was obtained using Method A.  Purification by 
flash chromatography (SiO2, petrol) afforded iodide 324 as a 
colourless oil: υmax/cm
1
 (CDCl3 cast) 3019, 2920, 1513; 
1
H NMR (CDCl3, 400 MHz) δ 
2.35 (3H, s, CH3), 3.16 (2H, t, J 8.0 Hz, PhCH2), 3.36 (2H, t, J 8.0 Hz, CH2I), 7. 11 
(2H, d, J 8.0 Hz) and 7.16 (2H, d, J 8.0 Hz, Aromatic CH); 
13
C NMR (CDCl3, 125 
MHz) δ 6.0 (CH2I), 21.2 (CH3), 40.1 (PhCH2), 128.3 and 129.4 (Aromatic CH), 136.6 
(MeC), 137.7 (CCH2CH2I); m/z (EI) 246 (M
+
, 23%), 167 (9), 149 (28), 128 (47), 127 
(33), 120 (69), 119 (100); HRMS found 245.9897, C9H11I (M
+
) requires 245.9900. 
 
4-Methylphenethyl formate (325) 
 
The crude material was obtained using Method A. Purification 
by flash chromatography (SiO2, petrol/EtOAc 9:1) afforded 
formate 325 as a colourless oil: υmax/cm
1
 (DCM cast) 2924, 1719, 1516; 
1
H NMR 
(CDCl3, 400 MHz) δ 2.37 (3H, s, CH3), 2.98 (2H, t, J 7.1 Hz, CH2O), 4.41 (2H, td, J 
7.1, 0.8 Hz, CH2CH2O), 7.16 (4H, s, Aromatic CH), 8.07 (1H, s, CHO); 
13
C NMR 
(CDCl3, 125 MHz) δ 21.1 (CH3), 34.6 (CH2O), 64.6 (CH2CH2O), 128.8 and 129.4 
(Aromatic CH), 134.4 (CH3C), 136.4 (CH2C), 161.1 (CHO); m/z (EI) 118 
([MCO2H2]
+
, 100%); HRMS found 118.0786, C9H10 ([MCO2H2]
+
) requires 
118.0783. 
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1-(2-Iodoethyl)-4-nitrobenzene  
 
The crude material was obtained using Method A. Purification by 
flash chromatography (SiO2, petrol/EtOAc 97:3) afforded the 
iodide as a white solid: mpt. 98-101 °C [Lit.
127
 97-98 °C]; υmax/cm
1
 (solid) 3053, 1601, 
1520, 1346; 
1
H NMR (CDCl3, 600 MHz) δ 3.31 (2H, t, J 7.3 Hz, PhCH2), 3.41 (2H, t, J 
7.3 Hz, CH2I), 7.37-7.40 (2H, m, NO2CCH), 8.19-8.23 (2H, m, CH2CCH);  
13
C NMR 
(CDCl3, 125 MHz) δ 3.7 (CH2I), 39.5 (PhCH2), 124.0 (CH2CCH), 129.4 (NO2CCH), 
147.1 (NO2C), 147.7 (CH2C); m/z (EI) 277 (M
+
, 59%), 261 (14), 242 (8), 231 (4), 150 
(100); HRMS found 276.9592, C8H8O2NI
+
 (M
+
) requires 276.9594. 
 
4-Nitrophenethyl formate 
 
The crude material was obtained using Method A. Purification 
by flash chromatography (SiO2, petrol/EtOAc 9:1) afforded the 
formate as a white solid: mpt. 65-67 C; υmax/cm
1
 (solid) 3081, 2968, 1713, 1697, 
1606, 1597, 1515, 1342; 
1
H NMR (CDCl3, 400 MHz) δ 3.11 (2H, t, J 6.7 Hz, 
CH2CH2O), 4.45 (2H, td, J 6.7, 0.7 Hz, CH2O), 7.41 (2H, m, CH2CCH), 8.04 (1H, s, 
CHO), 8.20 (2H, m, NO2CCH); 
13
C NMR (CDCl3, 125 MHz) δ 34.8 (CH2CH2O), 63.4 
(CH2O), 123.9 (NO2CCH), 129.8 (CH2CCH), 145.2 (NO2C), 147.1 (CH2C), 160.7 
(CHO); m/z (CI) 196 (MH
+
, 10%), 150 (100); HRMS found 196.0606, C9H10NO4 
(MH
+
) requires 196.0610. 
 
Tert-butyl 3-iodopropylcarbamate 
 
The crude material was obtained using Method A. Purification by 
flash chromatography (SiO2, petrolpetrol/EtOAc 19:1) afforded 
the iodide as a yellow oil: υmax/cm
1
 (CDCl3 cast) 3341 br, 2976, 2931, 1683, 1512; 
1
H 
NMR (CDCl3, 400 MHz) δ 1.42 (9H, s, C(CH3)3), 1.99 (2H, quin, J 6.7 Hz, 
NHCH2CH2), 3.18 (2H, t, J 6.7 Hz, NHCH2), 3.16-3.21 (2H, m, CH2I), 4.74 (1H, br s, 
NH); 
13
C NMR (CDCl3, 125 MHz) δ 3.2 (CH2I), 28.5 (C(CH3)3), 33.5 (NHCH2CH2), 
41.1 (NHCH2), 79.4 (CMe3), 156.0 (C=O); m/z (FAB
+
) 308 (MNa
+
, 49%), 286 (50), 
230 (100); HRMS found 308.0118, C8H16O2NINa (MNa
+
) requires 308.0123. 
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3-(Tert-butoxycarbonyl)propyl formate  
 
The crude material was obtained using Method A. 
Purification by flash chromatography (SiO2, petrol/EtOAc 9:185:15) afforded the 
formate as a colourless oil: υmax/cm
1
 (DCM cast) 3355 br, 2977, 2931, 1712, 1689; 
1
H 
NMR (CDCl3, 400 MHz) δ 1.45 (9H, s, C(CH3)3), 1.87 (2H, quin, J 6.5 Hz, 
NHCH2CH2), 3.23 (2H, m, NHCH2), 4.26 (2H, t, J 6.5 Hz, CH2O), 4.69 (1H, br s, NH), 
8.08 (1H, s, CHO); 
13
C NMR (CDCl3, 125 MHz) δ 30.6 (C(CH3)3), 31.2 (HCH2CH2), 
39.4 (NHCH2), 63.6 (CH2O), 80.0 (CMe3), 163.2 (CHO), 194.0 (C=ONH); m/z (CI) 
204 (MH
+
, 46%), 158 (100); HRMS found 204.1231, C9H18NO4 (MH
+
) requires 
204.1236.  
 
3-((2-Iodoethyl)(phenyl)amino)propanenitrile 
 
The crude material was obtained using Method A. Purification by flash 
chromatography (SiO2, petrol/EtOAc 19:19:1) afforded the iodide as a 
pale yellow solid: mpt. 59-62 °C; υmax/cm
1
 (solid) 3025, 2955, 2247, 1596, 1502; 
1
H 
NMR (CDCl3, 400 MHz) δ 2.64 (2H, t, J 6.8 Hz, CH2CN), 3.27 (2H, t, J 8.1 Hz, CH2I), 
3.76 (2H, t, J 6.88 Hz, CH2CH2CN), 3.80 (2H, t, J 8.1 Hz, CH2CH2I), 6.70 (2H, d, J 8.5 
Hz, NCCH), 6.83-6.86 (1H, m, NCCHCHCH), 7.27-7.33 (2H, m, NCCHCH);  
13
C 
NMR (CDCl3, 125 MHz) δ 1.7 (CH2I), 16.4 (CH2CN), 47.5 (CH2CH2CN), 54.6 
(CH2CH2I), 112.7 (NCCH), 118.2 (Aromatic C), 118.6 (NCCHCHCH), 130.0 
(NCCHCH), 145.2 (CN); m/z (EI) 300 (M
+
, 62%), 260 (86), 232 (8), 173 (23), 160 
(10), 159 (100); HRMS found 300.0122, C11H13N2I (M
+
) requires 300.0118. 
 
2-((2-Cyanoethyl)(phenyl)amino)ethyl formate  
 
The crude material was obtained using Method A. Purification by flash 
chromatography (SiO2, petrol/EtOAc 9:185:15) afforded the 
formate as a pale yellow oil: υmax/cm
1
 (neat) 3061, 2935, 2248, 1717, 
1598, 1504; 
1
H NMR (CDCl3, 400 MHz) δ 2.64 (2H, t, J 7.0 Hz, CNCH2), 3.72 (2H, t, 
J 6.0 Hz, CH2CH2O), 3.76 (2H, t, J 7.0 Hz, CNCH2CH2), 4.35 (2H, td, J 6.0, 0.6 Hz, 
CH2O), 6.73 (2H, m, NCCH), 6.83 (1H, m, NCCHCHCH), 7.30 (2H, m, NCCHCH); 
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13
C NMR (CDCl3, 125 MHz) δ 16.0 (CNCH2), 47.8 (CNCH2CH2), 50.1 (CH2CH2O), 
61.2 (CH2O), 112.9 (NCCH), 118.2 (Aromatic C), 118.5 (NCCHCHCH), 129.9 
(NCCHCH), 145.8 (CN), 160.8 (CHO); m/z (FAB
+
) 219 (MH
+
, 88%), 218 (100); 
HRMS found 219.1129, C12H15O2N2 (MH
+
) requires 219.1134. 
 
Tert-butyl(5-iodopentyloxy)dimethylsilane 
 
The crude material was obtained using Method A.  Purification by 
flash chromatography (SiO2, hexane) afforded the iodide as a colourless oil: υmax/cm
1
 
(neat) 2928, 2856; 
1
H NMR (CDCl3, 400 MHz) δ 0.05 (6H, s, Si(CH3)2), 0.91 (9H, s, 
C(CH3)3), 1.41-1.50 (2H, m, OCH2CH2CH2), 1.50-1.59 (2H, m, CH2CH2I), 1.86 (2H, tt, 
J 7.3, 7.0 Hz, OCH2CH2), 3.21 (2H, t, J 7.0 Hz, OCH2), 3.62 (2H, t, J 6.2 Hz, CH2I);  
13
C NMR (CDCl3, 125 MHz) δ 5.3 (Si(CH3)2), 7.1 (CH2I), 18.4 (CMe3), 26.0 
(C(CH3)3), 27.0 (OCH2CH2CH2), 31.8 (CH2CH2I), 33.4 (OCH2CH2), 62.9 (OCH2); m/z 
(CI) 329 (MH
+
, 5%), 327 (6), 313 (8), 271 (27), 201 (49), 197 (60), 177 (30), 146 (100); 
HRMS found 329.0793, C11H26OSiI (MH
+
) requires 329.0798. 
 
5-(Tert-butyldimethylsilyloxy)pentyl formate 
 
The crude material was obtained using Method A. 
Purification by flash chromatography (SiO2, hexane) afforded the formate as a viscous 
colourless oil: υmax/cm
1
 (DCM cast) 2929, 2857, 1729, 1472; 
1
H NMR (CDCl3, 400 
MHz) δ 0.06 (6H, s, Si(CH3)2), 0.90 (9H, s, C(CH3)3), 1.41-1.47 (2H, m, 
TBSOCH2CH2CH2), 1.53-1.58 (2H, m, TBSOCH2CH2), 1.60-1.67 (2H, m, 
CH2CH2OCHO), 3.63 (2H, t, J 6.3 Hz, TBSOCH2), 4.18 (2H, t, J 6.8 Hz, CH2OCHO), 
8.07 (1H, s, CHO); 
13
C NMR (CDCl3, 125 MHz) δ 5.2 (Si(CH3)2), 18.4 
(TBSOCH2CH2CH2), 22.3 (C(CH3)3), 26.0 (CH2CH2OCHO), 28.3 (TBSOCH2CH2), 
32.4 (CH2OCHO), 62.9 (CH2OCHO), 64.1 (CMe3), 161.2 (CHO); m/z (CI) 247 (MH
+
, 
3%), 201 (6), 97 (6), 84 (100); HRMS found 247.1733, C12H27O3Si (MH
+
) requires 
247.1729. 
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6-Iodohex-1-ene 
 
The crude material was obtained using Method A. Purification by 
flash chromatography (SiO2, hexane) afforded the iodide as a colourless liquid: 
υmax/cm
1
 (DCM cast) 3076, 2930, 2855, 1641; 
1
H NMR (CDCl3, 400 MHz) δ 1.47-1.55 
(2H, m, CH2CH2CH2I), 1.78-1.88 (2H, m, CH2CH2I), 2.06-2.12 (2H, m, CH2=CHCH2), 
3.21 (2H, t, J 7.1 Hz, CH2I), 4.96-5.06 (2H, m, CH2=CH), 5.80 (1H, ddt, J 17.1, 10.3, 
6.7 Hz, CH2=CH);  
13
C NMR (CDCl3, 125 MHz) δ 6.9 (CH2I), 29.8 (CH2CH2CH2I), 
32.7 (CH2=CHCH2), 32.9 (CH2CH2I), 115.1 (CH2=CH), 138.2 (CH2=CH); m/z (EI) 
210 (M
+
, 13%), 179 (12), 178 (100); HRMS found 209.9894, C6H11I (M
+
) requires 
209.9900. 
 
Hex-5-enyl formate 
 
The crude material was obtained using Method A.  Purification 
by flash chromatography (SiO2, hexane/EtOAc 19:1) afforded the formate as a pale 
yellow oil: υmax/cm
1
 (Et2O cast) 2927, 2856, 1726; 
1
H NMR (CDCl3, 400 MHz) δ 1.44-
1.54 (2H, m, CH2CH2CH2O), 1.65-1.74 (2H, m, CH2CH2O), 2.05-2.15 (2H, m, 
CH2=CHCH2), 4.19 (2H, td, J 6.7, 0.7 Hz, CH2O), 4.96-5.07 (2H, m, CH2=CH), 5.80 
(1H, ddt, J 17.0, 10.3, 6.7 Hz, CH2=CH), 8.07 (1H, s, CHO); 
13
C NMR (CDCl3, 100 
MHz) δ 15.3 (CH2CH2CH2O), 27.9 (CH2CH2O), 33.2 (CH2=CHCH2), 63.9 (CH2O), 
114.9 (CH2=CH), 138.2 (CH2=CH), 161.1 (CHO); m/z (CI) 129 (MH
+
, 100%); HRMS 
found 129.0912, C7H13O2 (MH
+
) requires 129.0916.  
 
Ethyl 6-iodohexanoate 
 
The crude material was obtained using Method A.   Purification 
by flash chromatography (SiO2, petrolpetrol/EtOAc 49:1) 
afforded the iodide as a colourless oil: υmax/cm
1
 (neat) 2935, 2864, 1730; 
1
H NMR 
(CDCl3, 400 MHz) δ 1.27 (3H, t, J 7.1 Hz, CH3), 1.41-1.48 (2H, m, CH2CH2CH2I), 
1.62-1.69 (2H, m, C=OCH2CH2), 1.85 (2H, quin, J 7.3 Hz, CH2CH2I), 2.32 (2H, t, J 7.6 
Hz, C=OCH2), 3.20 (2H, t, J 7.0 Hz, CH2I), 4.14 (2H, q, J 7.1 Hz, CH3CH2);  
13
C NMR 
(CDCl3, 125 MHz) δ 6.6 (CH2I), 14.3 (CH3), 23.9 (C=OCH2CH2), 30.0 (CH2CH2CH2I), 
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33.2 (CH2CH2I), 34.1 (C=OCH2), 60.4 (CH3CH2), 173.5 (C=O); m/z (CI) 271 (MH
+
, 
37%), 243 (22), 225 (18), 143 (73), 131 (100); HRMS found 271.0197, C8H16O2I 
(MH
+
) requires 271.0195. 
 
Ethyl 6-(formyloxy)hexanoate 
 
The crude material was obtained using Method A.   
Purification by flash chromatography (SiO2, petrol/EtOAc 
97:3) afforded the formate as a yellow oil: υmax/cm
1
 (DCM cast) 2937, 2869, 1722; 
1
H 
NMR (CDCl3, 400 MHz) δ 1.26 (3H, t, J 7.2 Hz, CH3), 1.38-1.46 (2H, m, 
C=OCH2CH2CH2), 1.61-1.72 (4H, m, C=OCH2CH2 and CH2CH2OCHO), 2.32 (2H, t, J 
7.4 Hz, C=OCH2), 4.14 (2H, q, J 7.2 Hz, CH3CH2), 4.18 (2H, t, J 6.7 Hz, CH2OCHO), 
8.07 (1H, s, CHO); 
13
C NMR (CDCl3, 125 MHz) δ 14.3 (CH3), 24.6 (C=OCH2CH2), 
25.5 (C=OCH2CH2CH2), 28.3 (CH2CH2OCHO), 34.2 (C=OCH2), 60.4 (CH3CH2), 63.8 
(CH2OCHO), 161.2 (CHO), 173.6 (OC=OCH2); m/z (CI) 189 (MH
+
, 49%), 144 (23), 
143 (100); HRMS found 189.1129, C9H17O4 (MH
+
) requires 189.1127. 
 
2-(2-Iodoethoxy)-tetrahydro-2H-pyran 
 
The crude material was obtained using Method A.  Purification by 
flash chromatography (SiO2, petrol) afforded the iodide as a yellow 
oil: υmax/cm
1
 (neat) 2940, 2870; 
1
H NMR (CDCl3, 400 MHz) δ 1.51-
1.67 (4H, m, C
2
HH, C
4
HH and C
3
H2), 1.73 (1H, m, C
4
HH), 1.84 (1H, m, C
2
HH), 3.30 
(2H, m, C
7
H2I), 3.47-3.57 (1H, m, C
1
HH), 3.73 (1H, dt, J 11.1, 6.8 Hz, C
6
HH), 3.86-
3.96 (1H, m,  C
1
HH), 3.95 (1H, ddd, J 11.1, 7.2, 6.5 Hz, C
6
HH) 4.68 (1H, t, J 3.4 Hz, 
C
5
H); 
13
C NMR (CDCl3, 125 MHz) δ 3.6 (C
7
), 19.3 (C
2
), 25.3 (C
3
), 30.5 (C
4
), 62.3 
(C
1
), 68.3 (C
6
), 98.8 (C
5
); m/z (EI) 256 (M
+
, 43%), 155 (100); HRMS found 255.9966, 
C7H13O2I (M
+
) requires 255.9955. 
 
2-(Tetrahydro-2H-pyran-2-yloxy)ethyl formate 
 
The crude material was obtained using Method A. Purification by 
flash chromatography (SiO2, petrol/EtOAc 19:19:1) afforded 
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the formate as a yellow oil: υmax/cm
1
 (neat) 2943, 2873, 1720; 
1
H NMR (CDCl3, 400 
MHz) δ 1.50-1.66 (4H, m, C4HH, C2H2 and C
3
HH), 1.67-1.76 (1H, m , C
4
HH), 1.70-
1.80 (1H, m, C
3
HH), 3.52 (1H, m, C
1
HH), 3.68 (1H, m, C
6
HH), 3.87 (1H, m, C
1
HH), 
3.96 (1H, m, C
6
HH), 4.30-4.42 (2H, m, C
7
H2), 4.65 (1H, m, C
5
H), 8.11 (1H, s, C
8
H); 
13
C NMR (CDCl3, 125 MHz) δ 19.3 (C
3
), 25.4 (C
4
), 30.5 (C
2
), 62.3 (C
1
), 63.2 (C
7
), 
64.9 (C
6
), 98.9 (C
5
), 161.1 (C
8
); m/z (CI) 175 (MH
+
, 100%); HRMS found 175.0976, 
(MH
+
) requires 175.0970. 
 
[(1S,2R,6R,8S,9R)-8-(Iodomethyl)-4,4,11,11-tetramethyl-3,5,7,10,12-
pentaoxatricyclo [7.3.0.0
2,6
]]dodecane  
 
The crude material was obtained using Method A.  Purification by flash 
chromatography (SiO2, petrolpetrol/EtOAc 49:1) afforded the iodide 
as a viscous yellow oil: 20][
D
 53.2 (c 0.9 in CHCl3); υmax/cm
1
 (DCM 
cast) 2988, 2935, 1067; 
1
H NMR (CDCl3, 400 MHz) δ 1.34 (3H, s), 1.36 (3H, s), 1.45 
(3H, s) and 1.55 (3H, s, CH3), 3.20 (1H, dd, J 10.1, 7.2 Hz, C
6
HHI), 3.32 (1H, dd J 
10.1, 6.9 Hz, C
6
HHI), 3.95 (1H, td, J 7.0, 1.8 Hz, C
5
H), 4.30 (1H, dd, J 5.1, 2.5 Hz, 
C
2
H), 4.41 (1H, dd, J 7.9, 1.8 Hz, C
4
H), 4.61 (1H, dd, J 7.9, 2.5 Hz, C
3
H), 5.55 (1H, d, 
J 5.1 Hz, C
1
H); 
13
C NMR (CDCl3, 125 MHz) δ 2.4 (C
6
), 24.5, 25.0, 26.0 and 26.1 
(CH3), 69.0 (C
5
), 70.6 (C
2
), 71.2 (C
3
), 71.7 (C
4
), 96.8 (C
1
), 108.9 and 109.6 (C(CH3)2); 
m/z (CI) 371 (MH
+
, 74%), 355 (96), 313 (100); HRMS found 371.0352, C12H20IO5 
(MH
+
) requires 371.0355. 
 
[(1S,2R,6R,8R,9S)-4,4,11,11-Tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0
2,6
] 
dodecan-8- yl]methyl formate 
 
The crude material was obtained using Method A.  Purification by flash 
chromatography (SiO2, petrol/EtOAc 49:119:1) afforded the formate 
as a yellow oil: υmax/cm
1
 (DCM cast) 2989, 2937, 1722; 
1
H NMR 
(CDCl3, 400 MHz) δ 1.34 (3H, s), 1.35 (3H, s), 1.46 (3H, s) and 1.53 
(3H, s,  4  CH3), 4.02-4.08 (1H, m, C
5
H), 4.25 (1H, dd, J 7.9, 2.0 Hz, C
4
H), 4.27-4.39 
(3H, m, C
2
H and C
6
H2), 4.64 (1H, dd, J 7.9, 2.6 Hz, C
3
H), 5.55 (1H, d, J 5.1 Hz, C
1
H), 
8.10 (1H, s, CHO); 
13
C NMR (CDCl3, 100 MHz) δ 24.5, 24.9, 25.9 and 26.0 (4  CH3), 
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63.0 (C
6
), 65.8 (C
5
), 70.3 (C
2
), 70.7 (C
3
), 70.9 (C
4
), 96.2 (C
1
), 108.8 and 109.7 (2  
C(CH3)2), 106.9 (CHO); m/z (CI) 289 (MH
+
, 15%), 273 (41), 231 (100); HRMS found 
289.1281, C13H21O7 (MH
+
) requires 289.1287. 
 
2,2-Diphenylpropan-1-ol 
 
To a solution of 2,2-Diphenylpropionic acid (1.00 g, 4.42 mmol) in 
THF (20 mL) at 0 C was added LiAlH4 (0.25 g, 6.57 mmol) 
portionwise and the solution stirred at rt for 1 h.  The reaction was 
quenched slowly with H2O (20 mL) and stirred for a further 0.5 h.  Following removal 
of THF in vacuo, the organic material was extracted with MeOH/Et2O (1:19, 3  60 
mL), washed with 1 M H2SO4 (100 mL), brine (100 mL), dried (MgSO4) and solvent 
removed in vacuo to afford the alcohol (0.74 g, 79%) as a colourless oil: υmax/cm
1
 
(DCM cast) 3393 br, 3056, 3027, 2971, 2877, 1599, 1494, 1444; 
1
H NMR (CDCl3, 400 
MHz) δ 1.74 (3H, s, CH3), 4.12 (2H, s, CH2), 7.21-7.38 (10H, m, Aromatic CH); 
13
C 
NMR (CDCl3, 150 MHz) δ 25.6 (CH3), 48.8 (CCH3), 70.9 (CH2), 126.4, 127.7 and 
128.4 (Aromatic CH), 146.6 (Aromatic C); m/z (EI) 211 (MH, 7%), 195 (65), 101 
(23), 84 (82), 83 (100); HRMS found 211.1117, C15H15O (MH) requires 211.1123. 
 
2,2-Diphenylpropyl formate 
 
The crude material was obtained using Method A.  Purification by 
flash chromatography (SiO2, petrol/EtOAc 19:1) afforded the formate 
as a pale yellow oil: υmax/cm
1
 (DCM cast) 2971, 1724, 1496; 
1
H NMR 
(CDCl3, 400 MHz) δ 1.79 (3H, s, CH3), 4.69 (2H, s, CH2), 7.19-7.39 (10H, m, Aromatic 
CH); 
13
C NMR (CDCl3, 125 MHz) δ 25.6 (CH3), 46.5 (CMePh2), 70.5 (CH2), 126.5, 
127.3 and 128.3 (Aromatic CH), 145.9 (Aromatic C), 160.9 (CHO); m/z (CI) 195 
([MCO2H]
+
, 100%); HRMS found 195.1169, C15H15 ([MCO2H]
+
) requires 195.1174. 
 
1-(3-Iodobutyl)benzene  
 
The crude material was obtained using Method A.  Purification by 
flash chromatography (SiO2, hexane) afforded the iodide as a pale 
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yellow oil: υmax/cm
1
 (DCM cast) 3026, 2915, 1602, 1495, 1452; 
1
H NMR (CDCl3, 600 
MHz) δ 1.86-1.94 (1H, dddd, J 14.5, 9.0, 7.0, 4.5 Hz, CH3CHCHH), 1.97 (3H, d, J 6.8 
Hz, CH3), 2.18 (1H, dtd, J 14.5, 9.0, 5.1 Hz, CH3CHCHH), 2.72 (1H, ddd, J 13.7, 9.0, 
7.0 Hz) and 2.88 (1H, ddd, J 13.7, 9.0, 5.1 Hz, PhCH2), 4.10-4.17 (1H, dqd, J 9.0, 6.8, 
4.5 Hz, CHI), 7.21-7.26 (3H, m) and 7.29-7.34 (2H, m, Aromatic CH);  
13
C NMR 
(CDCl3, 125 MHz) δ 29.1 (CH3), 29.7 (CHI), 35.9 (PhCH2), 44.5 (CH3CHCH2), 126.2 
and 128.6 (Aromatic CH), 140.8 (Aromatic C); m/z (EI) 260 (MH
+
, 15%), 133 (50), 91 
(100); HRMS found 260.0060, C10H13I (MH
+
) requires 260.0057. 
 
4-Phenylbutan-2-yl formate 
 
The crude material was obtained using Method A.  Purification by 
flash chromatography (SiO2, hexane/EtOAc 49:1) afforded the 
formate as a colourless oil: υmax/cm
1
 (DCM cast) 2923, 2855, 1720, 
1603, 1496; 
1
H NMR (CDCl3, 400 MHz) δ 1.30 (3H, d, J 6.3 Hz, 
CH3), 1.81-1.90 (1H, m , PhCH2CHH), 1.94-2.02 (1H, m, PhCH2CHH), 2.64 (1H, m, 
PhCHH), 2.70 (1H, m, PhCHH), 5.07 (1H, m, CHCH3), 7.20 (3H, m, CH2CCH and 
CH2CCHCHCH), 7.30 (2H, m, CH2CCHCH), 8.09 (1H, s, CHC=O); 
13
C NMR (CDCl3, 
125 MHz) δ 20.1 (CH3), 31.7 (PhCH2), 37.6 (PhCH2CH2), 70.6 (CHCH3), 126.1 
(CH2CCHCHCH), 128.4 (CH2CCH), 128.5 (CH2CCHCH), 141.3 (Aromatic C), 160.9 
(CHO); m/z (EI) 132 ([MCO2H2]
+
, 35%), 117 (57), 91 (100); HRMS found 132.0935, 
C10H12 (M[CO2H2]
+
) requires 132.0939. 
 
4-(Benzyloxy)butane-1,3-diol (333)
111
 
 
To a solution of triol 331 (269 µL, 3.02 mmol) in toluene (120 mL) 
was added dibutyltin dimethoxide (757 µL, 3.30 mmol) and the 
solution distilled until the volume had halved.  After cooling the resulting solution to rt, 
benzyl bromide (395 µL, 3.32 mmol) and tetrabutyl ammonium iodide (1.66 g, 4.49 
mmol) were added successively and the solution stirred at rt for 18 h.  Purification by 
flash chromatography (SiO2, petrolpetrol/EtOAc 3:7) afforded diol 333 (340 mg, 
58%) as a yellow solid: mpt. 74-76 C [Lit.128 75-76 C]; υmax/cm
1
 (solid) 3369 br, 
2925, 2865, 1496, 1453; 
1
H NMR (CDCl3, 600 MHz) δ 1.68-1.77 (2H, m, CH2CH2OH), 
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2.46 (1H, dd, J 6.0, 4.8 Hz, CH2OH), 2.78 (1H, dd, J, 3.8, 0.4 Hz, CHOH), 3.42 (1H, 
dd, J 9.4, 7.6 Hz) and 3.53 (1H, dd, J 9.4, 3.5 Hz, BnOCH2), 3.83-3.87 (2H, m, 
CH2OH), 4.07-4.11 (1H, dddd, J 8.6, 7.6, 6.8, 3.5 Hz, CHOH), 4.58 (2H, s, PhCH2), 
7.31-7.39 (Aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ); 34.8 (CH2CH2OH), 61.1 
(CH2OH), 70.4 (CHOH), 73.4 (PhCH2), 74.3 (BnOCH2), 127.8, 127.9 and 128.5 
(Aromatic CH), 137.8 (Aromatic C); m/z (CI) 197 (MH
+
, 7%), 181 (6), 119 (10), 92 
(17), 91 (24), 83 (100); HRMS found 197.1181, C11H17O3 (MH
+
) requires 197.1178. 
 
1-(Benzyloxy)-4-(tert-butyldimethylsilyloxy)butan-2-ol (334) 
 
To a solution of diol 333 (0.65 g, 3.31 mmol) and imidazole (0.25 
g, 3.67 mmol) in DCM (35 mL) at 0 C was added TBSCl (0.52 g, 
3.45 mmol) and the solution stirred at rt for 5 h.  H2O (20 mL) was added and the 
organic material extracted with DCM (3  30 mL).  The organic layers were combined, 
washed with brine (40 mL), dried (MgSO4) and concentrated in vacuo.  Purification by 
flash chromatography (SiO2, petrol/EtOAc 19:19:1) afforded silyl ether 334 (0.85 g, 
83%) as a colourless oil: υmax/cm
1
 (CDCl3 cast) 3464 br, 2928, 2857, 1471; 
1
H NMR 
(CDCl3, 600 MHz) δ 0.08 (6H, s, Si(CH3)2), 0.91 (9H, s, C(CH3)3), 1.70-1.74 (2H, m, 
CH2CH2OTBS), 3.20 (1H, s, OH), 3.44 (1H, dd, J 9.5, 6.8 Hz, BnOCHH), 3.47 (1H, 
dd, J 9.5, 4.4 Hz, BnOCHH), 3.80 (1H, dt, J 10.2, 6.0 Hz, CHHOTBS), 3.87 (1H, dt, J 
10.2, 5.5 Hz, CHHOTBS), 4.04 (1H, m, CHOH), 4.57 (1H, d, J 12.0 Hz) and 4.59 (1H, 
d, J 12.0 Hz, PhCH2), 7.29-7.32 (1H, m, Aromatic CH), 7.34-7.38 (4H, m, Aromatic 
CH);  
13
C NMR (CDCl3, 150 MHz) δ 5.5 (Si(CH3)2), 18.2 (CMe3), 25.9 (C(CH3)3), 
35.4 (CH2CH2OTBS), 61.5 (CH2OTBS), 69.8 (CHOH), 73.4 (PhCH2), 74.4 (BnOCH2), 
127.7, 127.8 and 128.4 (Aromatic CH), 138.2 (Aromatic C); m/z (ES
+
) 333 (MNa
+
, 
100%); HRMS found 333.1859, C17H30O3NaSi (MNa
+
) requires 333.1862.      
 
(4-(Benzyloxy)-3-iodobutoxy)(tert-butyl)dimethylsilane 
 
The crude material was obtained using Method A.   Purification by 
flash chromatography (SiO2, petrol) afforded the iodide as a 
colourless oil: υmax/cm
1
 (DCM cast) 2953, 2928, 2856; 
1
H NMR (CDCl3, 600 MHz) δ 
0.06 (3H, s) and 0.09 (3H, s, Si(CH3)2), 0.91 (9H, s, C(CH3)3), 1.95 (1H, ddt, J 14.6, 
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9.9, 4.5 Hz) and 2.07 (1H, dddd, J 14.6, 8.6, 5.8, 3.9 Hz, CH2CH2OTBS), 3.72 (1H, 
ddd, J 10.3, 8.6, 4.7 Hz, CHHOTBS), 3.73 (1H, dd, J 10.5, 6.5 Hz, BnOCHH), 3.78 
(1H, dd, J 10.5, 6.0 Hz, BnOCHH), 3.81 (1H, ddd, J 10.3, 5.8, 4.3 Hz, CHHOTBS), 
4.41 (1H, dtd, J 9.9, 6.2, 3.9 Hz, CHI), 4.61 (2H, s, CH2Ph), 7.30-7.39 (5H, m, 
Aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ 5.2 (Si(CH3)2), 18.4 (CMe3), 26.0 
(C(CH3)3), 30.5 (CHI), 39.4 (CH2CH2OTBS), 62.2 (CH2OTBS), 72.9 (CH2Ph), 75.9 
(BnOCH2), 127.7, 127.8 and 128.5 (Aromatic CH), 137.9 (Aromatic C); m/z (CI) 421 
(MH
+
, 6%), 313 (24), 187 (19), 145 (100); HRMS found 421.1066, C17H30IO2Si (MH
+
) 
requires 421.1060. 
 
1-(Benzyloxy)-4-(tert-butyldimethylsilyloxy)butan-2-yl formate 
 
The crude material was obtained using Method A.  Purification by 
flash chromatography (SiO2, petrol/EtOAc 19:1) afforded the 
formate as a pale yellow oil: υmax/cm
1
 (DCM cast) 2954, 2928, 
2857, 1724; 
1
H NMR (CDCl3, 600 MHz) δ 0.89 (6H, s, Si(CH3)2), 0.90 (9H, s, 
C(CH3)3), 1.84-1.90 (2H, m, CH2CH2OTBS), 3.58 (1H, dd, J 10.8, 6.2, Hz) and 3.64 
(1H, dd, J 10.8, 3.4 Hz, BnOCHH), 3.65-3.70 (2H, m, CH2OTBS), 4.53 (1H, d, J 12.0 
Hz) and 4.60 (1H, d, J 12.0 Hz, CH2Ph), 5.28 (1H, m, CHOCHO), 7.29-7.39 (5H, m, 
Aromatic CH), 8.13 (1H, s, CHO); 
13
C NMR (CDCl3, 150 MHz) δ 5.5 (Si(CH3)2), 
18.2 (CMe3), 25.9 (C(CH3)3), 33.7 (CH2CH2OTBS), 58.8 (CH2OTBS), 70.7 
(CHOCHO), 71.2 (BnOCH2), 73.2 (CH2Ph), 127.7, 127.8 and 128.4 (Aromatic CH), 
137.8 (Aromatic C), 161.0 (CHO); m/z (CI) 339 (MH
+
, 5%), 231 (26), 187 (17), 145 
(100); HRMS found 339.1983, C18H31O4Si (MH
+
) requires 339.1992. 
 
1,4-Bis(tert-butyldimethylsilyloxy)butan-2-ol (332) 
 
To a solution of triol 331 (0.42 mL, 4.71 mmol) and imidazole 
(706 mg, 10.4 mmol) in DCM (45 mL) at 0 C was added 
TBSCl (1.49 g, 9.89 mmol) and solution stirred for 18 h at rt.  H2O (30 mL) was added 
and the organic material extracted with DCM (3  40 mL), washed with brine (30 mL), 
dried (MgSO4) and solvent removed in vacuo.  Purification by flash chromatography 
(SiO2, petrolpetrol/EtOAc 19:1) afforded alcohol 332 (0.96 g, 61%) as a colourless 
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oil: υmax/cm
1
 (neat) 3471 br, 2954, 2929, 2858; 
1
H NMR (CDCl3, 400 MHz) δ 0.10 
(12H, s, 2  Si(CH3)2), 0.91 (18H, s, 2  C(CH3)3), 1.64-1.72 (2H, m, CH2CH2OTBS), 
3.01 (1H, d, J 3.0 Hz, OH), 3.53 (1H, dd, J 9.9, 6.4 Hz) and 3.61 (1H, dd, J 9.9, 5.0 Hz, 
TBSOCH2CH), 3.79-3.87 (3H, m, CH2CH2OTBS and CHOH); 
13
C NMR (CDCl3, 150 
MHz) δ -5.5 and -5.4 (2  Si(CH3)2), 18.2 and 18.3 (2  CMe3), 25.9 (C(CH3)3), 35.4 
(CH2CH2OTBS), 61.2 (CH2CH2OTBS), 67.2 (TBSOCH2CH), 70.9 (CHOH); m/z (ES

) 
333 ([MH]+, 100%); HRMS found 333.2278, C16H37O3Si2 ([MH]
+
) requires 
333.2281.        
 
1,4-Bis(tert-butyldimethylsilyloxy)-2-iodobutane 
 
The crude material was obtained using Method A.   Purification 
by flash chromatography (Al2O3, petrol) afforded the iodide as a 
colourless oil: υmax/cm
1
 (CDCl3 cast) 2954, 2929, 2857; 
1
H NMR (CDCl3, 600 MHz) δ 
0.08 (3H, s), 0.08 (3H, s), 0.09 (3H, s) and 0.10 (3H, s, 2  Si(CH3)2), 0.91 (9H, s) and 
0.92 (9H, s, 2  C(CH3)3), 1.87 (1H, dddd, J 14.6, 10.2, 4.9, 4.1 Hz) and 2.10 (1H, 
dddd, J 14.6, 8.6, 6.0, 3.6 Hz, CHICH2CH2OTBS), 3.71 (1H, ddd, J 10.3, 8.6, 4.9 Hz, 
CHICH2CHHOTBS), 3.80 (1H, dd, J 10.8, 7.3 Hz, CHICHHOTBS), 3.82 (1H, ddd, J 
10.3, 6.0, 4.1 Hz, CHICH2CHHOTBS), 3.91 (1H, dd, J 10.8, 5.4 Hz, CHICHHOTBS), 
4.26 (1H, dddd, J 10.2, 7.3, 5.4, 3.6 Hz, CHI); 
13
C NMR (CDCl3, 150 MHz) δ 5.3, 
5.3 and 5.2 (2  Si(CH3)2), 18.3 and 18.3 (2  CMe3), 25.9 and 25.9 (2  C(CH3)3), 
34.5 (CHI), 39.0 (CHICH2CH2OTBS), 62.4 (CHICH2CH2OTBS), 69.2 
(CHICH2OTBS); m/z (CI) 445 (MH
+
, 100%), 313 (20); HRMS found 445.1452, 
C16H38IO2Si2 (MH
+
) requires 445.1450. 
 
5-(2,2-Dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyl-tetrahydrofuro[2,3-d][1,3]dioxol-
6-yl formate 
 
The crude material was obtained using Method A.  Purification by 
flash chromatography (SiO2, petrolpetrol/EtOAc 17:3) afforded 
the formate as a colourless oil: υmax/cm
1
 (DCM cast) 2988, 2938, 
1729; 
1
H NMR (CDCl3, 400 MHz) δ 1.33 (6H, s), 1.43 (3H, s) and 1.54 (3H, s, CH3), 
4.04 (1H, dd, J 8.6, 4.0 Hz) and 4.11 (1H, dd, J 8.6, 5.4 Hz, C
6
H2), 4.18-4.28 (2H, m, 
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C
4
H and C
5
H), 4.55 (1H, d, J 3.7 Hz, C
2
H), 5.36 (1H, d, J 2.3 Hz, C
3
H), 5.90 (1H, d, J 
3.7 Hz, C
1
H), 8.15 (1H, s, C
7
H); 
13
C NMR (CDCl3, 125 MHz) δ 25.3, 26.3, 26.8 and 
27.1 (CH3), 67.5 (C
6
), 72.4 (C
4
), 76.0 (C
3
), 79.8 (C
5
), 83.4 (C
2
), 105.2 (one of 
C(CH3)2), 109.7 (C
1
), 112.6 (one of C(CH3)2), 159.7 (C
7
); m/z (ES
+
) 289 (MH
+
, 100%); 
HRMS found 289.1277, C13H21O7 (MH
+
) requires 289.1287.    
 
1-Iodo-3-phenoxypropan-2-ol (336) 
 
The crude material was obtained using Method A. Purification by 
flash chromatography (SiO2, petrol/EtOAc 19:19:1) afforded 
iodide 336 as a colourless oil: υmax/cm
1
 (DCM cast) 3390 br, 3038, 2926, 1598, 1597, 
1493; 
1
H NMR (CDCl3, 400 MHz) δ 2.20-2.80 (1H, br s, OH), 3.41 (1H, dd, J 10.3, 5.7 
Hz) and 3.49 (1H, dd, J 10.3, 5.3 Hz, CH2I), 4.01 (1H, qd, J 5.6, 4.5 Hz, CHOH), 4.06 
(1H, dd, J 9.4, 4.5, OCHH), 4.11 (1H, dd, J 9,4, 5.7 Hz, OCHH), 6.91-6.95 (2H, m, 
OCCH), 6.98-7.00 (1H, m, OCCHCHCH), 7.28-7.35 (2H, m, OCCHCH); 
13
C NMR 
(CDCl3, 125 MHz) δ 9.3 (CH2I), 69.7 (CHOH), 70.4 (OCH2), 114.7 (OCCH), 121.6 
(OCCHCHCH), 129.7 (OCCHCH), 158.2 (Aromatic C); m/z (EI) 278 (M
+
, 98%),  133 
(34), 107 (99), 94 (100); HRMS found 277.9788, C9H11O2I (M
+
) requires 277.9798. 
 
3-Iodo-1-phenoxypropan-2-yl formate (338) 
 
The crude material was obtained using Method A. Purification by 
flash chromatography (SiO2, petrol/EtOAc 49:119:1) afforded 
iodide 338 as a pale yellow oil: υmax/cm
1
 (DCM cast) 3041, 2927, 
1721, 1599, 1588, 1495; 
1
H NMR (CDCl3, 600 MHz) δ 3.49 (1H, dd, J 10.7, 5.5 Hz) 
and 3.57 (1H, dd, J  10.7, 6.0 Hz, CH2I), 4.17 (1H, dd, J 10.3, 4.9 Hz) and 4.26 (1H, dd, 
J 10.3, 5.0 Hz, OCH2), 5.23-5.29 (1H, m, OCH), 6.93 (2H, m, OCCH), 7.00 (1H, m, 
OCCHCHCH), 7.32 (2H, m, OCCHCH); 
13
C NMR (CDCl3, 150 MHz) δ 2.3 (CH2I), 
67.8 (OCH2), 70.7 (OCH), 114.6 (OCCH), 121.6 (OCCHCHCH), 129.6 (OCCHCH), 
158.0 (CHO), 159.8 (Aromatic C); m/z (EI) 306 (M
+
, 6%), 213 (100); HRMS found 
305.9748, C10H11O3I (M
+
) requires 305.9747. 
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1-(Allyloxy)benzene (337) 
 
The crude material was obtained using Method A. Purification by 
flash chromatography (SiO2, petrolpetrol/EtOAc 49:1) afforded 
allyl ether 337 as a colourless liquid: υmax/cm
1
 (DCM cast) 2922, 2853, 1729, 1599, 
1496; 
1
H NMR (CDCl3, 400 MHz) δ 4.55 (2H, dt, J 5.3, 1.5 Hz, OCH2), 5.27-5.31 (1H, 
m, CH=CHH), 5.40-5.46 (1H, m, CH=CHH), 6.03-6.13 (1H, m, CH=CH2), 6.91-6.98 
(3H, m, OCCH and OCCHCHCH), 7.27-7.33 (2H, m, OCCHCH); 
13
C NMR (CDCl3, 
125 MHz) δ 68.8 (OCH2), 114.8 (OCCHCHCH), 117.7 (CH=CH2), 120.9 (OCCH), 
129.5 (OCCHCH), 133.4 (CH=CH2), 158.7 (Aromatic C); m/z (EI) 134 (M
+
, 100%); 
HRMS found 134.0725, C9H10O (M
+
) requires 134.0726. 
 
1-(Benzyloxy)-4-iodobutan-2-ol (339) 
 
The crude material was obtained using Method A.   Purification by 
flash chromatography (SiO2, petrol/EtOAc 9:117:3) afforded iodide 339 as a 
colourless oil: υmax/cm
1
 (DCM cast) 3425 br, 3030, 2859, 1496, 1453; 
1
H NMR 
(CDCl3, 400 MHz) δ 1.88-2.04 (2H, m, CH2CH2I), 2.28-2.52 (1H, br s, OH), 3.30-3.35 
(2H, m, CH2I), 3.39 (1H, dd, J 9.4, 7.2 Hz, BnOCHH), 3.53 (1H, dd, J 9.4, 3.2 Hz, 
BnOCHH), 3.90-3.99 (1H, m, CH(OH)), 4.57 (2H, s, PhCH2), 7.30-7.41 (5H, m, 
Aromatic CH); 
13
C NMR (CDCl3, 125 MHz) δ 2.45 (CH2I), 37.0 (CH2CH2I), 70.4 
(CH(OH)), 73.5 (PhCH2), 73.8 (BnOCH2), 127.9, 128.0 and 128.6 (Aromatic CH), 
137.8 (Aromatic C); m/z (EI) 306 (M
+
, 17%), 199 (12), 181 (17), 92 (17), 91 (100); 
HRMS found 306.0120, C11H15O2I (M
+
) requires 306.0111. 
 
1-(Benzyloxy)-4-iodobutan-2-yl formate 
 
The crude material was obtained using Method A.  Purification by 
flash chromatography (SiO2, petrol/EtOAc 19:19:1) afforded the 
formate as a colourless oil: υmax/cm
1
 (DCM cast) 3030, 2919, 2862, 
1718; 
1
H NMR (CDCl3, 400 MHz) δ 2.15-2.34 (2H, m, CH2CH2I), 3.10-3.24 (2H, m, 
CH2I), 3.58-3.60 (2H, m, BnOCH2), 4.52 (1H, d, J 12.0 Hz, PhCHH), 4.56 (1H, d, J 
12.0 Hz, PhCHH), 5.17-5.24 (1H, m, CHOC=O), 7.29-7.40 (5H, m, Aromatic CH), 
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8.13 (1H, s, CHO); 
13
C NMR (CDCl3, 125 MHz) δ 0.1 (CH2I), 34.8 (CH2CH2I), 70.2 
(BnOCH2), 72.9 (CHOC=O), 73.4 (PhCH2), 127.8, 128.0 and 128.6 (Aromatic CH), 
137.6 (Aromatic C), 160.6 (O=CH); m/z (CI) 335 (MH
+
, 30%), 334 (33) 331 (24), 227 
(36), 181 (46), 91 (100); HRMS found 335.0135, C12H16O3I (MH
+
) requires 335.0144. 
 
1-((2,4-Diiodobutoxy)methyl)benzene 
 
The crude material was obtained using Method A.   Purification by 
flash chromatography (SiO2, petrolpetrol/EtOAc 19:1) afforded the 
diiodide as a colourless oil: υmax/cm
1
 (DCM cast) 3029, 2918, 2850; 
1
H NMR (CDCl3, 
400 MHz) δ 2.19-2.39 (2H, m, CH2CH2I), 3.24 (1H, ddd, J 9.9, 8.5, 7.1 Hz, CHHI), 
3.40 (1H, ddd, J 9.9, 7.1, 4.8 Hz, CHHI), 3.73 (1H, dd, J 10.4, 7.4 Hz, BnOCHH), 3.80 
(1H, dd, J 10.4, 5.3 Hz, BnOCHH), 4.26-4.34 (1H, m, CHI), 4.60 (2H, s, PhCH2), 7.30-
7.41 (5H, m, Aromatic CH); 
13
C NMR (CDCl3, 125 MHz) δ 5.7 (CH2I), 32.8 (CHI), 
39.8 (CH2CH2I), 73.1 (PhCH2), 75.1 (BnOCH2), 127.8, 128.0 and 128.6 (Aromatic 
CH), 137.7 (Aromatic C); m/z (EI) 416 (M
+
, 38%), 413 (35), 309 (44), 290 (35), 289 
(43), 259 (43), 181 (35), 131 (32), 91 (100); HRMS found 415.9119, C11H14OI2 (M
+
) 
requires 415.9129. 
 
(S,E)-4,5-Bis(tert-butyldimethylsilyloxy)-1-iodopent-2-ene 
 
The crude material was obtained using Method A.  Purification by 
flash chromatography (SiO2, petrol) afforded the iodide as a 
colourless oil: 21][
D
 = 17.0 (c 0.70 in CHCl3); υmax/cm
1
 (DCM cast) 2954, 2928, 2857; 
1
H NMR (CDCl3, 600 MHz) δ 0.06 (6H, s) and 0.08 (6H, s, 2  Si(CH3)2), 0.90 (9H, s) 
and 0.91 (9H, s, 2  C(CH3)3), 3.43 (1H, dd, J 10.0, 6.2 Hz) and 3.54 (1H, dd, J 10.0, 
6.3 Hz, OCH2), 3.89 (1H, dddd, J 10.6, 8.2, 1.0, 0.6 Hz) and 3.92 (1H, dddd, J 10.6, 
8.0, 1.0, 0.6 Hz, CH2I), 4.16 (1H, m, OCH),  5.74 (1H, ddt, J 15.1, 5.4, 1.0 Hz, 
ICH2CH=CH), 5.96 (1H, dtd, J 15.1, 8.1, 1.4 Hz, ICH2CH); 
13
C NMR (CDCl3, 125 
MHz) δ 4.6 and 4.5 (2  Si(CH3)2), 5.5 (CH2I), 18.4 and 18.5 (2  C(CH3)3), 26.0 
and 26.0 (2  C(CH3)3), 67.7 (TBSOCH2), 73.1 (TBSOCH), 128.4 (BrCH2CH=CH), 
134.7 (BrCH2CH=CH); m/z (EI) 399 ([M
t
Bu]
+
, 30%), 184 (24), 147 (100); HRMS 
found 399.0671, C13H28O2Si2I ([M
t
Bu]
+
) requires 399.0667. 
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(S,Z)-4-(3-Iodoprop-1-enyl)-2,2-dimethyl-1,3-dioxolane 
 
The crude material was obtained using Method A. Purification by flash 
chromatography (SiO2, petrol/EtOAc 97:3) afforded the iodide as a 
colourless oil: 20][
D
 = 163.2 (c 0.50 in CHCl3); υmax/cm
1
 (neat) 2985, 2932, 2868; 
1
H 
NMR (CDCl3, 600 MHz) δ 1.43 (3H, s) and 1.45 (3H, s, C(CH3)2), 3.60 (1H, t, J 7.9 
Hz, OCHH), 3.88 (1H, dd, J 9.8, 8.1 Hz) and 4.04 (1H, td, J 9.8, 0.9 Hz, CH2I), 4.21 
(1H, dd, J 8.3, 6.2 Hz, OCHH), 4.91 (1H, m, OCH), 5.47 (1H, dd, J 10.6, 8.3 Hz, 
ICH2CH=CH), 5.97 (1H, m, ICH2CH); 
13
C NMR (CDCl3, 150 MHz) δ 1.7 (CH2I), 
25.9 and 26.7 (C(CH3)2), 68.5 (OCH2), 71.0 (OCH), 109.6 (CMe2), 130.7 
(ICH2CH=CH), 130.9 (ICH2CH); m/z (CI) 286 (MNH4
+
, 15%), 269 (52), 228 (100), 
209 (32), 141 (21); HRMS found 269.0033, C8H14O2I (MH
+
) requires 269.0033. 
 
2-Iodooctane (341) 
 
The crude material was obtained using Method A.   Purification by 
flash chromatography (SiO2, petrol) afforded iodide 341 as a 
colourless oil: 24][
D
  (toluene) = +4.8 (c 3.7 in CHCl3), 
24][
D
  (THF) = +0.1 (c 3.7 in 
CHCl3); υmax/cm
1
 (CDCl3 cast) 2956, 2924, 2854; 
1
H NMR (CDCl3, 600 MHz) δ 0.90 
(3H, t, J 7.1 Hz, CH3CH2), 1.26-1.53(8H, m, CH3CH2CH2CH2CH2), 1.59-1.65 (1H, 
dddd, J 5.1, 9.9, 10.4, 14.3 Hz) and 1.82-1.89 (1H, dddd, J 4.7, 8.4, 9.9, 14.3 Hz, 
CH2CHI), 1.94 (3H, d, J 6.8 Hz, CH3CHI), 4.20 (1H, dqd, J 5.1, 6.8, 8.4 Hz, CHI); 
13
C 
NMR (CDCl3, 150 MHz) δ 14.1 (CH3CH2), 22.6 and 28.4 (2 of CH3CH2CH2CH2CH2), 
29.0 (CH3CHI), 29.7 (1 of CH3CH2CH2CH2CH2), 31.0 (CHI), 31.7 (1 of 
CH3CH2CH2CH2CH2), 42.9 (CH2CHI); m/z (EI) 240 (M
+
, 15%), 219 (37), 169 (28), 
155 (45), 128 (100); HRMS found 240.0376, C8H17I (M
+
) requires 240.0370. 
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Conversion of alcohols to 1-phenyltetrazol-5-yl sulphides 
 
N,N,N-Trimethylmethanethioamide tetrafluoroborate (342) 
 
To a solution of Me3O
+
BF4

 (5.73 g, 38.7 mmol) in DCM (70 mL) was 
added HCSNMe2 (3.00 mL, 35.2 mmol) and the solution stirred at rt for 
18 h.  The mixture was concentrated in vacuo to remove half of its volume and then 
transferred dropwise into Et2O (200 mL); the solution was then left in the fridge for 2 h.  
The resulting precipitate was collected by filtration under argon, washed with cold Et2O 
(2 × 30 mL) and dried in vacuo for 10 min to give salt 342 (6.25 g, 93%) as a white 
crystalline solid which was stored in a freezer under argon: mpt. 24-26 ºC; υmax/cm
1
 
(solid) 3083, 1647, 1627, 1428; 
1
H NMR (CDCl3, 600 MHz) δ 2.93 (3H, s, SCH3), 3.41 
(3H, s) and 3.73 (3H, s, N(CH3)2), 9.62 (1H, s, CH); 
13
C NMR (CDCl3, 150 MHz) δ 
17.1 (SCH3), 42.3 and 49.5 (N(CH3)2), 184.5 (C=SMe); m/z (CI) 104 ([MBF4]
+
, 
100%), 90 (26); HRMS found 104.0539, C4H10NS ([MBF4]
+
) requires 104.0534. 
 
N-Ethyl-N,N-dimethylmethanethioamide tetrafluoroborate (343) 
 
To a solution of Et3O
+
BF4

 (5.57 g, 29.3 mmol) in DCM (50 mL) was 
added HCSNMe2 (2.30 mL, 26.7 mmol) and the solution stirred at rt for 
18 h.  The mixture was concentrated in vacuo to remove half of its volume and then 
transferred dropwise into Et2O (100 mL); the solution was then left in the fridge for 2 h.  
The resulting precipitate was collected by filtration under argon, washed with cold Et2O 
(2 × 25 mL) and dried in vacuo for 10 min to give salt 343 (5.26 g, 96%) as a white 
crystalline solid which was stored in a freezer under argon: mpt. 20-21 ºC; υmax/cm
1
 
(solid) 3076, 1650, 1634, 1463; 
1
H NMR (CDCl3, 600 MHz) δ 1.51 (3H, t, J 7.5 Hz, 
CH2CH3), 3.40 (3H, s, NCH3CH3), 3.41 (2H, q, J 7.5 Hz, CH2), 3.73 (3H, s, 
NCH3CH3), 9.57 (1H, s, CH); 
13
C NMR (CDCl3, 150 MHz) δ 15.6 (CH2CH3), 30.1 
(CH2), 42.4 and 49.4 (N(CH3)2), 183.1 (C=SEt); m/z (CI) 118 ([MBF4]
+
, 100%), 90 
(48); HRMS found 118.0686, C5H12NS ([MBF4]
+
) requires 118.0691. 
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General procedure for C-S bond formation reactions – Method B 
 
To a solution of alcohol (1.0 equiv.) in toluene (0.4-0.5M substrate concentration) was 
added salt 343 (1.5 equiv.), imidazole (1.0 equiv. or 5.0 equiv. for acid sensitive 
substrates) and thiol (2.0 equiv. or 1.2 equiv. for allylic and benzylic alcohols) and the 
mixture heated to 90 °C.  Upon completion (reaction monitored by TLC or 
1
H NMR 
analysis), the solvent was removed in vacuo to give the crude product.  Purification by 
flash chromatography (as described) afforded pure products. 
 
For yields and reaction times, please refer to Table 9, section 4.2.1.2 
 
 
Ethyl 6-(1-phenyl-1H-tetrazol-5-ylthio)hexanoate (346) 
 
The crude material was obtained using Method B.  
Purification by flash chromatography (Al2O3, petrol/EtOAc 
19:19:1) gave sulfide 346 as a yellow oil: υmax/cm
1
 (CDCl3 cast) 2980, 2937, 2865, 
1729, 1597, 1500; 
1
H NMR (CDCl3, 600 MHz) δ 1.24 (3H, t, J 7.3 Hz, CH3), 1.48 (2H, 
app. quin, J 7.5 Hz, CH2CH2CH2S), 1.67 (2H, app. quin, J 7.5 Hz, CH2CH2C=O), 1.85 
(2H, app. quin, J 7.5 Hz, CH2CH2S), 2.30 (2H, t, J 7.5 Hz, CH2C=O), 3.39 (2H, t, J 7.4 
Hz, CH2S), 4.11 (2H, q, J 7.3 Hz, CH2CH3), 7.51-7.59 (5H, m, Aromatic CH); 
13
C 
NMR (CDCl3, 150 MHz) δ 14.4 (CH3), 24.4 (CH2CH2C=O), 28.2 (CH2CH2CH2S), 28.9 
(CH2CH2S), 33.2 (CH2S), 34.2 (CH2C=O), 60.4 (CH2CH3), 124.0, 129.9 and 130.2 
(Aromatic CH), 133.8 (Aromatic C), 154.5 (NCS), 173.6 (C=O); m/z (CI) 321 (MH
+
, 
100%), 275 (41), 119 (55); HRMS found 321.1379, C15H21N4O2S (MH
+
) requires 
321.1385. 
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Ethyl 6-(formyloxy)hexanoate 
 
The crude material was obtained using Method B.  
Purification by flash chromatography (Al2O3, 
petrolpetrol/EtOAc 19:1) gave the formate as a colourless oil: υmax/cm
1
 (DCM cast) 
2931, 2869, 1730, 1597; 
1
H NMR (CDCl3, 600 MHz) δ 1.24 (3H, t, J 7.1 Hz, CH3), 
1.36-1.42 (2H, m, CH2CH2CH2O), 1.61-1.70 (4H, m, CH2CH2O and CH2CH2C=O), 
2.30 (2H, t, J 7.4 Hz, CH2C=O), 4.11 (2H, q, J 7.1 Hz, CH2CH3), 4.15 (2H, t, J 6.7 Hz, 
CH2O), 8.04 (1H, s, CHO); 
13
C NMR (CDCl3, 150 MHz) δ 14.3 (CH3), 24.6 
(CH2CH2C=O), 25.5 (CH2CH2CH2O), 28.3 (CH2CH2O), 34.2 (CH2C=O), 60.4 
(CH2CH3), 63.8 (CH2O), 161.3 (CHO), 173.6 (C=O); m/z (CI) 189 (MH
+
, 8%), 143 
(100); HRMS found 189.1119, C9H17O4 (MH
+
) requires 189.1127. 
 
1-Phenyl-5-(2-(tetrahydro-2H-pyran-2-yloxy)ethylthio)-1H-tetrazole (349) 
 
The crude material was obtained using Method B.  Purification 
by flash chromatography (Al2O3, petrol/EtOAc 9:14:1) gave 
sulfide 349 as a colourless oil: υmax/cm
1
 (CDCl3 cast) 2942, 
2871, 1597, 1499; 
1
H NMR (CDCl3, 600 MHz) δ 1.45-1.60 (4H, m, C
2
HH, C
3
HH and 
C
4
H2), 1.65-1.72 (1H, m, C
2
HH), 1.73-1.80 (1H, m, C
3
HH), 3.49 (1H, m, C
1
HH), 3.61 
(1H, dt, J 13.6, 5.9 Hz) and 3.66 (1H, dt, J 13.6, 5.9 Hz, OCH2CH2S), 3.80-3.85 (2H, 
m, C
1
HH and OCHHCH2S), 4.08 (1H, dt, J 10.7, 5.9 Hz, OCHHCH2S), 4.63 (1H, dd, J 
4.1, 2.9 Hz, C
5
H), 7.51-7.59 (5H, m, Aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ 
19.5 (C
3
), 25.4 (C
4
), 30.5 (C
2
), 33.6 (OCH2CH2S), 62.5 (C
1
), 65.6 (OCH2CH2S), 99.1 
(C
5
), 124.0, 129.9 and 130.3 (Aromatic CH), 133.8 (Aromatic C), 154.4 (SCN); m/z 
(ES
+
) 329 (MNa
+
, 80%), 301 (31), 223 (100); HRMS found 329.1052, C14H18N4O2NaS 
(MNa
+
) requires 329.1048. 
 
1-Phenyl-5-(tetrahydro-2H-pyran-2-ylthio)-1H-tetrazole (350) 
 
The crude material was obtained using Method B.  Purification by 
flash chromatography (Al2O3, petrol  petrol/EtOAc 19:1) gave 
tetrazole 350 as a white solid: mpt. 69-71 ºC; υmax/cm
1
 (solid) 2966, 2941, 2851, 1595, 
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1498; 
1
H NMR (CDCl3, 600 MHz) δ 1.64-1.71 (1H, m, OCH2CHH), 1.73-1.83 (2H, m, 
SCHCH2CHH and OCH2CHH), 2.04 (1H, m, SCHCHH), 2.11-2.20 (1H, m, 
SCHCH2CHH), 2.36 (1H, dddd, J 13.1 11.8, 10.1, 4.2 Hz, SCHCHH), 3.80 (1H, td, J 
11.5, 2.7 Hz) and 4.16 (1H, m, OCH2), 5.98 (1H, dd, J 10.1, 2.8 Hz, OCHS), 7.48-7.57 
(3H, m) and 7.90-7.93 (2H, m, Aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ 22.3 
(SCHCH2CH2), 24.8 (OCH2CH2), 29.1 (SCHCH2), 68.5 (OCH2), 83.5 (OCHS), 124.2, 
129.4 and 129.8 (Aromatic CH), 134.6 (Aromatic C), 163.7 (SCN); m/z (CI) 263 (MH
+
, 
100%), 179 (100), 85 (23); HRMS found 263.0958, C12H15ON4S (MH
+
) requires 
263.0967. 
 
5-(Hex-5-enylthio)-1-phenyl-1H-tetrazole 
 
The crude material was obtained using Method B.  Purification 
by flash chromatography (Al2O3, petrolpetrol/EtOAc 19:1) gave the sulfide as a 
colourless oil: υmax/cm
1
 (DCM cast) 3071, 2927, 2856, 2640, 1597, 1499; 
1
H NMR 
(CDCl3, 600 MHz) δ 1.54 (2H, app. quin, J 7.4 Hz, CH2CH2CH=CH2), 1.83 (2H, app. 
quin, J 7.4 Hz, CH2CH2S), 2.08 (2H, q, J 7.0 Hz, CH2CH=CH2), 3.39 (2H, t, J 7.4 Hz, 
CH2S), 4.95 (1H, d, J 10.0 Hz) and 5.00 (1H, d, J 17.1 Hz, CH2=CH), 5.77 (1H, ddd, J 
17.1, 10.0, 7.0 Hz, CH2=CH), 7.50-7.59 (5H, m, Aromatic CH); 
13
C NMR (CDCl3, 150 
MHz) δ 27.9 (CH2CH2CH=CH2), 28.6 (CH2CH2S), 33.2 (CH2S), 33.3 (CH2CH=CH2), 
115.2 (CH2=CH), 123.9, 130.0 and 130.2 (Aromatic CH), 133.8 (Aromatic C), 138.1 
(CH2=CH), 154.6 (NCS); m/z (CI) 261 (MH
+
, 100%), 207 (28); HRMS found 
261.1165, C13H17N4S (MH
+
) requires 261.1174. 
 
tert-Butyl 3-(1-phenyl-1H-tetrazol-5-ylthio)propylcarbamate 
 
The crude material was obtained using Method B.  
Purification by flash chromatography (Al2O3, petrol/EtOAc 
9:117:3) gave the sulfide as a cloudy yellow oil: υmax/cm
1
 (CDCl3 cast) 3342 br, 
2978, 2929, 1696, 1597, 1500; 
1
H NMR (CDCl3, 600 MHz) δ 1.43 (9H, s, C(CH3)3), 
2.00-2.07 (2H, m, NCH2CH2), 3.22-3.30 (2H, m, CH2N), 3.40-3.45 (2H, td, J 6.9, 2.0 
Hz, CH2S), 4.81-5.00 (1H, br s, NH), 7.51-7.60 (5H, m, Aromatic CH); 
13
C NMR 
(CDCl3, 150 MHz) δ 28.5 (C(CH3)3), 29.8 (NCH2CH2), 30.6 (CH2S), 38.9 (CH2N), 
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79.5 (CMe3), 124.0, 129.9 and 130.3 (Aromatic CH), 133,7 (Aromatic C), 154.5 
(SCN), 156.2 (C=O); m/z (EI) 335 (M
+
, 8%), 279 (100); HRMS found 335.1420, 
C15H21N5O2S (M
+
) requires 335.1416. 
 
1-Phenyl-5-(4-phenylbutan-2-ylthio)-1H-tetrazole 
 
The crude material was obtained using Method B.  Purification by 
flash chromatography (SiO2, petrol  petrol/EtOAc 24:1) gave 
the sulfide as a colourless oil: υmax/cm
1
 (CDCl3 cast) 3063, 3027, 
2926, 2859, 1597, 1499, 1455, 1387; 
1
H NMR (CDCl3, 600 MHz) δ 1.56 (3H, d, J 6.8 
Hz, CH3), 2.02 (1H, ddt, J 13.7, 9.5, 6.8 Hz) and 2.14 (1H, ddt, J 13.7, 9.5, 6.8 Hz, 
SCHCH2), 2.72-2.83 (2H, m, PhCH2), 4.07 (1H, sext., J 6.8 Hz, SCH), 7.15-7.21 (3H, 
m), 7.25-7.30 (2H, m) and 7.51-7.60 (5H, m, Aromatic CH); 
13
C NMR (CDCl3, 150 
MHz) δ 21.6 (CH3), 33.3 (PhCH2), 38.3 (SCHCH2), 44.5 (SCH), 124.2, 126.3, 128.5, 
128.6, 129.9 and 130.2 (Aromatic CH), 133.8 and 141.0 (Aromatic C), 154.0 (SCN); 
m/z (CI) 311 (MH
+
, 100%), 119 (58); HRMS found 311.1327, C17H19N4S (MH
+
) 
requires 311.1330. 
 
5-(3-Methylbut-3-enylthio)-1-phenyl-1H-tetrazole 
 
The crude material was obtained using Method B.  Purification by 
flash chromatography (SiO2, petrol  petrol/EtOAc 24:1) gave 
the sulfide as a pale yellow oil: υmax/cm
1
 (CDCl3 cast) 3078, 2970, 2937, 1649, 1597, 
1499; 
1
H NMR (CDCl3, 600 MHz) δ 1.77 (3H, s, CH3), 2.53 (2H, t, J 7.5 Hz, 
CH2CH2S), 3.53 (2H, t, J 7.3 Hz, CH2CH2S), 4.77 (1H, s) and 4.83 (1H, s, CH2=C), 
7.51-7.59 (5H, m, Aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ 22.2 (CH3), 31.5 
(CH2CH2S), 37.0 (CH2CH2S), 112.6 (CH2=C), 124.0, 129.9 and 130.2 (Aromatic CH), 
133.8 (Aromatic C), 142.6 (CH2=C), 154.5 (SCN); m/z (EI) 246 (M
+
, 40%), 159 (45), 
135 (32), 85 (100); HRMS found 246.0935, C12H14N4S (M
+
) requires 246.0939. 
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3-(Phenyl(2-(1-phenyl-1H-tetrazol-5-ylthio)ethyl)amino)propanenitrile 
 
The crude material was obtained using Method B; in addition, an 
extra 1.0 equiv. imidazole (2.0 equiv. in total) was added to 
ensure reaction completion.  Purification by flash chromatography (SiO2, petrol/EtOAc 
17:31:4) gave the sulfide as a thick colourless oil: υmax/cm
1
 (neat) 3063, 2932, 2248, 
1693, 1597, 1499; 
1
H NMR (CDCl3, 600 MHz) δ 2.65 (2H, t, J 6.8 Hz, CNCH2), 3.53 
(2H, t, J 7.2 Hz, SCH2), 3.77 (2H, t, J 6.8 Hz, CNCH2CH2), 3.89 (2H, t, J 7.2 Hz, 
SCH2CH2), 6.80-6.84 (3H, m), 7.27-7.32 (2H, m) and 7.53-7.60 (5H, m, Aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ 16.3 (CNCH2), 30.1 (SCH2), 47.6 (CNCH2CH2), 50.9 
(SCH2CH2), 113.2 (Aromatic CH), 118.4 (CN), 118.7, 123.9, 130.0, 130.0 and 130.4 
(Aromatic CH), 133.6 (SCNC), 145.7 (CH2NC), 154.0 (SCN), ; m/z (ES
+
) 373 (MNa
+
, 
100%); HRMS found 373.1211, C18H18N6NaS (MNa
+
) requires 373.1211. 
 
5-(1-Phenyl-1H-tetrazol-5-ylthio)pentan-1-ol (353) 
 
The crude material was obtained using Method B.  
Purification by flash chromatography (SiO2, petrol/EtOAc 7:31:1) gave sulfide 353 as 
a colourless oil: υmax/cm
1
 (CDCl3 cast) 3414 br, 2941, 2865, 1597, 1500; 
1
H NMR 
(CDCl3, 600 MHz) δ 1.50-1.58 (2H, m, CH2CH2CH2O), 1.59-1.65 (2H, m, CH2CH2O), 
1.84-1.91 (2H, quin., J 7.3 Hz, CH2CH2S), 3.40 (2H, t, J 7.3 Hz, CH2S), 3.66 (2H, t, J 
6.3 Hz, CH2O), 7.51-7.60 (5H, m, Aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ 25.0 
(CH2CH2CH2O), 29.0 (CH2CH2S), 32.1 (CH2CH2O), 33.3 (CH2S), 62.7 (CH2O), 124.0, 
129.9 and 130.0 (Aromatic CH), 133.8 (Aromatic C), 154.5 (SCN); m/z (CI) 265 (MH
+
, 
100%); HRMS found 265.1114, C12H17ON4S (MH
+
) requires 265.1123. 
 
5-(Isobutylthio)-1-phenyl-1H-tetrazole 
 
The crude material was obtained using Method B.  Purification by 
flash chromatography (SiO2, petrol  petrol/Et2O 19:1) gave the 
sulfide as a colourless oil: υmax/cm
1
 (neat) 2960, 2929, 2871, 1597, 1499; 
1
H NMR 
(CDCl3, 600 MHz) δ 1.05 (6H, d, J 6.8 Hz, CH(CH3)2), 2.10 (1H, non, J 6.8 Hz, 
CH(CH3)2), 3.31 (2H, d, J 6.8 Hz, CH2), 7.52-7.60 (5H, m, aromatic CH); 
13
C NMR 
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(CDCl3, 150 MHz) δ 21.8 (CH(CH3)2), 28.4 (CHMe2), 41.9 (CH2), 124.0, 129.9 and 
130.2 (aromatic CH), 133.9 (aromatic C), 154.8 (SCN); m/z (CI) 235 (MH
+
, 100%); 
HRMS found 235.1022, C11H15N4S (MH
+
) requires 235.1017. 
 
5-{[(4-Methylphenyl)methyl]sulfanyl}-1-phenyl-1H-1,2,3,4-tetrazole 
 
The crude material was obtained using Method B.  Purification 
by flash chromatography (SiO2, petrol  petrol/EtOAc 19:1) 
gave the sulfide as a thick pale yellow oil: υmax/cm
1
 (CDCl3 
cast) 3043, 2922, 1597, 1515, 1499; 
1
H NMR (CDCl3, 600 MHz) δ 2.33 (3H, s, CH3), 
4.60 (2H, s, CH2), 7.13 (2H, d, J 7.9 Hz, CH3CCH), 7.31 (2H, d, J 7.9 Hz, SCH2CCH), 
7.50-7.54 (5H, m, aromatic CH); 
13
C NMR (CDCl3, 150 MHz) δ 21.3 (CH3), 37.6 
(CH2), 123.9, 129.3, 129.6, 129.9 and 130.2 (aromatic CH), 132.2 (SCH2C), 133.7 
(NCCH), 138.2 (CH3C), 154.1 (SCN); m/z (EI) 282 (M
+
, 30%), 221 (22), 137 (21), 118 
(19), 105 (100); HRMS found 282.0927, C15H14N4S (M
+
) requires 282.0934. 
 
(E)-5-(Cinnamylthio)-1-phenyl-1H-tetrazole 
 
The crude material was obtained using Method B.  
Purification by flash chromatography (SiO2, petrol  
petrol/EtOAc 19:1) gave the sulfide as a thick pale yellow oil: υmax/cm
1
 (CDCl3 cast) 
3060, 3027, 1597, 1499; 
1
H NMR (CDCl3, 600 MHz) δ 4.21 (2H, dd, J 7.5, 1.1 Hz, 
SCH2), 6.36 (1H, dt, J 15.7, 7.5 Hz, SCH2CH), 6.71 (1H, d, J 15.7 Hz, PhCH), 7.22-
7.26 (1H, m), 7.28-7.32 (2H, m), 7.34-7.37 (2H, m) and 7.51-7.60 (5H, m, aromatic 
CH); 
13
C NMR (CDCl3, 150 MHz) δ 36.0 (CH2), 122.5 (SCH2CH), 124.0, 126.7, 128.3, 
128.8, 129.9 and 130.3 (aromatic CH), 133.7 (NCCH), 135.3 (PhCH), 136.1 
(CCH=CH), 153.9 (SCN); m/z (EI) 294 (M
+
, 17%), 266 (16), 265 (16), 233 (15), 147 
(17), 118 (22), 117 (100); HRMS found 294.0925, C16H14N4S (M
+
) requires 294.0934. 
   
   
174 
 
7  References 
 
1 Cimino, G.; De Stefano, S.; Scognamiglio, G.; Sodano, G.; Trivellone, E. Bull. Soc. 
Chim. Belg. 1986, 95, 783. 
 
2 Cimino, G.; Spinella, A.; Trivellone, E. Tetrahedron Lett. 1989, 30, 133. 
 
3 Guo, Y.; Trivellone, E.; Scognamiglio, G.; Cimino, G. Tetrahedron 1996, 52, 14961. 
 
4 Cimino, G.; Puliti, R.; Scognamiglio, G.; Spinella, A.; Trivellone, E. Pure & Appl. 
Chem. 1989, 61, 535. 
 
5 Cimino, G.; Mattia, A.; Mazzarella, L.; Puliti, R.; Scognamiglio, G.; Spinella, A.; 
Trivellone, E. Tetrahedron 1989, 45, 3863. 
 
6 Guo, Y.; Madaio, E.; Trivellone, E.; Scognamiglio, G.; Cimino, G. Tetrahedron 1996, 
52, 8341. 
 
7 Cimino, G.; Scognamiglio, G.; Spinella, A.; Trivellone, E. J. Nat. Prod. 1990, 53, 
1519. 
 
8 Caprioli, V.; Cimino, G.; De Guilio, A.; Madaio, M.; Scognamiglio, G.; Trivellone, E. 
Comp. Biochem. Physiol. 1992, 103B, 293. 
 
9 Baldwin, J. E.; Whitehead, R. C. Tetrahedron Lett. 1992, 33, 2059. 
 
10 Baldwin, J. E.; Claridge, T. D. W.; Culshaw, A. J.; Heupel, F. A.; Lee, V.; Spring, D. 
R.; Whitehead, R. C.; Boughtflower, R. J.; Mutton, I. M.; Upton, R. J. Angew. Chem. 
Int. Ed. 1998, 37, 2661. 
 
11 Gil, L.; Gateau-Olesker, A.; Marazano, C.; Das, B. C. Tetrahedron Lett. 1995, 36, 
707. 
 
12 Hourcade, S.; Ferdenzi, A.; Retailleau, P.; Mons, S.; Marazano, C. Eur. J. Org. 
Chem. 2005, 1302. 
 
13 Sisko, J.; Weinreb, S. M. J. Org. Chem. 1991, 56, 3210. 
 
14 Downham, R.; Ng, F. W.; Overman, L. E. J. Org. Chem. 1998, 63, 8096. 
 
15 Yang, R; Huang, P; Chem. Eur. J. 2010, 16, 10319. 
 
16 Becker, M. H.; Chua, P.; Downham, R.; Douglas, C. J.; Garg, N. K.; Hiebert, 
S.;Jaroch, S.; Matsuoka, R. T.; Middleton, J. A.; Ng, F. W.; Overman, L. E. J. 
Am.Chem. Soc. 2007, 129, 11987. 
 
17 Garg, N. K.; Hiebert, S.; Overman, L. E. Angew. Chem. Int. Ed. 2006, 45, 2912. 
   
   
175 
 
                                                                                                                                               
18 Douglas, C. J.; Hiebert, S.; Overman, L. E. Org. Lett. 2005, 7, 933. 
 
19 Sisko, J.; Henry, J. R.; Weinreb, S. M. J. Org. Chem. 1993, 58, 4945. 
 
20 Irie, O.; Samizu, K.; Henry, J. R.; Weinreb, S. M. J. Org. Chem. 1999, 64, 587. 
 
21 Hong, S.; Yang, J.; Weinreb, S. M. J. Org. Chem. 2006, 71, 2078. 
 
22 Denhart, D. J.; Griffith, D. A.; Heathcock, C. H. J. Org. Chem. 1998, 63, 9616. 
 
23 Grigg, R. Chem. Soc. Rev. 1987, 16, 89. 
24 Heathcock, C. H.; Clasby, M.; Griffith, D. A.; Henke, B. R.; Sharp, M. J. Synlett 
1995, 467. 
 
25 Ge, C. S.; Hourcade, S.; Ferdenzi, A.; Chiaroni, A.; Mons, S.; Delpech, B.; 
Marazano, C. Eur. J. Org. Chem. 2006, 4106. 
 
26 Sung, M. J.; Lee, H. I.; Chong, Y.; Cha, J. K. Org. Lett. 1999, 1, 2017. 
 
27 Lee, H. I.; Sung, M. J.; Lee, H. B.; Cha, J. K. Heterocycles, 2004, 62, 407. 
 
28 Mortimer, A. J. P; Pang, P. S; Aliev, A. E; Tocher, D. A; Porter, M. J. Org. Biomol. 
Chem. 2008, 6, 2941. 
 
29 Pang, P. S; University College London, 2008, PhD thesis. 
 
30 Martin Castro, A. M. Chem. Rev. 2004, 104, 2939. 
 
31 Claisen, L. Chem. Ber. 1912, 45, 3157. 
 
32 Woodward, R. B.; Hoffmann, R. Angew. Chem. Int. Ed. Engl. 1969, 8, 781. 
 
33 Dewar, M. J. S.; Healy, E. F. J. Am. Chem. Soc. 1984, 106, 7127. 
 
34 Wiest, O.; Black, K. A.; Houk, K. N. J. Am. Chem. Soc. 1994, 116, 10336. 
 
35 Davidson, M. M.; Hillier, I. H.; Vincent, M. A. Chem. Phys. Lett. 1995, 246, 536. 
 
36 Meyer, M. P.; DelMonte, A. J.; Singleton, D. A. J. Am. Chem. Soc. 1999, 121, 
10865. 
 
37 McMichael, K. D.; Korver, G. L. J. Am. Chem. Soc. 1979, 101, 2746. 
 
38 Schuler, F. W.; Murphy, G. W. J. Am. Chem. Soc. 1950, 72, 3155. 
 
39 Kwart, H.; Hackett, C. M. J. Am. Chem. Soc. 1962, 84, 1754. 
 
40 Tamaru, Y.; Harada, T.; Yoshida, Z. I. J. Am. Chem. Soc. 1980, 102, 2392. 
   
   
176 
 
                                                                                                                                               
41 Lemieux, R. M.; Meyers, A. I. J. Am. Chem. Soc. 1998, 120, 5453. 
 
42 Takano, S.; Hirama, M.; Ogasawara, K. Tetrahedron Lett. 1982, 23, 881. 
 
43 Smith, D. C.; Fuchs, P. L. J. Org. Chem. 1995, 60, 2692. 
 
44 Takase, S.; Itoh, Y.; Uchida, I.; Tanaka, H.; Aoki, H. Tetrahedron 1986, 42, 5887. 
 
45 Majumdar, K. C.; Ghosh, S.; Ghosh, M. Tetrahedron 2003, 59, 7251. 
 
46 Hoffmann, R. W. Chem. Rev. 1989, 89, 1841. 
 
47 Houk, K. N.; Moses, S. R.; Wu, Y. -D.; Rondon, N. D.; Jäger, V.; Schohe, R.; 
Fronczek, F. R. J. Am. Chem. Soc. 1984, 106, 3880.  
 
48 Houk, K. N.; Padden-Row, M. N.; Rondon, N. G.; Wu, Y. -D.; Brown, F. K.; 
Spellmeyer, D. C.; Metz, J. T.; Li, Y.; Loncharich, R. J. Science 1986, 231, 1108. 
 
49 Wu, T. -D.; Houk, K. N.; J. Am. Chem. Soc. 1987, 109, 908. 
 
50 Li, Y.; Padden-Row, M. N.; Houk, K. N.; J. Am. Chem. Soc. 1988, 110, 3684. 
 
51 Kahn, S. D.; Hehre, W. J. J. Org. Chem. 1988, 53, 301. 
 
52 Chérest, M.; Felkin, H.; Prudent, N. Tetrahedron Let. 1968, 9, 2199. 
 
53 Anh, N. T.; Eisenstein, O. Tetrahedron Lett. 1976, 155. 
 
54 Anh, N. T. Top. Curr. Chem. 1980, 88, 145. 
 
55 Nubbemeyer, U.; Őhrlein, R.; Gonda, J.; Ernst, B.; Bellus, D. Angew. Chem. Int. Ed. 
Engl. 1991, 30, 1465. 
 
56 Nubbemeyer, U.; J Org. Chem. 1996, 61, 3677. 
 
57 Nubbemeyer, U.; J Org. Chem. 1995, 60, 3773. 
 
58 Désert, S.; Metzner, P. Tetrahedron 1992, 48, 10327. 
 
59 Tadano, K.; Minami, M.; Ogawa, S. J. Org. Chem. 1990, 55, 2108. 
 
60 Craig, D.; Harvey, J. W.; O’Brien, A. G.; White, A. J. P. Chem. Commun. 2010, 46, 
6932.  
 
61 Suzuki, T.; Sato, E.; Kamada, S.; Tada, H.; Unno, K.; Kametani, T. J. Chem. Soc., 
Perkin. Trans. 1 1986, 387. 
 
62 Takano, S.; Kurotani, A.; Takahashi. M.; Ogasawara, K. J. Chem. Soc., Perkin. 
Trans. 1 1987, 91. 
   
   
177 
 
                                                                                                                                               
63 Mulzer, J.; Shaynoor, M. Tetrahedron Lett. 1993, 34, 6545. 
 
64 Cha, J. K.; Lewis, S. C. Tetrahedron Lett. 1984, 25, 5263. 
 
65 Ellwood, A. R.; Mortimer, A. J. P.; Tocher, D. A.; Porter, M. J. Synlett 2008, 14, 
2199. 
 
66 Ellwood, A. R.; Mortimer, A. J. P.; Tocher, D. A.; Porter, M. J. Synlett 2009, 18, 
3052. 
 
67 Ellwood, A. R.; Mortimer, A. J. P.; Porter, M. J. Org. Biomol. Chem. 2011, in 
preparation.  
 
68 Marshall, J. A.; Trometer, J. D.; Cleary, D. G. Tetrahedron 1989, 45, 391. 
 
69 Takano, S.; Kurotaki, A.; Takahashi, M.; Ogasawara, K. Synthesis 1986, 403. 
 
70 Borcherding, D. R.; Narayanan, S.; Hasobe, M.; McKee, J. G.; Keller, B. T.; 
Borchardt, R. T. J. Med. Chem. 1988, 31, 1729. 
 
71 Leflemme, N.; Davies, H. M. L.; Rault, S.; Tetrahedron. Lett. 2004, 45, 1503. 
 
72 McKenna, C. E.; Khawli, L. A. J. Org. Chem. 1986, 51, 5467. 
 
73 Stork, G.;. Reynolds, M. E.; J. Am. Chem. Soc. 1988, 10, 6911. 
 
74 Zhong, Y. L.; Shing, T. K. M. J. Org. Chem. 1997, 62, 2622. 
 
75 Rossi, R.; Bellina, F.; Raugei, E. Synlett 2000, 1749. 
 
76 Scott, W. J.; Stille, J. K. J. Am. Chem. Soc. 1986, 108, 3033. 
 
77 Evans, P. A.; Cuijgharpure, S. J.; Hinkle, R. J. J. Am. Chem. Soc. 2003, 125, 11456. 
 
78 Matsunaga, H.; Sakamaki, T.; Nagaoka, H.; Yamada, Y. Tetrahedron Lett. 1983, 24, 
3009. 
 
79 Häfele, B.; Jäger, V. Liebigs Ann. Chem. 1987, 85. 
 
80 Nandra, G. S. University College London, 2004, PhD Thesis. 
 
81 Doering, H. J. Am. Chem. Soc. 1958, 80, 5274. 
 
82 Lui, J.; Yang, Z.; Wang, Z.; Wang, F.; Chen, X.; Lui, X.; Feng, X.; Su, Z.; Hu, C. J 
Am. Chem. Soc. 2008, 130, 5654. 
 
83 Bull, S. D.; Davies, S. G.; Fenton, G.; Mulvaney, A. W.; Shyam Prasad, R.; Smith, 
A. D. Chem. Commun. 2000, 337. 
 
   
   
178 
 
                                                                                                                                               
84 Rassu, R.; Auzzas, L.; Pinna, L.; Zambrano, V.; Zanardi, F.; Battistini, L.; 
Marrzocchi, L.; Acquotti, D.; Casiraghi, G. J. Org. Chem. 2002, 67, 5338. 
 
85 Galemmo, R. A.; Johnson, W. H.; Learn, K. S.; Lee, T. D.; Huang, F. C.; Campbell, 
H. F.; Youssefyeh, R.; O’Rourke, S. V.; Schuessler, G. J. Med. Chem., 1990, 33, 2828. 
 
86 Dieter, R. K.; Li, S.; J. Org. Chem., 1997, 62, 7726. 
 
87 Pereira, S.; Srebnik, M. Tetrahedron Lett. 1996, 37, 3283. 
 
88 Burgess, K.; van der Donk, W. A.; Westcott, S. A.; Marder, T. B.; Baker, R. T.; 
Calabrese, J. C.; J. Am. Chem. Soc. 1992, 114, 9350. 
 
89 Van Bekkum, H.; van Rantwijk, F.; van der Putte,T.; Tetrahedron Lett. 1969, 1. 
 
90 Edwards, D. R.; Crudden, C. M.; Yam, K. Adv. Synth. Catal. 2005, 347, 50. 
91 Ellwood, A. R.; Porter, M. J. J. Org. Chem. 2009, 74, 20, 7982. 
 
92 Castro, B. R. Organic Reactions 1983, 29, 1. 
 
93 Garegg, P. J.; Samuelsson, B. J. Chem. Soc., Chem. Commun. 1979, 978. 
 
94 Hanessian.S; Ponpipom, M. M.; Lavallee, P. Carbohydr. Res. 1972, 24, 45. 
 
95 Loibner, H.; Zbiral, E. Helv. Chim. Acta 1976, 59, 2100. 
 
96 Landauer, S. R.; Rydon, H. N. J. Chem. Soc. 1953, 2224. 
 
97 Rydon, H. N. Org. Syn. 1988, 50, 830. 
 
98 Vankar, Y. D.; Rao, C. T. Tetrahedron Lett. 1985, 26, 2717. 
 
99 Jung, M. E.; Ornstein, P. L. Tetrahedron Lett. 1977, 2659. 
 
100 Fernandez, I.; Garcia, B.; Munoz, S.; Pedro, J. R.; Delasalud, R. Synlett 1993, 489. 
 
101 Martinez, A. G.; Alvarez, R. M.; Vilar, E. T.; Fraile, A. G.; Barcina, J. O.; Hanack, 
M.; Subramanian, L. R. Tetrahedron Lett. 1987, 28, 6441. 
 
102 Olah, G. A.; Narang, S. C.; Gupta, B. G. B.; Malhotra, R. J. Org. Chem. 1979, 44, 
1247. 
 
103 Haynes, R. K.; Holden, M. Aust. J. Chem. 1982, 35, 517. 
 
104 Di Deo, M.; Marcantoni, E.; Torregiani, E.; Bartoli, G.; Bellucci, M. C.; Bosco, M.; 
Sambri, L. J. Org. Chem. 2000, 65, 2830. 
 
   
   
179 
 
                                                                                                                                               
105 Fujisaki, S.; Fujiwara, I.; Norisue, Y.; Kajigaeshi, S. Bull. Chem. Soc. Jpn. 1985, 
58, 2429. 
 
106 Hanessian.S; Plessas, N. R. Chem. Commun. 1967, 1152. 
 
107 Dods, R. F.; Roth, J. S. Tetrahedron Lett. 1969, 165. 
 
108 Hepburn, D. R.; Hudson, H. R. J. Chem. Soc., Perkin Trans. 1 1976, 754. 
 
109 Herr, M. E.; Johnson, R. A. J. Org. Chem. 1972, 37, 310. 
 
110 Boeckman, R. K.; Ganem, B. Tetrahedron Lett. 1974, 913. 
 
111 Boons, C. J.; Castle, G. H.; Clase, J. A.; Grice, P.; Ley, S. V.; Pinel, C. Synlett 
1994, 764. 
 
112 Hughes, E.D.; Juliusberger, F.; Masterman, S.;  Topley, B.; Weiss, J. J. Chem. Soc. 
1935, 1525. 
 
113 March J. March, M. B. Smith, Advanced Organic Chemistry, 5th ed., Wiley: New 
York, 2001.   
 
114 Clayden, J.; Greeves, N.; Warren, S.; Wothers, P. Organic Chemistry, Oxford 
University Press: New York, 2001. 
 
115 Ellwood, A. R.; Porter, M. J. Org. Biomol. Chem. 2011, 9, 2, 379. 
 
116 Evans, D. A.; Ripin, D. H.; Havard University, http://www2.lsdiv.harvard.edu 
/labs/evans /pdf/evans_pKa_table.pdf 
 
117 Dong, W. K.; Hwan-Jeong, J.; Seok, T. L.; Myung,-Hee, S. Angew. Chem. Int. Ed., 
2008, 47, 8404. 
 
118 Don, W. K.; Choong, E. S.; Dae, Y. C. J. Am. Chem. Soc. 2002, 124, 10278. 
 
119 Perrin, D. D.; Armarego, W. L. F. Purification of Laboratory Chemicals, Third 
ed., Pergamon Press: 1988. 
 
120 Clausen, T. K.; Scheibye, S.; Lawesson, S.-O.; Heathcock, C. H.; Sanner, M.; 
Rosen, T. Org. Synth. 1984, 62, 158. 
 
121 Boeckman, R. K.; Shao, P.; Mullins, J. J.; Minbiole, K. P.; Smith III, A. B. Org. 
Synth. 2000, 77, 141. 
 
122 Chittenden, G. J. F. Carbohydr. Res. 1980, 84, 350. 
 
123 Bukhari, M. A.; Webber, J. M.; Lehmann, J.; Randall, M. H.; Foster, A. B. J. 
Chem. Soc. 1963, 4167. 
 
   
   
180 
 
                                                                                                                                               
124 Leonard, J.; Mohialdin, S.; Swain, P. A. Synth. Commun. 1989, 19, 3529. 
 
125 Minami, N.; Ko, S. S.; Kishi, Y. J. Am. Chem. Soc, 1982, 104, 1109. 
 
126 Neto, B. A. D.; Lapis, A. A. M.; Bernd, A. B.; Russowsky, D. Tetrahedron 2009, 
65, 2484. 
  
127 Keeffe, J. R.; Jencks, W. P.; J. Am. Chem. Soc. 1983, 105, 265. 
 
128 Sax, M.; Fröhlich, R.; Schepmann, D.; Wünsch, B.; Eur. J. Org. Chem. 2008, 35, 
6015. 
